{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:07:57Z","timestamp":1794935277684,"version":"4.9.1"},"reference-count":1147,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006469","name":"Macao Science and Technology Development Fund","doi-asserted-by":"crossref","award":["0123\/2022\/A"],"award-info":[{"award-number":["0123\/2022\/A"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006469","name":"Macao Science and Technology Development Fund","doi-asserted-by":"crossref","award":["0008\/2023\/RIC"],"award-info":[{"award-number":["0008\/2023\/RIC"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006469","name":"Macao Science and Technology Development Fund","doi-asserted-by":"crossref","award":["001\/2023\/ALC"],"award-info":[{"award-number":["001\/2023\/ALC"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006469","name":"Macao Science and Technology Development Fund","doi-asserted-by":"crossref","award":["0006\/2020\/AKP"],"award-info":[{"award-number":["0006\/2020\/AKP"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006469","name":"Macao Science and Technology Development Fund","doi-asserted-by":"crossref","award":["005\/2023\/SKL"],"award-info":[{"award-number":["005\/2023\/SKL"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Outstanding Youth of the Fundamental Research Funds for the Central Universities","award":["lzujbky-2021-ey21"],"award-info":[{"award-number":["lzujbky-2021-ey21"]}]},{"name":"Shenzhen-Hong Kong-Macau S&T Program","award":["SGDX2020110309420200"],"award-info":[{"award-number":["SGDX2020110309420200"]}]},{"name":"Research Fund of University of Macau","award":["MYRG-GRG2023-00198-ICMS"],"award-info":[{"award-number":["MYRG-GRG2023-00198-ICMS"]}],"id":[{"id":"https:\/\/ror.org\/01r4q9n85","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research Fund of University of Macau","award":["SRG2022-00052-ICMS"],"award-info":[{"award-number":["SRG2022-00052-ICMS"]}],"id":[{"id":"https:\/\/ror.org\/01r4q9n85","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research Grants Committee Fund, Hong Kong","award":["17152116"],"award-info":[{"award-number":["17152116"]}]},{"name":"Research Grants Committee Fund, Hong Kong","award":["17121419"],"award-info":[{"award-number":["17121419"]}]},{"name":"Health and Medical Research Fund, Hong Kong","award":["18192141"],"award-info":[{"award-number":["18192141"]}]},{"name":"Health and Medical Research Fund, Hong Kong","award":["21222101"],"award-info":[{"award-number":["21222101"]}]},{"name":"Innovation and Technology Fund, Hong Kong","award":["PRP\/069\/22FX"],"award-info":[{"award-number":["PRP\/069\/22FX"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Herbal medicine exhibits a broad spectrum of potent anti-cancer properties, including the enhancement of tumor immune responses, reversal of multidrug resistance, regulation of autophagy and ferroptosis, as well as anti-proliferative, pro-apoptotic, and anti-metastatic effects. This review systematically explores recent advances (primarily documented since 2019) in research on key anti-cancer compounds derived from herbal medicine, such as apigenin, artemisinin, berberine, curcumin, emodin, epigallocatechin gallate (EGCG), ginsenosides, icariin, resveratrol, silibinin, triptolide, and ursolic acid (UA). These studies were sourced from scientific databases, including PubMed, Web of Science, Medline, Scopus, and Clinical Trials. The review focuses on the significant role that these natural products play in modern oncology, exploring their efficacy, mechanisms of action, and the challenges and prospects of integrating them into conventional cancer therapies. Furthermore, it highlights cutting-edge approaches in cancer research, such as the utilization of gut microbiota, omics technologies, synthetic derivatives, and advanced drug delivery systems (DDS). This review underscores the potential of these natural products to advance the development of novel anti-cancer treatments and support contemporary medicine. Additionally, recent multi-omics findings reveal how these compounds reshape transcriptional and metabolic networks, further broadening their therapeutic scope. Many natural products exhibit synergy with first-line chemotherapies or targeted therapies, thereby enhancing treatment efficacy and reducing side effects. Advanced nano-formulations and antibody\u2013drug conjugates have also substantially improved their bioavailability, making them promising candidates for future translational research.<\/jats:p>","DOI":"10.1186\/s13020-025-01124-y","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T06:25:49Z","timestamp":1749450349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Natural anti-cancer products: insights from herbal medicine"],"prefix":"10.1186","volume":"20","author":[{"given":"Dianxin","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianming","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangfeng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"issue":"3","key":"1124_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"issue":"1","key":"1124_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics. Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"Cancer J Clin"},{"issue":"6","key":"1124_CR3","first-page":"2595","volume":"15","author":"P Liao","year":"2024","unstructured":"Liao P, Yan B, Wang C, et al. Telomeres: dysfunction, maintenance, aging and cancer. Aging Dis. 2024;15(6):2595\u2013631.","journal-title":"Aging Dis"},{"issue":"2","key":"1124_CR4","first-page":"535","volume":"15","author":"P Kordowitzki","year":"2024","unstructured":"Kordowitzki P, Graczyk S, Mechsner S, et al. Shedding Light on the Interaction Between Rif1 and telomeres in ovarian cancer. Aging Dis. 2024;15(2):535\u201345.","journal-title":"Aging Dis"},{"issue":"4","key":"1124_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","author":"Cancer Genome Atlas Research N","year":"2015","unstructured":"Cancer Genome Atlas Research N. The molecular taxonomy of primary prostate cancer. Cell. 2015;163(4):1011\u201325.","journal-title":"Cell"},{"issue":"3","key":"1124_CR6","doi-asserted-by":"publisher","first-page":"840","DOI":"10.14336\/AD.2022.1010","volume":"14","author":"MF Megerian","year":"2023","unstructured":"Megerian MF, Kim JS, Badreddine J, et al. Melatonin and prostate cancer: anti-tumor roles and therapeutic application. Aging Dis. 2023;14(3):840\u201357.","journal-title":"Aging Dis"},{"issue":"7","key":"1124_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41568-024-00705-7","volume":"24","author":"AM Holder","year":"2024","unstructured":"Holder AM, Dedeilia A, Sierra-Davidson K, et al. Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours. Nat Rev Cancer. 2024;24(7):498\u2013512.","journal-title":"Nat Rev Cancer"},{"key":"1124_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclepro.2020.124657","volume":"283","author":"L Rani","year":"2021","unstructured":"Rani L, Thapa K, Kanojia N, et al. An extensive review on the consequences of chemical pesticides on human health and environment. J Clean Prod. 2021;283: 124657.","journal-title":"J Clean Prod"},{"key":"1124_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2024.108535","volume":"185","author":"X Tang","year":"2024","unstructured":"Tang X, Yang T, Yu D, et al. Current insights and future perspectives of ultraviolet radiation (UV) exposure: Friends and foes to the skin and beyond the skin. Environ Int. 2024;185: 108535.","journal-title":"Environ Int"},{"issue":"1","key":"1124_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.14336\/AD.2023.0517","volume":"15","author":"RM Pfefferkorn","year":"2024","unstructured":"Pfefferkorn RM, Mortzfeld BM, Fink C, et al. Recurrent phases of strict protein limitation inhibit tumor growth and restore lifespan in a drosophila intestinal cancer model. Aging Dis. 2024;15(1):226\u201344.","journal-title":"Aging Dis"},{"issue":"3","key":"1124_CR11","doi-asserted-by":"publisher","first-page":"992","DOI":"10.14336\/AD.2022.1021","volume":"14","author":"E Ruiz","year":"2023","unstructured":"Ruiz E, Kandil E, Alhassan S, et al. An integrative multi-omics analysis of the molecular links between aging and aggressiveness in thyroid cancers. Aging Dis. 2023;14(3):992\u20131012.","journal-title":"Aging Dis"},{"issue":"3","key":"1124_CR12","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/med.21876","volume":"42","author":"ZF Zhong","year":"2022","unstructured":"Zhong ZF, Vong CT, Chen FY, et al. Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets. Med Res Rev. 2022;42(3):1246\u201379.","journal-title":"Med Res Rev"},{"key":"1124_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155905","volume":"133","author":"J Huang","year":"2024","unstructured":"Huang J, Shi R, Chen F, et al. Exploring the anti-hepatocellular carcinoma effects of Xianglian pill: Integrating network pharmacology and RNA sequencing via in silico and in vitro studies. Phytomedicine. 2024;133: 155905.","journal-title":"Phytomedicine"},{"key":"1124_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-019-0270-9","author":"H Luo","year":"2019","unstructured":"Luo H, Vong CT, Chen H, et al. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med. 2019. https:\/\/doi.org\/10.1186\/s13020-019-0270-9.","journal-title":"Chin Med"},{"key":"1124_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1749-8546-6-27","volume":"6","author":"W Tan","year":"2011","unstructured":"Tan W, Lu J, Huang M, et al. Anti-cancer natural products isolated from Chinese medicinal herbs. Chin Med. 2011;6:27.","journal-title":"Chin Med"},{"key":"1124_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8546-6-27","author":"FF Zhou","year":"2021","unstructured":"Zhou FF, Aipire A, Xia LJ, et al. Marchantia polymorpha L. ethanol extract induces apoptosis in hepatocellular carcinoma cells via intrinsic- and endoplasmic reticulum stress-associated pathways. Chin Med. 2021. https:\/\/doi.org\/10.1186\/1749-8546-6-27.","journal-title":"Chin Med"},{"issue":"1","key":"1124_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-022-00581-z","volume":"17","author":"RYK Yuan","year":"2022","unstructured":"Yuan RYK, Fan QM, Liang XW, et al. Cucurbitacin B inhibits TGF-\u03b21-induced epithelial-mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K\/Akt\/mTOR pathways. Chin Med. 2022;17(1):1.","journal-title":"Chin Med"},{"key":"1124_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biopha.2020.110298","volume":"128","author":"XJ Dou","year":"2020","unstructured":"Dou XJ, Zhou ZQ, Ren RM, et al. Apigenin, flavonoid component isolated from Gentiana veitchiorum flower suppresses the oxidative stress through LDLR-LCAT signaling pathway. Biomed Pharmacother. 2020;128:40.","journal-title":"Biomed Pharmacother"},{"issue":"24","key":"1124_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/molecules27249055","volume":"27","author":"A Alghamdi","year":"2022","unstructured":"Alghamdi A, Almuqbil M, Alrofaidi MA, et al. Potential antioxidant activity of apigenin in the obviating stress-mediated depressive symptoms of experimental mice. Molecules. 2022;27(24):5.","journal-title":"Molecules"},{"key":"1124_CR20","first-page":"14","volume":"898","author":"SG Sherif","year":"2024","unstructured":"Sherif SG, Tarek M, Sabry YG, et al. Effect of apigenin on dynamin-related protein 1 in type 1 diabetic rats with cardiovascular complications. Gene. 2024;898:14.","journal-title":"Gene"},{"key":"1124_CR21","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.ijbiomac.2021.10.153","volume":"193","author":"S Hong","year":"2021","unstructured":"Hong S, Dia VP, Zhong QX. Synergistic anti-inflammatory activity of apigenin and curcumin co-encapsulated in caseins assessed with lipopolysaccharide-stimulated RAW 264.7 macrophages. Int J Biol Macromol. 2021;193:702\u201312.","journal-title":"Int J Biol Macromol"},{"key":"1124_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2021.05.019","volume":"515","author":"Z-B Jiang","year":"2021","unstructured":"Jiang Z-B, Wang W-J, Xu C, et al. Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer. Cancer Lett. 2021;515:36\u201348.","journal-title":"Cancer Lett"},{"key":"1124_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.btre.2022.e00730","volume":"34","author":"M Adel","year":"2022","unstructured":"Adel M, Zahmatkeshan M, Akbarzadeh A, et al. Chemotherapeutic effects of Apigenin in breast cancer: Preclinical evidence and molecular mechanisms; enhanced bioavailability by nanoparticles. Biotechnol Rep. 2022;34: e00730.","journal-title":"Biotechnol Rep"},{"issue":"5","key":"1124_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1042\/BSR20190452","volume":"39","author":"J Tong","year":"2019","unstructured":"Tong J, Shen Y, Zhang Z, et al. Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-\u03baB\/Snail signaling pathway. Biosci Rep. 2019;39(5):16.","journal-title":"Biosci Rep"},{"issue":"6","key":"1124_CR25","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.3892\/mmr.2020.11572","volume":"22","author":"J-S Woo","year":"2020","unstructured":"Woo J-S, Choo G-S, Yoo E-S, et al. Apigenin induces apoptosis by regulating Akt and MAPK pathways in human melanoma cell A375SM. Mol Med Rep. 2020;22(6):4877\u201389.","journal-title":"Mol Med Rep"},{"key":"1124_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-019-1247-3","volume":"38","author":"M-H Chien","year":"2019","unstructured":"Chien M-H, Lin Y-W, Wen Y-C, et al. Targeting the SPOCK1-snail\/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis. J Exp Clin Cancer Res. 2019;38:1\u201317.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"1124_CR27","first-page":"1","volume":"47","author":"Y Bao","year":"2022","unstructured":"Bao Y, Wu X, Jin X, et al. Apigenin inhibits renal cell carcinoma cell proliferation through G2\/M phase cell cycle arrest. Oncol Res. 2022;47(3):1\u20137.","journal-title":"Oncol Res"},{"issue":"7","key":"1124_CR28","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.3390\/cancers14071824","volume":"14","author":"Y-H Chen","year":"2022","unstructured":"Chen Y-H, Wu J-X, Yang S-F, et al. Anticancer effects and molecular mechanisms of apigenin in cervical cancer cells. Cancers. 2022;14(7):1824.","journal-title":"Cancers"},{"key":"1124_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116626","volume":"475","author":"S Heydarzadeh","year":"2023","unstructured":"Heydarzadeh S, Moshtaghie AA, Daneshpour M, et al. The effect of Apigenin on glycometabolism and cell death in an anaplastic thyroid cancer cell line. Toxicol Appl Pharmacol. 2023;475: 116626.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"1124_CR30","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1038\/cddis.2009.18","volume":"1","author":"R Ruela-de-Sousa","year":"2010","unstructured":"Ruela-de-Sousa R, Fuhler GM, Blom N, et al. Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy. Cell Death Dis. 2010;1(1):e19\u2013e19.","journal-title":"Cell Death Dis"},{"issue":"3","key":"1124_CR31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2174\/1871520622666220523151409","volume":"23","author":"J Huang","year":"2023","unstructured":"Huang J, Chen X, Chang Z, et al. Boosting anti-tumour immunity using adjuvant Apigenin. Anticancer Agents Med Chem. 2023;23(3):266\u201377.","journal-title":"Anticancer Agents Med Chem"},{"issue":"3","key":"1124_CR32","first-page":"1987","volume":"13","author":"Q Li","year":"2020","unstructured":"Li Q, Li L, Zhao X, et al. Apigenin induces apoptosis and reverses the drug resistance of ovarian cancer cells. Int J Clin Exp Med. 2020;13(3):1987\u201394.","journal-title":"Int J Clin Exp Med"},{"issue":"6","key":"1124_CR33","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1016\/j.fshw.2023.03.044","volume":"12","author":"Y Liang","year":"2023","unstructured":"Liang Y, Zhong Q, Ma R, et al. Apigenin, a natural flavonoid, promotes autophagy and ferroptosis in human endometrial carcinoma Ishikawa cells in vitro and in vivo. Food Sci Hum Wellness. 2023;12(6):2242\u201351.","journal-title":"Food Sci Hum Wellness"},{"issue":"1","key":"1124_CR34","doi-asserted-by":"publisher","first-page":"8172866","DOI":"10.1155\/2022\/8172866","volume":"2022","author":"W Wang","year":"2022","unstructured":"Wang W, Liu X, Zhang Z, et al. Apigenin induced apoptosis by downregulating Sulfiredoxin expression in cutaneous squamous cell carcinoma. Oxid Med Cell Longev. 2022;2022(1):8172866.","journal-title":"Oxid Med Cell Longev"},{"key":"1124_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43175-x","author":"S Akash","year":"2023","unstructured":"Akash S, Bayil I, Hossain MS, et al. Novel computational and drug design strategies for inhibition of human papillomavirus-associated cervical cancer and DNA polymerase theta receptor by Apigenin derivatives. Sci Rep. 2023. https:\/\/doi.org\/10.1038\/s41598-023-43175-x.","journal-title":"Sci Rep"},{"issue":"1","key":"1124_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijpharm.2012.07.002","volume":"436","author":"J Zhang","year":"2012","unstructured":"Zhang J, Liu D, Huang Y, et al. Biopharmaceutics classification and intestinal absorption study of apigenin. Int J Pharm. 2012;436(1):311\u20137.","journal-title":"Int J Pharm"},{"issue":"7","key":"1124_CR37","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.apt.2018.04.002","volume":"29","author":"MA Altamimi","year":"2018","unstructured":"Altamimi MA, Elzayat EM, Alshehri SM, et al. Utilizing spray drying technique to improve oral bioavailability of apigenin. Adv Powder Technol. 2018;29(7):1676\u201384.","journal-title":"Adv Powder Technol"},{"key":"1124_CR38","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jff.2018.07.035","volume":"48","author":"N Perez-Moral","year":"2018","unstructured":"Perez-Moral N, Saha S, Philo M, et al. Comparative bio-accessibility, bioavailability and bioequivalence of quercetin, apigenin, glucoraphanin and carotenoids from freeze-dried vegetables incorporated into a baked snack versus minimally processed vegetables: Evidence from in vitro models and a human bioavailability study. J Funct Foods. 2018;48:410\u20139.","journal-title":"J Funct Foods"},{"issue":"5","key":"1124_CR39","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3109\/03639045.2012.687378","volume":"39","author":"L Zhao","year":"2013","unstructured":"Zhao L, Zhang L, Meng L, et al. Design and evaluation of a self-microemulsifying drug delivery system for apigenin. Drug Dev Ind Pharm. 2013;39(5):662\u20139.","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"1124_CR40","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jsps.2018.11.008","volume":"27","author":"SM Alshehri","year":"2019","unstructured":"Alshehri SM, Shakeel F, Ibrahim MA, et al. Dissolution and bioavailability improvement of bioactive apigenin using solid dispersions prepared by different techniques. Saudi Pharm J. 2019;27(2):264\u201373.","journal-title":"Saudi Pharm J"},{"issue":"8","key":"1124_CR41","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.7150\/jca.34981","volume":"11","author":"S Huang","year":"2020","unstructured":"Huang S, Yu M, Shi N, et al. Apigenin and Abivertinib, a novel BTK inhibitor synergize to inhibit diffuse large B-cell lymphoma in vivo and vitro. J Cancer. 2020;11(8):2123.","journal-title":"J Cancer"},{"key":"1124_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144428","volume":"737","author":"N \u015eirin","year":"2020","unstructured":"\u015eirin N, Elmas L, Se\u00e7me M, et al. Investigation of possible effects of apigenin, sorafenib and combined applications on apoptosis and cell cycle in hepatocellular cancer cells. Gene. 2020;737: 144428.","journal-title":"Gene"},{"issue":"5","key":"1124_CR43","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/iub.2456","volume":"73","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang W, Chen F, et al. Combined effect of chrysin and apigenin on inhibiting the development and progression of colorectal cancer by suppressing the activity of P38-MAPK\/AKT pathway. IUBMB Life. 2021;73(5):774\u201383.","journal-title":"IUBMB Life"},{"issue":"4","key":"1124_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.12376","volume":"41","author":"X Zhou","year":"2017","unstructured":"Zhou X, Wang F, Zhou R, et al. Apigenin: A current review on its beneficial biological activities. J Food Biochem. 2017;41(4): e12376.","journal-title":"J Food Biochem"},{"key":"1124_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/03946320231161174","author":"K Villalobos-Ayala","year":"2020","unstructured":"Villalobos-Ayala K, Ortiz Rivera I, Alvarez C, et al. Apigenin increases SHIP-1 expression, promotes tumoricidal macrophages and anti-tumor immune responses in murine pancreatic cancer. Cancers. 2020. https:\/\/doi.org\/10.1177\/03946320231161174.","journal-title":"Cancers"},{"key":"1124_CR46","doi-asserted-by":"publisher","first-page":"039463202311611","DOI":"10.1177\/03946320231161174","volume":"37","author":"Y-B Feng","year":"2023","unstructured":"Feng Y-B, Chen L, Chen F-X, et al. Immunopotentiation effects of apigenin on NK cell proliferation and killing pancreatic cancer cells. Int J Immunopathol Pharmacol. 2023;37:03946320231161174.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"1124_CR47","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.canlet.2016.06.023","volume":"380","author":"MRP Coombs","year":"2016","unstructured":"Coombs MRP, Harrison ME, Hoskin DW. Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells. Cancer Lett. 2016;380(2):424\u201333.","journal-title":"Cancer Lett"},{"issue":"4","key":"1124_CR48","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/nu11040858","volume":"11","author":"A Ghi\u021bu","year":"2019","unstructured":"Ghi\u021bu A, Schwiebs A, Radeke HH, et al. A comprehensive assessment of apigenin as an antiproliferative, proapoptotic, antiangiogenic and immunomodulatory phytocompound. Nutrients. 2019;11(4):858.","journal-title":"Nutrients"},{"key":"1124_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-0929-6","volume":"37","author":"L Xu","year":"2018","unstructured":"Xu L, Zhang Y, Tian K, et al. Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects. J Exp Clin Cancer Res. 2018;37:1\u201315.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"1124_CR50","doi-asserted-by":"publisher","first-page":"821","DOI":"10.17576\/jsm-2021-5003-22","volume":"50","author":"A Myo","year":"2021","unstructured":"Myo A, Hasym M, Nor N, et al. Effects of apigenin, Luteolin, and Quercetin on the Natural Killer (NK-92) cells proliferation: a potential role as immunomodulator. SAINS MALAYS. 2021;50(3):821\u20138.","journal-title":"SAINS MALAYS"},{"key":"1124_CR51","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.biopha.2018.03.111","volume":"102","author":"W-J Hu","year":"2018","unstructured":"Hu W-J, Liu J, Zhong L-K, et al. Apigenin enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling. Biomed Pharmacother. 2018;102:681\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1124_CR52","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.canlet.2014.08.039","volume":"354","author":"C Boeckx","year":"2014","unstructured":"Boeckx C, Op de Beeck K, Wouters A, et al. Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP proteins. Cancer Lett. 2014;354(2):365\u201377.","journal-title":"Cancer Lett."},{"issue":"13","key":"1124_CR53","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1111\/bph.12668","volume":"171","author":"B Bhattacharya","year":"2014","unstructured":"Bhattacharya B, Low S, Soh C, et al. Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype. Br J Pharmacol. 2014;171(13):3255\u201367.","journal-title":"Br J Pharmacol"},{"key":"1124_CR54","doi-asserted-by":"publisher","first-page":"7865","DOI":"10.2147\/OTT.S176818","volume":"11","author":"T Jiang","year":"2018","unstructured":"Jiang T, Zhou M-L, Fan J. Inhibition of GLUT-1 expression and the PI3K\/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitro. Onco Targets Ther. 2018;11:7865\u201372.","journal-title":"Onco Targets Ther"},{"issue":"7","key":"1124_CR55","first-page":"3938","volume":"7","author":"YY Xu","year":"2014","unstructured":"Xu YY, Wu TT, Zhou SH, et al. Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: an in vitro study. Int J Clin Exp Pathol. 2014;7(7):3938\u201347.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"1124_CR56","first-page":"299","volume":"4","author":"GL Kelly","year":"2020","unstructured":"Kelly GL, Strasser A. Toward targeting antiapoptotic MCL-1 for cancer therapy. Annu Rev Cell Dev Biol. 2020;4(1):299\u2013313.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"2","key":"1124_CR57","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3892\/etm.2020.8880","volume":"20","author":"Y Qi","year":"2020","unstructured":"Qi Y, Ding Z, Yao Y, et al. Apigenin induces apoptosis and counteracts cisplatin-induced chemoresistance via Mcl-1 in ovarian cancer cells. Exp Ther Med. 2020;20(2):1329\u201336.","journal-title":"Exp Ther Med"},{"issue":"8","key":"1124_CR58","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/carcin\/bgt108","volume":"34","author":"AM Gao","year":"2013","unstructured":"Gao AM, Ke ZP, Wang JN, et al. Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402\/ADM cells to doxorubicin via inhibiting PI3K\/Akt\/Nrf2 pathway. Carcinogenesis. 2013;34(8):1806\u201314.","journal-title":"Carcinogenesis"},{"key":"1124_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cbi.2017.11.020","volume":"280","author":"AM Gao","year":"2018","unstructured":"Gao AM, Zhang XY, Hu JN, et al. Apigenin sensitizes hepatocellular carcinoma cells to doxorubic through regulating miR-520b\/ATG7 axis. Chem Biol Interact. 2018;280:45\u201350.","journal-title":"Chem Biol Interact"},{"issue":"2","key":"1124_CR60","first-page":"197","volume":"24","author":"A Angelini","year":"2010","unstructured":"Angelini A, Di Ilio C, Castellani ML, et al. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin-resistant sarcoma cells (MES-SA\/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. J Biol Regul Homeost Agents. 2010;24(2):197\u2013205.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"9","key":"1124_CR61","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1158\/1535-7163.MCT-13-0208","volume":"12","author":"Y Zhu","year":"2013","unstructured":"Zhu Y, Liu C, Nadiminty N, et al. Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer. Mol Cancer Ther. 2013;12(9):1829\u201336.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"1124_CR62","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3892\/or.2017.5752","volume":"38","author":"HS Seo","year":"2017","unstructured":"Seo HS, Ku JM, Choi HS, et al. Apigenin overcomes drug resistance by blocking the signal transducer and activator of transcription 3 signaling in breast cancer cells. Oncol Rep. 2017;38(2):715\u201324.","journal-title":"Oncol Rep"},{"issue":"2","key":"1124_CR63","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.bbrc.2020.03.010","volume":"526","author":"K Li","year":"2020","unstructured":"Li K, Li M, Luo Z, et al. Overcoming the hypoxia-induced drug resistance in liver tumor by the concurrent use of apigenin and paclitaxel. Biochem Biophys Res Commun. 2020;526(2):321\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1124_CR64","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jhep.2019.08.026","volume":"72","author":"Y Hazari","year":"2020","unstructured":"Hazari Y, Bravo-San Pedro JM, Hetz C, et al. Autophagy in hepatic adaptation to stress. J Hepatol. 2020;72(1):183\u201396.","journal-title":"J Hepatol"},{"issue":"3","key":"1124_CR65","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41418-019-0480-9","volume":"27","author":"Y Yang","year":"2020","unstructured":"Yang Y, Klionsky DJ. Autophagy and disease: unanswered questions. Cell Death Differ. 2020;27(3):858\u201371.","journal-title":"Cell Death Differ"},{"issue":"11","key":"1124_CR66","doi-asserted-by":"publisher","first-page":"19471","DOI":"10.1002\/jcp.28740","volume":"234","author":"M Ashrafizadeh","year":"2019","unstructured":"Ashrafizadeh M, Mohammadinejad R, Tavakol S, et al. Autophagy, anoikis, ferroptosis, necroptosis, and endoplasmic reticulum stress: potential applications in melanoma therapy. J Cell Physiol. 2019;234(11):19471\u20139.","journal-title":"J Cell Physiol"},{"issue":"5","key":"1124_CR67","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3892\/ijo.2014.2339","volume":"44","author":"Y Lee","year":"2014","unstructured":"Lee Y, Sung B, Kang YJ, et al. Apigenin-induced apoptosis is enhanced by inhibition of autophagy formation in HCT116 human colon cancer cells. Int J Oncol. 2014;44(5):1599\u2013606.","journal-title":"Int J Oncol"},{"key":"1124_CR68","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.biopha.2018.04.072","volume":"103","author":"J Yang","year":"2018","unstructured":"Yang J, Pi C, Wang G. Inhibition of PI3K\/Akt\/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells. Biomed Pharmacother. 2018;103:699\u2013707.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1124_CR69","first-page":"488","volume":"24","author":"X Chen","year":"2019","unstructured":"Chen X, Xu H, Yu X, et al. Apigenin inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant colon cancer cells by inducing autophagy, programmed cell death and targeting m-TOR\/PI3K\/Akt signalling pathway. J buon. 2019;24(2):488\u201393.","journal-title":"J buon"},{"issue":"2","key":"1124_CR70","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/jcb.21853","volume":"105","author":"KR Landis-Piwowar","year":"2008","unstructured":"Landis-Piwowar KR, Milacic V, Dou QP. Relationship between the methylation status of dietary flavonoids and their growth-inhibitory and apoptosis-inducing activities in human cancer cells. J Cell Biochem. 2008;105(2):514\u201323.","journal-title":"J Cell Biochem"},{"issue":"24","key":"1124_CR71","doi-asserted-by":"publisher","first-page":"13455","DOI":"10.3390\/ijms222413455","volume":"22","author":"TW Kim","year":"2021","unstructured":"Kim TW, Lee HG. Apigenin induces autophagy and cell death by targeting EZH2 under hypoxia conditions in gastric cancer cells. Int J Mol Sci. 2021;22(24):13455.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1124_CR72","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"key":"1124_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153371","volume":"80","author":"AN Adham","year":"2021","unstructured":"Adham AN, Abdelfatah S, Naqishbandi AM, et al. Cytotoxicity of apigenin toward multiple myeloma cell lines and suppression of iNOS and COX-2 expression in STAT1-transfected HEK293 cells. Phytomedicine. 2021;80: 153371.","journal-title":"Phytomedicine"},{"issue":"19","key":"1124_CR74","doi-asserted-by":"publisher","first-page":"10155","DOI":"10.1073\/pnas.1917946117","volume":"117","author":"C Shao","year":"2020","unstructured":"Shao C, Yuan J, Liu Y, et al. Epileptic brain fluorescent imaging reveals apigenin can relieve the myeloperoxidase-mediated oxidative stress and inhibit ferroptosis. Proc Natl Acad Sci U S A. 2020;117(19):10155\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1124_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.111719","volume":"120","author":"R Liu","year":"2021","unstructured":"Liu R, Rong G, Liu Y, et al. Delivery of apigenin-loaded magnetic Fe2O3\/Fe3O4@ mSiO2 nanocomposites to A549 cells and their antitumor mechanism. Mater Sci Eng C Mater Biol Appl. 2021;120: 111719.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"8","key":"1124_CR76","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1002\/ptr.6647","volume":"34","author":"M Imran","year":"2020","unstructured":"Imran M, Aslam Gondal T, Atif M, et al. Apigenin as an anticancer agent. Phytother Res. 2020;34(8):1812\u201328.","journal-title":"Phytother Res"},{"key":"1124_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153603","volume":"89","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Han X, Mo F, et al. Apigenin inhibits the growth of colorectal cancer through down-regulation of E2F1\/3 by miRNA-215-5p. Phytomedicine. 2021;89: 153603.","journal-title":"Phytomedicine"},{"issue":"4","key":"1124_CR78","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1158\/1535-7163.MCT-05-0370","volume":"5","author":"S Shukla","year":"2006","unstructured":"Shukla S, Gupta S. Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft. Mol Cancer Ther. 2006;5(4):843\u201352.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"1124_CR79","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1007\/s11030-022-10384-x","volume":"26","author":"A Sharma","year":"2022","unstructured":"Sharma A, Sinha S, Keswani H, et al. Kaempferol and Apigenin suppresses the stemness properties of TNBC cells by modulating Sirtuins. Mol Divers. 2022;26(6):3225\u201340.","journal-title":"Mol Divers"},{"issue":"12","key":"1124_CR80","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.lfs.2004.08.023","volume":"76","author":"P-W Zheng","year":"2005","unstructured":"Zheng P-W, Chiang L-C, Lin C-C. Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Life Sci. 2005;76(12):1367\u201379.","journal-title":"Life Sci"},{"issue":"6","key":"1124_CR81","first-page":"1477","volume":"36","author":"H-F Lu","year":"2010","unstructured":"Lu H-F, Chie Y-J, Yang M-S, et al. Apigenin induces caspase-dependent apoptosis in human lung cancer A549 cells through Bax-and Bcl-2-triggered mitochondrial pathway. Int J Oncol. 2010;36(6):1477\u201384.","journal-title":"Int J Oncol"},{"issue":"27","key":"1124_CR82","doi-asserted-by":"publisher","first-page":"41421","DOI":"10.18632\/oncotarget.9404","volume":"7","author":"Y Qin","year":"2016","unstructured":"Qin Y, Zhao D, Zhou HG, et al. Apigenin inhibits NF-\u03baB and snail signaling, EMT and metastasis in human hepatocellular carcinoma. Oncotarget. 2016;7(27):41421\u201331.","journal-title":"Oncotarget"},{"issue":"1","key":"1124_CR83","doi-asserted-by":"publisher","first-page":"21731","DOI":"10.1038\/srep21731","volume":"6","author":"H-H Cao","year":"2016","unstructured":"Cao H-H, Chu J-H, Kwan H-Y, et al. Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma. Sci Rep. 2016;6(1):21731.","journal-title":"Sci Rep"},{"key":"1124_CR84","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.foodres.2018.09.032","volume":"116","author":"I Abcha","year":"2019","unstructured":"Abcha I, Souilem S, Neves MA, et al. Ethyl oleate food-grade O\/W emulsions loaded with apigenin: Insights to their formulation characteristics and physico-chemical stability. Food Rev Int. 2019;116:953\u201362.","journal-title":"Food Rev Int"},{"key":"1124_CR85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.foodchem.2016.03.052","volume":"206","author":"BK Kim","year":"2016","unstructured":"Kim BK, Cho AR, Park DJ. Enhancing oral bioavailability using preparations of apigenin-loaded W\/O\/W emulsions: In vitro and in vivo evaluations. Food Chem. 2016;206:85\u201391.","journal-title":"Food Chem"},{"key":"1124_CR86","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jcis.2016.12.025","volume":"491","author":"K Banerjee","year":"2017","unstructured":"Banerjee K, Banerjee S, Mandal M. Enhanced chemotherapeutic efficacy of apigenin liposomes in colorectal cancer based on flavone-membrane interactions. J Colloid Interface Sci. 2017;491:98\u2013110.","journal-title":"J Colloid Interface Sci"},{"key":"1124_CR87","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.2147\/IJN.S140096","volume":"12","author":"X Jin","year":"2017","unstructured":"Jin X, Yang Q, Zhang Y. Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer. Int J Nanomedicine. 2017;12:5109\u201318.","journal-title":"Int J Nanomedicine"},{"issue":"10","key":"1124_CR88","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.1166\/jnn.2013.7763","volume":"13","author":"B Ding","year":"2013","unstructured":"Ding B, Chen H, Wang C, et al. Preparation and in vitro evaluation of apigenin loaded lipid nanocapsules. J Nanosci Nanotechnol. 2013;13(10):6546\u201352.","journal-title":"J Nanosci Nanotechnol"},{"issue":"2","key":"1124_CR89","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.toxlet.2013.09.012","volume":"223","author":"S Das","year":"2013","unstructured":"Das S, Das J, Samadder A, et al. Strategic formulation of apigenin-loaded PLGA nanoparticles for intracellular trafficking, DNA targeting and improved therapeutic effects in skin melanoma in vitro. Toxicol Lett. 2013;223(2):124\u201338.","journal-title":"Toxicol Lett"},{"issue":"3","key":"1124_CR90","first-page":"4764","volume":"10","author":"L Yu","year":"2017","unstructured":"Yu L, Zheng S, Chen Y, et al. Assessing the interactions between p53 gene and three types of flavonoid therapeutic compound in ovarian cancer cell line. Int J Chin Exp Med. 2017;10(3):4764\u201371.","journal-title":"Int J Chin Exp Med"},{"issue":"6","key":"1124_CR91","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.nano.2018.05.011","volume":"14","author":"S Bhattacharya","year":"2018","unstructured":"Bhattacharya S, Mondal L, Mukherjee B, et al. Apigenin loaded nanoparticle delayed development of hepatocellular carcinoma in rats. Nanomedicine. 2018;14(6):1905\u201317.","journal-title":"Nanomedicine"},{"issue":"6","key":"1124_CR92","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1002\/med.21837","volume":"41","author":"Y Meng","year":"2021","unstructured":"Meng Y, Ma N, Lyu H, et al. Recent pharmacological advances in the repurposing of artemisinin drugs. Med Res Rev. 2021;41(6):3156\u201381.","journal-title":"Med Res Rev"},{"key":"1124_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104901","volume":"158","author":"DHJ Cheong","year":"2020","unstructured":"Cheong DHJ, Tan DWS, Wong FWS, et al. Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases. Pharmacol Res. 2020;158: 104901.","journal-title":"Pharmacol Res"},{"key":"1124_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-023-00708-w","author":"S Chen","year":"2023","unstructured":"Chen S, Liao B, Guo S, et al. Genetic analysis reveals the inconsistency of amorpha-4,11-diene synthase, a key enzyme in the artemisinin synthesis pathway, in asteraceae. Chin Med. 2023. https:\/\/doi.org\/10.1186\/s13020-023-00708-w.","journal-title":"Chin Med"},{"issue":"23","key":"1124_CR95","doi-asserted-by":"publisher","first-page":"14903","DOI":"10.3390\/ijms232314903","volume":"23","author":"HA Shi","year":"2022","unstructured":"Shi HA, Wang ZQ, Xu FJ, et al. A discovery-based metabolomic approach using UPLC-Q-TOF-MS\/MS reveals potential antimalarial compounds present in artemisia annua L. Int J Mol Sci. 2022;23(23):14903.","journal-title":"Int J Mol Sci."},{"key":"1124_CR96","doi-asserted-by":"publisher","first-page":"104810","DOI":"10.1016\/j.antiviral.2020.104810","volume":"179","author":"XG Wang","year":"2020","unstructured":"Wang XG, Zheng BH, Ashraf U, et al. Artemisinin inhibits the replication of flaviviruses by promoting the type I interferon production. Antiviral Res. 2020;179:104810.","journal-title":"Antiviral Res"},{"issue":"1","key":"1124_CR97","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/21505594.2021.2021643","volume":"13","author":"IY Chung","year":"2022","unstructured":"Chung IY, Jang HJ, Yoo YJ, et al. Artemisinin displays bactericidal activity via copper-mediated DNA damage. Virulence. 2022;13(1):149\u201359.","journal-title":"Virulence"},{"key":"1124_CR98","doi-asserted-by":"publisher","first-page":"117299","DOI":"10.1016\/j.biopha.2024.117299","volume":"178","author":"FD Favero","year":"2024","unstructured":"Favero FD, Basting RT, de Freitas AS, et al. Artemisinin and deoxyartemisinin isolated from Artemisia annua L. promote distinct antinociceptive and anti-inflammatory effects in an animal model. Biomed Pharmacother. 2024;178:117299.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"1124_CR99","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1007\/s00204-021-03058-4","volume":"95","author":"O Kadioglu","year":"2021","unstructured":"Kadioglu O, Klauck SM, Fleischer E, et al. Selection of safe artemisinin derivatives using a machine learning-based cardiotoxicity platform and in vitro and in vivo validation. Arch Toxicol. 2021;95(7):2485\u201395.","journal-title":"Arch Toxicol"},{"key":"1124_CR100","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.2147\/DDDT.S414098","volume":"17","author":"Y Ye","year":"2023","unstructured":"Ye Y, Yang Y, Yan L, et al. Integrating network pharmacology and experimental validation to explore the effects and mechanisms of qinghao biejia decoction and its active compound artemisinin b against non-small-cell lung cancer. Drug Des Devel Ther. 2023;17:2461\u201379.","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"1124_CR101","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.3390\/cancers12092514","volume":"12","author":"X Zhou","year":"2020","unstructured":"Zhou X, Zijlstra SN, Soto-Gamez A, et al. Artemisinin derivatives stimulate DR5-specific TRAIL-induced apoptosis by regulating wildtype P53. Cancers. 2020;12(9):2514.","journal-title":"Cancers"},{"issue":"13","key":"1124_CR102","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.7150\/jca.57054","volume":"12","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Yi H, Yao H, et al. Artemisinin derivatives inhibit non-small cell lung cancer cells through induction of ROS-dependent apoptosis\/ferroptosis. J Cancer. 2021;12(13):4075\u201385.","journal-title":"J Cancer"},{"key":"1124_CR103","doi-asserted-by":"publisher","first-page":"109273","DOI":"10.1016\/j.cbi.2020.109273","volume":"331","author":"X Zhou","year":"2020","unstructured":"Zhou X, Chen Y, Wang F, et al. Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells. Chem Biol Interact. 2020;331:109273.","journal-title":"Chem Biol Interact"},{"key":"1124_CR104","doi-asserted-by":"publisher","first-page":"113000","DOI":"10.1016\/j.ejmech.2020.113000","volume":"211","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Li X, Chen K, et al. Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers. Eur J Med Chem. 2021;211:113000.","journal-title":"Eur J Med Chem"},{"issue":"3","key":"1124_CR105","first-page":"1330","volume":"25","author":"X Guan","year":"2020","unstructured":"Guan X, Guan Y. Artemisinin induces selective and potent anticancer effects in drug-resistant breast cancer cells by inducing cellular apoptosis and autophagy and G2\/M cell cycle arrest. J BUON. 2020;25(3):1330\u20136.","journal-title":"J BUON"},{"key":"1124_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114866","volume":"163","author":"AM Posadino","year":"2023","unstructured":"Posadino AM, Giordo R, Pintus G, et al. Medicinal and mechanistic overview of artemisinin in the treatment of human diseases. Biomed Pharmacother. 2023;163: 114866.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1124_CR107","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1002\/med.21580","volume":"39","author":"X Sun","year":"2019","unstructured":"Sun X, Yan P, Zou C, et al. Targeting autophagy enhances the anticancer effect of artemisinin and its derivatives. Med Res Rev. 2019;39(6):2172\u201393.","journal-title":"Med Res Rev"},{"issue":"2","key":"1124_CR108","doi-asserted-by":"publisher","first-page":"603","DOI":"10.7150\/ijbs.50364","volume":"17","author":"X Dai","year":"2021","unstructured":"Dai X, Zhang X, Chen W, et al. Dihydroartemisinin: a potential natural anticancer drug. Int J Biol Sci. 2021;17(2):603\u201322.","journal-title":"Int J Biol Sci"},{"key":"1124_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.828856","volume":"12","author":"Z Ma","year":"2021","unstructured":"Ma Z, Woon CY, Liu CG, et al. Repurposing artemisinin and its derivatives as anticancer drugs: a chance or challenge? Front Pharmacol. 2021;12: 828856.","journal-title":"Front Pharmacol"},{"key":"1124_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112044","volume":"188","author":"F Gao","year":"2020","unstructured":"Gao F, Sun Z, Kong F, et al. Artemisinin-derived hybrids and their anticancer activity. Eur J Med Chem. 2020;188: 112044.","journal-title":"Eur J Med Chem"},{"key":"1124_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.115000","volume":"247","author":"ZW Zeng","year":"2023","unstructured":"Zeng ZW, Chen D, Chen L, et al. A comprehensive overview of Artemisinin and its derivatives as anticancer agents. Eur J Med Chem. 2023;247: 115000.","journal-title":"Eur J Med Chem"},{"key":"1124_CR112","first-page":"1","volume":"2022","author":"M Zhang","year":"2022","unstructured":"Zhang M, Wang L, Liu W, et al. Targeting inhibition of accumulation and function of myeloid-derived suppressor Cells by Artemisinin via PI3K\/AKT, mTOR, and MAPK pathways enhances anti-PD-L1 immunotherapy in melanoma and liver tumors. J Immunol Res. 2022;2022:1.","journal-title":"J Immunol Res"},{"issue":"2","key":"1124_CR113","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.bbrc.2020.01.094","volume":"524","author":"Z Lu","year":"2020","unstructured":"Lu Z, Bi J, Wan X. Artemisinin sensitizes tumor cells to NK cell-mediated cytolysis. Biochem Biophys Res Commun. 2020;524(2):418\u201323.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1124_CR114","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00280-023-04623-7","volume":"93","author":"C-Z Wang","year":"2024","unstructured":"Wang C-Z, Wan C, Li C-H, et al. Ruthenium-dihydroartemisinin complex: a promising new compound for colon cancer prevention via G1 cell cycle arrest, apoptotic induction, and adaptive immune regulation. Cancer Chemother Pharmacol. 2024;93(5):411\u201325.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"9","key":"1124_CR115","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202200379","volume":"6","author":"G Xiong","year":"2022","unstructured":"Xiong G, Huang D, Lu L, et al. Near-infrared-II light induced mild hyperthermia activate cisplatin-artemisinin nanoparticle for enhanced chemo\/chemodynamic therapy and immunotherapy. Small Methods. 2022;6(9): e2200379.","journal-title":"Small Methods"},{"key":"1124_CR116","doi-asserted-by":"publisher","first-page":"152998","DOI":"10.1016\/j.phymed.2019.152998","volume":"60","author":"Y Wang","year":"2019","unstructured":"Wang Y, Li Y, Shang D, et al. Interactions between artemisinin derivatives and P-glycoprotein. Phytomedicine. 2019;60:152998.","journal-title":"Phytomedicine"},{"issue":"43","key":"1124_CR117","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.2174\/0113816128282248231205105408","volume":"29","author":"X Zhang","year":"2023","unstructured":"Zhang X, Li N, Zhang G, et al. Nano strategies for artemisinin derivatives to enhance reverse efficiency of multidrug resistance in breast cancer. Curr Pharm Des. 2023;29(43):3458\u201366.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"1124_CR118","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/15548627.2023.2261758","volume":"20","author":"Z Ma","year":"2024","unstructured":"Ma Z, Chen W, Liu Y, et al. Artesunate sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy. Autophagy. 2024;20(3):541\u201356.","journal-title":"Autophagy"},{"issue":"4","key":"1124_CR119","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41401-020-0445-z","volume":"42","author":"Z Li","year":"2021","unstructured":"Li Z, Zhu YT, Xiang M, et al. Enhanced lysosomal function is critical for paclitaxel resistance in cancer cells: reversed by artesunate. Acta Pharmacol Sin. 2021;42(4):624\u201332.","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"1124_CR120","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.32604\/or.2024.047257","volume":"32","author":"Z Zhuo","year":"2024","unstructured":"Zhuo Z, Zhang D, Lu W, et al. Reversal of tamoxifen resistance by artemisinin in ER+ breast cancer: bioinformatics analysis and experimental validation. Oncol Res. 2024;32(6):1093\u2013107.","journal-title":"Oncol Res"},{"key":"1124_CR121","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3389\/fonc.2020.00767","volume":"10","author":"Y Chen","year":"2020","unstructured":"Chen Y, Li R, Zhu Y, et al. Dihydroartemisinin induces growth arrest and overcomes dexamethasone resistance in multiple myeloma. Front Oncol. 2020;10:767.","journal-title":"Front Oncol"},{"issue":"5","key":"1124_CR122","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/ddr.22067","volume":"84","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yang Z, Zhu W, et al. Dihydroartemisinin inhibited stem cell-like properties and enhanced oxaliplatin sensitivity of colorectal cancer via AKT\/mTOR signaling. Drug Dev Res. 2023;84(5):988\u201398.","journal-title":"Drug Dev Res"},{"key":"1124_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105701","volume":"170","author":"X Cai","year":"2021","unstructured":"Cai X, Miao J, Sun R, et al. Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer. Pharmacol Res. 2021;170: 105701.","journal-title":"Pharmacol Res"},{"issue":"12","key":"1124_CR124","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3390\/cells9122643","volume":"9","author":"FG Zhao","year":"2020","unstructured":"Zhao FG, Vakhrusheva O, Markowitsch SD, et al. Artesunate impairs growth in cisplatin-resistant bladder cancer cells by cell cycle arrest, apoptosis and autophagy induction. Cells. 2020;9(12):2643.","journal-title":"Cells"},{"issue":"4","key":"1124_CR125","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/pharmaceutics15041107","volume":"15","author":"M Elbadawi","year":"2023","unstructured":"Elbadawi M, Boulos JC, Dawood M, et al. The novel artemisinin dimer isoniazide ELI-XXIII-98\u20132 induces c-MYC inhibition, DNA damage, and autophagy in leukemia cells. Pharmaceutics. 2023;15(4):1107.","journal-title":"Pharmaceutics"},{"key":"1124_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107705","volume":"97","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhou L, Xiang JD, et al. Artesunate-induced ATG5-related autophagy enhances the cytotoxicity of NK92 cells on endometrial cancer cells via interactions between CD155 and CD226\/TIGIT. Int Immunopharmacol. 2021;97: 107705.","journal-title":"Int Immunopharmacol"},{"key":"1124_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110167","volume":"88","author":"Y Chen","year":"2021","unstructured":"Chen Y, Wang F, Wu P, et al. Artesunate induces apoptosis, autophagy and ferroptosis in diffuse large B cell lymphoma cells by impairing STAT3 signaling. Cell Signal. 2021;88: 110167.","journal-title":"Cell Signal"},{"issue":"5","key":"1124_CR128","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/ptr.6332","volume":"33","author":"X Shi","year":"2019","unstructured":"Shi X, Wang L, Ren L, et al. Dihydroartemisinin, an antimalarial drug, induces absent in melanoma 2 inflammasome activation and autophagy in human hepatocellular carcinoma HepG2215 cells. Phytother Res. 2019;33(5):1413\u201325.","journal-title":"Phytother Res"},{"issue":"3","key":"1124_CR129","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2174\/0113816128289372240105041038","volume":"30","author":"F Chen","year":"2024","unstructured":"Chen F, Lu J, Zheng B, et al. artesunate inhibits the growth of insulinoma cells via SLC7A11\/GPX4-mediated ferroptosis. Curr Pharm Des. 2024;30(3):230\u20139.","journal-title":"Curr Pharm Des"},{"key":"1124_CR130","doi-asserted-by":"publisher","first-page":"107526","DOI":"10.1016\/j.phrs.2024.107526","volume":"210","author":"X Liu","year":"2024","unstructured":"Liu X, Cai Y, Zhang Y, et al. Artesunate: a potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma. Pharmacol Res. 2024;210:107526.","journal-title":"Pharmacol Res"},{"issue":"12","key":"1124_CR131","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.7150\/ijms.86409","volume":"20","author":"L Liang","year":"2023","unstructured":"Liang L, Liu Y, Wu X, et al. Artesunate induces ferroptosis by inhibiting the nuclear localization of SREBP2 in myeloma cells. Int J Med Sci. 2023;20(12):1535\u201350.","journal-title":"Int J Med Sci"},{"key":"1124_CR132","doi-asserted-by":"publisher","DOI":"10.3892\/or.2023.8584","author":"Y Chen","year":"2023","unstructured":"Chen Y, Tao H, Wang F, et al. Artesunate synergistically promotes sorafenib-induced apoptosis and ferroptosis in non-Hodgkin lymphoma cells through inhibition of the STAT3 pathway. Oncol Rep. 2023. https:\/\/doi.org\/10.3892\/or.2023.8584.","journal-title":"Oncol Rep"},{"key":"1124_CR133","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8191","author":"Z Wang","year":"2021","unstructured":"Wang Z, Li M, Liu Y, et al. Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response-induced upregulation of CHAC1 expression. Oncol Rep. 2021. https:\/\/doi.org\/10.3892\/or.2021.8191.","journal-title":"Oncol Rep"},{"issue":"1","key":"1124_CR134","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41418-019-0352-3","volume":"27","author":"GQ Chen","year":"2020","unstructured":"Chen GQ, Benthani FA, Wu J, et al. Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis. Cell Death Differ. 2020;27(1):242\u201354.","journal-title":"Cell Death Differ"},{"issue":"1","key":"1124_CR135","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41420-023-01371-8","volume":"9","author":"E Grignano","year":"2023","unstructured":"Grignano E, Cantero-Aguilar L, Tuerdi Z, et al. Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein. Cell Death Discov. 2023;9(1):97.","journal-title":"Cell Death Discov"},{"key":"1124_CR136","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.freeradbiomed.2018.12.011","volume":"131","author":"J Du","year":"2019","unstructured":"Du J, Wang T, Li Y, et al. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin. Free Radic Biol Med. 2019;131:356\u201369.","journal-title":"Free Radic Biol Med"},{"issue":"24","key":"1124_CR137","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3390\/ijms232415768","volume":"23","author":"Y Zhong","year":"2022","unstructured":"Zhong Y, Li ZN, Jiang XY, et al. Identification of novel artemisinin hybrids induce apoptosis and ferroptosis in MCF-7 cells. Int J Mol Sci. 2022;23(24):1568.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"1124_CR138","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.3390\/cells11162472","volume":"11","author":"Z Huang","year":"2022","unstructured":"Huang Z, Gan S, Zhuang X, et al. artesunate inhibits the cell growth in colorectal cancer by promoting ROS-dependent cell senescence and autophagy. Cells. 2022;11(16):2472.","journal-title":"Cells"},{"key":"1124_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109383","volume":"118","author":"C Yu","year":"2019","unstructured":"Yu C, Sun P, Zhou Y, et al. Inhibition of AKT enhances the anti-cancer effects of Artemisinin in clear cell renal cell carcinoma. Biomed Pharmacother. 2019;118: 109383.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1124_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152795","volume":"216","author":"HN Fan","year":"2020","unstructured":"Fan HN, Zhu MY, Peng SQ, et al. Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling. Pathol Res Pract. 2020;216(2): 152795.","journal-title":"Pathol Res Pract"},{"key":"1124_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.153318","volume":"218","author":"R Liang","year":"2021","unstructured":"Liang R, Chen W, Chen XY, et al. Dihydroartemisinin inhibits the tumorigenesis and invasion of gastric cancer by regulating STAT1\/KDR\/MMP9 and P53\/BCL2L1\/CASP3\/7 pathways. Pathol Res Pract. 2021;218: 153318.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"1124_CR142","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2174\/1389201021666200623132803","volume":"22","author":"Q Luo","year":"2021","unstructured":"Luo Q, Zhang S, Zhang D, et al. Effects and mechanisms of anlotinib and dihydroartemisinin combination therapy in ameliorating malignant biological behavior of gastric cancer cells. Curr Pharm Biotechnol. 2021;22(4):523\u201333.","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"1124_CR143","first-page":"177","volume":"69","author":"P Xiao","year":"2022","unstructured":"Xiao P, Liang Q, Chen Q, et al. Artemisinin potentiates apoptosis and triggers cell cycle arrest to attenuate malignant growth of salivary gland tumor cells. Acta Biochim Pol. 2022;69(1):177\u201387.","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"1124_CR144","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1021\/acs.molpharmaceut.0c00432","volume":"18","author":"J Tao","year":"2021","unstructured":"Tao J, Diao L, Chen F, et al. pH-sensitive nanoparticles codelivering docetaxel and dihydroartemisinin effectively treat breast cancer by enhancing reactive oxidative species-mediated mitochondrial apoptosis. Mol Pharm. 2021;18(1):74\u201386.","journal-title":"Mol Pharm"},{"issue":"4","key":"1124_CR145","first-page":"3017","volume":"22","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Liu J, Liu L. Artesunate inhibits lung cancer cells via regulation of mitochondrial membrane potential and induction of apoptosis. Mol Med Rep. 2020;22(4):3017\u201322.","journal-title":"Mol Med Rep"},{"issue":"3","key":"1124_CR146","doi-asserted-by":"publisher","first-page":"6590","DOI":"10.1080\/21655979.2022.2042141","volume":"13","author":"P Hu","year":"2022","unstructured":"Hu P, Ni C, Teng P. Effects of artesunate on the malignant biological behaviors of non-small cell lung cancer in human and its mechanism. Bioengineered. 2022;13(3):6590\u20139.","journal-title":"Bioengineered"},{"issue":"2","key":"1124_CR147","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jphs.2021.02.001","volume":"146","author":"J Zheng","year":"2021","unstructured":"Zheng J, Li X, Yang W, et al. Dihydroartemisinin regulates apoptosis, migration, and invasion of ovarian cancer cells via mediating RECK. J Pharmacol Sci. 2021;146(2):71\u201381.","journal-title":"J Pharmacol Sci"},{"issue":"7","key":"1124_CR148","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/cancers16071321","volume":"16","author":"JR McCorkle","year":"2024","unstructured":"McCorkle JR, Ahn R, Cao CD, et al. Antineoplastic drug synergy of artesunate with navitoclax in models of high-grade serous ovarian cancer. Cancers. 2024;16(7):1321.","journal-title":"Cancers"},{"issue":"8","key":"1124_CR149","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1111\/1759-7714.13570","volume":"11","author":"T Wang","year":"2020","unstructured":"Wang T, Wang J, Ren W, et al. Combination treatment with artemisinin and oxaliplatin inhibits tumorigenesis in esophageal cancer EC109 cell through Wnt\/\u03b2-catenin signaling pathway. Thorac Cancer. 2020;11(8):2316\u201324.","journal-title":"Thorac Cancer"},{"issue":"6","key":"1124_CR150","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/1440-1681.13287","volume":"47","author":"Z Wang","year":"2020","unstructured":"Wang Z, Wang Q, He T, et al. The combination of artesunate and carboplatin exerts a synergistic anti-tumour effect on non-small cell lung cancer. Clin Exp Pharmacol Physiol. 2020;47(6):1083\u201391.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1124_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.120083","volume":"592","author":"C Caddeo","year":"2021","unstructured":"Caddeo C, Gabriele M, N\u00e1cher A, et al. Resveratrol and artemisinin eudragit-coated liposomes: a strategy to tackle intestinal tumors. Int J Pharm. 2021;592: 120083.","journal-title":"Int J Pharm"},{"issue":"5","key":"1124_CR152","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3390\/cells9051260","volume":"9","author":"S D'Amico","year":"2020","unstructured":"D\u2019Amico S, Krasnowska EK, Manni I, et al. DHA affects microtubule dynamics through reduction of phospho-TCTP levels and enhances the antiproliferative effect of T-DM1 in trastuzumab-resistant HER2-positive breast cancer cell lines. Cells. 2020;9(5):1260.","journal-title":"Cells"},{"key":"1124_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.100991","volume":"51","author":"L Ni","year":"2024","unstructured":"Ni L, Zhu X, Zhao Q, et al. Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways. Neoplasia. 2024;51: 100991.","journal-title":"Neoplasia"},{"key":"1124_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216596","volume":"582","author":"X Dai","year":"2024","unstructured":"Dai X, Chen W, Qiao Y, et al. Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3\u03b2\/TCF7\/MMP9 pathway and synergies with capecitabine. Cancer Lett. 2024;582: 216596.","journal-title":"Cancer Lett"},{"key":"1124_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117454","volume":"248","author":"Y Li","year":"2020","unstructured":"Li Y, Zhou X, Liu J, et al. Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-\u03b21 signaling. Life Sci. 2020;248: 117454.","journal-title":"Life Sci"},{"issue":"11","key":"1124_CR156","doi-asserted-by":"publisher","first-page":"9573","DOI":"10.1039\/D0FO00996B","volume":"11","author":"J Gao","year":"2020","unstructured":"Gao J, Ma F, Wang X, et al. Combination of dihydroartemisinin and resveratrol effectively inhibits cancer cell migration via regulation of the DLC1\/TCTP\/Cdc42 pathway. Food Funct. 2020;11(11):9573\u201384.","journal-title":"Food Funct"},{"issue":"1","key":"1124_CR157","doi-asserted-by":"publisher","first-page":"20766","DOI":"10.1038\/s41598-021-99960-z","volume":"11","author":"A Ackermann","year":"2021","unstructured":"Ackermann A, \u00c7apc\u0131 A, Buchfelder M, et al. Chemical hybridization of sulfasalazine and dihydroartemisinin promotes brain tumor cell death. Sci Rep. 2021;11(1):20766.","journal-title":"Sci Rep"},{"issue":"3","key":"1124_CR158","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1182\/bloodadvances.2020003429","volume":"5","author":"BS Moses","year":"2021","unstructured":"Moses BS, McCullough S, Fox JM, et al. Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax. Blood Adv. 2021;5(3):711\u201324.","journal-title":"Blood Adv"},{"issue":"7","key":"1124_CR159","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41419-021-03996-y","volume":"12","author":"J Du","year":"2021","unstructured":"Du J, Wang X, Li Y, et al. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism. Cell Death Dis. 2021;12(7):705.","journal-title":"Cell Death Dis"},{"key":"1124_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117013","volume":"239","author":"Z Wang","year":"2019","unstructured":"Wang Z, Duan X, Lv Y, et al. Low density lipoprotein receptor (LDLR)-targeted lipid nanoparticles for the delivery of sorafenib and dihydroartemisinin in liver cancers. Life Sci. 2019;239: 117013.","journal-title":"Life Sci"},{"issue":"1","key":"1124_CR161","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jphs.2021.09.008","volume":"148","author":"Z Cui","year":"2022","unstructured":"Cui Z, Wang H, Li S, et al. Dihydroartemisinin enhances the inhibitory effect of sorafenib on HepG2 cells by inducing ferroptosis and inhibiting energy metabolism. J Pharmacol Sci. 2022;148(1):73\u201385.","journal-title":"J Pharmacol Sci"},{"issue":"12","key":"1124_CR162","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/s41401-020-0395-5","volume":"41","author":"X Yao","year":"2020","unstructured":"Yao X, Zhao CR, Yin H, et al. Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells. Acta Pharmacol Sin. 2020;41(12):1609\u201320.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"1124_CR163","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s40199-023-00495-7","volume":"32","author":"SJ Abdulkareem","year":"2024","unstructured":"Abdulkareem SJ, Jafari-Gharabaghlou D, Farhoudi-Sefidan-Jadid M, et al. Co-delivery of artemisinin and metformin via PEGylated niosomal nanoparticles: potential anti-cancer effect in treatment of lung cancer cells. Daru. 2024;32(1):133\u201344.","journal-title":"Daru"},{"issue":"6","key":"1124_CR164","first-page":"14","volume":"40","author":"AF Amandi","year":"2023","unstructured":"Amandi AF, Jokar E, Eslami M, et al. Enhanced anti-cancer effect of artemisinin- and curcumin-loaded niosomal nanoparticles against human colon cancer cells. Med Oncol. 2023;40(6):14.","journal-title":"Med Oncol"},{"issue":"1","key":"1124_CR165","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/21691401.2018.1543199","volume":"47","author":"F Nosrati","year":"2019","unstructured":"Nosrati F, Barzegari P, Danafar H, et al. Biotin-functionalized copolymeric PEG-PCL micelles for in vivo tumour-targeted delivery of artemisinin. Artif Cells Nanomed Biotechnol. 2019;47(1):104\u201314.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"10","key":"1124_CR166","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1007\/s12010-022-04000-9","volume":"194","author":"N Hassani","year":"2022","unstructured":"Hassani N, Jafari-Gharabaghlou D, Dadashpour M, et al. The effect of dual bioactive compounds artemisinin and metformin co-loaded in PLGA-PEG nano-particles on breast cancer cell lines: potential apoptotic and anti-proliferative action. Appl Biochem Biotechnol. 2022;194(10):4930\u201345.","journal-title":"Appl Biochem Biotechnol"},{"key":"1124_CR167","first-page":"32","volume":"32","author":"H Zhang","year":"2021","unstructured":"Zhang H, Li M, Zhu X, et al. Artemisinin co-delivery system based on manganese oxide for precise diagnosis and treatment of breast cancer. Nanotechnology. 2021;32:32.","journal-title":"Nanotechnology"},{"issue":"31","key":"1124_CR168","doi-asserted-by":"publisher","first-page":"13231","DOI":"10.1039\/D1NR01302E","volume":"13","author":"Q Wang","year":"2021","unstructured":"Wang Q, Wei N, Guo J, et al. Hemin-lipid assembly as an artemisinin oral delivery system for enhanced cancer chemotherapy and immunotherapy. Nanoscale. 2021;13(31):13231\u201340.","journal-title":"Nanoscale"},{"issue":"36","key":"1124_CR169","doi-asserted-by":"publisher","first-page":"8902","DOI":"10.1039\/D4TB01237B","volume":"12","author":"X Zhu","year":"2024","unstructured":"Zhu X, Bi C, Cao W, et al. A self-assembled copper-artemisinin nanoprodrug as an efficient reactive oxygen species amplified cascade system for cancer treatment. J Mater Chem B. 2024;12(36):8902\u201310.","journal-title":"J Mater Chem B"},{"issue":"5","key":"1124_CR170","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/pharmaceutics16050639","volume":"16","author":"J Cui","year":"2024","unstructured":"Cui J, Cai X, Qian R, et al. Tween 80 micelles loaded with Fe(3)O(4) nanoparticles and artemisinin for combined oxygen-independent ferroptosis therapy of cancer. Pharmaceutics. 2024;16(5):42.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1124_CR171","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/10717544.2020.1775725","volume":"27","author":"Y Lu","year":"2020","unstructured":"Lu Y, Wen Q, Luo J, et al. Self-assembled dihydroartemisinin nanoparticles as a platform for cervical cancer chemotherapy. Drug Deliv. 2020;27(1):876\u201387.","journal-title":"Drug Deliv"},{"issue":"3","key":"1124_CR172","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jdermsci.2020.08.001","volume":"99","author":"R Yu","year":"2020","unstructured":"Yu R, Jin L, Li F, et al. Dihydroartemisinin inhibits melanoma by regulating CTL\/Treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner. J Dermatol Sci. 2020;99(3):193\u2013202.","journal-title":"J Dermatol Sci"},{"key":"1124_CR173","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.727275","volume":"12","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Jin L, Jin Q, et al. Inhibitory effect of dihydroartemisinin on the proliferation and migration of melanoma cells and experimental lung metastasis from melanoma in mice. Front Pharmacol. 2021;12: 727275.","journal-title":"Front Pharmacol"},{"key":"1124_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113705","volume":"155","author":"D Cao","year":"2022","unstructured":"Cao D, Chen D, Xia JN, et al. Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation. Biomed Pharmacother. 2022;155: 113705.","journal-title":"Biomed Pharmacother"},{"key":"1124_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.153932","volume":"98","author":"Y Yu","year":"2022","unstructured":"Yu Y, Chen D, Wu T, et al. Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways. Phytomedicine. 2022;98: 153932.","journal-title":"Phytomedicine"},{"key":"1124_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.125163","volume":"244","author":"J Peng","year":"2023","unstructured":"Peng J, Zhou J, Sun R, et al. Dual-targeting of artesunate and chloroquine to tumor cells and tumor-associated macrophages by a biomimetic PLGA nanoparticle for colorectal cancer treatment. Int J Biol Macromol. 2023;244: 125163.","journal-title":"Int J Biol Macromol"},{"key":"1124_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121315","volume":"280","author":"W Han","year":"2022","unstructured":"Han W, Duan X, Ni K, et al. Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy. Biomaterials. 2022;280: 121315.","journal-title":"Biomaterials"},{"key":"1124_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153913","volume":"96","author":"L Hao","year":"2022","unstructured":"Hao L, Guo Y, Peng Q, et al. Dihydroartemisinin reduced lipid droplet deposition by YAP1 to promote the anti-PD-1 effect in hepatocellular carcinoma. Phytomedicine. 2022;96: 153913.","journal-title":"Phytomedicine"},{"issue":"1","key":"1124_CR179","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/s41467-019-09221-x","volume":"10","author":"X Duan","year":"2019","unstructured":"Duan X, Chan C, Han W, et al. Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors. Nat Commun. 2019;10(1):1899.","journal-title":"Nat Commun"},{"issue":"1","key":"1124_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113691","volume":"430","author":"W Ding","year":"2023","unstructured":"Ding W, Liao L, Liu J, et al. Lower dose of metformin combined with artesunate induced autophagy-dependent apoptosis of glioblastoma by activating ROS-AMPK-mTOR axis. Exp Cell Res. 2023;430(1): 113691.","journal-title":"Exp Cell Res"},{"key":"1124_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104496","volume":"106","author":"L Lin","year":"2021","unstructured":"Lin L, Lu W, Dai T, et al. Novel artemisinin derivatives with potent anticancer activities and the anti-colorectal cancer effect by the mitochondria-mediated pathway. Bioorg Chem. 2021;106: 104496.","journal-title":"Bioorg Chem"},{"key":"1124_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110062","volume":"365","author":"X Lu","year":"2022","unstructured":"Lu X, Elbadawi M, Blatt S, et al. Artemisinin derivative FO-ARS-123 as a novel VEGFR2 inhibitor suppresses angiogenesis, cell migration, and invasion. Chem Biol Interact. 2022;365: 110062.","journal-title":"Chem Biol Interact"},{"key":"1124_CR183","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.rvsc.2020.01.005","volume":"129","author":"J Dong","year":"2020","unstructured":"Dong J, Chen Y, Yang W, et al. Antitumor and anti-angiogenic effects of artemisinin on breast tumor xenografts in nude mice. Res Vet Sci. 2020;129:66\u20139.","journal-title":"Res Vet Sci"},{"issue":"1","key":"1124_CR184","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/fcp.12941","volume":"38","author":"Q Rao","year":"2024","unstructured":"Rao Q, Yu H, Li R, et al. Dihydroartemisinin inhibits angiogenesis in breast cancer via regulating VEGF and MMP-2\/-9. Fundam Clin Pharmacol. 2024;38(1):113\u201325.","journal-title":"Fundam Clin Pharmacol"},{"key":"1124_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175158","volume":"930","author":"X Lu","year":"2022","unstructured":"Lu X, Blatt S, Dawood M, et al. Novel artemisinin derivative FO8643 with anti-angiogenic activity inhibits growth and migration of cancer cells via VEGFR2 signaling. Eur J Pharmacol. 2022;930: 175158.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1124_CR186","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","volume":"42","author":"ZJ Li","year":"2021","unstructured":"Li ZJ, Dai HQ, Huang XW, et al. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin. 2021;42(2):301\u201310.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"1124_CR187","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s13046-019-1413-7","volume":"38","author":"Y Chen","year":"2019","unstructured":"Chen Y, Mi Y, Zhang X, et al. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK\/ATF4\/HSPA5 pathway in glioma cells. J Exp Clin Cancer Res. 2019;38(1):402.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1124_CR188","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12951-022-01455-0","volume":"20","author":"XX Yang","year":"2022","unstructured":"Yang XX, Xu X, Wang MF, et al. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin. J Nanobiotechnology. 2022;20(1):230.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"1124_CR189","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ptr.7592","volume":"37","author":"CX Tian","year":"2023","unstructured":"Tian CX, Li MY, Shuai XX, et al. Berberine plays a cardioprotective role by inhibiting macrophage Wnt5a\/beta-catenin pathway in the myocardium of mice after myocardial infarction. Phytother Res. 2023;37(1):50\u201361.","journal-title":"Phytother Res"},{"key":"1124_CR190","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-024-00988-w","author":"X Jiang","year":"2024","unstructured":"Jiang X, Wang H, Nie K, et al. Targeting lipid droplets and lipid droplet-associated proteins: a new perspective on natural compounds against metabolic diseases. Chin Med. 2024. https:\/\/doi.org\/10.1186\/s13020-024-00988-w.","journal-title":"Chin Med"},{"issue":"1","key":"1124_CR191","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1038\/s41467-020-18414-8","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Gu Y, Ren H, et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun. 2020;11(1):5015.","journal-title":"Nat Commun"},{"issue":"1","key":"1124_CR192","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1038\/s41467-021-25952-2","volume":"12","author":"M-M Zhao","year":"2021","unstructured":"Zhao M-M, Lu J, Li S, et al. Berberine is an insulin secretagogue targeting the KCNH6 potassium channel. Nat Commun. 2021;12(1):5616.","journal-title":"Nat Commun"},{"issue":"1","key":"1124_CR193","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-022-01027-6","volume":"7","author":"S-R Ma","year":"2022","unstructured":"Ma S-R, Tong Q, Lin Y, et al. Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota. Signal Transduct Target Ther. 2022;7(1):207.","journal-title":"Signal Transduct Target Ther"},{"issue":"39","key":"1124_CR194","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202405182","volume":"11","author":"J Hu","year":"2024","unstructured":"Hu J, Shi Q, Xue C, et al. Berberine protects against hepatocellular carcinoma progression by regulating intrahepatic T cell heterogeneity. Adv Sci. 2024;11(39): e2405182.","journal-title":"Adv Sci"},{"issue":"4","key":"1124_CR195","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2174\/0127724328250471231222094648","volume":"19","author":"C Coppinger","year":"2024","unstructured":"Coppinger C, Pomales B, Movahed MR, et al. Berberine: a multi-target natural PCSK9 inhibitor with the potential to treat diabetes, Alzheimer\u2019s, cancer and cardiovascular disease. Curr Rev Clin Exp Pharmacol. 2024;19(4):312\u201326.","journal-title":"Curr Rev Clin Exp Pharmacol"},{"issue":"12","key":"1124_CR196","doi-asserted-by":"publisher","first-page":"530","DOI":"10.4103\/2221-1691.363879","volume":"12","author":"S Samal","year":"2022","unstructured":"Samal S, Meher RK, Dubey D, et al. In-silico and in-vitro evaluation of docetaxel and berberine as potential p53 modulating apoptotic inducers in oral squamous cell carcinoma. Asian Pac J Trop Biomed. 2022;12(12):530\u201340.","journal-title":"Asian Pac J Trop Biomed"},{"issue":"1","key":"1124_CR197","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharep.2018.07.005","volume":"71","author":"PJ Kaboli","year":"2019","unstructured":"Kaboli PJ, Leong MP-Y, Ismail P, et al. Antitumor effects of berberine against EGFR, ERK1\/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study. Pharmacological Rep. 2019;71(1):13\u201323.","journal-title":"Pharmacological Rep"},{"issue":"12","key":"1124_CR198","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/biomedicines11123317","volume":"11","author":"A Sammarco","year":"2023","unstructured":"Sammarco A, Beffagna G, Sacchetto R, et al. Antitumor effect of berberine analogs in a canine mammary tumor cell line and in Zebrafish reporters via wnt\/\u03b2-catenin and hippo pathways. Biomedicines. 2023;11(12):9.","journal-title":"Biomedicines"},{"key":"1124_CR199","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cellimm.2024.104908","volume":"408","author":"J Xie","year":"2025","unstructured":"Xie J, Du X, Li Y, et al. Berberine shaping the tumor immune landscape via pyroptosis. Cell Immunol. 2025;408:39.","journal-title":"Cell Immunol"},{"issue":"37","key":"1124_CR200","doi-asserted-by":"publisher","first-page":"26884","DOI":"10.1039\/D4RA05618C","volume":"14","author":"LT Le","year":"2024","unstructured":"Le LT, Nguyen HT, Bui HTT, et al. Drug release system based on a composite polycaprolactone nanofiber membrane with dual functionality of shape memory effect and antibacterial ability. RSC Adv. 2024;14(37):26884\u201395.","journal-title":"RSC Adv"},{"issue":"11","key":"1124_CR201","doi-asserted-by":"publisher","first-page":"5818","DOI":"10.1021\/acs.molpharmaceut.4c00830","volume":"21","author":"F Costa","year":"2024","unstructured":"Costa F, Giorgini G, Minnelli C, et al. Membrane composition allows the optimization of berberine encapsulation in liposomes. Mol Pharm. 2024;21(11):5818\u201326.","journal-title":"Mol Pharm"},{"issue":"9","key":"1124_CR202","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2174\/0115672018258030230920035222","volume":"21","author":"M Heidarzadeh","year":"2024","unstructured":"Heidarzadeh M, Amininasab M, Rezayat SM, et al. Investigation of antioxidant and anti-inflammatory properties of berberine nanomicelles: in vitro and in vivo studies. Curr Drug Deliv. 2024;21(9):1273\u201383.","journal-title":"Curr Drug Deliv"},{"key":"1124_CR203","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.reth.2024.06.011","volume":"26","author":"W Qiao","year":"2024","unstructured":"Qiao W, Niu L, Jiang W, et al. Berberine ameliorates endothelial progenitor cell function and wound healing in vitro and in vivo via the miR-21-3p\/RRAGB axis for venous leg ulcers. Regen Ther. 2024;26:458\u201368.","journal-title":"Regen Ther"},{"key":"1124_CR204","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-023-00746-4","author":"Z Pu","year":"2023","unstructured":"Pu Z, Wen H, Jiang H, et al. Berberine improves negative symptoms and cognitive function in patients with chronic schizophrenia via anti-inflammatory effect: a randomized clinical trial. Chin Med. 2023. https:\/\/doi.org\/10.1186\/s13020-023-00746-4.","journal-title":"Chin Med"},{"key":"1124_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106817","volume":"193","author":"Y Sun","year":"2023","unstructured":"Sun Y, Zhou Q, Chen F, et al. Berberine inhibits breast carcinoma proliferation and metastasis under hypoxic microenvironment involving gut microbiota and endogenous metabolites. Pharmacol Res. 2023;193: 106817.","journal-title":"Pharmacol Res"},{"key":"1124_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155608","volume":"129","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zeng Y, Yang W, et al. Targeting CD8(+) T cells with natural products for tumor therapy: revealing insights into the mechanisms. Phytomedicine. 2024;129: 155608.","journal-title":"Phytomedicine"},{"issue":"1","key":"1124_CR207","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","volume":"9","author":"X Shi","year":"2024","unstructured":"Shi X, Wang X, Yao W, et al. Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives. Signal Transduct Target Ther. 2024;9(1):192.","journal-title":"Signal Transduct Target Ther"},{"issue":"18","key":"1124_CR208","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/molecules27185889","volume":"27","author":"SA Almatroodi","year":"2022","unstructured":"Almatroodi SA, Alsahli MA, Rahmani AH. Berberine: an important emphasis on its anticancer effects through modulation of various cell signaling pathways. Molecules. 2022;27(18):58.","journal-title":"Molecules"},{"key":"1124_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154842","volume":"115","author":"JW Shou","year":"2023","unstructured":"Shou JW, Shaw PC. Berberine activates PPARdelta and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma. Phytomedicine. 2023;115: 154842.","journal-title":"Phytomedicine"},{"issue":"12","key":"1124_CR210","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.apsb.2020.06.014","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu Y, Liu X, Zhang N, et al. Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5. Acta Pharm Sin B. 2020;10(12):2299\u2013312.","journal-title":"Acta Pharm Sin B"},{"key":"1124_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106787","volume":"87","author":"W Ma","year":"2020","unstructured":"Ma W, Zhang Y, Yu M, et al. In-vitro and in-vivo anti-breast cancer activity of synergistic effect of berberine and exercise through promoting the apoptosis and immunomodulatory effects. Int Immunopharmacol. 2020;87: 106787.","journal-title":"Int Immunopharmacol"},{"issue":"18","key":"1124_CR212","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.scib.2020.12.035","volume":"66","author":"Y Tong","year":"2021","unstructured":"Tong Y, Zhang J, Sun N, et al. Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p. Sci Bull (Beijing). 2021;66(18):1895\u2013905.","journal-title":"Sci Bull (Beijing)"},{"issue":"16","key":"1124_CR213","doi-asserted-by":"publisher","first-page":"10645","DOI":"10.1021\/acsomega.0c06288","volume":"6","author":"K Qian","year":"2021","unstructured":"Qian K, Tang CY, Chen LY, et al. Berberine reverses breast cancer multidrug resistance based on fluorescence pharmacokinetics in vitro and in vivo. ACS Omega. 2021;6(16):10645\u201354.","journal-title":"ACS Omega"},{"key":"1124_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111951","volume":"187","author":"H Mortazavi","year":"2020","unstructured":"Mortazavi H, Nikfar B, Esmaeili SA, et al. Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance. Eur J Med Chem. 2020;187: 111951.","journal-title":"Eur J Med Chem"},{"key":"1124_CR215","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2019.12.011","volume":"318","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Ji Y. Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity. J Control Release. 2020;318:38\u201349.","journal-title":"J Control Release"},{"key":"1124_CR216","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.2147\/OTT.S241632","volume":"13","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu Y, Du X, et al. Berberine reverses doxorubicin resistance by inhibiting autophagy through the PTEN\/Akt\/mTOR signaling pathway in breast cancer. Onco Targets Ther. 2020;13:1909\u201319.","journal-title":"Onco Targets Ther"},{"issue":"9","key":"1124_CR217","doi-asserted-by":"publisher","first-page":"14914","DOI":"10.1002\/jcp.28325","volume":"234","author":"R Mohammadinejad","year":"2019","unstructured":"Mohammadinejad R, Ahmadi Z, Tavakol S, et al. Berberine as a potential autophagy modulator. J Cell Physiol. 2019;234(9):14914\u201326.","journal-title":"J Cell Physiol"},{"key":"1124_CR218","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16593","volume":"11","author":"S Li","year":"2023","unstructured":"Li S, Cai X, Chen L, et al. Inhibition of hepatocellular carcinoma growth via modulation of the miR-221\/SOX11 axis by curcumin and berberine. PeerJ. 2023;11: e16593.","journal-title":"PeerJ"},{"issue":"7","key":"1124_CR219","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1007\/s11033-023-08381-w","volume":"50","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Lin X, Zeng W, et al. Berberine inhibits the progression of renal cell carcinoma cells by regulating reactive oxygen species generation and inducing DNA damage. Mol Biol Rep. 2023;50(7):5697\u2013707.","journal-title":"Mol Biol Rep"},{"key":"1124_CR220","doi-asserted-by":"publisher","first-page":"153473542211303","DOI":"10.1177\/15347354221130303","volume":"21","author":"Y Jin","year":"2022","unstructured":"Jin Y, Zhang J, Pan Y, et al. Berberine suppressed the progression of human glioma cells by inhibiting the TGF-\u03b21\/SMAD2\/3 signaling pathway. Integr Cancer Ther. 2022;21:15347354221130304.","journal-title":"Integr Cancer Ther"},{"issue":"4","key":"1124_CR221","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/ptr.6945","volume":"35","author":"M Mohammadlou","year":"2021","unstructured":"Mohammadlou M, Abdollahi M, Hemati M, et al. Apoptotic effect of berberine via Bcl-2, ROR1, and mir-21 in patients with B-chronic lymphocytic leukemia. Phytother Res. 2021;35(4):2025\u201333.","journal-title":"Phytother Res"},{"issue":"1","key":"1124_CR222","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12079-019-00525-7","volume":"14","author":"C Huang","year":"2020","unstructured":"Huang C, Wang XL, Qi FF, et al. Berberine inhibits epithelial-mesenchymal transition and promotes apoptosis of tumour-associated fibroblast-induced colonic epithelial cells through regulation of TGF-\u03b2 signalling. J Cell Commun Signal. 2020;14(1):53\u201366.","journal-title":"J Cell Commun Signal"},{"key":"1124_CR223","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jconrel.2018.11.014","volume":"294","author":"J Song","year":"2019","unstructured":"Song J, Lin C, Yang X, et al. Mitochondrial targeting nanodrugs self-assembled from 9-O-octadecyl substituted berberine derivative for cancer treatment by inducing mitochondrial apoptosis pathways. J Control Release. 2019;294:27\u201342.","journal-title":"J Control Release"},{"issue":"13","key":"1124_CR224","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1055\/a-1752-0311","volume":"88","author":"GS Park","year":"2022","unstructured":"Park GS, Park B, Lee MY. Berberine Induces Autophagic Cell Death by Inactivating the Akt\/mTOR Signaling Pathway. Planta Med. 2022;88(13):1116\u201322.","journal-title":"Planta Med"},{"key":"1124_CR225","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2147\/DDDT.S239247","volume":"14","author":"J Liu","year":"2020","unstructured":"Liu J, Liu P, Xu T, et al. Berberine induces autophagic cell death in acute lymphoblastic leukemia by inactivating AKT\/mTORC1 signaling. Drug Des Devel Ther. 2020;14:1813\u201323.","journal-title":"Drug Des Devel Ther"},{"key":"1124_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110245","volume":"128","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Wang X, Cao S, et al. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK\/mTOR\/p70S6K and Akt signaling pathways. Biomed Pharmacother. 2020;128: 110245.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1124_CR227","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13045-019-0759-9","volume":"12","author":"Q Wang","year":"2019","unstructured":"Wang Q, Yang S, Wang K, et al. MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer. J Hematol Oncol. 2019;12(1):63.","journal-title":"J Hematol Oncol"},{"key":"1124_CR228","doi-asserted-by":"publisher","first-page":"105998","DOI":"10.1016\/j.phrs.2021.105998","volume":"175","author":"Z Chen","year":"2022","unstructured":"Chen Z, Vallega KA, Chen H, et al. The natural product berberine synergizes with osimertinib preferentially against MET-amplified osimertinib-resistant lung cancer via direct MET inhibition. Pharmacol Res. 2022;175:105998\u2013105998.","journal-title":"Pharmacol Res"},{"issue":"1","key":"1124_CR229","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/ph16010042","volume":"16","author":"J He","year":"2022","unstructured":"He J, Wei Q, Jiang R, et al. The core-targeted RRM2 gene of berberine hydrochloride promotes breast cancer cell migration and invasion via the epithelial-mesenchymal transition. Pharmaceuticals. 2022;16(1):74.","journal-title":"Pharmaceuticals"},{"issue":"10","key":"1124_CR230","doi-asserted-by":"publisher","first-page":"6797","DOI":"10.1111\/jcmm.14560","volume":"23","author":"X Gao","year":"2019","unstructured":"Gao X, Wang J, Li M, et al. Berberine attenuates XRCC1-mediated base excision repair and sensitizes breast cancer cells to the chemotherapeutic drugs. J Cell Mol Med. 2019;23(10):6797\u2013804.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1124_CR231","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/cbdd.14231","volume":"102","author":"A Goel","year":"2023","unstructured":"Goel A. Current understanding and future prospects on Berberine for anticancer therapy. Chem Biol Drug Des. 2023;102(1):177\u2013200.","journal-title":"Chem Biol Drug Des"},{"issue":"Pt 3","key":"1124_CR232","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semcancer.2022.05.009","volume":"86","author":"D Ramesh-Kumar","year":"2022","unstructured":"Ramesh-Kumar D, Guil S. The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer. Semin Cancer Biol. 2022;86(Pt 3):18\u201331.","journal-title":"Semin Cancer Biol"},{"key":"1124_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105443","volume":"165","author":"M Alomari","year":"2021","unstructured":"Alomari M. TRIM21\u2014a potential novel therapeutic target in cancer. Pharmacol Res. 2021;165: 105443.","journal-title":"Pharmacol Res"},{"key":"1124_CR234","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110408","volume":"374","author":"Z Gui","year":"2023","unstructured":"Gui Z, Li J, Li J, et al. Berberine promotes IGF2BP3 ubiquitination by TRIM21 to induce G1\/S phase arrest in colorectal cancer cells. Chem Biol Interact. 2023;374: 110408.","journal-title":"Chem Biol Interact"},{"key":"1124_CR235","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.intimp.2018.11.020","volume":"66","author":"S Hu","year":"2019","unstructured":"Hu S, Chen CW, Chen ST, et al. Inhibitory effect of berberine on interleukin-2 secretion from PHA-treated lymphocytic Jurkat cells. Int Immunopharmacol. 2019;66:267\u201373.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"1124_CR236","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.5114\/aoms\/132969","volume":"19","author":"Q Li","year":"2023","unstructured":"Li Q, Zhao H, Chen W, et al. Berberine induces apoptosis and arrests the cell cycle in multiple cancer cell lines. Arch Med Sci. 2023;19(5):1530\u20137.","journal-title":"Arch Med Sci"},{"key":"1124_CR237","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2019.12.011","volume":"318","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Ji YH. Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity. J Controlled Release. 2020;318:38\u201349.","journal-title":"J Controlled Release"},{"issue":"2","key":"1124_CR238","doi-asserted-by":"publisher","first-page":"152","DOI":"10.56434\/j.arch.esp.urol.20237602.17","volume":"76","author":"Q Li","year":"2023","unstructured":"Li Q, Qing L, Xu W, et al. Berberine affects the proliferation, migration, invasion, cell cycle, and apoptosis of bladder cancer cells T24 and 5637 by down-regulating the HER2\/PI3K\/AKT signaling pathway. Arch Esp Urol. 2023;76(2):152\u201360.","journal-title":"Arch Esp Urol"},{"key":"1124_CR239","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115571","volume":"167","author":"F Cao","year":"2023","unstructured":"Cao F, Xia W, Dai S, et al. Berberine: an inspiring resource for the treatment of colorectal diseases. Biomed Pharmacother. 2023;167: 115571.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"1124_CR240","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1002\/iub.2350","volume":"72","author":"P Samadi","year":"2020","unstructured":"Samadi P, Sarvarian P, Gholipour E, et al. Berberine: a novel therapeutic strategy for cancer. IUBMB Life. 2020;72(10):2065\u201379.","journal-title":"IUBMB Life"},{"issue":"2","key":"1124_CR241","first-page":"729","volume":"15","author":"X Xu","year":"2023","unstructured":"Xu X, Liu M, Wu H. Berberine inhibits the growth of osteosarcoma through modulating MMP\/NM-23 and MAPK\/JNK signal pathways. Am J Transl Res. 2023;15(2):729\u201344.","journal-title":"Am J Transl Res"},{"issue":"13","key":"1124_CR242","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.1039\/D1NR00032B","volume":"13","author":"C Lin","year":"2021","unstructured":"Lin C, Yang X, Li H, et al. Self-assembled nanomedicine combining a berberine derivative and doxorubicin for enhanced antitumor and antimetastatic efficacy via mitochondrial pathways. Nanoscale. 2021;13(13):6605\u201323.","journal-title":"Nanoscale"},{"key":"1124_CR243","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbrc.2022.07.101","volume":"625","author":"Y Sun","year":"2022","unstructured":"Sun Y, Huang H, Zhan Z, et al. Berberine inhibits glioma cell migration and invasion by suppressing TGF-\u03b21\/COL11A1 pathway. Biochem Biophys Res Commun. 2022;625:38\u201345.","journal-title":"Biochem Biophys Res Commun"},{"key":"1124_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.116087","volume":"305","author":"LJ Yang","year":"2023","unstructured":"Yang LJ, He JB, Jiang Y, et al. Berberine hydrochloride inhibits migration ability via increasing inducible NO synthase and peroxynitrite in HTR-8\/SVneo cells. J Ethnopharmacol. 2023;305: 116087.","journal-title":"J Ethnopharmacol"},{"key":"1124_CR245","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120266","volume":"290","author":"M Xu","year":"2022","unstructured":"Xu M, Ren L, Fan J, et al. Berberine inhibits gastric cancer development and progression by regulating the JAK2\/STAT3 pathway and downregulating IL-6. Life Sci. 2022;290: 120266.","journal-title":"Life Sci"},{"issue":"6","key":"1124_CR246","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1002\/ptr.7032","volume":"35","author":"N Devarajan","year":"2021","unstructured":"Devarajan N, Jayaraman S, Mahendra J, et al. Berberine-A potent chemosensitizer and chemoprotector to conventional cancer therapies. Phytother Res. 2021;35(6):3059\u201377.","journal-title":"Phytother Res"},{"key":"1124_CR247","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.129618","volume":"260","author":"E Babaeenezhad","year":"2024","unstructured":"Babaeenezhad E, Rashidipour M, Jangravi Z, et al. Cytotoxic and epigenetic effects of berberine-loaded chitosan\/pectin nanoparticles on AGS gastric cancer cells: Role of the miR-185-5p\/KLF7 axis, DNMTs, and global DNA methylation. Int J Biol Macromol. 2024;260: 129618.","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"1124_CR248","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/molecules26061666","volume":"26","author":"X Gao","year":"2021","unstructured":"Gao X, Zhang C, Wang Y, et al. Berberine and cisplatin exhibit synergistic anticancer effects on osteosarcoma MG-63 cells by inhibiting the MAPK pathway. Molecules. 2021;26(6):35.","journal-title":"Molecules"},{"key":"1124_CR249","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120716","volume":"271","author":"X Zheng","year":"2021","unstructured":"Zheng X, Zhao Y, Jia Y, et al. Biomimetic co-assembled nanodrug of doxorubicin and berberine suppresses chemotherapy-exacerbated breast cancer metastasis. Biomaterials. 2021;271: 120716.","journal-title":"Biomaterials"},{"key":"1124_CR250","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.actbio.2019.09.034","volume":"100","author":"F Zhang","year":"2019","unstructured":"Zhang F, Jia Y, Zheng X, et al. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence. Acta Biomater. 2019;100:352\u201364.","journal-title":"Acta Biomater"},{"issue":"1","key":"1124_CR251","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jsps.2022.11.009","volume":"31","author":"MS Aleissa","year":"2023","unstructured":"Aleissa MS, Al-Zharani M, Alneghery LM, et al. Berberine enhances the sensitivity of radiotherapy in ovarian cancer cell line (SKOV-3). Saudi Pharm J. 2023;31(1):110\u20138.","journal-title":"Saudi Pharm J"},{"key":"1124_CR252","doi-asserted-by":"crossref","unstructured":"He L, Chen M, Liang Q et al. Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers. Frontiers in Pharmacology. 2022, 12:","DOI":"10.3389\/fphar.2021.775084"},{"issue":"1","key":"1124_CR253","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12967-022-03623-0","volume":"20","author":"Y Chen","year":"2022","unstructured":"Chen Y, Li K, Zhao H, et al. Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia. J Transl Med. 2022;20(1):412.","journal-title":"J Transl Med"},{"key":"1124_CR254","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.762673","volume":"8","author":"L Xing","year":"2021","unstructured":"Xing L, Zhou X, Li AH, et al. Atheroprotective effects and molecular mechanism of berberine. Front Mol Biosci. 2021;8: 762673.","journal-title":"Front Mol Biosci"},{"issue":"11","key":"1124_CR255","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ph17111509","volume":"17","author":"SF Guo","year":"2024","unstructured":"Guo SF, Wang ZB, Xie DD, et al. Berberine mediates exosomes regulating the lipid metabolism pathways to promote apoptosis of RA-FLS cells. Pharmaceuticals. 2024;17(11):4.","journal-title":"Pharmaceuticals"},{"key":"1124_CR256","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.870407","volume":"13","author":"X Fang","year":"2022","unstructured":"Fang X, Wu H, Wang X, et al. Modulation of gut microbiota and metabolites by berberine in treating mice with disturbances in glucose and lipid metabolism. Front Pharmacol. 2022;13: 870407.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1124_CR257","first-page":"362","volume":"10","author":"HB Ghanem","year":"2021","unstructured":"Ghanem HB, Emam MN, Mohammed DA, A, et al. Impact of berberine on some epigenetic, transcription regulation and inflammatory biomarkers in a mice model of epilepsy. Rep Biochem Mol Biol. 2021;10(3):362\u201372.","journal-title":"Rep Biochem Mol Biol"},{"key":"1124_CR258","doi-asserted-by":"publisher","first-page":"1460127","DOI":"10.3389\/fimmu.2024.1460127","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang Z, Du M, et al. Berberine alleviates ETEC-induced intestinal inflammation and oxidative stress damage by optimizing intestinal microbial composition in a weaned piglet model. Front Immunol. 2024;15:1460127.","journal-title":"Front Immunol"},{"issue":"1","key":"1124_CR259","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/ph17010007","volume":"17","author":"VR Askari","year":"2023","unstructured":"Askari VR, Khosravi K, Baradaran Rahimi V, et al. A mechanistic review on how berberine use combats diabetes and related complications: molecular, cellular, and metabolic effects. Pharmaceuticals. 2023;17(1):9.","journal-title":"Pharmaceuticals"},{"key":"1124_CR260","doi-asserted-by":"publisher","first-page":"1368950","DOI":"10.3389\/fphar.2024.1368950","volume":"15","author":"A Sun","year":"2024","unstructured":"Sun A, Yang H, Li T, et al. Molecular mechanisms, targets and clinical potential of berberine in regulating metabolism: a review focussing on databases and molecular docking studies. Front Pharmacol. 2024;15:1368950.","journal-title":"Front Pharmacol"},{"issue":"6","key":"1124_CR261","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1042\/BSR20210817","volume":"41","author":"LT Zeng","year":"2021","unstructured":"Zeng LT, Yu GP, Hao WS, et al. The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis. Biosci Rep. 2021;41(6):7.","journal-title":"Biosci Rep"},{"issue":"4","key":"1124_CR262","first-page":"479","volume":"14","author":"Z Li","year":"2022","unstructured":"Li Z, Hao E, Cao R, et al. Analysis on internal mechanism of zedoary turmeric in treatment of liver cancer based on pharmacodynamic substances and pharmacodynamic groups. Chin Herb Med. 2022;14(4):479\u201393.","journal-title":"Chin Herb Med"},{"key":"1124_CR263","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.phymed.2023.154986","volume":"119","author":"CZ Zhao","year":"2023","unstructured":"Zhao CZ, Zhou XE, Ye L, et al. Curcumin and analogues against head and neck cancer: from drug delivery to molecular mechanisms. Phytomedicine. 2023;119:75.","journal-title":"Phytomedicine"},{"key":"1124_CR264","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijbiomac.2023.123508","volume":"233","author":"MR Sharma","year":"2023","unstructured":"Sharma MR, Arya P, Kaur R, et al. Differential binding of piperine & curcumin with modified cellulose, alginate and pectin supports: in-vitro & in-silico studies. Int J Biol Macromol. 2023;233:7.","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"1124_CR265","first-page":"189","volume":"83","author":"Y Kura","year":"2023","unstructured":"Kura Y, De Velasco MA, Sakai K, et al. Immunomodulatory effects of curcumin monoglucuronide on PD1 immune checkpoint blockade in mouse Pten-null prostate cancer. Cancer Res. 2023;83(7):189.","journal-title":"Cancer Res."},{"issue":"1","key":"1124_CR266","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ptr.7305","volume":"36","author":"AJ Abadi","year":"2022","unstructured":"Abadi AJ, Mirzaei S, Mahabady MK, et al. Curcumin and its derivatives in cancer therapy: potentiating antitumor activity of cisplatin and reducing side effects. Phytother Res. 2022;36(1):189\u2013213.","journal-title":"Phytother Res"},{"key":"1124_CR267","doi-asserted-by":"publisher","first-page":"100663","DOI":"10.1016\/j.chphi.2024.100663","volume":"9","author":"R Yuvashri","year":"2024","unstructured":"Yuvashri R, Thendral ED, Jonathan DR, et al. Evaluating a series of new curcumin derivatives as potential anti-breast cancer agents: a collective analysis of in-vitro and in-silico characterization. Chemical Phys Impact. 2024;9:100663.","journal-title":"Chemical Phys Impact"},{"key":"1124_CR268","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30688","author":"A Akyuz","year":"2025","unstructured":"Akyuz A, Sirin DYASAR. In silico and in vitro verification of the effects of chemotherapeutic doxorubicin and 5-fluorouracil in combination with curcumin and vitamin C on MCF-7 Cells. J Cell Biochem. 2025. https:\/\/doi.org\/10.1002\/jcb.30688.","journal-title":"J Cell Biochem"},{"issue":"9","key":"1124_CR269","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/biomedicines9091086","volume":"9","author":"V Zoi","year":"2021","unstructured":"Zoi V, Galani V, Lianos GD, et al. The role of curcumin in cancer treatment. Biomedicines. 2021;9(9):1086.","journal-title":"Biomedicines"},{"key":"1124_CR270","doi-asserted-by":"crossref","unstructured":"Jiang T, Charcosset C. Encapsulation of curcumin within oil-in-water emulsions prepared by premix membrane emulsification: Impact of droplet size and carrier oil on the chemical stability of curcumin. Food Rev Int. 2022, 157.","DOI":"10.1016\/j.foodres.2022.111475"},{"issue":"27","key":"1124_CR271","doi-asserted-by":"publisher","first-page":"7103","DOI":"10.1021\/acs.jafc.0c01326","volume":"68","author":"Y Ma","year":"2020","unstructured":"Ma Y, Chen S, Liao W, et al. Formation, physicochemical stability, and redispersibility of curcumin-loaded rhamnolipid nanoparticles using the pH-driven method. J Agric Food Chem. 2020;68(27):7103\u201311.","journal-title":"J Agric Food Chem"},{"key":"1124_CR272","doi-asserted-by":"crossref","unstructured":"Lu ZH, Gao ZW, Song HY et al. Synthesis, Biological Evaluation and Action Mechanism Study of New Mitochondria-Targeted Curcumin Derivative as Potential Antitumor Drugs. Chem Biodivers. 2023.","DOI":"10.1002\/cbdv.202300086"},{"key":"1124_CR273","doi-asserted-by":"crossref","unstructured":"Deshpande SS, Veeragoni D, Rachamalla HK et al. Anticancer properties of ZnO-Curcumin nanocomposite against melanoma cancer and its genotoxicity profiling. J Drug Delivery Sci Technol. 2022, 75.","DOI":"10.1016\/j.jddst.2022.103703"},{"issue":"10","key":"1124_CR274","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.1002\/ptr.7240","volume":"35","author":"M Jin","year":"2021","unstructured":"Jin M, Kong L, Han Y, et al. Gut microbiota enhances the chemosensitivity of hepatocellular carcinoma to 5-fluorouracil in vivo by increasing curcumin bioavailability. Phytother Res. 2021;35(10):5823\u201337.","journal-title":"Phytother Res"},{"key":"1124_CR275","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jcis.2022.04.031","volume":"620","author":"FD Victorelli","year":"2022","unstructured":"Victorelli FD, Manni LS, Biffi S, et al. Potential of curcumin-loaded cubosomes for topical treatment of cervical cancer. J Colloid Interface Sci. 2022;620:419\u201330.","journal-title":"J Colloid Interface Sci"},{"issue":"13","key":"1124_CR276","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.2174\/1381612829666230331084848","volume":"29","author":"L Gholami","year":"2023","unstructured":"Gholami L, Momtazi-Borojeni AA, Malaekeh-Nikouei B, et al. Selective cellular uptake and cytotoxicity of curcumin-encapsulated SPC and HSPC liposome nanoparticles on human bladder cancer cells. Curr Pharm Des. 2023;29(13):1046\u201358.","journal-title":"Curr Pharm Des"},{"key":"1124_CR277","doi-asserted-by":"crossref","unstructured":"Gunther JR, Chadha AS, Guha S et al. A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer. J Gastrointest Oncol. 2022.","DOI":"10.21037\/jgo-22-259"},{"issue":"5\u20136","key":"1124_CR278","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/mutage\/geac020","volume":"37","author":"S Khan","year":"2022","unstructured":"Khan S, Miles GJ, Demetriou C, et al. Ex vivo explant model of adenoma and colorectal cancer to explore mechanisms of action and patient response to cancer prevention therapies. Mutagenesis. 2022;37(5\u20136):227\u201337.","journal-title":"Mutagenesis"},{"key":"1124_CR279","doi-asserted-by":"crossref","unstructured":"Sanlier N, Kocabas S, Erdogan K et al. Effects of curcumin, its analogues, and metabolites on various cancers: focusing on potential mechanisms. Food Rev Int. 2022.","DOI":"10.1080\/87559129.2022.2067173"},{"key":"1124_CR280","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.semcancer.2020.02.011","volume":"80","author":"W Weng","year":"2022","unstructured":"Weng W, Goel A. Curcumin and colorectal cancer: an update and current perspective on this natural medicine. Semin Cancer Biol. 2022;80:73\u201386.","journal-title":"Semin Cancer Biol"},{"key":"1124_CR281","doi-asserted-by":"publisher","first-page":"104921","DOI":"10.1016\/j.phrs.2020.104921","volume":"159","author":"S Hasanzadeh","year":"2020","unstructured":"Hasanzadeh S, Read MI, Bland AR, et al. Curcumin: an inflammasome silencer. Pharmacol Res. 2020;159:104921.","journal-title":"Pharmacol Res"},{"issue":"1","key":"1124_CR282","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/10408398.2017.1358139","volume":"59","author":"H Mollazadeh","year":"2019","unstructured":"Mollazadeh H, Cicero AFG, Blesso CN, et al. Immune modulation by curcumin: The role of interleukin-10. Crit Rev Food Sci Nutr. 2019;59(1):89\u2013101.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1124_CR283","doi-asserted-by":"publisher","first-page":"153758","DOI":"10.1016\/j.phymed.2021.153758","volume":"92","author":"L Liu","year":"2021","unstructured":"Liu L, Lim MA, Jung S-N, et al. The effect of Curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer. Phytomedicine. 2021;92:153758.","journal-title":"Phytomedicine"},{"key":"1124_CR284","doi-asserted-by":"publisher","DOI":"10.1002\/ca.24057","author":"Q Tong","year":"2023","unstructured":"Tong Q, Wu Z. Curcumin inhibits colon cancer malignant progression and promotes T cell killing by regulating miR-206 expression. Clin Anat. 2023. https:\/\/doi.org\/10.1002\/ca.24057.","journal-title":"Clin Anat"},{"key":"1124_CR285","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12547","author":"S Tian","year":"2021","unstructured":"Tian S, Liao L, Zhou Q, et al. Curcumin inhibits the growth of liver cancer by impairing myeloid-derived suppressor cells in murine tumor tissues. Oncol Lett. 2021. https:\/\/doi.org\/10.3892\/ol.2021.12547.","journal-title":"Oncol Lett"},{"key":"1124_CR286","doi-asserted-by":"crossref","unstructured":"Wang TT, Wang J, Jiang H et al. Targeted regulation of tumor microenvironment through the inhibition of MDSCs by curcumin loaded self-assembled nano-filaments. Materials Today Bio. 2022, 15.","DOI":"10.1016\/j.mtbio.2022.100304"},{"key":"1124_CR287","doi-asserted-by":"crossref","unstructured":"Jiang M, Qi Y, Huang W et al. Curcumin Reprograms TAMs from a Protumor Phenotype towards an Antitumor Phenotype via Inhibiting MAO-A\/STAT6 Pathway. Cells. 2022, 11(21).","DOI":"10.3390\/cells11213473"},{"issue":"5","key":"1124_CR288","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/cbdd.14330","volume":"102","author":"SK Ge","year":"2023","unstructured":"Ge SK, Sun X, Sang LM, et al. Curcumin inhibits malignant behavior of colorectal cancer cells by regulating M2 polarization of tumor-associated macrophages and metastasis associated in colon cancer 1 (MACC1) expression. Chem Biol Drug Des. 2023;102(5):1202\u201312.","journal-title":"Chem Biol Drug Des"},{"key":"1124_CR289","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CMAR.S316700","volume":"14","author":"Y Fan","year":"2022","unstructured":"Fan Y, He S. The characteristics of tumor microenvironment in triple negative breast cancer. Cancer Manag Res. 2022;14:1\u201317.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"1124_CR290","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","volume":"19","author":"DJ Propper","year":"2022","unstructured":"Propper DJ, Balkwill FR. Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol. 2022;19(4):237\u201353.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"1124_CR291","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1016\/j.xphs.2021.06.004","volume":"110","author":"MA Abdel-Hakeem","year":"2021","unstructured":"Abdel-Hakeem MA, Mongy S, Hassan B, et al. Curcumin loaded chitosan-protamine nanoparticles revealed antitumor activity via suppression of NF-kB, proinflammatory cytokines and Bcl-2 gene expression in the breast cancer cells. J Pharm Sci. 2021;110(9):3298\u2013305.","journal-title":"J Pharm Sci"},{"issue":"75","key":"1124_CR292","first-page":"539","volume":"17","author":"XW Qian","year":"2021","unstructured":"Qian XW, Jiang C, Zhu ZT, et al. Curcumin mediates the proliferation and apoptosis of colorectal cancer cells by downregulating the expression of interleukin-1\u03b2 through the nuclear factor-\u03baB signaling pathway. Pharmacogn Mag. 2021;17(75):539\u201344.","journal-title":"Pharmacogn Mag"},{"key":"1124_CR293","doi-asserted-by":"crossref","unstructured":"Afshari H, Noori S, Nourbakhsh M et al. A novel imidazo[1,2-a]pyridine derivative and its co-administration with curcumin exert anti-inflammatory effects by modulating the STAT3\/NF-\u03baB\/iNOS\/COX-2 signaling pathway in breast and ovarian cancer cell lines. Bioimpacts. 2023.","DOI":"10.34172\/bi.2023.27618"},{"issue":"11","key":"1124_CR294","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.1007\/s11033-020-05928-z","volume":"47","author":"A Coker-Gurkan","year":"2020","unstructured":"Coker-Gurkan A, Ozakaltun B, Akdeniz B-S, et al. Proinflammatory cytokine profile is critical in autocrine GH-triggered curcumin resistance engulf by atiprimod cotreatment in MCF-7 and MDA-MB-231 breast cancer cells. Mol Biol Rep. 2020;47(11):8797\u2013808.","journal-title":"Mol Biol Rep"},{"issue":"7","key":"1124_CR295","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/odi.13306","volume":"26","author":"PF Ba","year":"2020","unstructured":"Ba PF, Xu MC, Yu M, et al. Curcumin suppresses the proliferation and tumorigenicity of Cal27 by modulating cancer-associated fibroblasts of TSCC. Oral Dis. 2020;26(7):1375\u201383.","journal-title":"Oral Dis"},{"key":"1124_CR296","doi-asserted-by":"crossref","unstructured":"Liu L, Lim MA, Jung SN et al. The effect of Curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer. Phytomedicine. 2021, 92.","DOI":"10.1016\/j.phymed.2021.153758"},{"key":"1124_CR297","doi-asserted-by":"crossref","unstructured":"Tong Q, Wu ZQ. Curcumin inhibits colon cancer malignant progression and promotes T cell killing by regulating miR-206 expression. Clin Anat. 2023.","DOI":"10.1002\/ca.24057"},{"issue":"1","key":"1124_CR298","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.intimp.2012.06.016","volume":"14","author":"G-j Zhao","year":"2012","unstructured":"Zhao G-j, Lu Z-q, Tang L-m, et al. Curcumin inhibits suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. Int Immunopharmacol. 2012;14(1):99\u2013106.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"1124_CR299","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/ptr.5056","volume":"28","author":"Y Yamauchi","year":"2014","unstructured":"Yamauchi Y, Izumi Y, Yamamoto J, et al. Coadministration of erlotinib and curcumin augmentatively reduces cell viability in lung cancer cells. Phytother Res. 2014;28(5):728\u201335.","journal-title":"Phytother Res"},{"issue":"6","key":"1124_CR300","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1126\/sciadv.aay7785","volume":"6","author":"Z Xiao","year":"2020","unstructured":"Xiao Z, Su Z, Han S, et al. Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-\u03baB inhibitor for antitumor immunotherapy. Sci Adv. 2020;6(6):9.","journal-title":"Sci Adv"},{"key":"1124_CR301","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.biomaterials.2022.121407","volume":"282","author":"Y-X Ge","year":"2022","unstructured":"Ge Y-X, Zhang T-W, Zhou L, et al. Enhancement of anti-PD-1\/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework. Biomaterials. 2022;282:8.","journal-title":"Biomaterials"},{"key":"1124_CR302","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.semcancer.2020.06.014","volume":"80","author":"E Khatoon","year":"2022","unstructured":"Khatoon E, Banik K, Harsha C, et al. Phytochemicals in cancer cell chemosensitization: current knowledge and future perspectives. Semin Cancer Biol. 2022;80:306\u201339.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"1124_CR303","first-page":"83","volume":"19","author":"L Yang","year":"2020","unstructured":"Yang L, Li D, Tang PY, et al. Curcumin increases the sensitivity of K562\/DOX cells to doxorubicin by targeting S100 calcium-binding protein A8 and P-glycoprotein. Oncol Lett. 2020;19(1):83\u201392.","journal-title":"Oncol Lett"},{"key":"1124_CR304","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jpba.2021.114129","volume":"201","author":"N Zhang","year":"2021","unstructured":"Zhang N, Gao M, Wang ZH, et al. Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level. J Pharm Biomed Anal. 2021;201:7.","journal-title":"J Pharm Biomed Anal"},{"issue":"8\u20139","key":"1124_CR305","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.phymed.2012.03.005","volume":"19","author":"MX Ye","year":"2012","unstructured":"Ye MX, Zhao YL, Li Y, et al. Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549\/DDP cell apoptosis through HIF-1\u03b1 and caspase-3 mechanisms. Phytomedicine. 2012;19(8\u20139):779\u201387.","journal-title":"Phytomedicine"},{"key":"1124_CR306","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.drudis.2024.104161","volume":"29","author":"Y Guo","year":"2024","unstructured":"Guo Y, Ashrafizadeh M, Tambuwala MM, et al. P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators. Drug Discov Today. 2024;29:11.","journal-title":"Drug Discov Today"},{"issue":"70","key":"1124_CR307","doi-asserted-by":"publisher","first-page":"40873","DOI":"10.1039\/C9RA08202F","volume":"9","author":"L Diao","year":"2019","unstructured":"Diao L, Shen A, Yang YX, et al. CD44-targeted hyaluronic acid-curcumin reverses chemotherapeutics resistance by inhibiting P-gp and anti-apoptotic pathways. RSC Adv. 2019;9(70):40873\u201382.","journal-title":"RSC Adv"},{"key":"1124_CR308","doi-asserted-by":"publisher","first-page":"9453","DOI":"10.2147\/IJN.S224579","volume":"14","author":"MD Zhao","year":"2019","unstructured":"Zhao MD, Li JQ, Chen FY, et al. Co-delivery of curcumin and paclitaxel by \u201ccore-shell\u201d targeting amphiphilic copolymer to reverse resistance in the treatment of ovarian cancer. Int J Nanomedicine. 2019;14:9453\u201367.","journal-title":"Int J Nanomedicine"},{"issue":"21","key":"1124_CR309","doi-asserted-by":"publisher","first-page":"9249","DOI":"10.7314\/APJCP.2014.15.21.9249","volume":"15","author":"W Punfa","year":"2014","unstructured":"Punfa W, Suzuki S, Pitchakarn P, et al. Curcumin-loaded PLGA nanoparticles conjugated with anti-P-glycoprotein antibody to overcome multidrug resistance. Asian Pac J Cancer Prev. 2014;15(21):9249\u201358.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1124_CR310","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1155\/2020\/8394574","volume":"2020","author":"W Han","year":"2020","unstructured":"Han W, Yin HL, Ma H, et al. Curcumin regulates ERCC1 expression and enhances oxaliplatin sensitivity in resistant colorectal cancer cells through its effects on miR-409\u20133p. Evid Based Complement Alternat Med. 2020;2020:88.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1124_CR311","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.brainres.2016.10.020","volume":"1654","author":"M Kaur","year":"2017","unstructured":"Kaur M, Badhan RKS. Phytochemical mediated-modulation of the expression and transporter function of breast cancer resistance protein at the blood-brain barrier: an in-vitro study. Brain Res. 2017;1654:9\u201323.","journal-title":"Brain Res"},{"issue":"6","key":"1124_CR312","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/j.1476-5381.2012.01887.x","volume":"166","author":"H Kusuhara","year":"2012","unstructured":"Kusuhara H, Furuie H, Inano A, et al. Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP. Br J Pharmacol. 2012;166(6):1793\u2013803.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1124_CR313","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1517\/14656560903551283","volume":"11","author":"R Iyer","year":"2010","unstructured":"Iyer R, Bharthuar A. A review of erlotinib - an oral, selective epidermal growth factor receptor tyrosine kinase inhibitor. Expert Opin Pharmacother. 2010;11(2):311\u201320.","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"1124_CR314","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.bmc.2015.02.003","volume":"23","author":"K Wada","year":"2015","unstructured":"Wada K, Lee J-Y, Hung H-Y, et al. Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects. Bioorg Med Chem. 2015;23(7):1507\u201314.","journal-title":"Bioorg Med Chem"},{"issue":"12","key":"1124_CR315","first-page":"1667","volume":"13","author":"T-B Lee","year":"2018","unstructured":"Lee T-B, Seo E-J, Lee J-Y, et al. Synergistic anticancer effects of curcumin and hinokitiol on gefitinib resistant non-small cell lung cancer cells. Nat Prod Commun. 2018;13(12):1667\u201371.","journal-title":"Nat Prod Commun"},{"issue":"3","key":"1124_CR316","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3727\/096504013X13832473330032","volume":"21","author":"S Li","year":"2013","unstructured":"Li S, Liu Z, Zhu F, et al. Curcumin lowers erlotinib resistance in non-small cell lung carcinoma cells with mutated EGF receptor. Oncol Res. 2013;21(3):137\u201344.","journal-title":"Oncol Res"},{"issue":"4","key":"1124_CR317","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/cells12040612","volume":"12","author":"K Miyazaki","year":"2023","unstructured":"Miyazaki K, Morine Y, Xu CM, et al. Curcumin-mediated resistance to lenvatinib via EGFR signaling pathway in hepatocellular carcinoma. Cells. 2023;12(4):40.","journal-title":"Cells."},{"issue":"1","key":"1124_CR318","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-021-01489-2","volume":"21","author":"M Yi","year":"2022","unstructured":"Yi M, Zheng XL, Niu MK, et al. Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions. Mol Cancer. 2022;21(1):44.","journal-title":"Mol Cancer"},{"issue":"1","key":"1124_CR319","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/10717544.2021.1921077","volume":"28","author":"F Gong","year":"2021","unstructured":"Gong F, Ma J-C, Jia J, et al. Synergistic effect of the anti-PD-1 antibody with blood stable and reduction sensitive curcumin micelles on colon cancer. Drug Deliv. 2021;28(1):930\u201342.","journal-title":"Drug Deliv"},{"key":"1124_CR320","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phymed.2024.155600","volume":"129","author":"J Zhang","year":"2024","unstructured":"Zhang J, Li Y, Li S, et al. Natural products and derivatives for breast cancer treatment: From drug discovery to molecular mechanism. Phytomedicine. 2024;129:1.","journal-title":"Phytomedicine"},{"issue":"8","key":"1124_CR321","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1002\/ptr.8258","volume":"38","author":"T Ming","year":"2024","unstructured":"Ming T, Lei J, Peng Y, et al. Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11\/glutathione\/glutathione peroxidase 4 signaling axis. Phytother Res. 2024;38(8):3954\u201372.","journal-title":"Phytother Res"},{"issue":"5","key":"1124_CR322","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1002\/jcp.27404","volume":"234","author":"A Shakeri","year":"2019","unstructured":"Shakeri A, Cicero AFG, Panahi Y, et al. Curcumin: a naturally occurring autophagy modulator. J Cell Physiol. 2019;234(5):5643\u201354.","journal-title":"J Cell Physiol"},{"issue":"22","key":"1124_CR323","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.7150\/jca.45176","volume":"11","author":"T Wang","year":"2020","unstructured":"Wang T, Wu X, Ma AR, et al. Curcumin induces G2\/M arrest and triggers autophagy, ROS generation and cell senescence in cervical cancer cells. J Cancer. 2020;11(22):6704\u201315.","journal-title":"J Cancer"},{"issue":"1","key":"1124_CR324","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1080\/21655979.2021.1960765","volume":"12","author":"XL Gong","year":"2021","unstructured":"Gong XL, Jiang L, Li W, et al. Curcumin induces apoptosis and autophagy inhuman renal cell carcinoma cells via Akt\/mTOR suppression. Bioengineered. 2021;12(1):5017\u201327.","journal-title":"Bioengineered"},{"issue":"9","key":"1124_CR325","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1002\/1878-0261.13180","volume":"16","author":"JW Park","year":"2022","unstructured":"Park JW, Kim Y, Lee SB, et al. Autophagy inhibits cancer stemness in triple-negative breast cancer via miR-181a-mediated regulation of ATG5 and\/or ATG2B. Mol Oncol. 2022;16(9):1857\u201375.","journal-title":"Mol Oncol"},{"key":"1124_CR326","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2023.105669","volume":"93","author":"L Zhang","year":"2023","unstructured":"Zhang L, Qiu L, Xu SC, et al. Curcumin induces mitophagy by promoting mitochondrial succinate dehydrogenase activity and sensitizes human papillary thyroid carcinoma BCPAP cells to radioiodine treatment. Toxicol In Vitro. 2023;93: 105669.","journal-title":"Toxicol In Vitro"},{"key":"1124_CR327","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122224","volume":"334","author":"F Ravindran","year":"2023","unstructured":"Ravindran F, Mhatre A, Koroth J, et al. Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells. Life Sci. 2023;334: 122224.","journal-title":"Life Sci"},{"issue":"2","key":"1124_CR328","first-page":"114","volume":"18","author":"L Jong-Eun","year":"2020","unstructured":"Jong-Eun L, Sik YS, Jae-Wook L, et al. Curcumin-induced cell death depends on the level of autophagic flux in A172 and U87MG human gliabiastoma cells. Chin J Nat Med. 2020;18(2):114\u201322.","journal-title":"Chin J Nat Med"},{"issue":"4","key":"1124_CR329","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jbt.23307","volume":"37","author":"J Li","year":"2023","unstructured":"Li J, Wang SH, Liu YT, et al. Inhibition of autophagic flux by the curcumin analog EF-24 and its antiproliferative effect on MCF-7 cancer cells. J Biochem Mol Toxicol. 2023;37(4):9.","journal-title":"J Biochem Mol Toxicol"},{"key":"1124_CR330","doi-asserted-by":"crossref","unstructured":"Firouzjaei AA, Aghaee-Bakhtiari SH, Tafti A et al. Impact of curcumin on ferroptosis-related genes in colorectal cancer: Insights from in-silico and in-vitro studies. Cell Biochem Funct. 2023.","DOI":"10.1002\/cbf.3889"},{"issue":"2","key":"1124_CR331","doi-asserted-by":"publisher","first-page":"640","DOI":"10.14336\/AD.2023.0520","volume":"15","author":"KI Chan","year":"2024","unstructured":"Chan KI, Zhang S, Li G, et al. MYC oncogene: a druggable target for treating cancers with natural products. Aging Dis. 2024;15(2):640\u201397.","journal-title":"Aging Dis"},{"key":"1124_CR332","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1155\/2023\/6896790","volume":"2023","author":"H Chen","year":"2023","unstructured":"Chen H, Li Z, Xu J, et al. Curcumin induces ferroptosis in follicular thyroid cancer by upregulating HO-1 expression. Oxid Med Cell Longev. 2023;2023:5.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"1124_CR333","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1080\/01635581.2022.2139398","volume":"75","author":"M Chen","year":"2023","unstructured":"Chen M, Tan AH, Li J. Curcumin represses colorectal cancer cell proliferation by triggering ferroptosis via PI3K\/Akt\/mTOR signaling. Nutr Cancer. 2023;75(2):726\u201333.","journal-title":"Nutr Cancer"},{"key":"1124_CR334","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2020.111202","volume":"136","author":"HYJ Lin","year":"2021","unstructured":"Lin HYJ, Chen XT, Zhang CY, et al. EF24 induces ferroptosis in osteosarcoma cells through HMOX1. Biomed Pharmacother. 2021;136:1.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"1124_CR335","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.21037\/tcr-21-227","volume":"10","author":"B Xu","year":"2021","unstructured":"Xu B, Zhu W-J, Peng Y-J, et al. Curcumin reverses the sunitinib resistance in clear cell renal cell carcinoma (ccRCC) through the induction of ferroptosis via the ADAMTS18 gene. Transl Cancer Res. 2021;10(7):3158\u201367.","journal-title":"Transl Cancer Res"},{"issue":"8","key":"1124_CR336","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/ptr.6663","volume":"34","author":"P Liczbinski","year":"2020","unstructured":"Liczbinski P, Michalowicz J, Bukowska B. Molecular mechanism of curcumin action in signaling pathways: review of the latest research. Phytother Res. 2020;34(8):1992\u20132005.","journal-title":"Phytother Res"},{"issue":"11","key":"1124_CR337","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1055\/a-1201-2602","volume":"70","author":"MA Sarighieh","year":"2020","unstructured":"Sarighieh MA, Montazeri V, Shadboorestan A, et al. The inhibitory effect of curcumin on hypoxia inducer factors (Hifs) as a regulatory factor in the growth of tumor cells in breast cancer stem-like cells. Drug Res. 2020;70(11):512\u20138.","journal-title":"Drug Res"},{"key":"1124_CR338","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.lfs.2022.120804","volume":"306","author":"CH Bai","year":"2022","unstructured":"Bai CH, Zhao JQ, Su JL, et al. Curcumin induces mitochondrial apoptosis in human hepatoma cells through BCLAF1-mediated modulation of PI3K\/AKT\/GSK-3\u03b2 signaling. Life Sci. 2022;306:5.","journal-title":"Life Sci"},{"issue":"16","key":"1124_CR339","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules26164884","volume":"26","author":"YT Chou","year":"2021","unstructured":"Chou YT, Koh YC, Nagabhushanam K, et al. A natural degradant of curcumin, feruloylacetone inhibits cell proliferation via inducing cell cycle arrest and a mitochondrial apoptotic pathway in HCT116 colon cancer cells. Molecules. 2021;26(16):1.","journal-title":"Molecules"},{"key":"1124_CR340","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.molstruc.2022.133180","volume":"1263","author":"PH Li","year":"2022","unstructured":"Li PH, Pu SM, Lin C, et al. Curcumin selectively induces colon cancer cell apoptosis and S cell cycle arrest by regulates Rb\/E2F\/p53 pathway. J Mol Struct. 2022;1263:6.","journal-title":"J Mol Struct"},{"issue":"9","key":"1124_CR341","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/jfbc.13888","volume":"45","author":"Z Ye","year":"2021","unstructured":"Ye Z, Chen D, Zheng R, et al. Curcumin induced G2\/M cycle arrest in SK-N-SH neuroblastoma cells through the ROS-mediated p53 signaling pathway. J Food Biochem. 2021;45(9):8.","journal-title":"J Food Biochem"},{"issue":"1","key":"1124_CR342","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10856-014-5357-3","volume":"26","author":"B Teong","year":"2015","unstructured":"Teong B, Lin C-Y, Chang S-J, et al. Enhanced anti-cancer activity by curcumin-loaded hydrogel nanoparticle derived aggregates on A549 lung adenocarcinoma cells. J Mater Sci Mater Med. 2015;26(1):1.","journal-title":"J Mater Sci Mater Med"},{"issue":"3","key":"1124_CR343","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/jfpe.13246","volume":"43","author":"MMJ Moideen","year":"2020","unstructured":"Moideen MMJ, Karuppaiyan K, Kandhasamy R, et al. Skimmed milk powder and pectin decorated solid lipid nanoparticle containing soluble curcumin used for the treatment of colorectal cancer. J Food Process Eng. 2020;43(3):7.","journal-title":"J Food Process Eng"},{"issue":"4","key":"1124_CR344","first-page":"7","volume":"45","author":"H Zhou","year":"2021","unstructured":"Zhou H, Ning YC, Zeng GR, et al. Curcumin promotes cell cycle arrest and apoptosis of acute myeloid leukemia cells by inactivating AKT. Oncol Res. 2021;45(4):7.","journal-title":"Oncol Res"},{"issue":"11","key":"1124_CR345","first-page":"2293","volume":"18","author":"G Ting","year":"2019","unstructured":"Ting G, Jin W, Ting D, et al. Curcumin suppresses leukemia cell proliferation by down-regulation of P13K\/AKT\/mTOR signalling pathway. Trop J Pharm Res. 2019;18(11):2293\u20138.","journal-title":"Trop J Pharm Res"},{"issue":"5","key":"1124_CR346","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bcp.2005.04.043","volume":"70","author":"S Shishodia","year":"2005","unstructured":"Shishodia S, Amin HM, Lai R, et al. Curcumin (diferuloylmethane) inhibits constitutive NF-\u03baB activation, induces G1\/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol. 2005;70(5):700\u201313.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1124_CR347","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10637-009-9339-0","volume":"29","author":"TJ Somers-Edgar","year":"2011","unstructured":"Somers-Edgar TJ, Taurin S, Larsen L, et al. Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines. Invest New Drugs. 2011;29(1):87\u201397.","journal-title":"Invest New Drugs"},{"issue":"1","key":"1124_CR348","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10549-010-1089-3","volume":"128","author":"EM Al-Hujaily","year":"2011","unstructured":"Al-Hujaily EM, Mohamed AG, Al-Sharif I, et al. PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells. Breast Cancer Res Treat. 2011;128(1):97\u2013107.","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"1124_CR349","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1002\/jcb.24139","volume":"113","author":"Z-F Zhong","year":"2012","unstructured":"Zhong Z-F, Li Y-B, Wang S-P, et al. Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPAR\u03b3 independent manner. J Cell Biochem. 2012;113(8):2643\u201351.","journal-title":"J Cell Biochem"},{"issue":"5","key":"1124_CR350","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules26051277","volume":"26","author":"SK Yeap","year":"2021","unstructured":"Yeap SK, Mohd Ali N, Akhtar MN, et al. Induction of apoptosis and regulation of microRNA expression by (2E,6E)-2,6-bis-(4-hydroxy-3-methoxybenzylidene)-cyclohexanone (BHMC) treatment on MCF-7 breast cancer cells. Molecules. 2021;26(5):1.","journal-title":"Molecules"},{"issue":"5","key":"1124_CR351","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/mc.21875","volume":"52","author":"G Yan","year":"2013","unstructured":"Yan G, Graham K, Lanza-Jacoby S. Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells. Mol Carcinog. 2013;52(5):404\u201311.","journal-title":"Mol Carcinog"},{"issue":"4","key":"1124_CR352","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00204-011-0786-y","volume":"86","author":"A Kunwar","year":"2012","unstructured":"Kunwar A, Jayakumar S, Srivastava AK, et al. Dimethoxycurcumin-induced cell death in human breast carcinoma MCF7 cells: evidence for pro-oxidant activity, mitochondrial dysfunction, and apoptosis. Arch Toxicol. 2012;86(4):603\u201314.","journal-title":"Arch Toxicol"},{"issue":"10","key":"1124_CR353","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1021\/acs.biomac.7b00974","volume":"18","author":"L Pandolfi","year":"2017","unstructured":"Pandolfi L, Bellini M, Vanna R, et al. H-ferritin enriches the curcumin uptake and improves the therapeutic efficacy in triple negative breast cancer cells. Biomacromol. 2017;18(10):3318\u201330.","journal-title":"Biomacromol"},{"issue":"2","key":"1124_CR354","doi-asserted-by":"publisher","DOI":"10.1088\/2057-1976\/aaf2c3","volume":"5","author":"L Mittal","year":"2019","unstructured":"Mittal L, Raman V, Camarillo IG, et al. Viability and cell cycle studies of metastatic triple negative breast cancer cells using low voltage electrical pulses and herbal curcumin. Biomed Phys Eng Express. 2019;5(2): 025040.","journal-title":"Biomed Phys Eng Express"},{"issue":"4","key":"1124_CR355","doi-asserted-by":"publisher","first-page":"622","DOI":"10.38212\/2224-6614.3387","volume":"29","author":"TC Cheng","year":"2021","unstructured":"Cheng TC, Sayseng JO, Tu SH, et al. Curcumin-induced antitumor effects on triple-negative breast cancer patient-derived xenograft tumor mice through inhibiting salt-induced kinase-3 protein. J Food Drug Anal. 2021;29(4):622\u201337.","journal-title":"J Food Drug Anal"},{"issue":"12","key":"1124_CR356","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2022.119343","volume":"1869","author":"L Malhotra","year":"2022","unstructured":"Malhotra L, Sharma S, Hariprasad G, et al. Mechanism of apoptosis activation by curcumin rescued mutant p53Y220C in human pancreatic cancer. Biochim Biophys Acta Mol Cell Res. 2022;1869(12): 119343.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"15","key":"1124_CR357","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ijms23158248","volume":"23","author":"MF Wu","year":"2022","unstructured":"Wu MF, Huang YH, Chiu LY, et al. Curcumin induces apoptosis of chemoresistant lung cancer cells via ROS-regulated p38 MAPK phosphorylation. Int J Mol Sci. 2022;23(15):4.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"1124_CR358","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/21691401.2023.2238756","volume":"51","author":"S Harakeh","year":"2023","unstructured":"Harakeh S, Saber SH, Al-Raddadi R, et al. Novel curcumin nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells. Artif Cells Nanomed Biotechnol. 2023;51(1):361\u201370.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"1124_CR359","doi-asserted-by":"crossref","unstructured":"Zhao XY, Zhang RW, Song ZT et al. Curcumin suppressed the proliferation and apoptosis of HPV-positive cervical cancer cells by directly targeting the E6 protein. Phytother Res. 2023.","DOI":"10.1002\/ptr.7868"},{"issue":"5","key":"1124_CR360","first-page":"1997","volume":"44","author":"L Xiang","year":"2020","unstructured":"Xiang L, He B, Liu Q, et al. Antitumor effects of curcumin on the proliferation, migration and apoptosis of human colorectal carcinoma HCT-116 cells. Oncol Res. 2020;44(5):1997\u20132008.","journal-title":"Oncol Res"},{"key":"1124_CR361","unstructured":"Wang P, Wu Q, Peng Q et al. Comparative analysis of the molecular mechanism of inhibiting proliferation and migration in cervical cancer HeLa cell by curcumin and resveratrol. Nat Prod Res. 2022."},{"issue":"11","key":"1124_CR362","first-page":"538","volume":"76","author":"ZQ Dong","year":"2021","unstructured":"Dong ZQ, Feng QQ, Zhang H, et al. Curcumin enhances drug sensitivity of gemcitabine-resistant lung cancer cells and inhibits metastasis. Pharmazie. 2021;76(11):538\u201343.","journal-title":"Pharmazie"},{"key":"1124_CR363","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2021.114689","volume":"283","author":"MJ Li","year":"2022","unstructured":"Li MJ, Guo TT, Lin JY, et al. Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog\/Gli1 signaling pathway. J Ethnopharmacol. 2022;283:1.","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"1124_CR364","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/s41418-023-01178-1","volume":"30","author":"CF Liu","year":"2023","unstructured":"Liu CF, Rokavec M, Huang ZK, et al. Curcumin activates a ROS\/KEAP1\/NRF2\/miR-34a\/b\/c cascade to suppress colorectal cancer metastasis. Cell Death Differ. 2023;30(7):1771\u201385.","journal-title":"Cell Death Differ"},{"issue":"9","key":"1124_CR365","first-page":"9","volume":"9","author":"BH de la Parte","year":"2021","unstructured":"de la Parte BH, Rode\u00f1o-Casado M, Correcher SI, et al. curcumin reduces colorectal cancer cell proliferation and migration and slows in vivo growth of liver metastases in rats. Biomedicines. 2021;9(9):9.","journal-title":"Biomedicines"},{"issue":"1","key":"1124_CR366","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-020-01122-2","volume":"20","author":"MJ Kim","year":"2020","unstructured":"Kim MJ, Park KS, Kim KT, et al. The inhibitory effect of curcumin via fascin suppression through JAK\/STAT3 pathway on metastasis and recurrence of ovary cancer cells. BMC Womens Health. 2020;20(1):1.","journal-title":"BMC Womens Health"},{"issue":"1","key":"1124_CR367","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-021-00966-6","volume":"19","author":"HM Luo","year":"2021","unstructured":"Luo HM, Lu LS, Liu N, et al. Curcumin loaded sub-30 nm targeting therapeutic lipid nanoparticles for synergistically blocking nasopharyngeal cancer growth and metastasis. J Nanobiotechnol. 2021;19(1):1.","journal-title":"J Nanobiotechnol"},{"issue":"7","key":"1124_CR368","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/s41418-023-01178-1","volume":"30","author":"C Liu","year":"2023","unstructured":"Liu C, Rokavec M, Huang Z, et al. Curcumin activates a ROS\/KEAP1\/NRF2\/<i>miR-34a\/b\/c<\/i> cascade to suppress colorectal cancer metastasis. Cell Death Differ. 2023;30(7):1771\u201385.","journal-title":"Cell Death Differ"},{"issue":"12","key":"1124_CR369","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.7150\/jca.85966","volume":"14","author":"LJ Luo","year":"2023","unstructured":"Luo LJ, Lin CJ, Wang PF, et al. Combined use of immune checkpoint inhibitors and phytochemicals as a novel therapeutic strategy against cancer. J Cancer. 2023;14(12):2315\u201328.","journal-title":"J Cancer"},{"issue":"12","key":"1124_CR370","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1111\/cas.14675","volume":"111","author":"T Hayakawa","year":"2020","unstructured":"Hayakawa T, Yaguchi T, Kawakami Y. Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3. Cancer Sci. 2020;111(12):4326\u201335.","journal-title":"Cancer Sci"},{"key":"1124_CR371","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.lfs.2021.119359","volume":"279","author":"L Guo","year":"2021","unstructured":"Guo L, Li H, Fan T, et al. Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma. Life Sci. 2021;279:2.","journal-title":"Life Sci"},{"key":"1124_CR372","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fbioe.2020.00050","volume":"8","author":"ZB Bolat","year":"2020","unstructured":"Bolat ZB, Islek Z, Demir BN, et al. Curcumin- and piperine-loaded emulsomes as combinational treatment approach enhance the anticancer activity of curcumin on HCT116 colorectal cancer model. Front Bioeng Biotechnol. 2020;8:8.","journal-title":"Front Bioeng Biotechnol"},{"key":"1124_CR373","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12659\/MSM.924507","volume":"26","author":"X Jiang","year":"2020","unstructured":"Jiang X, Huang YL. Curcumin derivative c086 combined with cisplatin inhibits proliferation of osteosarcoma cells. Med Sci Monit. 2020;26:1.","journal-title":"Med Sci Monit"},{"issue":"6","key":"1124_CR374","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.3390\/cimb45060319","volume":"45","author":"A Semlali","year":"2023","unstructured":"Semlali A, Beji S, Ajala I, et al. Synergistic effects of new curcumin analog (pac) and cisplatin on oral cancer therapy. Curr Issues Mol Biol. 2023;45(6):5018\u201335.","journal-title":"Curr Issues Mol Biol"},{"issue":"10","key":"1124_CR375","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/pol.20210600","volume":"60","author":"SP Sheng","year":"2022","unstructured":"Sheng SP, Wei C, Ma T, et al. Multiplex fluorescence imaging-guided programmed delivery of doxorubicin and curcumin from a nanoparticles\/hydrogel system for synergistic chemotherapy. J Polym Sci. 2022;60(10):1557\u201370.","journal-title":"J Polym Sci"},{"issue":"3","key":"1124_CR376","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/pharmaceutics15030849","volume":"15","author":"YL Yin","year":"2023","unstructured":"Yin YL, Jiang H, Wang Y, et al. Self-assembled nanodelivery system with rapamycin and curcumin for combined photo-chemotherapy of breast cancer. Pharmaceutics. 2023;15(3):9.","journal-title":"Pharmaceutics"},{"key":"1124_CR377","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fbioe.2021.747637","volume":"9","author":"ST Zuo","year":"2021","unstructured":"Zuo ST, Wang ZY, An XQ, et al. Self-assembly engineering nanodrugs composed of paclitaxel and curcumin for the combined treatment of triple negative breast cancer. Front Bioeng Biotechnol. 2021;9:7.","journal-title":"Front Bioeng Biotechnol"},{"issue":"10","key":"1124_CR378","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1007\/s13738-022-02604-w","volume":"19","author":"S-S Jalaladdiny","year":"2022","unstructured":"Jalaladdiny S-S, Badoei-dalfard A, Karami Z, et al. Co-delivery of doxorubicin and curcumin to breast cancer cells by a targeted delivery system based on Ni\/Ta core-shell metal-organic framework coated with folic acid-activated chitosan nanoparticles. J Iran Chem Soc. 2022;19(10):4287\u201398.","journal-title":"J Iran Chem Soc"},{"issue":"6","key":"1124_CR379","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1021\/acs.molpharmaceut.8b01221","volume":"16","author":"C Karavasili","year":"2019","unstructured":"Karavasili C, Andreadis DA, Katsamenis OL, et al. Synergistic antitumor potency of a self-assembling peptide hydrogel for the local co-delivery of doxorubicin and curcumin in the treatment of head and neck cancer. Mol Pharm. 2019;16(6):2326\u201341.","journal-title":"Mol Pharm"},{"issue":"1","key":"1124_CR380","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s13346-018-00598-8","volume":"9","author":"A Sesarman","year":"2019","unstructured":"Sesarman A, Tefas L, Sylvester B, et al. Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment. Drug Deliv Transl Res. 2019;9(1):260\u201372.","journal-title":"Drug Deliv Transl Res"},{"issue":"2","key":"1124_CR381","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3892\/ijo.2020.5067","volume":"57","author":"Z Yang","year":"2020","unstructured":"Yang Z, Liu J, Lu Y. Doxorubicin and CD-CUR inclusion complex co-loaded in thermosensitive hydrogel PLGA-PEG-PLGA localized administration for osteosarcoma. Int J Oncol. 2020;57(2):433\u201344.","journal-title":"Int J Oncol"},{"issue":"7","key":"1124_CR382","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/jn\/nxz029","volume":"149","author":"LM Howells","year":"2019","unstructured":"Howells LM, Iwuji COO, Irving GRB, et al. Curcumin combined with FOLFOX chemotherapy is safe and tolerable in patients with metastatic colorectal cancer in a randomized phase IIA trial. J Nutr. 2019;149(7):1133\u20139.","journal-title":"J Nutr"},{"key":"1124_CR383","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.abb.2018.04.012","volume":"648","author":"J Guorgui","year":"2018","unstructured":"Guorgui J, Wang R, Mattheolabakis G, et al. Curcumin formulated in solid lipid nanoparticles has enhanced efficacy in Hodgkin\u2019s lymphoma in mice. Arch Biochem Biophys. 2018;648:12\u20139.","journal-title":"Arch Biochem Biophys"},{"key":"1124_CR384","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jpba.2015.04.007","volume":"111","author":"W Ma","year":"2015","unstructured":"Ma W, Wang J, Gun Q, et al. Simultaneous determination of doxorubicin and curcumin in rat plasma by LC-MS\/MS and its application to pharmacokinetic study. J Pharm Biomed Anal. 2015;111:215\u201321.","journal-title":"J Pharm Biomed Anal"},{"issue":"39","key":"1124_CR385","doi-asserted-by":"publisher","first-page":"63870","DOI":"10.18632\/oncotarget.11563","volume":"7","author":"BH Park","year":"2016","unstructured":"Park BH, Lim JE, Jeon HG, et al. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1\/2. Oncotarget. 2016;7(39):63870\u201386.","journal-title":"Oncotarget"},{"issue":"18","key":"1124_CR386","doi-asserted-by":"publisher","first-page":"6738","DOI":"10.1158\/1078-0432.CCR-05-0171","volume":"11","author":"S Lev-Ari","year":"2005","unstructured":"Lev-Ari S, Strier L, Kazanov D, et al. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res. 2005;11(18):6738\u201344.","journal-title":"Clin Cancer Res"},{"key":"1124_CR387","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2019.104454","volume":"150","author":"R Wu","year":"2019","unstructured":"Wu R, Mei X, Ye Y, et al. Zn(II)-curcumin solid dispersion impairs hepatocellular carcinoma growth and enhances chemotherapy by modulating gut microbiota-mediated zinc homeostasis. Pharmacol Res. 2019;150:1.","journal-title":"Pharmacol Res"},{"issue":"10","key":"1124_CR388","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1136\/gutjnl-2020-321153","volume":"69","author":"WY Cheng","year":"2020","unstructured":"Cheng WY, Wu C-Y, Yu J. The role of gut microbiota in cancer treatment: friend or foe? Gut. 2020;69(10):1867\u201376.","journal-title":"Gut"},{"key":"1124_CR389","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fphar.2021.714322","volume":"12","author":"JF Gu","year":"2021","unstructured":"Gu JF, Sun RL, Wang QH, et al. Standardized astragalus mongholicus bunge- curcuma aromatica salisb extract efficiently suppresses colon cancer progression through gut microbiota modification in CT26-bearing mice. Front Pharmacol. 2021;12:8.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1124_CR390","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-29462-7","volume":"13","author":"F Gholipour","year":"2023","unstructured":"Gholipour F, Amini M, Baradaran B, et al. Anticancer properties of curcumin-treated Lactobacillus plantarum against the HT-29 colorectal adenocarcinoma cells. Sci Rep. 2023;13(1):1.","journal-title":"Sci Rep"},{"issue":"4","key":"1124_CR391","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3322\/caac.21670","volume":"71","author":"DR Schmidt","year":"2021","unstructured":"Schmidt DR, Patel R, Kirsch DG, et al. Metabolomics in cancer research and emerging applications in clinical oncology. CA Cancer J Clin. 2021;71(4):333\u201358.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1124_CR392","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","volume":"20","author":"E Heitzer","year":"2019","unstructured":"Heitzer E, Haque IS, Roberts CES, et al. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20(2):71\u201388.","journal-title":"Nat Rev Genet"},{"issue":"7747","key":"1124_CR393","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","volume":"567","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Sun AH, Zhao Y, et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature. 2019;567(7747):257\u201361.","journal-title":"Nature"},{"issue":"5","key":"1124_CR394","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis R, Engblom C, Pfirschke C, et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity. 2019;50(5):1317\u201334.","journal-title":"Immunity"},{"issue":"7","key":"1124_CR395","doi-asserted-by":"publisher","first-page":"e28807","DOI":"10.1016\/j.heliyon.2024.e28807","volume":"10","author":"Y Guo","year":"2024","unstructured":"Guo Y, Su J, Jiang S, et al. Transcriptomics and metabonomics study on the effect of exercise combined with curcumin supplementation on breast cancer in mice. Heliyon. 2024;10(7):e28807\u2013e28807.","journal-title":"Heliyon"},{"key":"1124_CR396","doi-asserted-by":"publisher","first-page":"112738","DOI":"10.1016\/j.jpba.2019.06.035","volume":"175","author":"J-L Zhou","year":"2019","unstructured":"Zhou J-L, Zheng J-Y, Cheng X-Q, et al. Chemical markers\u2019 knockout coupled with UHPLC-HRMS-based metabolomics reveals anti-cancer integration effects of the curcuminoids of turmeric (Curcuma longa L.) on lung cancer cell line. J Pharm Biomed Anal. 2019;175:112738.","journal-title":"J Pharm Biomed Anal"},{"issue":"10","key":"1124_CR397","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1596","volume":"5","author":"S Nirgude","year":"2022","unstructured":"Nirgude S, Desai S, Choudhary B. Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA\/mRNA expression analysis. Cancer Rep. 2022;5(10): e1596.","journal-title":"Cancer Rep"},{"key":"1124_CR398","doi-asserted-by":"crossref","unstructured":"Ravindran F, Mhatre A, Koroth J et al. Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells. Life Sci. 2023, 334.","DOI":"10.1016\/j.lfs.2023.122224"},{"key":"1124_CR399","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioelechem.2019.107350","volume":"131","author":"L Mittal","year":"2020","unstructured":"Mittal L, Aryal UK, Camarillo IG, et al. Effective electrochemotherapy with curcumin in MDA-MB-231-human, triple negative breast cancer cells: a global proteomics study. Bioelectrochemistry. 2020;131: 107350.","journal-title":"Bioelectrochemistry"},{"issue":"1","key":"1124_CR400","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13765-023-00844-9","volume":"66","author":"D Yoon","year":"2023","unstructured":"Yoon D, Choi B-R, Shin WC, et al. Metabolomics reveals that Curcuma longa and demethoxycurcumin inhibit HCT116 human colon cancer cell growth. Appl Biol Chem. 2023;66(1):84.","journal-title":"Appl Biol Chem"},{"issue":"5","key":"1124_CR401","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.21873\/invivo.12062","volume":"34","author":"F-S Chueh","year":"2020","unstructured":"Chueh F-S, Lien J-C, Chou Y-C, et al. Demethoxycurcumin inhibits in vivo growth of xenograft tumors of human cervical cancer cells. In Vivo. 2020;34(5):2469\u201374.","journal-title":"In Vivo"},{"issue":"4","key":"1124_CR402","doi-asserted-by":"publisher","first-page":"687","DOI":"10.4314\/tjpr.v20i4.4","volume":"20","author":"Y Chen","year":"2021","unstructured":"Chen Y, Wu M. Demethoxycurcumin inhibits the growth of human lung cancer cells by targeting of PI3K\/AKT\/m-TOR signalling pathway, induction of apoptosis and inhibition of cell migration and invasion. Trop J Pharm Res. 2021;20(4):687\u201393.","journal-title":"Trop J Pharm Res"},{"issue":"11","key":"1124_CR403","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/tox.23332","volume":"36","author":"C-C Kao","year":"2021","unstructured":"Kao C-C, Cheng Y-C, Yang M-H, et al. Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K\/Akt pathway. Environ Toxicol. 2021;36(11):2186\u201395.","journal-title":"Environ Toxicol"},{"issue":"3","key":"1124_CR404","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S1734-1140(13)71048-X","volume":"65","author":"YB Li","year":"2013","unstructured":"Li YB, Gao JL, Zhong ZF, et al. Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways. Pharmacol Rep. 2013;65(3):700\u20139.","journal-title":"Pharmacol Rep"},{"issue":"48","key":"1124_CR405","doi-asserted-by":"publisher","first-page":"14557","DOI":"10.1021\/acs.jafc.1c05585","volume":"69","author":"CH Chou","year":"2021","unstructured":"Chou CH, Wang HK, Lin YC, et al. Bisdemethoxycurcumin promotes apoptosis and inhibits the epithelial-mesenchymal transition through the inhibition of the G-protein-coupled receptor 161\/mammalian target of rapamycin signaling pathway in triple negative breast cancer cells. J Agric Food Chem. 2021;69(48):14557\u201367.","journal-title":"J Agric Food Chem"},{"issue":"11","key":"1124_CR406","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.3390\/molecules27113446","volume":"27","author":"X Wang","year":"2022","unstructured":"Wang X, Zhou Q, Li X, et al. Insights into aptamer-drug delivery systems against prostate cancer. Molecules. 2022;27(11):3446.","journal-title":"Molecules"},{"issue":"48","key":"1124_CR407","doi-asserted-by":"publisher","first-page":"15166","DOI":"10.1021\/acs.jafc.2c04428","volume":"70","author":"A Wang","year":"2022","unstructured":"Wang A, Jain S, Dia V, et al. Shellac micelles loaded with curcumin using a ph cycle to improve dispersibility, bioaccessibility, and potential for colon delivery. J Agric Food Chem. 2022;70(48):15166\u201377.","journal-title":"J Agric Food Chem"},{"key":"1124_CR408","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.120052","volume":"592","author":"M Soleymani","year":"2021","unstructured":"Soleymani M, Velashjerdi M, Asgari M. Preparation of hyaluronic acid-decorated mixed nanomicelles for targeted delivery of hydrophobic drugs to CD44-overexpressing cancer cells. Int J Pharm. 2021;592: 120052.","journal-title":"Int J Pharm"},{"key":"1124_CR409","doi-asserted-by":"crossref","unstructured":"Pakian S, Radmanesh F, Sadeghi-Abandansari H et al. Gelatin-Based Injectable Hydrogel\/Microgel Composite as a Combinational Dual Drug Delivery System for Local Co-delivery of Curcumin and 5-Fluorouracil in Synergistic Therapy of Colorectal Cancer br. ACS Appl Polym Mater. 2022.","DOI":"10.1021\/acsapm.2c01188"},{"key":"1124_CR410","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jare.2019.02.036","volume":"18","author":"M Kundu","year":"2019","unstructured":"Kundu M, Sadhukhan P, Ghosh N, et al. pH-responsive and targeted delivery of curcumin via phenylboronic acid-functionalized ZnO nanoparticles for breast cancer therapy. J Adv Res. 2019;18:161\u201372.","journal-title":"J Adv Res"},{"issue":"1","key":"1124_CR411","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/polym15010116","volume":"15","author":"T Kaewruethai","year":"2023","unstructured":"Kaewruethai T, Lin Y, Wang Q, et al. The dual modification of PNIPAM and \u03b2-cyclodextrin grafted on hyaluronic acid as self-assembled nanogel for curcumin delivery. Polymers-Basel. 2023;15(1):116.","journal-title":"Polymers-Basel"},{"issue":"1","key":"1124_CR412","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1166\/jbn.2020.2878","volume":"16","author":"Y He","year":"2020","unstructured":"He Y, Wu C, Duan J, et al. Anti-glioma effect with targeting therapy using folate modified nano-micelles delivery curcumin. J Biomed Nanotechnol. 2020;16(1):1\u201313.","journal-title":"J Biomed Nanotechnol"},{"issue":"4","key":"1124_CR413","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1021\/acsabm.3c01145","volume":"7","author":"J Chae","year":"2024","unstructured":"Chae J, Choi Y, Hong J, et al. Anticancer and antibacterial properties of curcumin-loaded mannosylated solid lipid nanoparticles for the treatment of lung diseases. ACS Appl Bio Mater. 2024;7(4):2175\u201385.","journal-title":"ACS Appl Bio Mater"},{"key":"1124_CR414","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.111404","volume":"197","author":"S Ghosh","year":"2021","unstructured":"Ghosh S, Dutta S, Sarkar A, et al. Targeted delivery of curcumin in breast cancer cells via hyaluronic acid modified mesoporous silica nanoparticle to enhance anticancer efficiency. Colloids Surf B Biointerfaces. 2021;197: 111404.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"5","key":"1124_CR415","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1039\/D0FO00260G","volume":"11","author":"X Lin","year":"2020","unstructured":"Lin X, Wang L, Zhao L, et al. Curcumin micelles suppress gastric tumor cell growth by upregulating ROS generation, disrupting redox equilibrium and affecting mitochondrial bioenergetics. Food Funct. 2020;11(5):4146\u201359.","journal-title":"Food Funct"},{"issue":"1","key":"1124_CR416","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1133","volume":"2","author":"FU Vaidya","year":"2019","unstructured":"Vaidya FU, Sharma R, Shaikh S, et al. Pluronic micelles encapsulated curcumin manifests apoptotic cell death and inhibits pro-inflammatory cytokines in human breast adenocarcinoma cells. Cancer Rep. 2019;2(1): e1133.","journal-title":"Cancer Rep"},{"issue":"9","key":"1124_CR417","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/gels9090762","volume":"9","author":"J Shen","year":"2023","unstructured":"Shen J, Zhang J, Wu W, et al. Biocompatible anisole-nonlinear PEG core-shell nanogels for high loading capacity, excellent stability, and controlled release of curcumin. Gels. 2023;9(9):762.","journal-title":"Gels"},{"issue":"2","key":"1124_CR418","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/polym13020194","volume":"13","author":"JA Luckanagul","year":"2021","unstructured":"Luckanagul JA, Ratnatilaka NBP, Muangnoi C, et al. Self-assembled thermoresponsive nanogel from grafted hyaluronic acid as a biocompatible delivery platform for curcumin with enhanced drug loading and biological activities. Polymers-Basel. 2021;13(2):194.","journal-title":"Polymers-Basel"},{"key":"1124_CR419","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.602941","volume":"8","author":"F Howaili","year":"2021","unstructured":"Howaili F, Ozliseli E, Kucukturkmen B, et al. Stimuli-responsive, plasmonic nanogel for dual delivery of curcumin and photothermal therapy for cancer treatment. Front Chem. 2021;8: 602941.","journal-title":"Front Chem"},{"key":"1124_CR420","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120628","volume":"602","author":"Y Wang","year":"2021","unstructured":"Wang Y, Ding R, Zhang Z, et al. Curcumin-loaded liposomes with the hepatic and lysosomal dual-targeted effects for therapy of hepatocellular carcinoma. Int J Pharm. 2021;602: 120628.","journal-title":"Int J Pharm"},{"issue":"2","key":"1124_CR421","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/08982104.2020.1755981","volume":"31","author":"M Moballegh-Nasery","year":"2021","unstructured":"Moballegh-Nasery M, Mandegary A, Eslaminejad T, et al. Cytotoxicity evaluation of curcumin-loaded affibody-decorated liposomes against breast cancerous cell lines. J Liposome Res. 2021;31(2):189\u201394.","journal-title":"J Liposome Res"},{"key":"1124_CR422","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jconrel.2015.06.029","volume":"219","author":"L Milane","year":"2015","unstructured":"Milane L, Singh A, Mattheolabakis G, et al. Exosome mediated communication within the tumor microenvironment. J Control Release. 2015;219:278\u201394.","journal-title":"J Control Release"},{"issue":"9","key":"1124_CR423","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/mt.2010.105","volume":"18","author":"D Sun","year":"2010","unstructured":"Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther. 2010;18(9):1606\u201314.","journal-title":"Mol Ther"},{"issue":"6","key":"1124_CR424","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1208\/s12248-017-0154-9","volume":"19","author":"F Aqil","year":"2017","unstructured":"Aqil F, Munagala R, Jeyabalan J, et al. Exosomes for the enhanced tissue bioavailability and efficacy of curcumin. Aaps J. 2017;19(6):1691\u2013702.","journal-title":"Aaps J"},{"issue":"52","key":"1124_CR425","doi-asserted-by":"publisher","first-page":"87081","DOI":"10.18632\/oncotarget.13499","volume":"7","author":"H Wu","year":"2016","unstructured":"Wu H, Zhou J, Zeng C, et al. Curcumin increases exosomal TCF21 thus suppressing exosome-induced lung cancer. Oncotarget. 2016;7(52):87081\u201390.","journal-title":"Oncotarget"},{"issue":"26","key":"1124_CR426","doi-asserted-by":"publisher","first-page":"21918","DOI":"10.18632\/oncotarget.4204","volume":"6","author":"S Taverna","year":"2015","unstructured":"Taverna S, Giallombardo M, Pucci M, et al. Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21. Oncotarget. 2015;6(26):21918\u201333.","journal-title":"Oncotarget"},{"issue":"12","key":"1124_CR427","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-14-3095","volume":"75","author":"Q Wang","year":"2015","unstructured":"Wang Q, Ren Y, Mu J, et al. Grapefruit-derived nanovectors use an activated leukocyte trafficking pathway to deliver therapeutic agents to inflammatory tumor sites. Cancer Res. 2015;75(12):2520\u20139.","journal-title":"Cancer Res"},{"issue":"2","key":"1124_CR428","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/10715760000300141","volume":"32","author":"M Sato","year":"2000","unstructured":"Sato M, Maulik G, Bagchi D, et al. Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin. Free Radical Res. 2000;32(2):135\u201344.","journal-title":"Free Radical Res"},{"issue":"11","key":"1124_CR429","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S0024-3205(00)01033-X","volume":"68","author":"YC Kuo","year":"2001","unstructured":"Kuo YC, Tsai WJ, Meng HC, et al. Immune reponses in human mesangial cells regulated by emodin from polygonum hypoleucum ohwi. Life Sci. 2001;68(11):1271\u201386.","journal-title":"Life Sci"},{"issue":"11","key":"1124_CR430","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0278-6915(91)90185-A","volume":"29","author":"H Lee","year":"1991","unstructured":"Lee H, Tsai SJ. Effect of emodin on cooked-food mutagen activation. Food Chem Toxicol. 1991;29(11):765\u201370.","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"1124_CR431","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1128\/am.30.1.26-28.1975","volume":"30","author":"JM Wells","year":"1975","unstructured":"Wells JM, Cole RJ, Kirksey JW. Emodin, a toxic metabolite of Aspergillus wentii isolated from weevil-damaged chestnuts. Appl Microbiol. 1975;30(1):26\u20138.","journal-title":"Appl Microbiol"},{"issue":"3","key":"1124_CR432","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0378-8741(84)90016-3","volume":"10","author":"X Peigen","year":"1984","unstructured":"Peigen X, Liyi H, Liwei W. Ethnopharmacologic study of Chinese rhubarb. J Ethnopharmacol. 1984;10(3):275\u201393.","journal-title":"J Ethnopharmacol"},{"key":"1124_CR433","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114539","volume":"161","author":"X Wang","year":"2023","unstructured":"Wang X, Yang S, Li Y, et al. Role of emodin in atherosclerosis and other cardiovascular diseases: pharmacological effects, mechanisms, and potential therapeutic target as a phytochemical. Biomed Pharmacother. 2023;161: 114539.","journal-title":"Biomed Pharmacother"},{"key":"1124_CR434","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-025-01065-6","author":"L Qu","year":"2025","unstructured":"Qu L, Jiao M, Zhang Z, et al. A strategy for selective screening of dual-target bioactive compounds against hypertrophic scar through inhibiting angiotensin II type 1 receptor while stimulating type 2 receptor from Chinese herbs. Chin Med. 2025. https:\/\/doi.org\/10.1186\/s13020-025-01065-6.","journal-title":"Chin Med"},{"issue":"1","key":"1124_CR435","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-023-00801-0","volume":"18","author":"Y-Y Xu","year":"2023","unstructured":"Xu Y-Y, Zhu M, Wu J, et al. A mannitol-modified emodin nano-drug restores the intestinal barrier function and alleviates inflammation in a mouse model of DSS-induced ulcerative colitis. Chin Med. 2023;18(1):1.","journal-title":"Chin Med"},{"issue":"8","key":"1124_CR436","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.7150\/ijbs.70447","volume":"18","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Chen WW, Sun X, et al. The versatile emodin: a natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers. Int J Biol Sci. 2022;18(8):3498\u2013527.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"1124_CR437","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/med.20095","volume":"27","author":"G Srinivas","year":"2007","unstructured":"Srinivas G, Babykutty S, Sathiadevan PP, et al. Molecular mechanism of emodin action: transition from laxative ingredient to an antitumor agent. Med Res Rev. 2007;27(5):591\u2013608.","journal-title":"Med Res Rev"},{"key":"1124_CR438","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.biopha.2022.113008","volume":"150","author":"AE Mohammed","year":"2022","unstructured":"Mohammed AE, Ameen F, Aabed K, et al. In-silico predicting as a tool to develop plant-based biomedicines and nanoparticles: Lycium shawii metabolites. Biomed Pharmacother. 2022;150:2.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"1124_CR439","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph15111348","volume":"15","author":"W Ahmad","year":"2022","unstructured":"Ahmad W, Ansari MA, Alsayari A, et al. In vitro, molecular docking and in silico adme\/tox studies of emodin and chrysophanol against human colorectal and cervical carcinoma. Pharmaceuticals. 2022;15(11):1.","journal-title":"Pharmaceuticals"},{"issue":"15","key":"1124_CR440","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.7150\/thno.43622","volume":"10","author":"G Zou","year":"2020","unstructured":"Zou G, Zhang X, Wang L, et al. Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription. Theranostics. 2020;10(15):6839\u201353.","journal-title":"Theranostics"},{"issue":"3","key":"1124_CR441","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1039\/C8BM01530A","volume":"7","author":"Y Song","year":"2019","unstructured":"Song Y, Sheng Z, Xu Y, et al. Magnetic liposomal emodin composite with enhanced killing efficiency against breast cancer. Biomater Sci. 2019;7(3):867\u201375.","journal-title":"Biomater Sci"},{"issue":"3","key":"1124_CR442","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/1061186X.2019.1656725","volume":"28","author":"M Fu","year":"2020","unstructured":"Fu M, Tang W, Liu J-J, et al. Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer. J Drug Target. 2020;28(3):245\u201358.","journal-title":"J Drug Target"},{"key":"1124_CR443","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.109813","volume":"103","author":"M Siri","year":"2019","unstructured":"Siri M, Ruocco MJF, Achilli E, et al. Effect of structure in ionised albumin based nanoparticle: characterisation, emodin interaction, and in vitro cytotoxicity. Mater Sci Eng C Mater Biol Appl. 2019;103: 109813.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1124_CR444","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.2147\/IJN.S335588","volume":"16","author":"S Ren","year":"2021","unstructured":"Ren S, Song L, Tian Y, et al. Emodin-conjugated PEGylation of Fe3O4 nanoparticles for FI\/MRI dual-modal imaging and therapy in pancreatic cancer. Int J Nanomedicine. 2021;16:7463\u201378.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"1124_CR445","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12967-019-1838-y","volume":"17","author":"Z Li","year":"2019","unstructured":"Li Z, Lin Y, Zhang S, et al. Emodin regulates neutrophil phenotypes to prevent hypercoagulation and lung carcinogenesis. J Transl Med. 2019;17(1):90.","journal-title":"J Transl Med"},{"key":"1124_CR446","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fimmu.2016.00373","volume":"7","author":"A-K Olsson","year":"2016","unstructured":"Olsson A-K, Cedervall J. NETosis in cancer\u2014platelet-neutrophil crosstalk promotes tumor-associated pathology. Front Immunol. 2016;7:373.","journal-title":"Front Immunol"},{"issue":"2","key":"1124_CR447","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.canlet.2014.05.008","volume":"352","author":"Q-M Fan","year":"2014","unstructured":"Fan Q-M, Jing Y-Y, Yu G-F, et al. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett. 2014;352(2):160\u20138.","journal-title":"Cancer Lett"},{"issue":"18","key":"1124_CR448","doi-asserted-by":"publisher","first-page":"8365","DOI":"10.7150\/thno.45395","volume":"10","author":"Q Liu","year":"2020","unstructured":"Liu Q, Hodge J, Wang J, et al. Emodin reduces breast cancer lung metastasis by suppressing macrophage-induced breast cancer cell epithelial-mesenchymal transition and cancer stem cell formation. Theranostics. 2020;10(18):8365\u201381.","journal-title":"Theranostics"},{"issue":"4","key":"1124_CR449","doi-asserted-by":"publisher","first-page":"9548","DOI":"10.1080\/21655979.2022.2061295","volume":"13","author":"J Yin","year":"2022","unstructured":"Yin J, Zhao X, Chen X, et al. Emodin suppresses hepatocellular carcinoma growth by regulating macrophage polarization via microRNA-26a\/transforming growth factor beta 1\/protein kinase B. Bioengineered. 2022;13(4):9548\u201363.","journal-title":"Bioengineered"},{"issue":"3","key":"1124_CR450","doi-asserted-by":"publisher","first-page":"G383","DOI":"10.1152\/ajpgi.00303.2021","volume":"322","author":"AT Sougiannis","year":"2022","unstructured":"Sougiannis AT, VanderVeen B, Chatzistamou I, et al. Emodin reduces tumor burden by diminishing M2-like macrophages in colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2022;322(3):G383\u201395.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1124_CR451","doi-asserted-by":"publisher","first-page":"8840590","DOI":"10.1155\/2021\/8840590","volume":"2021","author":"K-J Wang","year":"2021","unstructured":"Wang K-J, Meng X-Y, Chen J-F, et al. Emodin induced necroptosis and inhibited glycolysis in the renal cancer cells by enhancing ROS. Oxid Med Cell Longev. 2021;2021:8840590.","journal-title":"Oxid Med Cell Longev"},{"issue":"9\u201310","key":"1124_CR452","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1007\/s10495-024-01973-2","volume":"29","author":"Z Shen","year":"2024","unstructured":"Shen Z, Zhao L, Yoo S-A, et al. Emodin induces ferroptosis in colorectal cancer through NCOA4-mediated ferritinophagy and NF-\u03bab pathway inactivation. Apoptosis. 2024;29(9\u201310):1810\u201323.","journal-title":"Apoptosis"},{"issue":"6","key":"1124_CR453","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202201130","volume":"20","author":"X Zhou","year":"2023","unstructured":"Zhou X, Yeasmin Khusbu F, Xie Y, et al. Emodin-induced necroptosis in prostate cancer cells via the mitochondrial fission HSP90\/MLKL\/PGAM pathway. Chem Biodivers. 2023;20(6): e202201130.","journal-title":"Chem Biodivers"},{"issue":"1","key":"1124_CR454","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10637-019-00764-w","volume":"38","author":"J Zhou","year":"2020","unstructured":"Zhou J, Li G, Han G, et al. Emodin induced necroptosis in the glioma cell line U251 via the TNF-\u03b1\/RIP1\/RIP3 pathway. Invest New Drugs. 2020;38(1):50\u20139.","journal-title":"Invest New Drugs"},{"key":"1124_CR455","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.06.006","volume":"619","author":"W Wu","year":"2022","unstructured":"Wu W, Lu P, Huang Y, et al. Emodin regulates the autophagy via the miR-371a-5p\/PTEN axis to inhibit hepatic malignancy. Biochem Biophys Res Commun. 2022;619:1\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1124_CR456","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1186\/s12885-022-09684-0","volume":"22","author":"B Qin","year":"2022","unstructured":"Qin B, Zeng Z, Xu J, et al. Emodin inhibits invasion and migration of hepatocellular carcinoma cells via regulating autophagy-mediated degradation of snail and \u03b2-catenin. BMC Cancer. 2022;22(1):671.","journal-title":"BMC Cancer"},{"issue":"8","key":"1124_CR457","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/gtc.12712","volume":"24","author":"Y Sugiyama","year":"2019","unstructured":"Sugiyama Y, Shudo T, Hosokawa S, et al. Emodin, as a mitochondrial uncoupler, induces strong decreases in adenosine triphosphate (ATP) levels and proliferation of B16F10 cells, owing to their poor glycolytic reserve. Genes Cells. 2019;24(8):569\u201384.","journal-title":"Genes Cells"},{"issue":"7","key":"1124_CR458","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/nu14071508","volume":"14","author":"X-Q Fang","year":"2022","unstructured":"Fang X-Q, Kim Y-S, Lee Y-M, et al. Polygonum cuspidatum extract (Pc-Ex) containing emodin suppresses lung cancer-induced cachexia by suppressing TCF4\/TWIST1 complex-induced PTHrP expression. Nutrients. 2022;14(7):1508.","journal-title":"Nutrients"},{"issue":"11","key":"1124_CR459","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3390\/cancers11111795","volume":"11","author":"C-C Wu","year":"2019","unstructured":"Wu C-C, Chen M-S, Cheng Y-J, et al. Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis. Cancers (Basel). 2019;11(11):1795.","journal-title":"Cancers (Basel)"},{"key":"1124_CR460","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2021.105728","volume":"170","author":"S Wang","year":"2021","unstructured":"Wang S, Fu J-L, Hao H-F, et al. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Pharmacol Res. 2021;170:1.","journal-title":"Pharmacol Res"},{"issue":"1","key":"1124_CR461","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12935-020-01711-z","volume":"21","author":"M Li","year":"2021","unstructured":"Li M, Jin S, Cao Y, et al. Emodin regulates cell cycle of non-small lung cancer (NSCLC) cells through hyaluronan synthase 2 (HA2)-HA-CD44\/receptor for hyaluronic acid-mediated motility (RHAMM) interaction-dependent signaling pathway. Cancer Cell Int. 2021;21(1):19.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"1124_CR462","doi-asserted-by":"publisher","first-page":"679","DOI":"10.21873\/anticanres.13163","volume":"39","author":"W Trybus","year":"2019","unstructured":"Trybus W, Kr\u00f3l T, Trybus E, et al. Emodin induces death in human cervical cancer cells through mitotic catastrophe. Anticancer Res. 2019;39(2):679\u201386.","journal-title":"Anticancer Res"},{"issue":"3","key":"1124_CR463","doi-asserted-by":"publisher","first-page":"652","DOI":"10.7150\/jca.41160","volume":"12","author":"D Wahi","year":"2021","unstructured":"Wahi D, Soni D, Grover A. A double-edged sword: the anti-cancer effects of emodin by inhibiting the redox-protective protein MTH1 and augmenting ROS in NSCLC. J Cancer. 2021;12(3):652\u201381.","journal-title":"J Cancer"},{"key":"1124_CR464","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1515\/biol-2018-0058","volume":"13","author":"J Jiang","year":"2018","unstructured":"Jiang J, Zhou N, Ying P, et al. Emodin promotes apoptosis of human endometrial cancer through regulating the MAPK and PI3K\/ AKT pathways. Open Life Sci. 2018;13:489\u201396.","journal-title":"Open Life Sci"},{"issue":"1","key":"1124_CR465","doi-asserted-by":"publisher","first-page":"2365590","DOI":"10.1080\/13510002.2024.2365590","volume":"29","author":"HM Hassan","year":"2024","unstructured":"Hassan HM, Hamdan AM, Alattar A, et al. Evaluating anticancer activity of emodin by enhancing antioxidant activities and affecting PKC\/ADAMTS4 pathway in thioacetamide-induced hepatocellular carcinoma in rats. Redox Rep. 2024;29(1):2365590.","journal-title":"Redox Rep"},{"issue":"6","key":"1124_CR466","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1248\/bpb.b20-00807","volume":"44","author":"C Liu","year":"2021","unstructured":"Liu C, Chen L, Wang W, et al. Emodin suppresses the migration and invasion of melanoma cells. Biol Pharm Bull. 2021;44(6):771\u20139.","journal-title":"Biol Pharm Bull"},{"issue":"10","key":"1124_CR467","doi-asserted-by":"publisher","first-page":"6198","DOI":"10.21037\/tcr-20-1040","volume":"9","author":"M Yuan","year":"2020","unstructured":"Yuan M, Chen L, Wang W, et al. Emodin inhibits the proliferation and migration of B16F10 cells and induces their apoptosis. Transl Cancer Res. 2020;9(10):6198\u2013205.","journal-title":"Transl Cancer Res"},{"key":"1124_CR468","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154149","volume":"102","author":"G Dai","year":"2022","unstructured":"Dai G, Wang D, Ma S, et al. ACSL4 promotes colorectal cancer and is a potential therapeutic target of emodin. Phytomedicine. 2022;102: 154149.","journal-title":"Phytomedicine"},{"issue":"2","key":"1124_CR469","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10637-019-00777-5","volume":"38","author":"J Bai","year":"2020","unstructured":"Bai J, Wu J, Tang R, et al. Emodin, a natural anthraquinone, suppresses liver cancer in vitro and in vivo by regulating VEGFR2 and miR-34a. Invest New Drugs. 2020;38(2):229\u201345.","journal-title":"Invest New Drugs"},{"issue":"3","key":"1124_CR470","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3892\/ol.2022.13215","volume":"23","author":"H Long","year":"2022","unstructured":"Long H, Chen H, Yan J, et al. Emodin exerts antitumor effects in ovarian cancer cell lines by preventing the development of cancer stem cells via epithelial mesenchymal transition. Oncol Lett. 2022;23(3):95.","journal-title":"Oncol Lett"},{"issue":"6","key":"1124_CR471","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17052","volume":"9","author":"F Li","year":"2023","unstructured":"Li F, Song X, Zhou X, et al. Emodin attenuates high lipid-induced liver metastasis through the AKT and ERK pathways in vitro in breast cancer cells and in a mouse xenograft model. Heliyon. 2023;9(6): e17052.","journal-title":"Heliyon"},{"key":"1124_CR472","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.622046","volume":"11","author":"N Zhang","year":"2020","unstructured":"Zhang N, Wang J, Sheng A, et al. Emodin inhibits the proliferation of MCF-7 human breast cancer cells through activation of aryl hydrocarbon receptor (AhR). Front Pharmacol. 2020;11: 622046.","journal-title":"Front Pharmacol"},{"key":"1124_CR473","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153786","volume":"95","author":"F-Y Zhang","year":"2022","unstructured":"Zhang F-Y, Li R-Z, Xu C, et al. Emodin induces apoptosis and suppresses non-small-cell lung cancer growth via downregulation of sPLA2-IIa. Phytomedicine. 2022;95: 153786.","journal-title":"Phytomedicine"},{"issue":"5","key":"1124_CR474","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2174\/0115680096256913231101103719","volume":"24","author":"Y Gao","year":"2024","unstructured":"Gao Y, Li Y, Zhu Y, et al. Emodin is a potential drug targeting CD44-positive hepatocellular cancer. Curr Cancer Drug Targets. 2024;24(5):510\u20138.","journal-title":"Curr Cancer Drug Targets"},{"issue":"6","key":"1124_CR475","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3892\/ol.2023.14101","volume":"26","author":"X Liu","year":"2023","unstructured":"Liu X, Wei W, Wu Y-Z, et al. Emodin treatment of papillary thyroid cancer cell lines in vitro inhibits proliferation and enhances apoptosis via downregulation of NF-\u03baB and its upstream TLR4 signaling. Oncol Lett. 2023;26(6):514.","journal-title":"Oncol Lett"},{"issue":"11","key":"1124_CR476","doi-asserted-by":"publisher","first-page":"6276","DOI":"10.3390\/ijms23116276","volume":"23","author":"M Nowak-Perlak","year":"2022","unstructured":"Nowak-Perlak M, Bromke MA, Zi\u00f3\u0142kowski P, et al. The comparison of the efficiency of emodin and aloe-emodin in photodynamic therapy. Int J Mol Sci. 2022;23(11):6276.","journal-title":"Int J Mol Sci"},{"issue":"07","key":"1124_CR477","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1142\/S0192415X23500787","volume":"51","author":"W Liu","year":"2023","unstructured":"Liu W, Qaed E, Zhu Y, et al. Research progress and new perspectives of anticancer effects of emodin. Am J Chin Med. 2023;51(07):1751\u201393.","journal-title":"Am J Chin Med"},{"key":"1124_CR478","doi-asserted-by":"crossref","unstructured":"Varli M, Ji M, Kim E et al. Emodin disrupts the KITENIN oncogenic complex by binding ErbB4 and suppresses colorectal cancer progression in dual blockade with KSRP-binding compound. Phytomedicine. 2025, 136.","DOI":"10.1016\/j.phymed.2024.156247"},{"issue":"11","key":"1124_CR479","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165897","volume":"1866","author":"L Ponnusamy","year":"2020","unstructured":"Ponnusamy L, Kothandan G, Manoharan R. Berberine and emodin abrogates breast cancer growth and facilitates apoptosis through inactivation of SIK3-induced mTOR and Akt signaling pathway. Biochim Biophys Acta Mol Basis Dis. 2020;1866(11): 165897.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"11","key":"1124_CR480","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2020.129695","volume":"1864","author":"M Bhattacharjee","year":"2020","unstructured":"Bhattacharjee M, Upadhyay P, Sarker S, et al. Combinatorial therapy of thymoquinone and emodin synergistically enhances apoptosis, attenuates cell migration and reduces stemness efficiently in breast cancer. Biochim Biophys Acta Gen Subj. 2020;1864(11): 129695.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"1124_CR481","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.2147\/DDDT.S196319","volume":"13","author":"S Chen","year":"2019","unstructured":"Chen S, Zhang Z, Zhang J. Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo. Drug Des Devel Ther. 2019;13:1145\u201353.","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"1124_CR482","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3892\/ol.2021.12491","volume":"21","author":"S Peng","year":"2021","unstructured":"Peng S, Wang J, Lu C, et al. Emodin enhances cisplatin sensitivity in non-small cell lung cancer through Pgp downregulation. Oncol Lett. 2021;21(3):230.","journal-title":"Oncol Lett"},{"issue":"9","key":"1124_CR483","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/CAD.0000000000001086","volume":"32","author":"X Teng","year":"2021","unstructured":"Teng X, Wang SY, Shi YQ, et al. The role of emodin on cisplatin resistance reversal of lung adenocarcinoma A549\/DDP cell. Anticancer Drugs. 2021;32(9):939\u201349.","journal-title":"Anticancer Drugs"},{"issue":"5","key":"1124_CR484","first-page":"1851","volume":"12","author":"T Li","year":"2020","unstructured":"Li T, Si W, Zhu J, et al. Emodin reverses 5-Fu resistance in human colorectal cancer via downregulation of PI3K\/Akt signaling pathway. Am J Transl Res. 2020;12(5):1851\u201361.","journal-title":"Am J Transl Res"},{"key":"1124_CR485","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155821","volume":"132","author":"G Zhou","year":"2024","unstructured":"Zhou G, Xie R-F, Li S-N, et al. Synergic effects and possible mechanism of emodin and stilbene glycosides on colorectal cancer. Phytomedicine. 2024;132: 155821.","journal-title":"Phytomedicine"},{"issue":"15","key":"1124_CR486","doi-asserted-by":"publisher","first-page":"8510","DOI":"10.3390\/ijms23158510","volume":"23","author":"W Trybus","year":"2022","unstructured":"Trybus W, Trybus E, Kr\u00f3l T. Emodin sensitizes cervical cancer cells to vinblastine by inducing apoptosis and mitotic death. Int J Mol Sci. 2022;23(15):8510.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1124_CR487","first-page":"1","volume":"74","author":"M Yang","year":"2023","unstructured":"Yang M, Xiong Z, Deng H, et al. Effect of emodin combined with cisplatin on the invasion and migration of HepG2 hepatoma cells. J Physiol Pharmacol. 2023;74(4):1.","journal-title":"J Physiol Pharmacol"},{"key":"1124_CR488","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.2147\/CMAR.S221877","volume":"11","author":"Z Wang","year":"2019","unstructured":"Wang Z, Chen H, Chen J, et al. Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway. Cancer Manag Res. 2019;11:8463\u201373.","journal-title":"Cancer Manag Res"},{"key":"1124_CR489","doi-asserted-by":"publisher","first-page":"116509","DOI":"10.1016\/j.bcp.2024.116509","volume":"2024","author":"C Xu","year":"2024","unstructured":"Xu C, Pascual-Sabater S, Fillat C, et al. The LAMB3-EGFR signaling pathway mediates synergistic Anti-Cancer effects of berberine and emodin in Pancreatic cancer. Biochem Pharmacol. 2024;2024:116509.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1124_CR490","first-page":"260","volume":"43","author":"W Ma","year":"2020","unstructured":"Ma W, Liu F, Yuan L, et al. Emodin and AZT synergistically inhibit the proliferation and induce the apoptosis of leukemia K562 cells through the EGR1 and the Wnt\/\u03b2-catenin pathway. Oncol Res. 2020;43(1):260\u20139.","journal-title":"Oncol Res"},{"issue":"10","key":"1124_CR491","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1248\/bpb.b20-00325","volume":"43","author":"X-Y Wang","year":"2020","unstructured":"Wang X-Y, Sun G-B, Wang Y-J, et al. Emodin inhibits resistance to imatinib by downregulation of Bcr-Abl and STAT5 and allosteric inhibition in chronic myeloid leukemia cells. Biol Pharm Bull. 2020;43(10):1526\u201333.","journal-title":"Biol Pharm Bull"},{"key":"1124_CR492","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.2147\/DDDT.S333383","volume":"15","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zou Z, Jaisi A, et al. Unravelling the protective effects of emodin against cyclophosphamide induced gonadotoxicity in male wistar rats. Drug Des Devel Ther. 2021;15:4403\u201311.","journal-title":"Drug Des Devel Ther"},{"issue":"7","key":"1124_CR493","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/biomedicines10071638","volume":"10","author":"C-M Hsu","year":"2022","unstructured":"Hsu C-M, Yen C-H, Wang S-C, et al. Emodin ameliorates the efficacy of carfilzomib in multiple myeloma cells via apoptosis and autophagy. Biomedicines. 2022;10(7):1638.","journal-title":"Biomedicines"},{"issue":"7","key":"1124_CR494","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41419-019-1768-x","volume":"10","author":"R Liu","year":"2019","unstructured":"Liu R, Liu J, Wang S, et al. Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage\/dysfunction and cell death. Cell Death Dis. 2019;10(7):527.","journal-title":"Cell Death Dis"},{"key":"1124_CR495","doi-asserted-by":"crossref","unstructured":"Karatoprak GS, Akkol EK, Yucel C et al. Advances in Understanding the Role of Aloe Emodin and Targeted Drug Delivery Systems in Cancer. Oxidative Medicine and Cellular Longevity. 2022, 2022.","DOI":"10.1155\/2022\/7928200"},{"key":"1124_CR496","doi-asserted-by":"crossref","unstructured":"Nowak-Perlak M, Ziolkowski P, Wozniak M. A promising natural anthraquinones mediated by photodynamic therapy for anti-cancer therapy. Phytomedicine. 2023, 119.","DOI":"10.1016\/j.phymed.2023.155035"},{"issue":"21","key":"1124_CR497","doi-asserted-by":"publisher","first-page":"7366","DOI":"10.3390\/molecules28217366","volume":"28","author":"E Okon","year":"2023","unstructured":"Okon E, Koval M, Wawruszak A, et al. Emodin-8-O-glucoside-isolation and the screening of the anticancer potential against the nervous system tumors. Molecules. 2023;28(21):7366.","journal-title":"Molecules"},{"issue":"3","key":"1124_CR498","first-page":"281","volume":"49","author":"C Li","year":"2019","unstructured":"Li C, Gao S, Yang W-S, et al. \u03b2-dihydroartemisinin-emodin promotes apoptosis by activating extrinsic and intrinsic pathways in human liver cancer cells. Ann Clin Lab Sci. 2019;49(3):281\u201390.","journal-title":"Ann Clin Lab Sci"},{"issue":"3","key":"1124_CR499","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/19390211.2023.2284985","volume":"21","author":"MT He","year":"2024","unstructured":"He MT, Nguyen QN, Cho EJ, et al. Aloe-emodin isolated from rheum Undulatum L. regulates cell cycle distribution and cellular senescence in human prostate cancer lncap cells. J Diet Suppl. 2024;21(3):389\u2013407.","journal-title":"J Diet Suppl"},{"key":"1124_CR500","doi-asserted-by":"publisher","first-page":"1325184","DOI":"10.3389\/fphar.2023.1325184","volume":"14","author":"T Hussain","year":"2023","unstructured":"Hussain T, Alafnan A, Almazni IA, et al. Aloe-emodin exhibits growth-suppressive effects on androgen-independent human prostate cancer DU145 cells via inhibiting the Wnt\/\u03b2-catenin signaling pathway: an in vitro and in silico study. Front Pharmacol. 2023;14:1325184.","journal-title":"Front Pharmacol"},{"key":"1124_CR501","doi-asserted-by":"publisher","first-page":"5108298","DOI":"10.1155\/2020\/5108298","volume":"2020","author":"X Jiang","year":"2020","unstructured":"Jiang X, Liu Y, Zhang G, et al. Aloe-emodin induces breast tumor cell apoptosis through upregulation of miR-15a\/miR-16-1 that suppresses BCL2. Evid Based Complement Alternat Med. 2020;2020:5108298.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"5","key":"1124_CR502","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s43440-020-00062-w","volume":"72","author":"S Wang","year":"2020","unstructured":"Wang S, Yan W-W, He M, et al. Aloe emodin inhibits telomerase activity in breast cancer cells: transcriptional and enzymological mechanism. Pharmacol Rep. 2020;72(5):1383\u201396.","journal-title":"Pharmacol Rep"},{"issue":"22","key":"1124_CR503","doi-asserted-by":"publisher","first-page":"13738","DOI":"10.3390\/ijms232213738","volume":"23","author":"G Cheng","year":"2022","unstructured":"Cheng G, Liu Z, Zheng Z, et al. Cell metabolomics reveals the potential mechanism of aloe emodin and emodin inhibiting breast cancer metastasis. Int J Mol Sci. 2022;23(22):13738.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1124_CR504","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1002\/ptr.7096","volume":"35","author":"G Cheng","year":"2021","unstructured":"Cheng G, Pi Z, Zhuang X, et al. The effects and mechanisms of aloe-emodin on reversing adriamycin-induced resistance of MCF-7\/ADR cells. Phytother Res. 2021;35(7):3886\u201397.","journal-title":"Phytother Res"},{"key":"1124_CR505","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173550","volume":"886","author":"F Shen","year":"2020","unstructured":"Shen F, Ge C, Yuan P. Aloe-emodin induces autophagy and apoptotic cell death in non-small cell lung cancer cells via Akt\/mTOR and MAPK signaling. Eur J Pharmacol. 2020;886: 173550.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1124_CR506","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12935-021-01942-8","volume":"21","author":"D Jiang","year":"2021","unstructured":"Jiang D, Ding S, Mao Z, et al. Integrated analysis of potential pathways by which aloe-emodin induces the apoptosis of colon cancer cells. Cancer Cell Int. 2021;21(1):238.","journal-title":"Cancer Cell Int"},{"issue":"23","key":"1124_CR507","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.21037\/atm-21-5437","volume":"9","author":"M Du","year":"2021","unstructured":"Du M, Shen P, Tan R, et al. Aloe-emodin inhibits the proliferation, migration, and invasion of melanoma cells via inactivation of the Wnt\/beta-catenin signaling pathway. Ann Transl Med. 2021;9(23):1722.","journal-title":"Ann Transl Med"},{"issue":"7","key":"1124_CR508","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1002\/ptr.7793","volume":"37","author":"S Chen","year":"2023","unstructured":"Chen S, Guan X, Xie L, et al. Aloe-emodin targets multiple signaling pathways by blocking ubiquitin-mediated degradation of DUSP1 in nasopharyngeal carcinoma cells. Phytother Res. 2023;37(7):2979\u201394.","journal-title":"Phytother Res"},{"issue":"2","key":"1124_CR509","first-page":"746","volume":"24","author":"Y Du","year":"2019","unstructured":"Du Y, Zhang J, Tao Z, et al. Aloe emodin exerts potent anticancer effects in MIAPaCa-2 and PANC-1 human pancreatic adenocarcinoma cell lines through activation of both apoptotic and autophagic pathways, sub-G1 cell cycle arrest and disruption of mitochondrial membrane potential (\u039b\u03a8m). J BUON. 2019;24(2):746\u201353.","journal-title":"J BUON"},{"issue":"16","key":"1124_CR510","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.3390\/molecules28166024","volume":"28","author":"S Staffieri","year":"2023","unstructured":"Staffieri S, Russo V, Oliva MA, et al. Aloe-emodin overcomes anti-cancer drug resistance to temozolomide and prevents colony formation and migration in primary human glioblastoma cell lines NULU and ZAR. Molecules. 2023;28(16):6024.","journal-title":"Molecules"},{"key":"1124_CR511","doi-asserted-by":"crossref","unstructured":"Maimaiti A, Xingliang L, Shi L. In vitro and in vivo anti-lung cancer activity of emodin: A RNA-seq transcriptome analysis. Curr Med Chem. 2022.","DOI":"10.2174\/0929867329666220921120314"},{"issue":"1","key":"1124_CR512","doi-asserted-by":"publisher","first-page":"9379","DOI":"10.1038\/s41598-018-27359-4","volume":"8","author":"C Chen","year":"2018","unstructured":"Chen C, Gao J, Wang T-S, et al. NMR-based metabolomic techniques identify the toxicity of emodin in HepG2 cells. Sci Rep. 2018;8(1):9379.","journal-title":"Sci Rep"},{"issue":"1","key":"1124_CR513","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s11671-020-03304-1","volume":"15","author":"X Jiang","year":"2020","unstructured":"Jiang X, Ma M, Li M, et al. Preparation and evaluation of novel emodin-loaded stearic acid-g-chitosan oligosaccharide nanomicelles. Nanoscale Res Lett. 2020;15(1):93.","journal-title":"Nanoscale Res Lett"},{"issue":"8","key":"1124_CR514","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1016\/j.xphs.2021.04.006","volume":"110","author":"H Liu","year":"2021","unstructured":"Liu H, Zhuang Y, Wang P, et al. Polymeric lipid hybrid nanoparticles as a delivery system enhance the antitumor effect of emodin in vitro and in vivo. J Pharm Sci. 2021;110(8):2986\u201396.","journal-title":"J Pharm Sci"},{"issue":"1","key":"1124_CR515","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1080\/10717544.2021.1971795","volume":"28","author":"W Wei","year":"2021","unstructured":"Wei W, Tang J, Hu L, et al. Experimental anti-tumor effect of emodin in suspension - in situ hydrogels formed with self-assembling peptide. Drug Deliv. 2021;28(1):1810\u201321.","journal-title":"Drug Deliv"},{"issue":"1","key":"1124_CR516","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/08982104.2022.2086568","volume":"33","author":"L Tang","year":"2023","unstructured":"Tang L, Liu X-X, Yang X-D, et al. A compound formulation of EGF-modified paclitaxel micelles and EGF-modified emodin micelles enhance the therapeutic effect of ovarian cancer. J Liposome Res. 2023;33(1):89\u2013101.","journal-title":"J Liposome Res"},{"issue":"6","key":"1124_CR517","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1208\/s12249-023-02594-9","volume":"24","author":"X Cao","year":"2023","unstructured":"Cao X, Deng T, Zhu Q, et al. Photothermal therapy mediated hybrid membrane derived nano-formulation for enhanced cancer therapy. AAPS PharmSciTech. 2023;24(6):146.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"1124_CR518","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12951-023-02282-7","volume":"22","author":"Y Ye","year":"2024","unstructured":"Ye Y, Zhong W, Luo R, et al. Thermosensitive hydrogel with emodin-loaded triple-targeted nanoparticles for a rectal drug delivery system in the treatment of chronic non-bacterial prostatitis. J Nanobiotechnology. 2024;22(1):33.","journal-title":"J Nanobiotechnology"},{"key":"1124_CR519","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tifs.2021.05.023","volume":"114","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zhang X, Bi K, et al. Potential protective mechanisms of green tea polyphenol EGCG against COVID-19. Trends Food Sci Technol. 2021;114:11\u201324.","journal-title":"Trends Food Sci Technol"},{"key":"1124_CR520","doi-asserted-by":"crossref","unstructured":"Wu Z, Huang S, Li T et al. Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. Microbiome. 2021, 9(1).","DOI":"10.1186\/s40168-021-01115-9"},{"key":"1124_CR521","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.semcancer.2020.05.011","volume":"80","author":"V Aggarwal","year":"2022","unstructured":"Aggarwal V, Tuli HS, Tania M, et al. Molecular mechanisms of action of epigallocatechin gallate in cancer: recent trends and advancement. Semin Cancer Biol. 2022;80:256\u201375.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"1124_CR522","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.radonc.2013.10.014","volume":"110","author":"H Zhao","year":"2014","unstructured":"Zhao H, Zhu W, Xie P, et al. A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer. Radiother Oncol. 2014;110(1):132\u20136.","journal-title":"Radiother Oncol"},{"key":"1124_CR523","doi-asserted-by":"crossref","unstructured":"Suhail M, Rehan M, Tarique M et al. Targeting a transcription factor NF-\u03baB by green tea catechins using in silico and in vitro studies in pancreatic cancer. Front Nutr. 2023, 9.","DOI":"10.3389\/fnut.2022.1078642"},{"key":"1124_CR524","doi-asserted-by":"crossref","unstructured":"Xu X, Li H, Chen J et al. A Universal Strategy to Construct High-Performance Homo- and Heterogeneous Microgel Assembly Bioinks. Small Methods. 2024, 8(12).","DOI":"10.1002\/smtd.202400223"},{"issue":"7","key":"1124_CR525","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305922","volume":"11","author":"X Zheng","year":"2024","unstructured":"Zheng X, Chen J, Deng M, et al. G3BP1 and SLU7 jointly promote immune evasion by downregulating MHC-I via PI3K\/Akt activation in bladder cancer. Adv Sci. 2024;11(7): e2305922.","journal-title":"Adv Sci"},{"key":"1124_CR526","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jconrel.2024.09.042","volume":"375","author":"M Mu","year":"2024","unstructured":"Mu M, Chen B, Li H, et al. Augmented the sensitivity of photothermal-ferroptosis therapy in triple-negative breast cancer through mitochondria-targeted nanoreactor. J Control Release. 2024;375:733\u201344.","journal-title":"J Control Release"},{"issue":"11","key":"1124_CR527","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3390\/ph14111081","volume":"14","author":"D Ravindran Menon","year":"2021","unstructured":"Ravindran Menon D, Li Y, Yamauchi T, et al. EGCG inhibits tumor growth in melanoma by targeting JAK-STAT signaling and its downstream PD-L1\/PD-L2-PD1 axis in tumors and enhancing cytotoxic T-cell responses. Pharmaceuticals. 2021;14(11):1081.","journal-title":"Pharmaceuticals"},{"key":"1124_CR528","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150907","volume":"736","author":"J Lei","year":"2024","unstructured":"Lei J, Chen J, Chen J, et al. Epigallocatechin-3-gallate induces immunogenic cell death and enhances cancer immunotherapy in colorectal cancer. Biochem Biophys Res Commun. 2024;736: 150907.","journal-title":"Biochem Biophys Res Commun"},{"issue":"23","key":"1124_CR529","doi-asserted-by":"publisher","first-page":"7881","DOI":"10.3390\/molecules28237881","volume":"28","author":"Y Guo","year":"2023","unstructured":"Guo Y, Guo Y, Guo Z, et al. Effect of fragment 1 on the binding of epigallocatechin gallate to the PD-L1 dimer explored by molecular dynamics. Molecules. 2023;28(23):7881.","journal-title":"Molecules"},{"issue":"20","key":"1124_CR530","doi-asserted-by":"publisher","first-page":"10924","DOI":"10.3390\/ijms222010924","volume":"22","author":"Y Guo","year":"2021","unstructured":"Guo Y, Liang J, Liu B, et al. Molecular mechanism of food-derived polyphenols on PD-L1 dimerization: a molecular dynamics simulation study. Int J Mol Sci. 2021;22(20):10924.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1124_CR531","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3390\/nu12041042","volume":"12","author":"P Xu","year":"2020","unstructured":"Xu P, Yan F, Zhao Y, et al. Green tea polyphenol EGCG attenuates MDSCs-mediated immunosuppression through canonical and non-canonical pathways in a 4T1 murine breast cancer model. Nutrients. 2020;12(4):1042.","journal-title":"Nutrients"},{"issue":"22","key":"1124_CR532","doi-asserted-by":"publisher","first-page":"2105077","DOI":"10.1002\/advs.202105077","volume":"9","author":"M Zhou","year":"2022","unstructured":"Zhou M, Dong J, Huang J, et al. Chitosan-gelatin-EGCG nanoparticle-meditated LncRNA TMEM44-AS1 silencing to activate the P53 signaling pathway for the synergistic reversal of 5-FU resistance in gastric cancer. Adv Sci (Weinh). 2022;9(22):2105077.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"1124_CR533","doi-asserted-by":"publisher","first-page":"740","DOI":"10.20892\/j.issn.2095-3941.2020.0219","volume":"17","author":"J Chen","year":"2020","unstructured":"Chen J, Zhang F, Ren X, et al. Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiation via downregulating frizzled class receptor 10. Cancer Biol Med. 2020;17(3):740.","journal-title":"Cancer Biol Med"},{"issue":"12","key":"1124_CR534","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.1002\/ptr.7990","volume":"37","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Huang S, Guo Y, et al. Epigallocatechin gallate circumvents drug-induced resistance in non-small-cell lung cancer by modulating glucose metabolism and AMPK\/AKT\/MAPK axis. Phytother Res. 2023;37(12):5837\u201353.","journal-title":"Phytother Res"},{"issue":"5","key":"1124_CR535","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.3390\/ijms24054377","volume":"24","author":"W Sun","year":"2023","unstructured":"Sun W, Wong IL, Law HK-W, et al. In vivo reversal of P-glycoprotein-mediated drug resistance in a breast cancer xenograft and in leukemia models using a novel, potent, and nontoxic epicatechin EC31. Int J Mol Sci. 2023;24(5):4377.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1124_CR536","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biopha.2005.01.002","volume":"59","author":"F Qian","year":"2005","unstructured":"Qian F, Wei D, Zhang Q, et al. Modulation of P-glycoprotein function and reversal of multidrug resistance by (\u2013)-epigallocatechin gallate in human cancer cells. Biomed Pharmacother. 2005;59(3):64\u20139.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1124_CR537","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/bph.15360","volume":"178","author":"X Wang","year":"2021","unstructured":"Wang X, Chen B, Xu D, et al. Molecular mechanism and pharmacokinetics of flavonoids in the treatment of resistant EGF receptor-mutated non-small-cell lung cancer: a narrative review. Br J Pharmacol. 2021;178(6):1388\u2013406.","journal-title":"Br J Pharmacol"},{"key":"1124_CR538","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.tifs.2019.09.017","volume":"93","author":"W Zhang","year":"2019","unstructured":"Zhang W, Zhang W, Sun L, et al. The effects and mechanisms of epigallocatechin-3-gallate on reversing multidrug resistance in cancer. Trends Food Sci Technol. 2019;93:221\u201333.","journal-title":"Trends Food Sci Technol"},{"issue":"2","key":"1124_CR539","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.apsb.2018.10.001","volume":"9","author":"Y Wen","year":"2019","unstructured":"Wen Y, Zhao R, Gupta P, et al. The epigallocatechin gallate derivative Y6 reverses drug resistance mediated by the ABCB1 transporter both in vitro and in vivo. Acta Pharm Sin B. 2019;9(2):316\u201323.","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"1124_CR540","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.21873\/anticanres.16247","volume":"43","author":"BF Mayer","year":"2023","unstructured":"Mayer BF, Stagno MJ, Fuchs J, et al. Epigallocatechin gallate inhibits cell growth and hedgehog signalling in human rhabdomyosarcoma cell lines. Anticancer Res. 2023;43(3):1025\u201330.","journal-title":"Anticancer Res"},{"key":"1124_CR541","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.2147\/OTT.S209441","volume":"12","author":"J Meng","year":"2019","unstructured":"Meng J, Chang C, Chen Y, et al. EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC. Onco Targets Ther. 2019;12:6033\u201343.","journal-title":"Onco Targets Ther"},{"issue":"34","key":"1124_CR542","doi-asserted-by":"publisher","first-page":"37914","DOI":"10.1021\/acsami.0c11650","volume":"12","author":"Z Yi","year":"2020","unstructured":"Yi Z, Chen X, Chen G, et al. General nanomedicine platform by solvent-mediated disassembly\/reassembly of scalable natural polyphenol colloidal spheres. ACS Appl Mater Interfaces. 2020;12(34):37914\u201328.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"1124_CR543","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/ijms24010381","volume":"24","author":"KH Bae","year":"2022","unstructured":"Bae KH, Lai F, Oruc B, et al. Self-assembled daunorubicin\/epigallocatechin gallate nanocomplex for synergistic reversal of chemoresistance in leukemia. Int J Mol Sci. 2022;24(1):381.","journal-title":"Int J Mol Sci"},{"key":"1124_CR544","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109491","volume":"120","author":"C-Y Chen","year":"2019","unstructured":"Chen C-Y, Lin Y-J, Wang CC, et al. Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin\/Smad1 signaling in human umbilical vein endothelium cells. Biomed Pharmacother. 2019;120: 109491.","journal-title":"Biomed Pharmacother"},{"key":"1124_CR545","doi-asserted-by":"crossref","unstructured":"Dong Z, Wu J, He L et al. EGCG inhibits tobacco smoke-promoted proliferation of lung cancer cells through targeting CCL5. Phytomedicine. 2025, 139.","DOI":"10.1016\/j.phymed.2025.156512"},{"issue":"5","key":"1124_CR546","first-page":"3873","volume":"22","author":"Y Tang","year":"2020","unstructured":"Tang Y, Cao J, Cai Z, et al. Epigallocatechin gallate induces chemopreventive effects on rats with diethylnitrosamine-induced liver cancer via inhibition of cell division cycle 25A. Mol Med Rep. 2020;22(5):3873\u201385.","journal-title":"Mol Med Rep"},{"issue":"11","key":"1124_CR547","first-page":"484","volume":"10","author":"M Kedhari Sundaram","year":"2020","unstructured":"Kedhari Sundaram M, Haque S, Somvanshi P, et al. Epigallocatechin gallate inhibits HeLa cells by modulation of epigenetics and signaling pathways. Biotech. 2020;10(11):484.","journal-title":"Biotech"},{"key":"1124_CR548","doi-asserted-by":"publisher","DOI":"10.1590\/1519-6984.248746","volume":"83","author":"MA Al-Ghamdi","year":"2021","unstructured":"Al-Ghamdi MA, Al-Enazy A, Huwait E, et al. Enhancement of Annexin V in response to combination of epigallocatechin gallate and quercetin as a potent arrest the cell cycle of colorectal cancer. Braz J Biol. 2021;83: e248746.","journal-title":"Braz J Biol"},{"issue":"6","key":"1124_CR549","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s10522-022-09976-9","volume":"23","author":"B Diwan","year":"2022","unstructured":"Diwan B, Sharma RJB. Green tea EGCG effectively alleviates experimental colitis in middle-aged male mice by attenuating multiple aspects of oxi-inflammatory stress and cell cycle deregulation. Biogerontology. 2022;23(6):789\u2013807.","journal-title":"Biogerontology"},{"issue":"1","key":"1124_CR550","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/nu12010092","volume":"12","author":"J Chen","year":"2019","unstructured":"Chen J, Zhang L, Li C, et al. Lipophilized epigallocatechin gallate derivative exerts anti-proliferation efficacy through induction of cell cycle arrest and apoptosis on DU145 human prostate cancer cells. Nutrients. 2019;12(1):92.","journal-title":"Nutrients"},{"issue":"17","key":"1124_CR551","first-page":"3602","volume":"14","author":"S Zhang","year":"2022","unstructured":"Zhang S, Jiang S, Deng N, et al. Phytochemical profiles, antioxidant activity and antiproliferative mechanism of Rhodiola rosea L. Phenolic Extract Nutrients. 2022;14(17):3602.","journal-title":"Phenolic Extract Nutrients"},{"issue":"3","key":"1124_CR552","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/10799893.2020.1805628","volume":"41","author":"B Sarkar","year":"2021","unstructured":"Sarkar B, Ullah MA, Islam SS, et al. Analysis of plant-derived phytochemicals as anti-cancer agents targeting cyclin dependent kinase-2, human topoisomerase IIa and vascular endothelial growth factor receptor-2. J Recept Signal Transduct Res. 2021;41(3):217\u201333.","journal-title":"J Recept Signal Transduct Res"},{"issue":"2","key":"1124_CR553","first-page":"1139","volume":"20","author":"H Yoshimura","year":"2019","unstructured":"Yoshimura H, Yoshida H, Matsuda S, et al. The therapeutic potential of epigallocatechin-3-gallate against human oral squamous cell carcinoma through inhibition of cell proliferation and induction of apoptosis: In vitro and in vivo murine xenograft study. Mol Med Rep. 2019;20(2):1139\u201348.","journal-title":"Mol Med Rep"},{"key":"1124_CR554","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111856","volume":"147","author":"C-C Teng","year":"2021","unstructured":"Teng C-C, Tung S-Y, Lee K-C, et al. Novel regulator role of CIL-102 in the epigenetic modification of TNFR1\/TRAIL to induce cell apoptosis in human gastric cancer. Food Chem Toxicol. 2021;147: 111856.","journal-title":"Food Chem Toxicol"},{"issue":"7","key":"1124_CR555","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/molecules24071445","volume":"24","author":"W Wang","year":"2019","unstructured":"Wang W, Xiong X, Li X, et al. In silico investigation of the anti-tumor mechanisms of epigallocatechin-3-gallate. Molecules. 2019;24(7):1445.","journal-title":"Molecules"},{"issue":"13","key":"1124_CR556","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.3390\/molecules28135246","volume":"28","author":"M Kciuk","year":"2023","unstructured":"Kciuk M, Alam M, Ali N, et al. Epigallocatechin-3-gallate therapeutic potential in cancer: mechanism of action and clinical implications. Molecules. 2023;28(13):5246.","journal-title":"Molecules"},{"key":"1124_CR557","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.652033","volume":"11","author":"Y Xia","year":"2021","unstructured":"Xia Y, Chen R, Lu G, et al. Natural phytochemicals in bladder cancer prevention and therapy. Front Oncol. 2021;11: 652033.","journal-title":"Front Oncol"},{"key":"1124_CR558","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10522-018-9785-1","volume":"20","author":"R Kumar","year":"2019","unstructured":"Kumar R, Sharma A, Kumari A, et al. Epigallocatechin gallate suppresses premature senescence of preadipocytes by inhibition of PI3K\/Akt\/mTOR pathway and induces senescent cell death by regulation of Bax\/Bcl-2 pathway. Biogerontology. 2019;20:171\u201389.","journal-title":"Biogerontology"},{"key":"1124_CR559","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145638","volume":"787","author":"M Panji","year":"2021","unstructured":"Panji M, Behmard V, Zare Z, et al. Synergistic effects of green tea extract and paclitaxel in the induction of mitochondrial apoptosis in ovarian cancer cell lines. Gene. 2021;787: 145638.","journal-title":"Gene"},{"issue":"23","key":"1124_CR560","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.3390\/cells11233852","volume":"11","author":"Z Chen","year":"2022","unstructured":"Chen Z, Wei Y, Zheng Y, et al. SERPINB2, an early responsive gene to epigallocatechin gallate, inhibits migration and promotes apoptosis in esophageal cancer cells. Cells. 2022;11(23):3852.","journal-title":"Cells"},{"issue":"3","key":"1124_CR561","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/molecules25030467","volume":"25","author":"M Sharifirad","year":"2020","unstructured":"Sharifirad M, Pezzani R, Redaelli M, et al. Preclinical activities of epigallocatechin gallate in signaling pathways in cancer. Molecules. 2020;25(3):467.","journal-title":"Molecules"},{"issue":"6","key":"1124_CR562","first-page":"1885","volume":"43","author":"J Qin","year":"2020","unstructured":"Qin J, Fu M, Wang J, et al. PTEN\/AKT\/mTOR signaling mediates anticancer effects of epigallocatechin-3-gallate in ovarian cancer. Oncol Rep. 2020;43(6):1885\u201396.","journal-title":"Oncol Rep"},{"key":"1124_CR563","doi-asserted-by":"crossref","unstructured":"Bing-Xin D, Pei L, Jun LJCJONM. EGCG and ECG induce apoptosis and decrease autophagy via the AMPK\/mTOR and PI3K\/AKT\/mTOR pathway in human melanoma cells. Chin J Nat Med. 2022, 20(4):290\u2013300.","DOI":"10.1016\/S1875-5364(22)60166-3"},{"issue":"4","key":"1124_CR564","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s11010-022-04550-w","volume":"478","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhu Q, Wang S, et al. Epigallocatechin-3-gallate inhibits the formation of neutrophil extracellular traps and suppresses the migration and invasion of colon cancer cells by regulating STAT3\/CXCL8 pathway. Mol Cell Biochem. 2023;478(4):887\u201398.","journal-title":"Mol Cell Biochem"},{"key":"1124_CR565","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115112","volume":"202","author":"N Yang","year":"2022","unstructured":"Yang N, Li XJBP. Epigallocatechin gallate relieves asthmatic symptoms in mice by suppressing HIF-1\u03b1\/VEGFA-mediated M2 skewing of macrophages. Biochem Pharmacol. 2022;202: 115112.","journal-title":"Biochem Pharmacol"},{"key":"1124_CR566","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112852","volume":"259","author":"Z-H Liao","year":"2020","unstructured":"Liao Z-H, Zhu H-Q, Chen Y-Y, et al. The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK\/ERK1\/2 and PI3K\/AKT\/HIF-1\u03b1\/VEGF dependent pathways. J Ethnopharmacol. 2020;259: 112852.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1124_CR567","first-page":"155","volume":"23","author":"J Fu","year":"2019","unstructured":"Fu J, Yao J, Wang H, et al. Effects of EGCG on proliferation and apoptosis of gastric cancer SGC7901 cells via down-regulation of HIF-1\u03b1 and VEGF under a hypoxic state. Eur Rev Med Pharmacol Sci. 2019;23(1):155\u201361.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1124_CR568","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145774","volume":"794","author":"M Panji","year":"2021","unstructured":"Panji M, Behmard V, Zare Z, et al. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-\u03b2-induced epithelial-to-mesenchymal transition via ROS\/Smad signaling in human cervical cancer cells. Gene. 2021;794: 145774.","journal-title":"Gene"},{"issue":"1","key":"1124_CR569","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/21655979.2019.1632669","volume":"10","author":"T Li","year":"2019","unstructured":"Li T, Zhao N, Lu J, et al. Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-\u03b21\/Smad signaling pathways. Bioengineered. 2019;10(1):282\u201391.","journal-title":"Bioengineered"},{"issue":"1","key":"1124_CR570","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-021-01053-x","volume":"14","author":"B-G Kim","year":"2021","unstructured":"Kim B-G, Malek E, Choi SH, et al. Novel therapies emerging in oncology to target the TGF-\u03b2 pathway. J Hematol Oncol. 2021;14(1):1\u201320.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1124_CR571","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/01480545.2019.1696813","volume":"45","author":"C-L Weng","year":"2022","unstructured":"Weng C-L, Chen C-C, Tsou H-H, et al. Areca nut procyanidins prevent ultraviolet light B-induced photoaging via suppression of cyclooxygenase-2 and matrix metalloproteinases in mouse skin. Drug Chem Toxicol. 2022;45(1):353\u20139.","journal-title":"Drug Chem Toxicol"},{"issue":"23","key":"1124_CR572","doi-asserted-by":"publisher","first-page":"13006","DOI":"10.3390\/ijms222313006","volume":"22","author":"S Djediai","year":"2021","unstructured":"Djediai S, Gonzalez Suarez N, El Cheikh-Hussein L, et al. MT1-MMP cooperates with TGF-\u03b2 receptor-mediated signaling to trigger SNAIL and induce epithelial-to-mesenchymal-like transition in U87 glioblastoma cells. Int J Mol Sci. 2021;22(23):13006.","journal-title":"Int J Mol Sci"},{"key":"1124_CR573","first-page":"1","volume":"22","author":"X Peng","year":"2024","unstructured":"Peng X, McClements DJ, Liu X, et al. EGCG-based nanoparticles: synthesis, properties, and applications. Crit Rev Food Sci Nutr. 2024;22:1\u201322.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"1124_CR574","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/10717544.2020.1862363","volume":"28","author":"J Li","year":"2021","unstructured":"Li J, Jiang X, Shang L, et al. L-EGCG-Mn nanoparticles as a pH-sensitive MRI contrast agent. Drug Deliv. 2021;28(1):126\u201335.","journal-title":"Drug Deliv"},{"key":"1124_CR575","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.actbio.2023.01.049","volume":"159","author":"T Liao","year":"2023","unstructured":"Liao T, Chen Z, Kuang Y, et al. Small-size Ti3C2Tx MXene nanosheets coated with metal-polyphenol nanodots for enhanced cancer photothermal therapy and anti-inflammation. Acta Biomater. 2023;159:312\u201323.","journal-title":"Acta Biomater"},{"issue":"24","key":"1124_CR576","doi-asserted-by":"publisher","first-page":"9012","DOI":"10.3390\/molecules27249012","volume":"27","author":"SL Shah","year":"2022","unstructured":"Shah SL, Bashir K, Rasheed HM, et al. LC-MS\/MS-based metabolomic profiling of constituents from Glochidion velutinum and its activity against cancer cell lines. Molecules. 2022;27(24):9012.","journal-title":"Molecules"},{"issue":"2","key":"1124_CR577","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1021\/acs.langmuir.0c03449","volume":"37","author":"X Chen","year":"2021","unstructured":"Chen X, Liu B, Tong R, et al. Improved stability and targeted cytotoxicity of epigallocatechin-3-gallate palmitate for anticancer therapy. Langmuir. 2021;37(2):969\u201377.","journal-title":"Langmuir"},{"issue":"11","key":"1124_CR578","doi-asserted-by":"publisher","first-page":"9686","DOI":"10.1039\/D0FO01542C","volume":"11","author":"Q-Q Zhu","year":"2020","unstructured":"Zhu Q-Q, Yang X-Y, Zhang X-J, et al. EGCG targeting Notch to attenuate renal fibrosis via inhibition of TGF\u03b2\/Smad3 signaling pathway activation in streptozotocin-induced diabetic mice. Food Funct. 2020;11(11):9686\u201395.","journal-title":"Food Funct"},{"key":"1124_CR579","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108546","volume":"692","author":"R Wei","year":"2020","unstructured":"Wei R, Wirkus J, Yang Z, et al. EGCG sensitizes chemotherapeutic-induced cytotoxicity by targeting the ERK pathway in multiple cancer cell lines. Arch Biochem Biophys. 2020;692: 108546.","journal-title":"Arch Biochem Biophys"},{"issue":"7832","key":"1124_CR580","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-020-2836-1","volume":"587","author":"M Liu","year":"2020","unstructured":"Liu M, Kuo F, Capistrano KJ, et al. TGF-\u03b2 suppresses type 2 immunity to cancer. Nature. 2020;587(7832):115\u201320.","journal-title":"Nature"},{"issue":"22","key":"1124_CR581","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1080\/14786419.2019.1698575","volume":"35","author":"C Knidel","year":"2021","unstructured":"Knidel C, Pereira MF, Barcelos DHF, et al. Epigallocatechin gallate has antibacterial and antibiofilm activity in methicillin resistant and susceptible Staphylococcus aureus of different lineages in non-cytotoxic concentrations. Nat Prod Res. 2021;35(22):4643\u20137.","journal-title":"Nat Prod Res"},{"issue":"16","key":"1124_CR582","doi-asserted-by":"publisher","first-page":"7913","DOI":"10.1111\/jcmm.16718","volume":"25","author":"W Wu","year":"2021","unstructured":"Wu W, Dong J, Gou H, et al. EGCG synergizes the therapeutic effect of irinotecan through enhanced DNA damage in human colorectal cancer cells. J Cell Mol Med. 2021;25(16):7913\u201321.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"1124_CR583","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3390\/molecules24081580","volume":"24","author":"AM McDonnell","year":"2019","unstructured":"McDonnell AM, Pyles HM, Diaz-Cruz ES, et al. Enoxacin and epigallocatechin gallate (EGCG) act synergistically to inhibit the growth of cervical cancer cells in culture. Molecules. 2019;24(8):1580.","journal-title":"Molecules"},{"issue":"8","key":"1124_CR584","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3390\/nu11081856","volume":"11","author":"R Wei","year":"2019","unstructured":"Wei R, Cortez Penso NE, Hackman RM, et al. Epigallocatechin-3-gallate (EGCG) suppresses pancreatic cancer cell growth, invasion, and migration partly through the inhibition of Akt pathway and epithelial\u2013mesenchymal transition: enhanced efficacy when combined with gemcitabine. Nutrients. 2019;11(8):1856.","journal-title":"Nutrients"},{"key":"1124_CR585","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.archoralbio.2019.02.018","volume":"101","author":"EP-F L\u00f3pez","year":"2019","unstructured":"L\u00f3pez EP-F, Garc\u00eda FG, Jornet PLJAOOB. Combination of 5-florouracil and polyphenol EGCG exerts suppressive effects on oral cancer cells exposed to radiation. Arch Oral Biol. 2019;101:8\u201312.","journal-title":"Arch Oral Biol"},{"issue":"1","key":"1124_CR586","first-page":"65","volume":"77","author":"K Sato","year":"2023","unstructured":"Sato K, Takigawa N, Kubo T, et al. Effect of a cyclooxygenase-2 inhibitor in combination with (\u2212)-epigallocatechin gallate or polyphenon E on cisplatin-induced lung tumorigenesis in A\/J mice. Acta Med Okayama. 2023;77(1):65\u201370.","journal-title":"Acta Med Okayama"},{"key":"1124_CR587","doi-asserted-by":"publisher","first-page":"515819","DOI":"10.3389\/fphar.2020.00358","volume":"11","author":"AJ Yool","year":"2020","unstructured":"Yool AJ, Ramesh SJFIP. Molecular targets for combined therapeutic strategies to limit glioblastoma cell migration and invasion. Front Pharmacol. 2020;11:515819.","journal-title":"Front Pharmacol"},{"issue":"7","key":"1124_CR588","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3390\/cells8070745","volume":"8","author":"L Zhang","year":"2019","unstructured":"Zhang L, He Y, Wu X, et al. Melatonin and (\u2212)-epigallocatechin-3-gallate: partners in fighting cancer. Cells. 2019;8(7):745.","journal-title":"Cells"},{"issue":"3","key":"1124_CR589","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.drudis.2024.103885","volume":"29","author":"H Jin","year":"2024","unstructured":"Jin H, Cui D, Fan Y, et al. Recent advances in bioaffinity strategies for preclinical and clinical drug discovery: Screening natural products, small molecules and antibodies. Drug Discov Today. 2024;29(3):3.","journal-title":"Drug Discov Today"},{"key":"1124_CR590","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.trac.2024.118042","volume":"181","author":"S Chen","year":"2024","unstructured":"Chen S, Shen C, Li W, et al. Recent advances in bioactivity-guided drug screening strategies for pre-clinical and clinical drug discovery. Trac-Trends Anal Chem. 2024;181:7.","journal-title":"Trac-Trends Anal Chem"},{"issue":"4","key":"1124_CR591","first-page":"341","volume":"4","author":"T Bai","year":"2023","unstructured":"Bai T, Ali M, Somers B, et al. The combination of natural compounds Crila and epigallocatechin gallate showed enhanced antiproliferative effects on human uterine fibroid cells compared with single treatments. F S Sci. 2023;4(4):341\u20139.","journal-title":"F S Sci"},{"issue":"5","key":"1124_CR592","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3892\/or.2021.8038","volume":"45","author":"A Amin","year":"2021","unstructured":"Amin A, Wang D, Nannapaneni S, et al. Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth in vivo in head and neck cancer models. Oncol Rep. 2021;45(5):87.","journal-title":"Oncol Rep"},{"issue":"6","key":"1124_CR593","first-page":"3344","volume":"24","author":"G Porcaro","year":"2020","unstructured":"Porcaro G, Santamaria A, Giordano D, et al. Vitamin D plus epigallocatechin gallate: a novel promising approach for uterine myomas. Eur Rev Med Pharmacol Sci. 2020;24(6):3344\u201351.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"1124_CR594","first-page":"2843","volume":"25","author":"D Miriello","year":"2021","unstructured":"Miriello D, Galanti F, Cignini P, et al. Uterine fibroids treatment: do we have new valid alternative? Experiencing the combination of vitamin D plus epigallocatechin gallate in childbearing age affected women. Eur Rev Med Pharmacol Sci. 2021;25(7):2843\u201351.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1124_CR595","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.115100","volume":"401","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhang S, Yang J, et al. Integrated transcriptomic and metabolomic analyses to characterize the anti-cancer effects of (\u2212)-epigallocatechin-3-gallate in human colon cancer cells. Toxicol Appl Pharmacol. 2020;401: 115100.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1124_CR596","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.732716","volume":"12","author":"T Pan","year":"2021","unstructured":"Pan T, Han D, Xu Y, et al. LC\u2013MS based metabolomics study of the effects of EGCG on A549 cells. Front Pharmacol. 2021;12: 732716.","journal-title":"Front Pharmacol"},{"issue":"24","key":"1124_CR597","doi-asserted-by":"publisher","first-page":"1900811","DOI":"10.1002\/mnfr.201900811","volume":"63","author":"GY Sasaki","year":"2019","unstructured":"Sasaki GY, Li J, Cichon MJ, et al. Green tea extract treatment in obese mice with nonalcoholic steatohepatitis restores the hepatic metabolome in association with limiting endotoxemia-TLR4-NF\u03baB-mediated inflammation. Mol Nutr Food Res. 2019;63(24):1900811.","journal-title":"Mol Nutr Food Res"},{"key":"1124_CR598","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-15-S11-S3","volume":"15","author":"H Zhou","year":"2014","unstructured":"Zhou H, Chen JX, Yang CS, et al. Gene regulation mediated by microRNAs in response to green tea polyphenol EGCG in mouse lung cancer. BMC Genomics. 2014;15:1\u201310.","journal-title":"BMC Genomics"},{"issue":"1","key":"1124_CR599","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1080\/21655979.2019.1657327","volume":"10","author":"L Zan","year":"2019","unstructured":"Zan L, Chen Q, Zhang L, et al. Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25. Bioengineered. 2019;10(1):374\u201382.","journal-title":"Bioengineered"},{"issue":"11","key":"1124_CR600","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2174\/1389450121666200504080112","volume":"21","author":"L Yang","year":"2020","unstructured":"Yang L, Zhang W, Chopra S, et al. The epigenetic modification of epigallocatechin gallate (EGCG) on cancer. Curr Drug Targets. 2020;21(11):1099\u2013104.","journal-title":"Curr Drug Targets"},{"key":"1124_CR601","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117462","volume":"321","author":"L She","year":"2024","unstructured":"She L, Tang H, Zeng Y, et al. Ginsenoside RK3 promotes neurogenesis in Alzheimer\u2019s disease through activation of the CREB\/BDNF pathway. J Ethnopharmacol. 2024;321: 117462.","journal-title":"J Ethnopharmacol"},{"key":"1124_CR602","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116955","volume":"177","author":"J Zhang","year":"2024","unstructured":"Zhang J, Duan M, Wu S, et al. Comprehensive pharmacological and experimental study of Ginsenoside Re as a potential therapeutic agent for non-alcoholic fatty liver disease. Biomed Pharmacother. 2024;177: 116955.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1124_CR603","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jgr.2022.10.004","volume":"47","author":"Q Huang","year":"2023","unstructured":"Huang Q, Li J, Chen J, et al. Ginsenoside compound K protects against cerebral ischemia\/reperfusion injury via Mul1\/Mfn2-mediated mitochondrial dynamics and bioenergy. J Ginseng Res. 2023;47(3):408\u201319.","journal-title":"J Ginseng Res"},{"issue":"1","key":"1124_CR604","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-023-00822-9","volume":"18","author":"R-y Jiang","year":"2023","unstructured":"Jiang R-y, Fang Z-r, Zhang H-p, et al. Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer. Chin Med. 2023;18(1):1.","journal-title":"Chin Med"},{"issue":"21","key":"1124_CR605","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/molecules25214905","volume":"25","author":"M Nakhjavani","year":"2020","unstructured":"Nakhjavani M, Smith E, Townsend AR, et al. Anti-angiogenic properties of ginsenoside Rg3. Molecules. 2020;25(21):2.","journal-title":"Molecules"},{"key":"1124_CR606","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.975784","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Zeng L, Zhang Y, et al. Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent. Front Pharmacol. 2022;13: 975784.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1124_CR607","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jgr.2021.06.009","volume":"46","author":"X Sun","year":"2022","unstructured":"Sun X, Hong Y, Shu Y, et al. The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside. J Ginseng Res. 2022;46(2):266\u201374.","journal-title":"J Ginseng Res"},{"issue":"1","key":"1124_CR608","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.apsb.2021.06.005","volume":"12","author":"D Sun","year":"2022","unstructured":"Sun D, Zou Y, Song L, et al. A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer. Acta Pharm Sin B. 2022;12(1):378\u201393.","journal-title":"Acta Pharm Sin B"},{"key":"1124_CR609","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112086","volume":"145","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Nian Q, Chen N, et al. Ginsenoside Rg3 inhibits angiogenesis in gastric precancerous lesions through downregulation of Glut1 and Glut4. Biomed Pharmacother. 2022;145: 112086.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1124_CR610","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jgr.2021.07.002","volume":"46","author":"YJ Chen","year":"2022","unstructured":"Chen YJ, Wu JY, Deng YY, et al. Ginsenoside Rg3 in combination with artesunate overcomes sorafenib resistance in hepatoma cell and mouse models. J Ginseng Res. 2022;46(3):418\u201325.","journal-title":"J Ginseng Res"},{"issue":"6","key":"1124_CR611","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41419-020-2597-7","volume":"11","author":"X Liu","year":"2020","unstructured":"Liu X, Mi X, Wang Z, et al. Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway. Cell Death Dis. 2020;11(6):454.","journal-title":"Cell Death Dis"},{"issue":"8","key":"1124_CR612","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41401-021-00830-1","volume":"43","author":"Q Lai","year":"2022","unstructured":"Lai Q, Liu FM, Rao WL, et al. Aminoacylase-1 plays a key role in myocardial fibrosis and the therapeutic effects of 20(S)-ginsenoside Rg3 in mouse heart failure. Acta Pharmacol Sin. 2022;43(8):2003\u201315.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"1124_CR613","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom11010118","volume":"11","author":"H Kim","year":"2021","unstructured":"Kim H, Ji HW, Kim HW, et al. Ginsenoside Rg3 prevents oncogenic long noncoding RNA ATXN8OS from inhibiting tumor-suppressive microRNA-424\u20135p in breast cancer cells. Biomolecules. 2021;11(1):1.","journal-title":"Biomolecules"},{"issue":"23","key":"1124_CR614","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules27238311","volume":"27","author":"J Nahar","year":"2022","unstructured":"Nahar J, Boopathi V, Murugesan M, et al. Investigating the anticancer activity of G-Rh1 using in silico and in vitro studies (A549 lung cancer cells). Molecules. 2022;27(23):1.","journal-title":"Molecules"},{"key":"1124_CR615","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fphar.2023.1149191","volume":"14","author":"L Cui","year":"2023","unstructured":"Cui L, Liu X, Yan R, et al. Amino acid modified OCMC-g-Suc-\u03b2-CD nanohydrogels carrying lapatinib and ginsenoside Rg1 exhibit high anticancer activity in a zebrafish model. Front Pharmacol. 2023;14:3.","journal-title":"Front Pharmacol"},{"key":"1124_CR616","doi-asserted-by":"publisher","first-page":"174480692211260","DOI":"10.1177\/17448069221126078","volume":"18","author":"YY Fu","year":"2022","unstructured":"Fu YY, Cen JK, Song HL, et al. Ginsenoside Rh2 ameliorates neuropathic pain by inhibition of the miRNA21-TLR8-mitogen-activated protein kinase axis. Mol Pain. 2022;18:17448069221126078.","journal-title":"Mol Pain"},{"key":"1124_CR617","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154121","volume":"101","author":"S Chen","year":"2022","unstructured":"Chen S, He Z, Xie W, et al. Ginsenoside Rh2 attenuates CDAHFD-induced liver fibrosis in mice by improving intestinal microbial composition and regulating LPS-mediated autophagy. Phytomedicine. 2022;101: 154121.","journal-title":"Phytomedicine"},{"key":"1124_CR618","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.113997","volume":"274","author":"X Chen","year":"2021","unstructured":"Chen X, Xu T, Lv X, et al. Ginsenoside Rh2 alleviates ulcerative colitis by regulating the STAT3\/miR-214 signaling pathway. J Ethnopharmacol. 2021;274: 113997.","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"1124_CR619","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2705","volume":"12","author":"LS Shi","year":"2022","unstructured":"Shi LS, Ji CH, Liu Y, et al. Ginsenoside Rh2 administration produces crucial antidepressant-like effects in a CUMS-induced mice model of depression. Brain Behav. 2022;12(8): e2705.","journal-title":"Brain Behav"},{"issue":"6","key":"1124_CR620","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13246","volume":"55","author":"J Hou","year":"2022","unstructured":"Hou J, Yun Y, Cui C, et al. Ginsenoside Rh2 mitigates doxorubicin-induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer-bearing mice. Cell Prolif. 2022;55(6): e13246.","journal-title":"Cell Prolif"},{"key":"1124_CR621","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106988","volume":"198","author":"MY Huang","year":"2023","unstructured":"Huang MY, Chen YC, Lyu WY, et al. Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8(+) T cells via increasing intratumoral CXCL10. Pharmacol Res. 2023;198: 106988.","journal-title":"Pharmacol Res"},{"issue":"4","key":"1124_CR622","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2174\/1574892816666210607100239","volume":"16","author":"F Zhang","year":"2021","unstructured":"Zhang F, Xu H, Xia R, et al. Pseudo-ginsenoside Rh2 induces protective autophagy in hepatocellular carcinoma HepG2 cells. Recent Pat Anticancer Drug Discov. 2021;16(4):521\u201332.","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"1","key":"1124_CR623","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s13659-023-00405-z","volume":"13","author":"L Ding","year":"2023","unstructured":"Ding L, Gao Z, Wu S, et al. Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress. Nat Prod Bioprospect. 2023;13(1):49.","journal-title":"Nat Prod Bioprospect"},{"issue":"2","key":"1124_CR624","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3892\/etm.2023.12105","volume":"26","author":"Y Li","year":"2023","unstructured":"Li Y, Wu J, Zhuo N. Ginsenoside compound K alleviates osteoarthritis by inhibiting NLRP3-mediated pyroptosis. Exp Ther Med. 2023;26(2):406.","journal-title":"Exp Ther Med"},{"issue":"1","key":"1124_CR625","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13019-022-01846-2","volume":"17","author":"J Huang","year":"2022","unstructured":"Huang J, Pan D, Liu F, et al. Ginsenoside compound K inhibits the proliferation, migration and invasion of Eca109 cell via VEGF-A\/Pi3k\/Akt pathway. J Cardiothorac Surg. 2022;17(1):99.","journal-title":"J Cardiothorac Surg"},{"key":"1124_CR626","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154584","volume":"109","author":"M Liu","year":"2023","unstructured":"Liu M, Zhang Y, Zhang A, et al. Compound K is a potential clinical anticancer agent in prostate cancer by arresting cell cycle. Phytomedicine. 2023;109: 154584.","journal-title":"Phytomedicine"},{"issue":"1","key":"1124_CR627","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12906-024-04471-9","volume":"24","author":"J Chen","year":"2024","unstructured":"Chen J, Wang Z, Fu J, et al. Ginsenoside compound K induces ferroptosis via the FOXO pathway in liver cancer cells. BMC Complement Med Ther. 2024;24(1):174.","journal-title":"BMC Complement Med Ther"},{"issue":"14","key":"1124_CR628","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033463","volume":"102","author":"S Gao","year":"2023","unstructured":"Gao S, Fang C, Wang T, et al. The effect of ginsenoside Rg3 combined with chemotherapy on immune function in non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials. Medicine. 2023;102(14): e33463.","journal-title":"Medicine"},{"key":"1124_CR629","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jconrel.2020.12.036","volume":"330","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Liang J, Gao C, et al. Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy. J Control Release. 2021;330:641\u201357.","journal-title":"J Control Release"},{"issue":"6","key":"1124_CR630","doi-asserted-by":"publisher","first-page":"eabj1262","DOI":"10.1126\/sciadv.abj1262","volume":"8","author":"J Xia","year":"2022","unstructured":"Xia J, Ma S, Zhu X, et al. Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches. Sci Adv. 2022;8(6):eabj1262.","journal-title":"Sci Adv"},{"issue":"1","key":"1124_CR631","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12951-022-01623-2","volume":"20","author":"J Xia","year":"2022","unstructured":"Xia J, Zhang S, Zhang R, et al. Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes. J Nanobiotechnol. 2022;20(1):414.","journal-title":"J Nanobiotechnol"},{"key":"1124_CR632","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155180","volume":"123","author":"C Yang","year":"2024","unstructured":"Yang C, Qian C, Zheng W, et al. Ginsenoside Rh2 enhances immune surveillance of natural killer (NK) cells via inhibition of ERp5 in breast cancer. Phytomedicine. 2024;123: 155180.","journal-title":"Phytomedicine"},{"key":"1124_CR633","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109217","volume":"248","author":"Q Li","year":"2023","unstructured":"Li Q, He J, Li S, et al. The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 \/ NF-kappaB pathway. Clin Immunol. 2023;248: 109217.","journal-title":"Clin Immunol"},{"issue":"1","key":"1124_CR634","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13020-024-00904-2","volume":"19","author":"H Wang","year":"2024","unstructured":"Wang H, Huang M, Zhu M, et al. Paclitaxel combined with compound K inducing pyroptosis of non-small cell lung cancer cells by regulating Treg\/Th17 balance. Chin Med. 2024;19(1):26.","journal-title":"Chin Med"},{"issue":"8","key":"1124_CR635","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells10082151","volume":"10","author":"JH Lee","year":"2021","unstructured":"Lee JH, Lee DY, Lee HJ, et al. Inhibition of STAT3\/PD-L1 and activation of miR193a-5p are critically involved in apoptotic effect of compound k in prostate cancer cells. Cells. 2021;10(8):1.","journal-title":"Cells"},{"issue":"1","key":"1124_CR636","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/cas.13881","volume":"110","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wei X, Shen L, et al. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma. Cancer Sci. 2019;110(1):389\u2013400.","journal-title":"Cancer Sci"},{"issue":"6","key":"1124_CR637","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/tox.22899","volume":"35","author":"Q Tan","year":"2020","unstructured":"Tan Q, Lin S, Zeng Y, et al. Ginsenoside Rg3 attenuates the osimertinib resistance by reducing the stemness of non-small cell lung cancer cells. Environ Toxicol. 2020;35(6):643\u201351.","journal-title":"Environ Toxicol"},{"issue":"7","key":"1124_CR638","doi-asserted-by":"publisher","first-page":"10680","DOI":"10.1002\/jcp.27731","volume":"234","author":"B Ahmmed","year":"2019","unstructured":"Ahmmed B, Kampo S, Khan M, et al. Rg3 inhibits gemcitabine-induced lung cancer cell invasiveness through ROS-dependent, NF-\u03baB- and HIF-1\u03b1-mediated downregulation of PTX3. J Cell Physiol. 2019;234(7):10680\u201397.","journal-title":"J Cell Physiol"},{"key":"1124_CR639","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jare.2022.09.007","volume":"49","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Wang A, Zhang S, et al. Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells. J Adv Res. 2023;49:159\u201373.","journal-title":"J Adv Res"},{"issue":"4","key":"1124_CR640","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/cbin.12123","volume":"48","author":"W Zhao","year":"2024","unstructured":"Zhao W, Ma J, Zhang Q, et al. Ginsenoside Rg3 overcomes tamoxifen resistance through inhibiting glycolysis in breast cancer cells. Cell Biol Int. 2024;48(4):496\u2013509.","journal-title":"Cell Biol Int"},{"issue":"6","key":"1124_CR641","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22480","volume":"34","author":"J Zou","year":"2020","unstructured":"Zou J, Su H, Zou C, et al. Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling. J Biochem Mol Toxicol. 2020;34(6): e22480.","journal-title":"J Biochem Mol Toxicol"},{"key":"1124_CR642","doi-asserted-by":"crossref","unstructured":"Wu Y, Zhang J, Tian Y et al. 20(S)-Ginsenoside Rh2 overcomes gemcitabine resistance in pancreatic cancer by inhibiting LAMC2-Modulated ABC transporters. J Adv Res. 2024, 11:S2090\u20131232(2024)00390\u201300394.","DOI":"10.1016\/j.jare.2024.09.006"},{"issue":"20","key":"1124_CR643","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.3390\/molecules24203655","volume":"24","author":"S Bian","year":"2019","unstructured":"Bian S, Zhao Y, Li F, et al. 20(S)-ginsenoside Rg3 promotes HeLa cell apoptosis by regulating autophagy. Molecules. 2019;24(20):3655.","journal-title":"Molecules"},{"issue":"1","key":"1124_CR644","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jgr.2023.06.001","volume":"48","author":"YJ Jeong","year":"2024","unstructured":"Jeong YJ, Yu MH, Cho Y, et al. Rg3-enriched red ginseng extracts enhance apoptosis in CoCl(2)-stimulated breast cancer cells by suppressing autophagy. J Ginseng Res. 2024;48(1):31\u20139.","journal-title":"J Ginseng Res"},{"key":"1124_CR645","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.663089","volume":"8","author":"SL Lu","year":"2021","unstructured":"Lu SL, Wang YH, Liu GF, et al. Graphene oxide nanoparticle-loaded ginsenoside Rg3 improves photodynamic therapy in inhibiting malignant progression and stemness of osteosarcoma. Front Mol Biosci. 2021;8: 663089.","journal-title":"Front Mol Biosci"},{"key":"1124_CR646","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.actbio.2022.08.026","volume":"151","author":"X Zhao","year":"2022","unstructured":"Zhao X, Wu J, Guo D, et al. Dynamic ginsenoside-sheltered nanocatalysts for safe ferroptosis-apoptosis combined therapy. Acta Biomater. 2022;151:549\u201360.","journal-title":"Acta Biomater"},{"issue":"1","key":"1124_CR647","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13020-020-00396-w","volume":"15","author":"J Wang","year":"2020","unstructured":"Wang J, Bian S, Wang S, et al. Ginsenoside Rh2 represses autophagy to promote cervical cancer cell apoptosis during starvation. Chin Med. 2020;15(1):118.","journal-title":"Chin Med"},{"issue":"12","key":"1124_CR648","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1039\/D1FO00348H","volume":"12","author":"Q Yin","year":"2021","unstructured":"Yin Q, Chen H, Ma RH, et al. Ginsenoside CK induces apoptosis of human cervical cancer HeLa cells by regulating autophagy and endoplasmic reticulum stress. Food Funct. 2021;12(12):5301\u201316.","journal-title":"Food Funct"},{"issue":"4","key":"1124_CR649","first-page":"711","volume":"68","author":"B Wang","year":"2021","unstructured":"Wang B, Xu Q, Zhou C, et al. Liposomes co-loaded with ursolic acid and ginsenoside Rg3 in the treatment of hepatocellular carcinoma. Acta Biochim Pol. 2021;68(4):711\u20135.","journal-title":"Acta Biochim Pol"},{"issue":"4","key":"1124_CR650","first-page":"1333","volume":"44","author":"S Hong","year":"2020","unstructured":"Hong S, Cai W, Huang Z, et al. Ginsenoside Rg3 enhances the anticancer effect of 5-FU in colon cancer cells via the PI3K\/AKT pathway. Oncol Rep. 2020;44(4):1333\u201342.","journal-title":"Oncol Rep"},{"issue":"1","key":"1124_CR651","first-page":"1139","volume":"17","author":"Y Peng","year":"2019","unstructured":"Peng Y, Zhang R, Yang X, et al. Ginsenoside Rg3 suppresses the proliferation of prostate cancer cell line PC3 through ROS-induced cell cycle arrest. Oncol Lett. 2019;17(1):1139\u201345.","journal-title":"Oncol Lett"},{"issue":"6","key":"1124_CR652","first-page":"2069","volume":"54","author":"L Meng","year":"2019","unstructured":"Meng L, Ji R, Dong X, et al. Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways. Int J Oncol. 2019;54(6):2069\u201379.","journal-title":"Int J Oncol"},{"issue":"1","key":"1124_CR653","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11626-023-00749-3","volume":"59","author":"J Li","year":"2023","unstructured":"Li J, Yang B. Ginsenoside Rg3 enhances the radiosensitivity of lung cancer A549 and H1299 cells via the PI3K\/AKT signaling pathway. In Vitro Cell Dev Biol Anim. 2023;59(1):19\u201330.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"3","key":"1124_CR654","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jgr.2021.07.004","volume":"46","author":"H Zhang","year":"2022","unstructured":"Zhang H, Yi JK, Huang H, et al. 20 (S)-ginsenoside Rh2 inhibits colorectal cancer cell growth by suppressing the Axl signaling pathway in vitro and in vivo. J Ginseng Res. 2022;46(3):396\u2013407.","journal-title":"J Ginseng Res"},{"issue":"1","key":"1124_CR655","doi-asserted-by":"publisher","first-page":"227","DOI":"10.21873\/anticanres.14769","volume":"41","author":"H Zhang","year":"2021","unstructured":"Zhang H, Yi J, Kim E, et al. 20(S)-ginsenoside Rh2 suppresses oral cancer cell growth by inhibiting the Src-Raf-ERK signaling pathway. Anticancer Res. 2021;41(1):227\u201335.","journal-title":"Anticancer Res"},{"issue":"6","key":"1124_CR656","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jgr.2024.07.002","volume":"48","author":"JK Li","year":"2024","unstructured":"Li JK, Jiang XL, Zhang Z, et al. 20(S)-ginsenoside Rh2 induces apoptosis and autophagy in melanoma cells via suppressing Src\/STAT3 signaling. J Ginseng Res. 2024;48(6):559\u201369.","journal-title":"J Ginseng Res"},{"key":"1124_CR657","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.583334","volume":"11","author":"S Zhang","year":"2020","unstructured":"Zhang S, Zhang M, Chen J, et al. Ginsenoside compound K regulates HIF-1alpha-mediated glycolysis through bclaf1 to inhibit the proliferation of human liver cancer cells. Front Pharmacol. 2020;11: 583334.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1124_CR658","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12906-022-03669-z","volume":"22","author":"S Lv","year":"2022","unstructured":"Lv S, Chen X, Chen Y, et al. Ginsenoside Rg3 induces apoptosis and inhibits proliferation by down-regulating TIGAR in rats with gastric precancerous lesions. BMC Complement Med Ther. 2022;22(1):188.","journal-title":"BMC Complement Med Ther"},{"issue":"1","key":"1124_CR659","first-page":"953","volume":"17","author":"Y Dai","year":"2019","unstructured":"Dai Y, Wang W, Sun Q, et al. Ginsenoside Rg3 promotes the antitumor activity of gefitinib in lung cancer cell lines. Exp Ther Med. 2019;17(1):953\u20139.","journal-title":"Exp Ther Med"},{"key":"1124_CR660","doi-asserted-by":"publisher","first-page":"3815786","DOI":"10.1155\/2019\/3815786","volume":"2019","author":"S Hu","year":"2019","unstructured":"Hu S, Zhu Y, Xia X, et al. Ginsenoside Rg3 prolongs survival of the orthotopic hepatocellular carcinoma model by inducing apoptosis and inhibiting angiogenesis. Anal Cell Pathol. 2019;2019:3815786.","journal-title":"Anal Cell Pathol"},{"issue":"6","key":"1124_CR661","first-page":"3209","volume":"41","author":"L Zhao","year":"2019","unstructured":"Zhao L, Shou H, Chen L, et al. Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells. Oncol Rep. 2019;41(6):3209\u201318.","journal-title":"Oncol Rep"},{"key":"1124_CR662","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.823182","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, He R, Geng L, et al. Ginsenoside Rg3 alleviates cisplatin resistance of gastric cancer cells through inhibiting SOX2 and the PI3K\/Akt\/mTOR signaling axis by up-regulating miR-429. Front Genet. 2022;13: 823182.","journal-title":"Front Genet"},{"issue":"2","key":"1124_CR663","doi-asserted-by":"publisher","first-page":"357","DOI":"10.21037\/tcr.2018.11.15","volume":"8","author":"JH Kim","year":"2019","unstructured":"Kim JH, Bae YC, Lee JW, et al. Effects of ginsenoside Rg3 on apoptosis in A375.S2 melanoma cells. Transl Cancer Res. 2019;8(2):357\u201366.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"1124_CR664","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/jpp\/rgac072","volume":"75","author":"Z Ma","year":"2023","unstructured":"Ma Z, Zuo Y, Wang W. Ginsenoside Rg3 inhibits renal cell carcinoma cell migration, invasion, colony formation, and tube formation and enhances apoptosis through promoting the DNA demethylation and histone acetylation. J Pharm Pharmacol. 2023;75(1):76\u201386.","journal-title":"J Pharm Pharmacol"},{"issue":"12","key":"1124_CR665","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22597","volume":"34","author":"C Li","year":"2020","unstructured":"Li C, Gao H, Feng X, et al. Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF-kappaB, MAPK, and PI3K\/Akt\/mTOR signaling pathways in osteosarcoma cells. J Biochem Mol Toxicol. 2020;34(12): e22597.","journal-title":"J Biochem Mol Toxicol"},{"issue":"17","key":"1124_CR666","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.3390\/molecules27175602","volume":"27","author":"H Li","year":"2022","unstructured":"Li H, Han C, Chen C, et al. (20S) ginsenoside Rh2-activated, distinct apoptosis pathways in highly and poorly differentiated human esophageal cancer cells. Molecules. 2022;27(17):5602.","journal-title":"Molecules"},{"issue":"2","key":"1124_CR667","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jgr.2020.01.007","volume":"45","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhou J, Yuan Q, et al. Characterization of ginsenoside compound K loaded ionically cross-linked carboxymethyl chitosan-calcium nanoparticles and its cytotoxic potential against prostate cancer cells. J Ginseng Res. 2021;45(2):228\u201335.","journal-title":"J Ginseng Res"},{"issue":"1","key":"1124_CR668","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1142\/S0192415X21500129","volume":"49","author":"X Li","year":"2021","unstructured":"Li X, Liu W, Geng C, et al. Ginsenoside Rg3 suppresses epithelial-mesenchymal transition via downregulating notch-Hes1 signaling in colon cancer cells. Am J Chin Med. 2021;49(1):217\u201335.","journal-title":"Am J Chin Med"},{"key":"1124_CR669","doi-asserted-by":"publisher","first-page":"6065124","DOI":"10.1155\/2020\/6065124","volume":"2020","author":"X Mao","year":"2020","unstructured":"Mao X, Jin Y, Feng T, et al. Ginsenoside rg3 inhibits the growth of osteosarcoma and attenuates metastasis through the Wnt\/\u03b2-catenin and EMT signaling pathway. Evid Based Complement Alternat Med. 2020;2020:6065124.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1124_CR670","first-page":"8407683","volume":"2019","author":"D Wang","year":"2019","unstructured":"Wang D, Wu C, Liu D, et al. Ginsenoside Rg3 inhibits migration and invasion of nasopharyngeal carcinoma cells and suppresses epithelial mesenchymal transition. Biomed Res Int. 2019;2019:8407683.","journal-title":"Biomed Res Int"},{"issue":"1","key":"1124_CR671","first-page":"965","volume":"17","author":"MY Sun","year":"2019","unstructured":"Sun MY, Song YN, Zhang M, et al. Ginsenoside Rg3 inhibits the migration and invasion of liver cancer cells by increasing the protein expression of ARHGAP9. Oncol Lett. 2019;17(1):965\u201373.","journal-title":"Oncol Lett"},{"issue":"5","key":"1124_CR672","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3724\/abbs.2022039","volume":"54","author":"K Peng","year":"2022","unstructured":"Peng K, Luo T, Li J, et al. Ginsenoside Rh2 inhibits breast cancer cell growth via ERbeta-TNFalpha pathway. Acta Biochim Biophys Sin. 2022;54(5):647\u201356.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"1","key":"1124_CR673","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40824-022-00329-8","volume":"26","author":"H Wu","year":"2022","unstructured":"Wu H, Wei G, Luo L, et al. Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti-cancer evaluation of peritumoral hydrogel injection combined with PD-L1 antibody. Biomater Res. 2022;26(1):77.","journal-title":"Biomater Res"},{"key":"1124_CR674","doi-asserted-by":"publisher","first-page":"2813142","DOI":"10.1155\/2022\/2813142","volume":"2022","author":"K Shan","year":"2022","unstructured":"Shan K, Deng Y, Du Z, et al. Examination of combined treatment of ginsenoside Rg3 and 5-fluorouracil in lung adenocarcinoma cells. Comput Math Methods Med. 2022;2022:2813142.","journal-title":"Comput Math Methods Med"},{"issue":"6","key":"1124_CR675","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1248\/bpb.b18-00852","volume":"42","author":"K Shan","year":"2019","unstructured":"Shan K, Wang Y, Hua H, et al. Ginsenoside Rg3 combined with oxaliplatin inhibits the proliferation and promotes apoptosis of hepatocellular carcinoma cells via downregulating PCNA and cyclin D1. Biol Pharm Bull. 2019;42(6):900\u20135.","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"1124_CR676","doi-asserted-by":"publisher","first-page":"13919","DOI":"10.1080\/21655979.2022.2074616","volume":"13","author":"Q Wei","year":"2022","unstructured":"Wei Q, Ren Y, Zheng X, et al. Ginsenoside Rg3 and sorafenib combination therapy relieves the hepatocellular carcinomaprogression through regulating the HK2-mediated glycolysis and PI3K\/Akt signaling pathway. Bioengineered. 2022;13(5):13919\u201328.","journal-title":"Bioengineered"},{"issue":"11","key":"1124_CR677","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/jpp\/rgad070","volume":"75","author":"X Zeng","year":"2023","unstructured":"Zeng X, Liu S, Yang H, et al. Synergistic anti-tumour activity of ginsenoside Rg3 and doxorubicin on proliferation, metastasis and angiogenesis in osteosarcoma by modulating mTOR\/HIF-1\u03b1\/VEGF and EMT signalling pathways. J Pharm Pharmacol. 2023;75(11):1405\u201317.","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"1124_CR678","first-page":"291","volume":"46","author":"V Changizi","year":"2021","unstructured":"Changizi V, Gharekhani V, Motavaseli E. Co-treatment with ginsenoside 20(S)-Rg3 and curcumin increases radiosensitivity of MDA-MB-231 Cancer Cell Line. Iran J Med Sci. 2021;46(4):291\u20137.","journal-title":"Iran J Med Sci"},{"issue":"6","key":"1124_CR679","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1021\/acs.bioconjchem.3c00207","volume":"34","author":"H Gu","year":"2023","unstructured":"Gu H, Shi R, Xu C, et al. EGFR-targeted liposomes combined with ginsenoside Rh2 inhibit triple-negative breast cancer growth and metastasis. Bioconjug Chem. 2023;34(6):1157\u201365.","journal-title":"Bioconjug Chem"},{"issue":"2","key":"1124_CR680","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201905233","volume":"16","author":"Z Ren","year":"2020","unstructured":"Ren Z, Chen X, Hong L, et al. Nanoparticle conjugation of ginsenoside Rg3 inhibits hepatocellular carcinoma development and metastasis. Small. 2020;16(2): e1905233.","journal-title":"Small"},{"key":"1124_CR681","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116515","volume":"174","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Li Y, Wu S, et al. Host-microbiota interactions in collagen-induced arthritis rats treated with human umbilical cord mesenchymal stem cell exosome and ginsenoside Rh2. Biomed Pharmacother. 2024;174: 116515.","journal-title":"Biomed Pharmacother"},{"key":"1124_CR682","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112582","volume":"203","author":"T Xia","year":"2020","unstructured":"Xia T, Zhang B, Li Y, et al. New insight into 20(S)-ginsenoside Rh2 against T-cell acute lymphoblastic leukemia associated with the gut microbiota and the immune system. Eur J Med Chem. 2020;203: 112582.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"1124_CR683","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13020-022-00701-9","volume":"17","author":"L Wang","year":"2022","unstructured":"Wang L, Shao L, Chen MY, et al. Effect of ginsenoside compound K on alleviating colitis via modulating gut microbiota. Chin Med. 2022;17(1):146.","journal-title":"Chin Med"},{"issue":"10","key":"1124_CR684","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1039\/D4BM00159A","volume":"12","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zheng B, Wei Y, et al. Bioinspired ginsenoside Rg3 PLGA nanoparticles coated with tumor-derived microvesicles to improve chemotherapy efficacy and alleviate toxicity. Biomater Sci. 2024;12(10):2672\u201388.","journal-title":"Biomater Sci"},{"key":"1124_CR685","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.omto.2021.08.008","volume":"22","author":"S He","year":"2021","unstructured":"He S, Tian S, He X, et al. Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma. Mol Ther Oncolytics. 2021;22:604\u201316.","journal-title":"Mol Ther Oncolytics"},{"issue":"23","key":"1124_CR686","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.3390\/molecules24234367","volume":"24","author":"R Mathiyalagan","year":"2019","unstructured":"Mathiyalagan R, Wang C, Kim YJ, et al. Preparation of polyethylene glycol-ginsenoside Rh1 and Rh2 conjugates and their efficacy against lung cancer and inflammation. Molecules. 2019;24(23):4367.","journal-title":"Molecules"},{"issue":"1","key":"1124_CR687","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1080\/10717544.2020.1825542","volume":"27","author":"X Xia","year":"2020","unstructured":"Xia X, Tao J, Ji Z, et al. Increased antitumor efficacy of ginsenoside Rh(2) via mixed micelles: in vivo and in vitro evaluation. Drug Deliv. 2020;27(1):1369\u201377.","journal-title":"Drug Deliv"},{"key":"1124_CR688","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123718","volume":"650","author":"J Long","year":"2024","unstructured":"Long J, Hu W, Ren T, et al. Combating multidrug resistance of breast cancer with ginsenoside Rh2-irrigated nano-in-thermogel. Int J Pharm. 2024;650: 123718.","journal-title":"Int J Pharm"},{"issue":"3","key":"1124_CR689","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/polym16030405","volume":"16","author":"X You","year":"2024","unstructured":"You X, Liu H, Chen Y, et al. Multifunctional liposomes co-modified with ginsenoside compound K and hyaluronic acid for tumor-targeted therapy. POLYMERS-BASEL. 2024;16(3):405.","journal-title":"POLYMERS-BASEL"},{"issue":"1","key":"1124_CR690","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/21691401.2018.1541900","volume":"47","author":"YJ Kim","year":"2019","unstructured":"Kim YJ, Perumalsamy H, Markus J, et al. Development of Lactobacillus kimchicus DCY51(T)-mediated gold nanoparticles for delivery of ginsenoside compound K: in vitro photothermal effects and apoptosis detection in cancer cells. Artif Cells Nanomed Biotechnol. 2019;47(1):30\u201344.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"1124_CR691","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2019.115576","volume":"230","author":"J Zhang","year":"2020","unstructured":"Zhang J, Jiang Y, Li Y, et al. Micelles modified with a chitosan-derived homing peptide for targeted intracellular delivery of ginsenoside compound K to liver cancer cells. Carbohydr Polym. 2020;230: 115576.","journal-title":"Carbohydr Polym"},{"key":"1124_CR692","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jpba.2012.03.053","volume":"66","author":"Q Qian","year":"2012","unstructured":"Qian Q, Li SL, Sun E, et al. Metabolite profiles of icariin in rat plasma by ultra-fast liquid chromatography coupled to triple-quadrupole\/time-of-flight mass spectrometry. J Pharm Biomed Anal. 2012;66:392\u20138.","journal-title":"J Pharm Biomed Anal"},{"key":"1124_CR693","doi-asserted-by":"publisher","first-page":"1389221","DOI":"10.3389\/fphar.2024.1389221","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Xia H, Zhong X. In Vitro evaluation of the anti-pancreatic cancer activity of epimedium herb. Front Pharmacol. 2024;15:1389221.","journal-title":"Front Pharmacol"},{"key":"1124_CR694","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174269","volume":"906","author":"WD Zhang","year":"2021","unstructured":"Zhang WD, Li N, Du ZR, et al. IGF-1 receptor is involved in the regulatory effects of icariin and icaritin in astrocytes under basal conditions and after an inflammatory challenge. Eur J Pharmacol. 2021;906: 174269.","journal-title":"Eur J Pharmacol"},{"key":"1124_CR695","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.110926","volume":"392","author":"X Zhou","year":"2024","unstructured":"Zhou X, Wu D, Mi T, et al. Icaritin activates p53 and inhibits aerobic glycolysis in liver cancer cells. Chem Biol Interact. 2024;392: 110926.","journal-title":"Chem Biol Interact"},{"key":"1124_CR696","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216621","volume":"587","author":"P Luo","year":"2024","unstructured":"Luo P, An Y, He J, et al. Icaritin with autophagy\/mitophagy inhibitors synergistically enhances anticancer efficacy and apoptotic effects through PINK1\/Parkin-mediated mitophagy in hepatocellular carcinoma. Cancer Lett. 2024;587: 216621.","journal-title":"Cancer Lett"},{"issue":"11","key":"1124_CR697","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1111\/cas.14648","volume":"111","author":"L Song","year":"2020","unstructured":"Song L, Chen X, Mi L, et al. Icariin-induced inhibition of SIRT6\/NF-\u03baB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer. Cancer Sci. 2020;111(11):4242\u201356.","journal-title":"Cancer Sci"},{"key":"1124_CR698","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109275","volume":"118","author":"X Zheng","year":"2019","unstructured":"Zheng X, Li D, Li J, et al. Optimization of the process for purifying icariin from Herba Epimedii by macroporous resin and the regulatory role of icariin in the tumor immune microenvironment. Biomed Pharmacother. 2019;118: 109275.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"1124_CR699","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/eji.201948225","volume":"49","author":"H Hao","year":"2019","unstructured":"Hao H, Zhang Q, Zhu H, et al. Icaritin promotes tumor T-cell infiltration and induces antitumor immunity in mice. Eur J Immunol. 2019;49(12):2235\u201344.","journal-title":"Eur J Immunol"},{"key":"1124_CR700","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.926829","volume":"10","author":"JJ Huang","year":"2022","unstructured":"Huang JJ, Hu HX, Lu YJ, et al. Computer-aided design of \u03b1-L-rhamnosidase to increase the synthesis efficiency of icariside I. Front Bioeng Biotechnol. 2022;10: 926829.","journal-title":"Front Bioeng Biotechnol"},{"issue":"4","key":"1124_CR701","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4014\/jmb.2112.12036","volume":"32","author":"Z Wang","year":"2022","unstructured":"Wang Z, Liu C, Yu H, et al. Icaritin preparation from icariin by a special epimedium flavonoid-glycosidase from Aspergillus sp.y848 strain. J Microbiol Biotechnol. 2022;32(4):437\u201346.","journal-title":"J Microbiol Biotechnol."},{"key":"1124_CR702","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.omto.2022.04.012","volume":"25","author":"C Zhang","year":"2022","unstructured":"Zhang C, Xu H, Sui X, et al. Icaritin inhibits PLK1 to activate DNA damage response in NK\/T cell lymphoma and increases sensitivity to GELOX regime. Mol Ther Oncolytics. 2022;25:288\u2013304.","journal-title":"Mol Ther Oncolytics"},{"issue":"1","key":"1124_CR703","first-page":"69","volume":"9","author":"Y Lu","year":"2022","unstructured":"Lu Y, Gao Y, Yang H, et al. Nanomedicine-boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma. Mil Med Res. 2022;9(1):69.","journal-title":"Mil Med Res"},{"key":"1124_CR704","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155076","volume":"120","author":"C Chen","year":"2023","unstructured":"Chen C, Wang S, Wang N, et al. Icariin inhibits prostate cancer bone metastasis and destruction via suppressing TAM\/CCL5-mediated osteoclastogenesis. Phytomedicine. 2023;120: 155076.","journal-title":"Phytomedicine"},{"key":"1124_CR705","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2022.113180","volume":"151","author":"Z Bi","year":"2022","unstructured":"Bi Z, Zhang W, Yan X. Anti-inflammatory and immunoregulatory effects of icariin and icaritin. Biomed Pharmacother. 2022;151:1.","journal-title":"Biomed Pharmacother."},{"issue":"7","key":"1124_CR706","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.intimp.2011.01.007","volume":"11","author":"J Zhou","year":"2011","unstructured":"Zhou J, Wu J, Chen X, et al. Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions. Int Immunopharmacol. 2011;11(7):890\u20138.","journal-title":"Int Immunopharmacol"},{"key":"1124_CR707","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.609295","volume":"12","author":"H Tao","year":"2021","unstructured":"Tao H, Liu M, Wang Y, et al. Icaritin induces anti-tumor immune responses in hepatocellular carcinoma by inhibiting splenic myeloid-derived suppressor cell generation. Front Immunol. 2021;12: 609295.","journal-title":"Front Immunol"},{"issue":"1","key":"1124_CR708","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12935-021-01910-2","volume":"21","author":"C Li","year":"2021","unstructured":"Li C, Yang S, Ma H, et al. Influence of icariin on inflammation, apoptosis, invasion, and tumor immunity in cervical cancer by reducing the TLR4\/MyD88\/NF-\u03baB and Wnt\/\u03b2-catenin pathways. Cancer Cell Int. 2021;21(1):206.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"1124_CR709","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1248\/bpb.b23-00668","volume":"47","author":"B Song","year":"2024","unstructured":"Song B, Wei F, Peng J, et al. Icariin regulates EMT and stem cell-like character in breast cancer through modulating lncRNA NEAT1\/TGF\u03b2\/SMAD2 signaling pathway. Biol Pharm Bull. 2024;47(2):399\u2013410.","journal-title":"Biol Pharm Bull"},{"issue":"10","key":"1124_CR710","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1097\/CAD.0000000000000976","volume":"31","author":"X Zhao","year":"2020","unstructured":"Zhao X, Lin Y, Jiang B, et al. Icaritin inhibits lung cancer-induced osteoclastogenesis by suppressing the expression of IL-6 and TNF-a and through AMPK\/mTOR signaling pathway. Anticancer Drugs. 2020;31(10):1004\u201311.","journal-title":"Anticancer Drugs"},{"issue":"4","key":"1124_CR711","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/eji.202048905","volume":"51","author":"D Mo","year":"2021","unstructured":"Mo D, Zhu H, Wang J, et al. Icaritin inhibits PD-L1 expression by targeting protein I\u03baB kinase \u03b1. Eur J Immunol. 2021;51(4):978\u201388.","journal-title":"Eur J Immunol"},{"issue":"11","key":"1124_CR712","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1111\/cas.14641","volume":"111","author":"SK Qin","year":"2020","unstructured":"Qin SK, Li Q, Ming XuJ, et al. Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: immunodynamic biomarkers and overall survival. Cancer Sci. 2020;111(11):4218\u201331.","journal-title":"Cancer Sci"},{"issue":"2","key":"1124_CR713","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.18632\/aging.202410","volume":"13","author":"C Huang","year":"2021","unstructured":"Huang C, Li Z, Zhu J, et al. Systems pharmacology dissection of Epimedium targeting tumor microenvironment to enhance cytotoxic T lymphocyte responses in lung cancer. Aging (Albany NY). 2021;13(2):2912\u201340.","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"1124_CR714","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1016\/j.apsb.2022.03.016","volume":"12","author":"Y Cao","year":"2022","unstructured":"Cao Y, Fang J, Shi Y, et al. Screening potential P-glycoprotein inhibitors by combination of a detergent-free membrane protein extraction with surface plasmon resonance biosensor. Acta Pharm Sin B. 2022;12(7):3113\u201323.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"1124_CR715","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/jfb14010044","volume":"14","author":"Z Seyedi","year":"2023","unstructured":"Seyedi Z, Amiri MS, Mohammadzadeh V, et al. Icariin: a promising natural product in biomedicine and tissue engineering. J Funct Biomater. 2023;14(1):7.","journal-title":"J Funct Biomater"},{"issue":"6","key":"1124_CR716","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s12282-019-00980-5","volume":"26","author":"X Cheng","year":"2019","unstructured":"Cheng X, Tan S, Duan F, et al. Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7\/TAM. Breast Cancer. 2019;26(6):766\u201375.","journal-title":"Breast Cancer"},{"issue":"6","key":"1124_CR717","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.3892\/mmr.2013.1742","volume":"8","author":"L Sun","year":"2013","unstructured":"Sun L, Chen W, Qu L, et al. Icaritin reverses multidrug resistance of HepG2\/ADR human hepatoma cells via downregulation of MDR1 and P-glycoprotein expression. Mol Med Rep. 2013;8(6):1883\u20137.","journal-title":"Mol Med Rep"},{"issue":"1","key":"1124_CR718","first-page":"20","volume":"16","author":"ZD Wang","year":"2018","unstructured":"Wang ZD, Wang RZ, Xia YZ, et al. Reversal of multidrug resistance by icaritin in doxorubicin-resistant human osteosarcoma cells. Chin J Nat Med. 2018;16(1):20\u20138.","journal-title":"Chin J Nat Med"},{"key":"1124_CR719","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2020.109124","volume":"325","author":"C Bailly","year":"2020","unstructured":"Bailly C. Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma. Chem-Biol Interact. 2020;325:1.","journal-title":"Chem-Biol Interact"},{"issue":"6","key":"1124_CR720","first-page":"1933","volume":"54","author":"S Jiang","year":"2019","unstructured":"Jiang S, Chang H, Deng S, et al. Icariin enhances the chemosensitivity of cisplatin-resistant ovarian cancer cells by suppressing autophagy via activation of the AKT\/mTOR\/ATG5 pathway. Int J Oncol. 2019;54(6):1933\u201342.","journal-title":"Int J Oncol"},{"issue":"1","key":"1124_CR721","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12935-024-03266-9","volume":"24","author":"M Zhao","year":"2024","unstructured":"Zhao M, Xu P, Shi W, et al. Icariin exerts anti-tumor activity by inducing autophagy via AMPK\/mTOR\/ULK1 pathway in triple-negative breast cancer. Cancer Cell Int. 2024;24(1):74.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"1124_CR722","first-page":"990","volume":"24","author":"S Huang","year":"2019","unstructured":"Huang S, Xie T, Liu W. Icariin inhibits the growth of human cervical cancer cells by inducing apoptosis and autophagy by targeting mTOR\/PI3K\/AKT signalling pathway. J buon. 2019;24(3):990\u20136.","journal-title":"J buon"},{"issue":"1","key":"1124_CR723","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/1566524020666200530212440","volume":"21","author":"CC Tao","year":"2021","unstructured":"Tao CC, Wu Y, Gao X, et al. The antitumor effects of icaritin against breast cancer is related to estrogen receptors. Curr Mol Med. 2021;21(1):73\u201385.","journal-title":"Curr Mol Med"},{"issue":"4","key":"1124_CR724","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1021\/acsnano.0c00708","volume":"14","author":"Z Yu","year":"2020","unstructured":"Yu Z, Guo J, Hu M, et al. Icaritin exacerbates mitophagy and synergizes with doxorubicin to induce immunogenic cell death in hepatocellular carcinoma. ACS Nano. 2020;14(4):4816\u201328.","journal-title":"ACS Nano"},{"issue":"1","key":"1124_CR725","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/ijms18010132","volume":"18","author":"JG Yang","year":"2017","unstructured":"Yang JG, Lu R, Ye XJ, et al. Icaritin reduces oral squamous cell carcinoma progression via the inhibition of STAT3 signaling. Int J Mol Sci. 2017;18(1):132.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1124_CR726","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3892\/or.2022.8326","volume":"47","author":"F Zhu","year":"2022","unstructured":"Zhu F, Ren Z. Icariin inhibits the malignant progression of lung cancer by affecting the PI3K\/Akt pathway through the miR-205-5p\/PTEN axis. Oncol Rep. 2022;47(6):115.","journal-title":"Oncol Rep"},{"key":"1124_CR727","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8830","volume":"8","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li M, Han X. Icariin affects cell cycle progression and proliferation of human retinal pigment epithelial cells via enhancing expression of H19. PeerJ. 2020;8: e8830.","journal-title":"PeerJ"},{"issue":"4","key":"1124_CR728","first-page":"2321","volume":"41","author":"P Wang","year":"2019","unstructured":"Wang P, Zhang J, Xiong X, et al. Icariin suppresses cell cycle transition and cell migration in ovarian cancer cells. Oncol Rep. 2019;41(4):2321\u20138.","journal-title":"Oncol Rep"},{"issue":"2","key":"1124_CR729","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/aps.2012.162","volume":"34","author":"DC Zhang","year":"2013","unstructured":"Zhang DC, Liu JL, Ding YB, et al. Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-\u03baB. Acta Pharmacol Sin. 2013;34(2):301\u20138.","journal-title":"Acta Pharmacol Sin"},{"key":"1124_CR730","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.940926","volume":"12","author":"Y Fu","year":"2022","unstructured":"Fu Y, Liu H, Long M, et al. Icariin attenuates the tumor growth by targeting miR-1-3p\/TNKS2\/Wnt\/\u03b2-catenin signaling axis in ovarian cancer. Front Oncol. 2022;12: 940926.","journal-title":"Front Oncol"},{"issue":"1","key":"1124_CR731","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/13880209.2019.1628073","volume":"57","author":"S Wang","year":"2019","unstructured":"Wang S, Wang Q, Wang H, et al. Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells. Pharm Biol. 2019;57(1):424\u201331.","journal-title":"Pharm Biol"},{"key":"1124_CR732","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155062","volume":"120","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang G, Liu Y, et al. Icaritin inhibits endometrial carcinoma cells by suppressing O-GlcNAcylation of FOXC1. Phytomedicine. 2023;120: 155062.","journal-title":"Phytomedicine"},{"key":"1124_CR733","doi-asserted-by":"publisher","first-page":"993022","DOI":"10.3389\/fphar.2022.993022","volume":"13","author":"M Liu","year":"2022","unstructured":"Liu M, Hu T, Gou W, et al. Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation. Front Pharmacol. 2022;13:993022.","journal-title":"Front Pharmacol"},{"issue":"9","key":"1124_CR734","first-page":"104991","volume":"25","author":"C Zhang","year":"2022","unstructured":"Zhang C, Wang X, Zhang C. Icaritin inhibits CDK2 expression and activity to interfere with tumor progression. Science. 2022;25(9):104991.","journal-title":"Science"},{"issue":"1","key":"1124_CR735","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13046-015-0133-x","volume":"34","author":"T Wu","year":"2015","unstructured":"Wu T, Wang S, Wu J, et al. Icaritin induces lytic cytotoxicity in extranodal NK\/T-cell lymphoma. J Exp Clin Cancer Res. 2015;34(1):17.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"1124_CR736","first-page":"765","volume":"41","author":"X Chen","year":"2019","unstructured":"Chen X, Song L, Hou Y, et al. Reactive oxygen species induced by icaritin promote DNA strand breaks and apoptosis in human cervical cancer cells. Oncol Rep. 2019;41(2):765\u201378.","journal-title":"Oncol Rep"},{"issue":"3","key":"1124_CR737","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3892\/etm.2021.10374","volume":"22","author":"L Sun","year":"2021","unstructured":"Sun L, Zhang J. Icariin inhibits oral squamous cell carcinoma cell proliferation and induces apoptosis via inhibiting the NF-\u03baB and PI3K\/AKT pathways. Exp Ther Med. 2021;22(3):942.","journal-title":"Exp Ther Med"},{"issue":"9","key":"1124_CR738","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10495-015-1142-0","volume":"20","author":"S Di","year":"2015","unstructured":"Di S, Fan C, Yang Y, et al. Activation of endoplasmic reticulum stress is involved in the activity of icariin against human lung adenocarcinoma cells. Apoptosis. 2015;20(9):1229\u201341.","journal-title":"Apoptosis"},{"key":"1124_CR739","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113189","volume":"262","author":"S Wang","year":"2020","unstructured":"Wang S, Gao J, Li Q, et al. Study on the regulatory mechanism and experimental verification of icariin for the treatment of ovarian cancer based on network pharmacology. J Ethnopharmacol. 2020;262: 113189.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"1124_CR740","first-page":"973","volume":"39","author":"Q Wang","year":"2011","unstructured":"Wang Q, Hao J, Pu J, et al. Icariin induces apoptosis in mouse MLTC-10 Leydig tumor cells through activation of the mitochondrial pathway and down-regulation of the expression of piwil4. Int J Oncol. 2011;39(4):973\u201380.","journal-title":"Int J Oncol"},{"key":"1124_CR741","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116879","volume":"239","author":"X Wu","year":"2019","unstructured":"Wu X, Kong W, Qi X, et al. Icariin induces apoptosis of human lung adenocarcinoma cells by activating the mitochondrial apoptotic pathway. Life Sci. 2019;239: 116879.","journal-title":"Life Sci"},{"key":"1124_CR742","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.13703","volume":"10","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Huang N, Li Y, et al. Effect of icaritin on autophagy-related protein expression in TDP-43-transfected SH-SY5Y cells. PeerJ. 2022;10: e13703.","journal-title":"PeerJ"},{"issue":"1","key":"1124_CR743","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13046-021-01881-2","volume":"40","author":"Z Cao","year":"2021","unstructured":"Cao Z, Cheng Y, Wang J, et al. HBP1-mediated transcriptional repression of AFP inhibits hepatoma progression. J Exp Clin Cancer Res. 2021;40(1):118.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1124_CR744","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12885-021-08043-9","volume":"21","author":"H Li","year":"2021","unstructured":"Li H, Liu Y, Jiang W, et al. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma. BMC Cancer. 2021;21(1):318.","journal-title":"BMC Cancer"},{"issue":"3","key":"1124_CR745","first-page":"821","volume":"56","author":"B Kim","year":"2020","unstructured":"Kim B, Seo JH, Lee KY, et al. Icariin sensitizes human colon cancer cells to TRAIL-induced apoptosis via ERK-mediated upregulation of death receptors. Int J Oncol. 2020;56(3):821\u201334.","journal-title":"Int J Oncol"},{"key":"1124_CR746","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2147\/DDDT.S398887","volume":"17","author":"S Gao","year":"2023","unstructured":"Gao S, Zhang X, Liu J, et al. Icariin Induces Triple-Negative Breast Cancer Cell Apoptosis and Suppresses Invasion by Inhibiting the JNK\/c-Jun Signaling Pathway. Drug Des Devel Ther. 2023;17:821\u201336.","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"1124_CR747","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/kjm2.12504","volume":"38","author":"YH Zhu","year":"2022","unstructured":"Zhu YH, Zhang XR, Zhang Q, et al. Icaritin-elevated circ_0000190 suppresses the malignant progression of multiple myeloma by targeting miR-301a. Kaohsiung J Med Sci. 2022;38(5):447\u201356.","journal-title":"Kaohsiung J Med Sci"},{"issue":"4","key":"1124_CR748","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.bbrc.2018.08.060","volume":"504","author":"S Han","year":"2018","unstructured":"Han S, Gou Y, Jin D, et al. Effects of Icaritin on the physiological activities of esophageal cancer stem cells. Biochem Biophys Res Commun. 2018;504(4):792\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"1124_CR749","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.843489","volume":"12","author":"L Gao","year":"2022","unstructured":"Gao L, Ouyang Y, Li R, et al. icaritin inhibits migration and invasion of human ovarian cancer cells via the Akt\/mTOR signaling pathway. Front Oncol. 2022;12: 843489.","journal-title":"Front Oncol"},{"issue":"2","key":"1124_CR750","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/biof.1927","volume":"49","author":"W Xu","year":"2023","unstructured":"Xu W, Ding J, Li B, et al. Effects of icariin and curcumol on autophagy, ferroptosis, and lipid metabolism based on miR-7\/m-TOR\/SREBP1 pathway on prostate cancer. BioFactors. 2023;49(2):438\u201356.","journal-title":"BioFactors"},{"issue":"1","key":"1124_CR751","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1080\/10717544.2022.2147601","volume":"29","author":"H Zeng","year":"2022","unstructured":"Zeng H, Li X, Liu Y, et al. An icaritin-loaded microemulsion based on coix oil for improved pharmacokinetics and enhanced antitumor efficacy. Drug Deliv. 2022;29(1):3454\u201366.","journal-title":"Drug Deliv"},{"issue":"10","key":"1124_CR752","first-page":"1665","volume":"43","author":"T Hu","year":"2023","unstructured":"Hu T, Gou W, Ren Z, et al. Icaritin increases radiosensitivity of nasopharyngeal carcinoma cells by regulating iron death. Nan Fang Yi Ke Da Xue Xue Bao. 2023;43(10):1665\u201373.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"1124_CR753","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.biopha.2018.01.139","volume":"99","author":"X Zhang","year":"2018","unstructured":"Zhang X, Kang Z, Li Q, et al. Antigen-adjuvant effects of icariin in enhancing tumor-specific immunity in mastocytoma-bearing DBA\/2J mice. Biomed Pharmacother. 2018;99:810\u20136.","journal-title":"Biomed Pharmacother"},{"key":"1124_CR754","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109093","volume":"111","author":"Z Dongye","year":"2022","unstructured":"Dongye Z, Wu X, Wen Y, et al. Icaritin and intratumoral injection of CpG treatment synergistically promote T cell infiltration and antitumor immune response in mice. Int Immunopharmacol. 2022;111: 109093.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1124_CR755","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12951-023-01939-7","volume":"21","author":"Z Li","year":"2023","unstructured":"Li Z, Liu P, Chen W, et al. Hypoxia-cleavable and specific targeted nanomedicine delivers epigenetic drugs for enhanced treatment of breast cancer and bone metastasis. J Nanobiotechnology. 2023;21(1):221.","journal-title":"J Nanobiotechnology"},{"key":"1124_CR756","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175914","volume":"955","author":"K He","year":"2023","unstructured":"He K, Wang J, Zhou Y, et al. Network pharmacology analysis of Icariside II against bladder cancer. Eur J Pharmacol. 2023;955: 175914.","journal-title":"Eur J Pharmacol"},{"key":"1124_CR757","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154638","volume":"110","author":"Q Kong","year":"2023","unstructured":"Kong Q, Ma M, Zhang L, et al. Icariside II potentiates the anti-PD-1 antitumor effect by reducing chemotactic infiltration of myeloid-derived suppressor cells into the tumor microenvironment via ROS-mediated inactivation of the SRC\/ERK\/STAT3 signaling pathways. Phytomedicine. 2023;110: 154638.","journal-title":"Phytomedicine"},{"key":"1124_CR758","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.2147\/DDDT.S268524","volume":"14","author":"S Li","year":"2020","unstructured":"Li S, Zhan Y, Xie Y, et al. The impact of icariside II on human prostate cancer cell proliferation, mobility, and autophagy via PI3K-AKT-mTOR signaling pathway. Drug Des Devel Ther. 2020;14:4169\u201378.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"1124_CR759","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12935-022-02621-y","volume":"22","author":"C Yang","year":"2022","unstructured":"Yang C, Jin YY, Mei J, et al. Identification of icaritin derivative IC2 as an SCD-1 inhibitor with anti-breast cancer properties through induction of cell apoptosis. Cancer Cell Int. 2022;22(1):202.","journal-title":"Cancer Cell Int"},{"key":"1124_CR760","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111542","volume":"140","author":"G Chen","year":"2021","unstructured":"Chen G, Cao Z, Shi Z, et al. Microbiome analysis combined with targeted metabolomics reveal immunological anti-tumor activity of icariside I in a melanoma mouse model. Biomed Pharmacother. 2021;140: 111542.","journal-title":"Biomed Pharmacother"},{"key":"1124_CR761","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113387","volume":"153","author":"G Chen","year":"2022","unstructured":"Chen G, Huang J, Lei H, et al. Icariside I\u2014a novel inhibitor of the kynurenine-AhR pathway with potential for cancer therapy by blocking tumor immune escape. Biomed Pharmacother. 2022;153: 113387.","journal-title":"Biomed Pharmacother"},{"key":"1124_CR762","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110013","volume":"125","author":"YS Sun","year":"2020","unstructured":"Sun YS, Thakur K, Hu F, et al. Icariside II suppresses cervical cancer cell migration through JNK modulated matrix metalloproteinase-2\/9 inhibition in vitro and in vivo. Biomed Pharmacother. 2020;125: 110013.","journal-title":"Biomed Pharmacother"},{"key":"1124_CR763","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104616","volume":"152","author":"YS Sun","year":"2020","unstructured":"Sun YS, Thakur K, Hu F, et al. Icariside II inhibits tumorigenesis via inhibiting AKT\/Cyclin E\/ CDK 2 pathway and activating mitochondria-dependent pathway. Pharmacol Res. 2020;152: 104616.","journal-title":"Pharmacol Res"},{"issue":"5","key":"1124_CR764","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.7150\/ijbs.66630","volume":"18","author":"Z Tang","year":"2022","unstructured":"Tang Z, Du W, Xu F, et al. Icariside II enhances cisplatin-induced apoptosis by promoting endoplasmic reticulum stress signalling in non-small cell lung cancer cells. Int J Biol Sci. 2022;18(5):2060\u201374.","journal-title":"Int J Biol Sci"},{"key":"1124_CR765","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.105800","volume":"124","author":"CJ Shi","year":"2022","unstructured":"Shi CJ, Li SY, Shen CH, et al. Icariside II suppressed tumorigenesis by epigenetically regulating the circ\u03b2-catenin-Wnt\/\u03b2-catenin axis in colorectal cancer. Bioorg Chem. 2022;124: 105800.","journal-title":"Bioorg Chem"},{"issue":"1","key":"1124_CR766","first-page":"360","volume":"44","author":"X Liu","year":"2020","unstructured":"Liu X, Li Z, Li M, et al. Icariside II overcomes BRAF inhibitor resistance in melanoma by inducing ROS production and inhibiting MITF. Oncol Rep. 2020;44(1):360\u201370.","journal-title":"Oncol Rep"},{"key":"1124_CR767","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154182","volume":"102","author":"R Yu","year":"2022","unstructured":"Yu R, Zhou Y, Shi S, et al. Icariside II induces ferroptosis in renal cell carcinoma cells by regulating the miR-324-3p\/GPX4 axis. Phytomedicine. 2022;102: 154182.","journal-title":"Phytomedicine"},{"key":"1124_CR768","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejphar.2018.12.026","volume":"846","author":"J Yang","year":"2019","unstructured":"Yang J, Lan J, Du H, et al. Icariside II induces cell cycle arrest and differentiation via TLR8\/MyD88\/p38 pathway in acute myeloid leukemia cells. Eur J Pharmacol. 2019;846:12\u201322.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1124_CR769","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/molecules28031109","volume":"28","author":"YX Wang","year":"2023","unstructured":"Wang YX, Jin YY, Wang J, et al. Icaritin derivative IC2 induces cytoprotective autophagy of breast cancer cells via SCD1 inhibition. Molecules. 2023;28(3):1109.","journal-title":"Molecules"},{"issue":"2","key":"1124_CR770","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1021\/acs.jnatprod.2c00908","volume":"86","author":"J Li","year":"2023","unstructured":"Li J, Shen S, Liu Z, et al. Synthesis and structure-activity analysis of icaritin derivatives as potential tumor growth inhibitors of hepatocellular carcinoma cells. J Nat Prod. 2023;86(2):290\u2013306.","journal-title":"J Nat Prod"},{"issue":"20","key":"1124_CR771","doi-asserted-by":"publisher","first-page":"14942","DOI":"10.1021\/acs.jmedchem.1c00087","volume":"64","author":"Y Hou","year":"2021","unstructured":"Hou Y, Kuang W, Min W, et al. Design, synthesis, and biological evaluation of icaritin derivatives as novel putative deptor inhibitors for multiple myeloma treatment. J Med Chem. 2021;64(20):14942\u201354.","journal-title":"J Med Chem"},{"key":"1124_CR772","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116765","volume":"317","author":"YM Liu","year":"2023","unstructured":"Liu YM, Li XQ, Zhang XR, et al. Uncovering the key pharmacodynamic material basis and possible molecular mechanism of extract of epimedium against liver cancer through a comprehensive investigation. J Ethnopharmacol. 2023;317: 116765.","journal-title":"J Ethnopharmacol"},{"key":"1124_CR773","doi-asserted-by":"publisher","first-page":"1205604","DOI":"10.3389\/fonc.2023.1205604","volume":"13","author":"YB Jin","year":"2023","unstructured":"Jin YB, Liang XC, Cai JH, et al. Mechanism of action of icaritin on uterine corpus endometrial carcinoma based on network pharmacology and experimental evaluation. Front Oncol. 2023;13:1205604.","journal-title":"Front Oncol"},{"key":"1124_CR774","doi-asserted-by":"publisher","first-page":"1178724","DOI":"10.3389\/fphar.2023.1178724","volume":"14","author":"W Chen","year":"2023","unstructured":"Chen W, Xin J, Wei X, et al. Integrated transcriptomic and metabolomic profiles reveal the protective mechanism of modified Danggui Buxue decoction on radiation-induced leukopenia in mice. Front Pharmacol. 2023;14:1178724.","journal-title":"Front Pharmacol"},{"key":"1124_CR775","doi-asserted-by":"publisher","first-page":"1208495","DOI":"10.3389\/fphar.2023.1208495","volume":"14","author":"Z Xue","year":"2023","unstructured":"Xue Z, Zhang F, Xu S, et al. Investigating the effect of icaritin on hepatocellular carcinoma based on network pharmacology. Front Pharmacol. 2023;14:1208495.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1124_CR776","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/pharmaceutics13010020","volume":"13","author":"UA Fahmy","year":"2020","unstructured":"Fahmy UA, Fahmy O, Alhakamy NA. Optimized icariin cubosomes exhibit augmented cytotoxicity against SKOV-3 ovarian cancer cells. Pharmaceutics. 2020;13(1):20.","journal-title":"Pharmaceutics"},{"key":"1124_CR777","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175225","volume":"931","author":"Y Ji","year":"2022","unstructured":"Ji Y, Zhang Z, Hou W, et al. Enhanced antitumor effect of icariin nanoparticles coated with iRGD functionalized erythrocyte membrane. Eur J Pharmacol. 2022;931: 175225.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1124_CR778","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1080\/10717544.2022.2079769","volume":"29","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Yao W, Lin M, et al. Icaritin-loaded PLGA nanoparticles activate immunogenic cell death and facilitate tumor recruitment in mice with gastric cancer. Drug Deliv. 2022;29(1):1712\u201325.","journal-title":"Drug Deliv"},{"key":"1124_CR779","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.124406","volume":"240","author":"J Liu","year":"2023","unstructured":"Liu J, Lin S, Dang J, et al. Anticancer and bone-enhanced nano-hydroxyapatite\/gelatin\/polylactic acid fibrous membrane with dual drug delivery and sequential release for osteosarcoma. Int J Biol Macromol. 2023;240: 124406.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"1124_CR780","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1080\/10717544.2019.1669734","volume":"26","author":"M Liu","year":"2019","unstructured":"Liu M, Wang B, Guo C, et al. Novel multifunctional triple folic acid, biotin and CD44 targeting pH-sensitive nano-actiniaes for breast cancer combinational therapy. Drug Deliv. 2019;26(1):1002\u201316.","journal-title":"Drug Deliv"},{"issue":"12","key":"1124_CR781","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/ph14121309","volume":"14","author":"NA Alhakamy","year":"2021","unstructured":"Alhakamy NA, Badr-Eldin SM, Alharbi WS, et al. Development of an icariin-loaded bilosome-melittin formulation with improved anticancer activity against cancerous pancreatic cells. Pharmaceuticals. 2021;14(12):1309.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"1124_CR782","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1038\/s41598-019-42909-0","volume":"9","author":"X Song","year":"2019","unstructured":"Song X, Gan K, Qin S, et al. Preparation and characterization of general-purpose gelatin-based co-loading flavonoids nano-core structure. Sci Rep. 2019;9(1):6365.","journal-title":"Sci Rep"},{"issue":"7","key":"1124_CR783","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2174\/1567201818999201210211636","volume":"18","author":"JG Yang","year":"2021","unstructured":"Yang JG, Zhang J, Chen XJ, et al. Stable loading and delivery of icaritin using PEG-PCL micelles for effective treatment of oral squamous cell carcinoma. Curr Drug Deliv. 2021;18(7):975\u201383.","journal-title":"Curr Drug Deliv"},{"key":"1124_CR784","doi-asserted-by":"publisher","first-page":"1117052","DOI":"10.3389\/fphar.2023.1117052","volume":"14","author":"L Xiang","year":"2023","unstructured":"Xiang L, Li Y, Gu X, et al. Nucleolin recognizing silica nanoparticles inhibit cell proliferation by activating the Bax\/Bcl-2\/caspase-3 signalling pathway to induce apoptosis in liver cancer. Front Pharmacol. 2023;14:1117052.","journal-title":"Front Pharmacol"},{"key":"1124_CR785","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120533","volume":"601","author":"J Guo","year":"2021","unstructured":"Guo J, Zeng H, Liu Y, et al. Multicomponent thermosensitive lipid complexes enhance desmoplastic tumor therapy through boosting anti-angiogenesis and synergistic strategy. Int J Pharm. 2021;601: 120533.","journal-title":"Int J Pharm"},{"key":"1124_CR786","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.foodhyd.2019.04.048","volume":"95","author":"Y Wei","year":"2019","unstructured":"Wei Y, Yu Z, Lin K, et al. Fabrication and characterization of resveratrol loaded zein-propylene glycol alginate-rhamnolipid composite nanoparticles: physicochemical stability, formation mechanism and in vitro digestion. Food Hydrocolloids. 2019;95:336\u201348.","journal-title":"Food Hydrocolloids"},{"key":"1124_CR787","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2022.134705","volume":"434","author":"J Zheng","year":"2022","unstructured":"Zheng J, Zhao R, Uliana AA, et al. Separation of textile wastewater using a highly permeable resveratrol-based loose nanofiltration membrane with excellent anti-fouling performance. Chem Eng J. 2022;434: 134705.","journal-title":"Chem Eng J"},{"issue":"1","key":"1124_CR788","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12934-020-01401-5","volume":"19","author":"SF Yuan","year":"2020","unstructured":"Yuan SF, Yi X, Johnston TG, et al. De novo resveratrol production through modular engineering of an Escherichia coli-Saccharomyces cerevisiae co-culture. Microb Cell Fact. 2020;19(1):143.","journal-title":"Microb Cell Fact"},{"issue":"2","key":"1124_CR789","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.synbio.2022.03.001","volume":"7","author":"J Li","year":"2022","unstructured":"Li J, Qiu ZT, Zhao GR. Modular engineering of E. coli coculture for efficient production of resveratrol from glucose and arabinose mixture. Synth Syst Biotechnol. 2022;7(2):718\u201329.","journal-title":"Synth Syst Biotechnol"},{"key":"1124_CR790","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jff.2019.04.007","volume":"57","author":"H Jayan","year":"2019","unstructured":"Jayan H, Leena MM, Sundari SKS, et al. Improvement of bioavailability for resveratrol through encapsulation in zein using electrospraying technique. J Funct Foods. 2019;57:417\u201324.","journal-title":"J Funct Foods"},{"issue":"1","key":"1124_CR791","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-024-00900-6","volume":"19","author":"Z Chen","year":"2024","unstructured":"Chen Z, Wang X, Du S, et al. A review on traditional Chinese medicine natural products and acupuncture intervention for Alzheimer\u2019s disease based on the neuroinflammatory. Chin Med. 2024;19(1):1.","journal-title":"Chin Med"},{"issue":"1","key":"1124_CR792","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-024-00902-4","volume":"19","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Xu Z, Wang S, et al. Optimized new shengmai powder modulation of cAMP\/Rap1A signaling pathway attenuates myocardial fibrosis in heart failure. Chin Med. 2024;19(1):1.","journal-title":"Chin Med"},{"key":"1124_CR793","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","volume":"515","author":"B Ren","year":"2021","unstructured":"Ren B, Kwah MX-Y, Liu C, et al. Resveratrol for cancer therapy: challenges and future perspectives. Cancer Lett. 2021;515:63\u201372.","journal-title":"Cancer Lett."},{"key":"1124_CR794","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110409","volume":"376","author":"YM Zhang","year":"2023","unstructured":"Zhang YM, Zhang Z, Mousavi M, et al. Resveratrol inhibits glioblastoma cells and chemoresistance progression through blockade P-glycoprotein and targeting AKT\/PTEN signaling pathway. Chem Biol Interact. 2023;376: 110409.","journal-title":"Chem Biol Interact"},{"issue":"6","key":"1124_CR795","first-page":"6869","volume":"18","author":"CJ Cho","year":"2019","unstructured":"Cho CJ, Yang CW, Wu CL, et al. The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol. Oncol Lett. 2019;18(6):6869\u201376.","journal-title":"Oncol Lett"},{"issue":"11","key":"1124_CR796","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.3390\/cells10113213","volume":"10","author":"A Ferraresi","year":"2021","unstructured":"Ferraresi A, Esposito A, Girone C, et al. Resveratrol contrasts LPA-induced ovarian cancer cell migration and platinum resistance by rescuing hedgehog-mediated autophagy. Cells. 2021;10(11):3213.","journal-title":"Cells"},{"issue":"3","key":"1124_CR797","first-page":"7","volume":"31","author":"DM Alexandru","year":"2021","unstructured":"Alexandru DM, Coman AM, Gruia MI, et al. Study on the antioxidant properties of resveratrol in oncology prophylaxis. Rev Romana Med Vet. 2021;31(3):7\u201311.","journal-title":"Rev Romana Med Vet"},{"issue":"3","key":"1124_CR798","first-page":"2783","volume":"20","author":"L Yuan","year":"2019","unstructured":"Yuan L, Zhou MM, Huang DW, et al. Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial-mesenchymal transition via the AKT\/GSK-3\u03b2\/Snail signaling pathway. Mol Med Rep. 2019;20(3):2783\u201395.","journal-title":"Mol Med Rep"},{"issue":"1","key":"1124_CR799","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12903-024-04045-8","volume":"24","author":"MK Alam","year":"2024","unstructured":"Alam MK, Alqhtani NR, Alnufaiy B, et al. A systematic review and meta-analysis of the impact of resveratrol on oral cancer: potential therapeutic implications. BMC Oral Health. 2024;24(1):412.","journal-title":"BMC Oral Health"},{"issue":"11","key":"1124_CR800","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3390\/ph14111068","volume":"14","author":"A Arena","year":"2021","unstructured":"Arena A, Romeo MA, Benedetti R, et al. New insights into curcumin- and resveratrol-mediated anti-cancer effects. Pharmaceuticals. 2021;14(11):1068.","journal-title":"Pharmaceuticals"},{"key":"1124_CR801","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108461","volume":"689","author":"P Bian","year":"2020","unstructured":"Bian P, Hu W, Liu C, et al. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K\/AKT\/mTOR pathway involved. Arch Biochem Biophys. 2020;689: 108461.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"1124_CR802","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2020.112126","volume":"394","author":"G Srivani","year":"2020","unstructured":"Srivani G, Behera SK, Dariya B, et al. Resveratrol binds and inhibits transcription factor HIF-1\u03b1 in pancreatic cancer. Exp Cell Res. 2020;394(1):1.","journal-title":"Exp Cell Res"},{"key":"1124_CR803","unstructured":"Moar K, Brahma M, Kakde GS et al. Protective Effect of Resveratrol Against Non-Small Cell Lung Cancer: In-Vitro and In-Silico Studies. Polycyclic Aromat Compd. 2024."},{"issue":"6","key":"1124_CR804","first-page":"5","volume":"7","author":"G-Y Liu","year":"2024","unstructured":"Liu G-Y, Xiao K-H, Li H, et al. Efficacy and safety of resveratrol in the treatment of bladder cancer derived organoids. Adv Ther. 2024;7(6):5.","journal-title":"Adv Ther"},{"issue":"1","key":"1124_CR805","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/2162402X.2020.1829346","volume":"9","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Huang H, Zheng F, et al. Resveratrol exerts antitumor effects by downregulating CD8+CD122+ Tregs in murine hepatocellular carcinoma. Oncoimmunology. 2020;9(1):8.","journal-title":"Oncoimmunology"},{"issue":"33","key":"1124_CR806","doi-asserted-by":"publisher","first-page":"12422","DOI":"10.1080\/10408398.2022.2101428","volume":"63","author":"S-X Wu","year":"2023","unstructured":"Wu S-X, Xiong R-G, Huang S-Y, et al. Effects and mechanisms of resveratrol for prevention and management of cancers: an updated review. Crit Rev Food Sci Nutr. 2023;63(33):12422\u201340.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"21","key":"1124_CR807","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.3390\/nu15214667","volume":"15","author":"WH Neamah","year":"2023","unstructured":"Neamah WH, Rutkovsky A, Abdullah O, et al. Resveratrol attenuates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of myeloid-derived suppressor cells (MDSC) and their functions. Nutrients. 2023;15(21):4667.","journal-title":"Nutrients"},{"key":"1124_CR808","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2024.109568","volume":"125","author":"R Pradhan","year":"2024","unstructured":"Pradhan R, Paul S, Acharya SS, et al. Nano formulated resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6\/JAK2\/STAT3 signaling axis. J Nutr Biochem. 2024;125: 109568.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"1124_CR809","doi-asserted-by":"publisher","first-page":"13278","DOI":"10.1038\/s41598-023-39279-z","volume":"13","author":"CC Li","year":"2023","unstructured":"Li CC, Xu YJ, Zhang JF, et al. The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice. Sci Rep. 2023;13(1):13278.","journal-title":"Sci Rep"},{"key":"1124_CR810","doi-asserted-by":"publisher","first-page":"1031438","DOI":"10.3389\/fphar.2022.1031438","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Zhang RH, Chang ZG, et al. Resveratrol activates CD8+ T cells through IL-18 bystander activation in lung adenocarcinoma. Front Pharmacol. 2022;13:1031438.","journal-title":"Front Pharmacol"},{"issue":"6","key":"1124_CR811","first-page":"1405","volume":"56","author":"JS Kim","year":"2020","unstructured":"Kim JS, Jeong SK, Oh SJ, et al. The resveratrol analogue, HS-1793, enhances the effects of radiation therapy through the induction of anti-tumor immunity in mammary tumor growth. Int J Oncol. 2020;56(6):1405\u201316.","journal-title":"Int J Oncol"},{"issue":"7","key":"1124_CR812","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.21873\/anticanres.13523","volume":"39","author":"D Ivanova","year":"2019","unstructured":"Ivanova D, Zhelev Z, Semkova S, et al. Resveratrol modulates the redox-status and cytotoxicity of anticancer drugs by sensitizing leukemic lymphocytes and protecting normal lymphocytes. Anticancer Res. 2019;39(7):3745\u201355.","journal-title":"Anticancer Res"},{"issue":"11","key":"1124_CR813","doi-asserted-by":"publisher","first-page":"688","DOI":"10.21037\/atm-19-4324","volume":"8","author":"XX Sui","year":"2020","unstructured":"Sui XX, Zhang CJ, Jiang YD, et al. Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer\/T cell lymphoma. Ann Transl Med. 2020;8(11):688.","journal-title":"Ann Transl Med"},{"issue":"1","key":"1124_CR814","doi-asserted-by":"publisher","first-page":"1829346","DOI":"10.1080\/2162402X.2020.1829346","volume":"9","author":"QF Zhang","year":"2020","unstructured":"Zhang QF, Huang HD, Zheng F, et al. Resveratrol exerts antitumor effects by downregulating CD8(+)CD122(+) Tregs in murine hepatocellular carcinoma. Oncoimmunology. 2020;9(1):1829346.","journal-title":"Oncoimmunology"},{"issue":"2","key":"1124_CR815","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000510315","volume":"13","author":"Y Lee","year":"2021","unstructured":"Lee Y, Shin H, Kim J. In vivo anti-cancer effects of resveratrol mediated by NK cell activation. J Innate Immun. 2021;13(2):94\u2013106.","journal-title":"J Innate Immun"},{"issue":"24","key":"1124_CR816","doi-asserted-by":"publisher","first-page":"9575","DOI":"10.3390\/ijms21249575","volume":"21","author":"YJ Lee","year":"2020","unstructured":"Lee YJ, Kim J. Resveratrol activates natural killer cells through Akt- and mTORC2-mediated c-Myb upregulation. Int J Mol Sci. 2020;21(24):9575.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1124_CR817","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/ibd\/izz149","volume":"25","author":"DB Yao","year":"2019","unstructured":"Yao DB, Dong M, Dai CL, et al. Inflammation and inflammatory cytokine contribute to the initiation and development of ulcerative colitis and its associated cancer. Inflamm Bowel Dis. 2019;25(10):1595\u2013602.","journal-title":"Inflamm Bowel Dis"},{"issue":"18","key":"1124_CR818","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.3390\/molecules25184292","volume":"25","author":"C Buhrmann","year":"2020","unstructured":"Buhrmann C, Shayan P, Brockmueller A, et al. Resveratrol suppresses cross-talk between colorectal cancer cells and stromal cells in multicellular tumor microenvironment: a bridge between in vitro and in vivo tumor microenvironment study. Molecules. 2020;25(18):4292.","journal-title":"Molecules"},{"issue":"1","key":"1124_CR819","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1535370218824538","volume":"244","author":"C Buhrmann","year":"2019","unstructured":"Buhrmann C, Yazdi M, Popper B, et al. Evidence that TNF-\u03b2 induces proliferation in colorectal cancer cells and resveratrol can down-modulate it. Exp Biol Med. 2019;244(1):1\u201312.","journal-title":"Exp Biol Med"},{"issue":"9","key":"1124_CR820","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.4251\/wjgo.v16.i9.3980","volume":"16","author":"H Jiang","year":"2024","unstructured":"Jiang H, Wang GT, Wang Z, et al. Resveratrol inhibits pancreatic cancer proliferation and metastasis by depleting senescent tumor-associated fibroblasts. World J Gastrointest Oncol. 2024;16(9):3980\u201393.","journal-title":"World J Gastrointest Oncol"},{"issue":"3","key":"1124_CR821","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jds.2019.01.013","volume":"14","author":"CC Lin","year":"2019","unstructured":"Lin CC, Chin YT, Shih YJ, et al. Resveratrol antagonizes thyroid hormone-induced expression of checkpoint and proliferative genes in oral cancer cells. J Dent Sci. 2019;14(3):255\u201362.","journal-title":"J Dent Sci"},{"key":"1124_CR822","doi-asserted-by":"publisher","first-page":"1000957","DOI":"10.3389\/fonc.2022.1000957","volume":"12","author":"A Pilankar","year":"2022","unstructured":"Pilankar A, Singhavi H, Raghuram GV, et al. A pro-oxidant combination of resveratrol and copper down-regulates hallmarks of cancer and immune checkpoints in patients with advanced oral cancer: results of an exploratory study (RESCU 004). Front Oncol. 2022;12:1000957.","journal-title":"Front Oncol"},{"issue":"5","key":"1124_CR823","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.4149\/neo_2022_220414N410","volume":"69","author":"J Chen","year":"2022","unstructured":"Chen J, Huang ST, Chen JG, et al. Resveratrol reduces lactate production and modifies the ovarian cancer immune microenvironment. Neoplasma. 2022;69(5):1129\u201337.","journal-title":"Neoplasma"},{"key":"1124_CR824","doi-asserted-by":"publisher","first-page":"12179","DOI":"10.1038\/s41598-019-48717-w","volume":"9","author":"K Uzawa","year":"2019","unstructured":"Uzawa K, Amelio AL, Kasamatsu A, et al. Resveratrol targets urokinase-type plasminogen activator receptor expression to overcome cetuximab-resistance in oral squamous cell carcinoma. Sci Rep. 2019;9:12179.","journal-title":"Sci Rep"},{"issue":"8","key":"1124_CR825","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.3390\/cancers12082141","volume":"12","author":"CK Singh","year":"2020","unstructured":"Singh CK, Chhabra G, Ndiaye MA, et al. Quercetin-resveratrol combination for prostate cancer management in TRAMP mice. Cancers. 2020;12(8):2141.","journal-title":"Cancers"},{"issue":"6","key":"1124_CR826","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/cancers14061372","volume":"14","author":"H Moreira","year":"2022","unstructured":"Moreira H, Szyjka A, Grzesik J, et al. Celastrol and resveratrol modulate SIRT genes expression and exert anticancer activity in colon cancer cells and cancer stem-like cells. Cancers. 2022;14(6):1372.","journal-title":"Cancers"},{"issue":"3","key":"1124_CR827","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/cam4.1993","volume":"8","author":"XX Jin","year":"2019","unstructured":"Jin XX, Wei YZ, Liu YS, et al. Resveratrol promotes sensitization to doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1\/\u03b2-catenin signaling pathway in breast cancer. Cancer Med. 2019;8(3):1246\u201357.","journal-title":"Cancer Med"},{"issue":"17","key":"1124_CR828","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.3390\/ijms22179511","volume":"22","author":"D Komorowska","year":"2021","unstructured":"Komorowska D, Gajewska A, Hikisz P, et al. Comparison of the effects of resveratrol and its derivatives on the radiation response of MCF-7 breast cancer cells. Int J Mol Sci. 2021;22(17):9511.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1124_CR829","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1002\/ptr.7082","volume":"35","author":"S Patra","year":"2021","unstructured":"Patra S, Pradhan B, Nayak R, et al. Apoptosis and autophagy modulating dietary phytochemicals in cancer therapeutics: current evidences and future perspectives. Phytother Res. 2021;35(8):4194\u2013214.","journal-title":"Phytother Res"},{"key":"1124_CR830","doi-asserted-by":"crossref","unstructured":"Peng L, Hu X-Z, Liu Z-Q et al. Therapeutic potential of resveratrol through ferroptosis modulation: insights and future directions in disease therapeutics. Frontiers in Pharmacology. 2024, 15.","DOI":"10.3389\/fphar.2024.1473939"},{"issue":"4","key":"1124_CR831","first-page":"3269","volume":"19","author":"HW Yao","year":"2020","unstructured":"Yao HW, Fan M, He XZ. Autophagy suppresses resveratrol-induced apoptosis in renal cell carcinoma 786-O cells. Oncol Lett. 2020;19(4):3269\u201377.","journal-title":"Oncol Lett"},{"issue":"6","key":"1124_CR832","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/abbs\/gmab042","volume":"53","author":"RY Ma","year":"2021","unstructured":"Ma RY, Yu DD, Peng Y, et al. Resveratrol induces AMPK and mTOR signaling inhibition-mediated autophagy and apoptosis in multiple myeloma cells. Acta Biochim Biophys Sin (Shanghai). 2021;53(6):775\u201383.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"5","key":"1124_CR833","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1002\/jcb.28053","volume":"120","author":"HY Wang","year":"2019","unstructured":"Wang HY, Peng Y, Wang J, et al. Effect of autophagy on the resveratrol-induced apoptosis of ovarian cancer SKOV3 cells. J Cell Biochem. 2019;120(5):7788\u201393.","journal-title":"J Cell Biochem"},{"key":"1124_CR834","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110645","volume":"382","author":"DP Sun","year":"2023","unstructured":"Sun DP, Chen JT, Yang ST, et al. Resveratrol triggers the ER stress-mediated intrinsic apoptosis of neuroblastoma cells coupled with suppression of Rho-dependent migration and consequently prolongs mouse survival. Chem Biol Interact. 2023;382: 110645.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"1124_CR835","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ptr.7608","volume":"37","author":"J Wang","year":"2023","unstructured":"Wang J, Huang P, Pan XF, et al. Resveratrol reverses TGF-\u03b21-mediated invasion and metastasis of breast cancer cells via the SIRT3\/AMPK\/autophagy signal axis. Phytother Res. 2023;37(1):211\u201330.","journal-title":"Phytother Res"},{"issue":"2","key":"1124_CR836","doi-asserted-by":"publisher","first-page":"446","DOI":"10.55730\/1300-0144.5604","volume":"53","author":"Z Xu","year":"2023","unstructured":"Xu Z, Sun XA, Ding B, et al. Resveratrol attenuated high intensity exercise training-induced inflammation and ferroptosis via Nrf2\/FTH1\/GPX4 pathway in intestine of mice. Turk J Med Sci. 2023;53(2):446\u201354.","journal-title":"Turk J Med Sci"},{"issue":"11","key":"1124_CR837","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3390\/ani14111636","volume":"14","author":"TT Zhu","year":"2024","unstructured":"Zhu TT, Jin SZ, Tong DN, et al. Enhancing the anti-tumor efficacy of NK cells on canine mammary tumors through resveratrol activation. Animals. 2024;14(11):1636.","journal-title":"Animals"},{"issue":"5","key":"1124_CR838","first-page":"751","volume":"17","author":"ZT Zhang","year":"2022","unstructured":"Zhang ZT, Ji Y, Hu N, et al. Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment. Asian J Pharm Sci. 2022;17(5):751\u201366.","journal-title":"Asian J Pharm Sci"},{"issue":"6","key":"1124_CR839","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/jpp\/rgae009","volume":"76","author":"RF Diab","year":"2024","unstructured":"Diab RF, Abdelghany TM, Gad S, et al. Novel resveratrol smart lipids; design, formulation, and biological evaluation of anticancer activity. J Pharm Pharmacol. 2024;76(6):631\u201345.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"1124_CR840","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113338","volume":"420","author":"S Sinha","year":"2022","unstructured":"Sinha S, Chatterjee S, Paul S, et al. Olaparib enhances the resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway. Exp Cell Res. 2022;420(1): 113338.","journal-title":"Exp Cell Res"},{"issue":"12","key":"1124_CR841","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/cbin.11695","volume":"45","author":"MS D'Arcy","year":"2021","unstructured":"D\u2019Arcy MS, Pike CVS, Coussons PJ. A novel combined resveratrol\/berberine phytochemotheraputic using the HePG2 cell line as a model for the treatment of hepatocarcinoma. Cell Biol Int. 2021;45(12):2499\u2013509.","journal-title":"Cell Biol Int"},{"issue":"1","key":"1124_CR842","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12032-021-01611-w","volume":"39","author":"S Cesmeli","year":"2022","unstructured":"Cesmeli S, Bagca BG, Caglar HO, et al. Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs. Med Oncol. 2022;39(1):12.","journal-title":"Med Oncol"},{"issue":"2","key":"1124_CR843","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2174\/18755666MTA2pODE0z","volume":"21","author":"P Amini","year":"2021","unstructured":"Amini P, Nodooshan SJ, Ashrafizadeh M, et al. Resveratrol induces apoptosis and attenuates proliferation of MCF-7 cells in combination with radiation and hyperthermia. Curr Mol Med. 2021;21(2):142\u201350.","journal-title":"Curr Mol Med"},{"issue":"9\u201310","key":"1124_CR844","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s10495-024-01995-w","volume":"29","author":"Y Wang","year":"2024","unstructured":"Wang Y, Su LX, Hu ZS, et al. Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy. Apoptosis. 2024;29(9\u201310):1429\u201353.","journal-title":"Apoptosis"},{"issue":"1","key":"1124_CR845","first-page":"630","volume":"43","author":"D Li","year":"2019","unstructured":"Li D, Wang GC, Jin GG, et al. Resveratrol suppresses colon cancer growth by targeting the AKT\/STAT3 signaling pathway. Int J Mol Med. 2019;43(1):630\u201340.","journal-title":"Int J Mol Med"},{"issue":"22","key":"1124_CR846","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.3390\/molecules28227614","volume":"28","author":"XK Yu","year":"2023","unstructured":"Yu XK, Sun ZY, Nie SY, et al. Effects of resveratrol on mouse B16 melanoma cell proliferation through the SHCBP1-ERK1\/2 signaling pathway. Molecules. 2023;28(22):7614.","journal-title":"Molecules"},{"issue":"1","key":"1124_CR847","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3892\/ijmm.2020.4789","volume":"47","author":"XD Sun","year":"2021","unstructured":"Sun XD, Fu P, Xie LX, et al. Resveratrol inhibits the progression of cervical cancer by suppressing the transcription and expression of HPV E6 and E7 genes. Int J Mol Med. 2021;47(1):335\u201345.","journal-title":"Int J Mol Med"},{"issue":"1\u20132","key":"1124_CR848","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11010-019-03606-8","volume":"462","author":"Y Sawata","year":"2019","unstructured":"Sawata Y, Matsukawa T, Doi S, et al. A novel compound, ferulic acid-bound resveratrol, induces the tumor suppressor gene p15 and inhibits the three-dimensional proliferation of colorectal cancer cells. Mol Cell Biochem. 2019;462(1\u20132):25\u201331.","journal-title":"Mol Cell Biochem"},{"key":"1124_CR849","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115252","volume":"133","author":"D Ali","year":"2020","unstructured":"Ali D, Chen L, Kowal JM, et al. Resveratrol inhibits adipocyte differentiation and cellular senescence of human bone marrow stromal stem cells. Bone. 2020;133: 115252.","journal-title":"Bone"},{"key":"1124_CR850","doi-asserted-by":"publisher","first-page":"960327123118829","DOI":"10.1177\/09603271231188293","volume":"42","author":"Y Gao","year":"2023","unstructured":"Gao Y, Zhang D, Wang P, et al. Acrylamide-induced meiotic arrest of spermatocytes in adolescent mice by triggering excessive DNA strand breaks: potential therapeutic effects of resveratrol. Hum Exp Toxicol. 2023;42:9603271231188292.","journal-title":"Hum Exp Toxicol"},{"key":"1124_CR851","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fonc.2019.00352","volume":"9","author":"K Chatterjee","year":"2019","unstructured":"Chatterjee K, Mukherjee S, Vanmanen J, et al. Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an in vitro and in vivo analysis. Front Oncol. 2019;9:352.","journal-title":"Front Oncol"},{"issue":"12","key":"1124_CR852","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.3390\/ijms22126322","volume":"22","author":"M Bostan","year":"2021","unstructured":"Bostan M, Mihaila M, Petrica-Matei GG, et al. Resveratrol modulation of apoptosis and cell cycle response to cisplatin in head and neck cancer cell lines. Int J Mol Sci. 2021;22(12):6322.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1124_CR853","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.3390\/ijms24065715","volume":"24","author":"A Synowiec","year":"2023","unstructured":"Synowiec A, Brodaczewska K, Wcislo G, et al. Hypoxia, but not normoxia, reduces effects of resveratrol on cisplatin treatment in A2780 ovarian cancer cells: a challenge for resveratrol use in anticancer adjuvant cisplatin therapy. Int J Mol Sci. 2023;24(6):5715.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1124_CR854","volume":"23","author":"S Madencioglu","year":"2021","unstructured":"Madencioglu S, Becer E, Kabadayi H, et al. Resveratrol triggers apoptosis in colon cancer cells rather than senescence. PROG NUTR. 2021;23(1): e2021018.","journal-title":"PROG NUTR"},{"issue":"11","key":"1124_CR855","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/tox.22988","volume":"35","author":"L Chen","year":"2020","unstructured":"Chen L, Xia JS, Wu JH, et al. Resveratrol inhibits oral squamous cell carcinoma cells proliferation while promoting apoptosis through inhibition ofCBX7protein. Environ Toxicol. 2020;35(11):1234\u201340.","journal-title":"Environ Toxicol"},{"issue":"4","key":"1124_CR856","first-page":"3353","volume":"19","author":"TH Kim","year":"2019","unstructured":"Kim TH, Park JH, Woo JS. Resveratrol induces cell death through ROS-dependent downregulation of Notch1\/PTEN\/Akt signaling in ovarian cancer cells. Mol Med Rep. 2019;19(4):3353\u201360.","journal-title":"Mol Med Rep"},{"issue":"4","key":"1124_CR857","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/antiox8040099","volume":"8","author":"HY Chen","year":"2019","unstructured":"Chen HY, Lin PH, Shih YH, et al. Natural antioxidant resveratrol suppresses uterine fibroid cell growth and extracellular matrix formation in vitro and in vivo. Antioxidants. 2019;8(4):99.","journal-title":"Antioxidants"},{"issue":"1","key":"1124_CR858","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1039\/C9TB02051A","volume":"8","author":"YN Zhao","year":"2020","unstructured":"Zhao YN, Cao YN, Sun J, et al. Anti-breast cancer activity of resveratrol encapsulated in liposomes. J Mater Chem B. 2020;8(1):27\u201337.","journal-title":"J Mater Chem B"},{"issue":"6","key":"1124_CR859","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3390\/molecules24061131","volume":"24","author":"Y Sun","year":"2019","unstructured":"Sun Y, Zhou QM, Lu YY, et al. Resveratrol Inhibits the migration and metastasis of MDA-MB-231 human breast cancer by reversing TGF-\u03b21-induced epithelial-mesenchymal transition. Molecules. 2019;24(6):1131.","journal-title":"Molecules"},{"key":"1124_CR860","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.semcancer.2020.10.010","volume":"73","author":"S Patra","year":"2021","unstructured":"Patra S, Pradhan B, Nayak R, et al. Chemotherapeutic efficacy of curcumin and resveratrol against cancer: chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics. Semin Cancer Biol. 2021;73:310\u201320.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"1124_CR861","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1039\/C9FO01014A","volume":"10","author":"LI Gavrilas","year":"2019","unstructured":"Gavrilas LI, Cruceriu D, Ionescu C, et al. Pro-apoptotic genes as new targets for single and combinatorial treatments with resveratrol and curcumin in colorectal cancer. Food Funct. 2019;10(6):3717\u201326.","journal-title":"Food Funct"},{"issue":"5","key":"1124_CR862","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1039\/C8RA08364A","volume":"9","author":"L Huang","year":"2019","unstructured":"Huang L, Zhang S, Zhou J, et al. Effect of resveratrol on drug resistance in colon cancer chemotherapy. RSC Adv. 2019;9(5):2572\u201380.","journal-title":"RSC Adv"},{"key":"1124_CR863","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.sajb.2023.04.023","volume":"157","author":"K Wang","year":"2023","unstructured":"Wang K, Hou DZ, Ouyang YM, et al. Resveratrol enhances paclitaxel-induced apoptosis through oxidative DNA damage in Caco-2 human colon cancer cells. S Afr J Bot. 2023;157:579\u201386.","journal-title":"S Afr J Bot"},{"issue":"16","key":"1124_CR864","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.3390\/cancers13164002","volume":"13","author":"YT Zhang","year":"2021","unstructured":"Zhang YT, Li Y, Sun CC, et al. Effect of pterostilbene, a natural derivative of resveratrol, in the treatment of colorectal cancer through Top1\/Tdp1-mediated DNA repair pathway. Cancers. 2021;13(16):4002.","journal-title":"Cancers"},{"issue":"1","key":"1124_CR865","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/molecules25010228","volume":"25","author":"HJ Shin","year":"2020","unstructured":"Shin HJ, Han JM, Choi YS, et al. Pterostilbene suppresses both cancer cells and cancer stem-like cells in cervical cancer with superior bioavailability to resveratrol. Molecules. 2020;25(1):228.","journal-title":"Molecules"},{"issue":"20","key":"1124_CR866","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.3390\/ijms21207797","volume":"21","author":"D Iacopetta","year":"2020","unstructured":"Iacopetta D, Lappano R, Mariconda A, et al. Newly synthesized imino-derivatives analogues of resveratrol exert inhibitory effects in breast tumor cells. Int J Mol Sci. 2020;21(20):7797.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1124_CR867","doi-asserted-by":"publisher","first-page":"8","DOI":"10.32725\/jab.2020.001","volume":"18","author":"Z Awan","year":"2020","unstructured":"Awan Z, Kutbi HI, Ahmad A, et al. Molecular design, synthesis and biological characterization of novel Resveratrol derivative as potential anticancer agent targeting NF-\u03baB. J Appl Biomed. 2020;18(1):8\u201317.","journal-title":"J Appl Biomed"},{"key":"1124_CR868","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114962","volume":"246","author":"L Grau","year":"2023","unstructured":"Grau L, Soucek R, Pujol MD. Resveratrol derivatives: synthesis and their biological activities. Eur J Med Chem. 2023;246: 114962.","journal-title":"Eur J Med Chem"},{"key":"1124_CR869","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.636213","volume":"12","author":"X Chen","year":"2021","unstructured":"Chen X, Wang YT, Tian J, et al. Quantitative chemical proteomics reveals resveratrol inhibition of A549 cell migration through binding multiple targets to regulate cytoskeletal remodeling and suppress EMT. Front Pharmacol. 2021;12: 636213.","journal-title":"Front Pharmacol"},{"key":"1124_CR870","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115851","volume":"435","author":"D Ancic","year":"2022","unstructured":"Ancic D, Orsolic N, Odeh D, et al. Resveratrol and its nanocrystals: a promising approach for cancer therapy? Toxicol Appl Pharmacol. 2022;435: 115851.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"1124_CR871","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1021\/acsami.2c10221","volume":"15","author":"XJ Liu","year":"2023","unstructured":"Liu XJ, Liu JH, Xu SS, et al. Gold nanoparticles functionalized with au-se-bonded peptides used as gatekeepers for the off-target release of resveratrol in the treatment of triple-negative breast cancer. ACS Appl Mater Interfaces. 2023;15(2):2529\u201337.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1124_CR872","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.2147\/IJN.S204443","volume":"14","author":"VC Thipe","year":"2019","unstructured":"Thipe VC, Amiri KP, Bloebaum P, et al. Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers. Int J Nanomedicine. 2019;14:4413\u201328.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"1124_CR873","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/21691401.2018.1548468","volume":"47","author":"BL Lian","year":"2019","unstructured":"Lian BL, Wu MF, Feng ZQ, et al. Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors. Artif Cells Nanomed Biotechnol. 2019;47(1):154\u201365.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"1124_CR874","doi-asserted-by":"publisher","DOI":"10.1016\/j.bej.2022.108529","volume":"185","author":"BL Melo","year":"2022","unstructured":"Melo BL, Lima-Sousa R, Alves CG, et al. Chitosan-based injectable in situ forming hydrogels containing dopamine-reduced graphene oxide and resveratrol for breast cancer chemo-photothermal therapy. Biochem Eng J. 2022;185: 108529.","journal-title":"Biochem Eng J"},{"issue":"9","key":"1124_CR875","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.1021\/acsbiomaterials.0c00429","volume":"6","author":"S Jagwani","year":"2020","unstructured":"Jagwani S, Jalalpure S, Dhamecha D, et al. Pharmacokinetic and pharmacodynamic evaluation of resveratrol loaded cationic liposomes for targeting hepatocellular carcinoma. ACS Biomater Sci Eng. 2020;6(9):4969\u201384.","journal-title":"ACS Biomater Sci Eng"},{"issue":"4","key":"1124_CR876","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.apsb.2019.02.006","volume":"9","author":"Y Liu","year":"2019","unstructured":"Liu Y, Xu W, Zhai T, et al. Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway. Acta Pharm Sin B. 2019;9(4):745\u201357.","journal-title":"Acta Pharm Sin B"},{"key":"1124_CR877","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.freeradbiomed.2022.05.018","volume":"187","author":"M Sun","year":"2022","unstructured":"Sun M, Zhao H, Jin Z, et al. Silibinin protects against sepsis and septic myocardial injury in an NR1H3-dependent pathway. Free Radic Biol Med. 2022;187:141\u201357.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1124_CR878","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12906-021-03330-1","volume":"21","author":"S Sameri","year":"2021","unstructured":"Sameri S, Mohammadi C, Mehrabani M, et al. Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer. BMC Complement Med Ther. 2021;21(1):160.","journal-title":"BMC Complement Med Ther"},{"key":"1124_CR879","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.semcancer.2020.09.014","volume":"73","author":"HS Tuli","year":"2021","unstructured":"Tuli HS, Mittal S, Aggarwal D, et al. Path of Silibinin from diet to medicine: a dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance. Semin Cancer Biol. 2021;73:196\u2013218.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"1124_CR880","doi-asserted-by":"publisher","first-page":"415","DOI":"10.34172\/bi.2022.23336","volume":"12","author":"J Firouzi","year":"2022","unstructured":"Firouzi J, Sotoodehnejadnematalahi F, Shokouhifar A, et al. Silibinin exhibits anti-tumor effects in a breast cancer stem cell model by targeting stemness and induction of differentiation and apoptosis. Bioimpacts. 2022;12(5):415\u201329.","journal-title":"Bioimpacts"},{"issue":"7","key":"1124_CR881","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/ibd\/izz007","volume":"25","author":"W Li","year":"2019","unstructured":"Li W, Zhao X, Lv X, et al. Silibinin retards colitis-associated carcinogenesis by repression of Cdc25C in mouse model. Inflamm Bowel Dis. 2019;25(7):1187\u201395.","journal-title":"Inflamm Bowel Dis"},{"issue":"13","key":"1124_CR882","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.7150\/jca.63514","volume":"13","author":"W Dan","year":"2022","unstructured":"Dan W, Fan Y, Hou T, et al. Silibinin inhibits the migration, invasion and epithelial-mesenchymal transition of prostate cancer by activating the autophagic degradation of YAP. J Cancer. 2022;13(13):3415\u201326.","journal-title":"J Cancer"},{"key":"1124_CR883","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114938","volume":"288","author":"XL Wang","year":"2022","unstructured":"Wang XL, Lin FL, Xu W, et al. Silybin B exerts protective effect on cisplatin-induced neurotoxicity by alleviating DNA damage and apoptosis. J Ethnopharmacol. 2022;288: 114938.","journal-title":"J Ethnopharmacol"},{"key":"1124_CR884","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3389\/fbioe.2020.00495","volume":"8","author":"M Durymanov","year":"2020","unstructured":"Durymanov M, Permyakova A, Reineke J. Pre-treatment With PLGA\/Silibinin nanoparticles mitigates dacarbazine-induced hepatotoxicity. Front Bioeng Biotechnol. 2020;8:495.","journal-title":"Front Bioeng Biotechnol"},{"key":"1124_CR885","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00495","author":"D Venkatesh","year":"2025","unstructured":"Venkatesh D, Sarkar S, Kandasamy T, et al. In-silico identification and validation of Silibinin as a dual inhibitor for ENO1 and GLUT4 to curtail EMT signaling and TNBC progression. Comput Biol Chem. 2025. https:\/\/doi.org\/10.3389\/fbioe.2020.00495.","journal-title":"Comput Biol Chem"},{"key":"1124_CR886","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.phymed.2024.155493","volume":"128","author":"S Verdura","year":"2024","unstructured":"Verdura S, Encinar JA, Gratchev A, et al. Silibinin is a suppressor of the metastasis-promoting transcription factor ID3. Phytomedicine. 2024;128:5.","journal-title":"Phytomedicine"},{"issue":"1","key":"1124_CR887","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ph15010019","volume":"15","author":"J Bosch-Barrera","year":"2021","unstructured":"Bosch-Barrera J, Roque A, Teixidor E, et al. Clinical management of COVID-19 in cancer patients with the STAT3 inhibitor silibinin. Pharmaceuticals. 2021;15(1):19.","journal-title":"Pharmaceuticals"},{"issue":"11","key":"1124_CR888","first-page":"1879","volume":"30","author":"S Elyasi","year":"2016","unstructured":"Elyasi S, Hosseini S, Niazi Moghadam MR, et al. Effect of oral silymarin administration on prevention of radiotherapy induced mucositis: a randomized, double-blinded. Placebo-Controlled Clinical Trial Phytother Res. 2016;30(11):1879\u201385.","journal-title":"Placebo-Controlled Clinical Trial Phytother Res"},{"issue":"7","key":"1124_CR889","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.3390\/cells10071632","volume":"10","author":"A Rugamba","year":"2021","unstructured":"Rugamba A, Kang DY, Sp N, et al. Silibinin regulates tumor progression and tumorsphere formation by suppressing PD-L1 expression in non-small cell lung cancer (NSCLC) cells. Cells. 2021;10(7):1632.","journal-title":"Cells"},{"key":"1124_CR890","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120333","volume":"598","author":"S Wu","year":"2021","unstructured":"Wu S, Liu D, Li W, et al. Enhancing TNBC chemo-immunotherapy via combination reprogramming tumor immune microenvironment with immunogenic cell death. Int J Pharm. 2021;598: 120333.","journal-title":"Int J Pharm"},{"key":"1124_CR891","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117977","volume":"256","author":"MLF Bittencourt","year":"2020","unstructured":"Bittencourt MLF, Rodrigues RP, Kitagawa RR, et al. The gastroprotective potential of silibinin against Helicobacter pylori infection and gastric tumor cells. Life Sci. 2020;256: 117977.","journal-title":"Life Sci"},{"issue":"6","key":"1124_CR892","doi-asserted-by":"publisher","first-page":"672","DOI":"10.2174\/0118715303248000230922185110","volume":"24","author":"W Xie","year":"2024","unstructured":"Xie W, Li H, Lin Q, et al. Network pharmacological analysis and experimental validation of the effects of silybin on proliferation, migration, and immunotherapy of papillary thyroid cancer. Endocr Metab Immune Disord Drug Targets. 2024;24(6):672\u201390.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1124_CR893","first-page":"474","volume":"27","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Li C, Zhang Y, et al. Nanomaterials with dual immunomodulatory functions for synergistic therapy of breast cancer brain metastases. Bioact Mater. 2023;27:474\u201387.","journal-title":"Bioact Mater"},{"key":"1124_CR894","unstructured":"Banafshe Abadi JA, Farnaz Sedghy, Merat Mahmoodi, Hossein Fallah. Silibinin improved the function of T cells in peripheral blood mononuclear cells (PBMCs) co-cultured with U-87 MG cell line. Avicenna J Phytomed. 2023 14(2):166\u2013176."},{"issue":"1","key":"1124_CR895","doi-asserted-by":"publisher","first-page":"51","DOI":"10.34172\/bi.2022.23698","volume":"13","author":"S Jafari","year":"2023","unstructured":"Jafari S, Heydarian S, Lai R, et al. Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy. Bioimpacts. 2023;13(1):51\u201361.","journal-title":"Bioimpacts"},{"key":"1124_CR896","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109808","volume":"116","author":"S Tang","year":"2023","unstructured":"Tang S, Zhang X, Duan Z, et al. The novel hepatoprotective mechanisms of silibinin-phospholipid complex against d-GalN\/LPS-induced acute liver injury. Int Immunopharmacol. 2023;116: 109808.","journal-title":"Int Immunopharmacol"},{"key":"1124_CR897","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108479","volume":"690","author":"LS Sellam","year":"2020","unstructured":"Sellam LS, Zappasodi R, Chettibi F, et al. Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism. Arch Biochem Biophys. 2020;690: 108479.","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"1124_CR898","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.21873\/anticanres.14702","volume":"40","author":"M Miyazawa","year":"2020","unstructured":"Miyazawa M, Yasuda M, Miyazawa M, et al. Hypoxia-inducible factor-1alpha suppression in ovarian clear-cell carcinoma cells by silibinin administration. Anticancer Res. 2020;40(12):6791\u20138.","journal-title":"Anticancer Res"},{"key":"1124_CR899","doi-asserted-by":"crossref","unstructured":"Ashrafizadeh M, Zhang W, Zou R et al. A bioinformatics analysis, pre-clinical and clinical conception of autophagy in pancreatic cancer: Complexity and simplicity in crosstalk. Pharmacological Research. 2023, 194.","DOI":"10.1016\/j.phrs.2023.106822"},{"key":"1124_CR900","doi-asserted-by":"publisher","first-page":"7111","DOI":"10.2147\/CMAR.S201341","volume":"11","author":"Z Yang","year":"2019","unstructured":"Yang Z, Pan Q, Zhang D, et al. Silibinin restores the sensitivity of cisplatin and taxol in A2780-resistant cell and reduces drug-induced hepatotoxicity. Cancer Manag Res. 2019;11:7111\u201322.","journal-title":"Cancer Manag Res"},{"key":"1124_CR901","doi-asserted-by":"crossref","unstructured":"Sharifi-Azad M, Kaveh Zenjanab M, Shahpouri M et al. Codelivery of methotrexate and silibinin by niosome nanoparticles for enhanced chemotherapy of CT26 colon cancer cells. Biomed Mater. 2024, 19(5).","DOI":"10.1088\/1748-605X\/ad5d9b"},{"issue":"16","key":"1124_CR902","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.3390\/cancers13164168","volume":"13","author":"J Bosch-Barrera","year":"2021","unstructured":"Bosch-Barrera J, Verdura S, Ruffinelli JC, et al. Silibinin suppresses tumor cell-intrinsic resistance to nintedanib and enhances its clinical activity in lung cancer. Cancers. 2021;13(16):4168.","journal-title":"Cancers"},{"issue":"24","key":"1124_CR903","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.3390\/cancers14246101","volume":"14","author":"S Verdura","year":"2022","unstructured":"Verdura S, Encinar JA, Teixidor E, et al. Silibinin overcomes EMT-driven lung cancer resistance to new-generation ALK inhibitors. Cancers. 2022;14(24):6101.","journal-title":"Cancers"},{"issue":"3","key":"1124_CR904","doi-asserted-by":"publisher","first-page":"170","DOI":"10.15430\/JCP.2022.27.3.170","volume":"27","author":"M Rajput","year":"2022","unstructured":"Rajput M, Mishra D, Kumar K, et al. Silibinin radiosensitizes EGF receptor-knockdown prostate cancer cells by attenuating DNA repair pathways. J Cancer Prev. 2022;27(3):170\u201381.","journal-title":"J Cancer Prev"},{"issue":"2","key":"1124_CR905","first-page":"79","volume":"13","author":"M Hossein-Tehrani","year":"2024","unstructured":"Hossein-Tehrani M, Abbasalipourkabir R, Ziamajidi N. The role of miR-133a in silibinin-mediated inhibition of the PI3K\/AKT\/mTOR pathway in MCF-7 breast carcinoma cells. Mol Biol Res Commun. 2024;13(2):79\u201383.","journal-title":"Mol Biol Res Commun"},{"key":"1124_CR906","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2021.11.110","volume":"589","author":"C Hua","year":"2022","unstructured":"Hua C, Wang X, Liang S, et al. BNIP3 contributes to silibinin-induced DNA double strand breaks in glioma cells via inhibition of mTOR. Biochem Biophys Res Commun. 2022;589:1\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1124_CR907","doi-asserted-by":"publisher","first-page":"632","DOI":"10.2174\/1871530319666190207163325","volume":"19","author":"Y Li","year":"2019","unstructured":"Li Y, Ren L, Song G, et al. Silibinin ameliorates fructose-induced lipid accumulation and activates autophagy in HepG2 cells. Endocr Metab Immune Disord Drug Targets. 2019;19(5):632\u201342.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1124_CR908","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111186","volume":"119","author":"J Fu","year":"2024","unstructured":"Fu J, Liu W, Liu S, et al. Inhibition of YAP\/TAZ pathway contributes to the cytotoxicity of silibinin in MCF-7 and MDA-MB-231 human breast cancer cells. Cell Signal. 2024;119: 111186.","journal-title":"Cell Signal"},{"issue":"5","key":"1124_CR909","first-page":"1341","volume":"45","author":"YZ Fan","year":"2020","unstructured":"Fan YZ, Hou T, Dan WC, et al. Silibinin inhibits epithelial-mesenchymal transition of renal cell carcinoma through autophagy-dependent Wnt\/\u03b2-catenin signaling. Int J Mol Med. 2020;45(5):1341\u201350.","journal-title":"Int J Mol Med"},{"key":"1124_CR910","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112409","volume":"145","author":"NYS Yassin","year":"2022","unstructured":"Yassin NYS, AbouZid SF, El-Kalaawy AM, et al. Silybum marianum total extract, silymarin and silibinin abate hepatocarcinogenesis and hepatocellular carcinoma growth via modulation of the HGF\/c-Met, Wnt\/beta-catenin, and PI3K\/Akt\/mTOR signaling pathways. Biomed Pharmacother. 2022;145: 112409.","journal-title":"Biomed Pharmacother"},{"key":"1124_CR911","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108458","volume":"689","author":"W Liu","year":"2020","unstructured":"Liu W, Ji Y, Sun Y, et al. Estrogen receptors participate in silibinin-caused nuclear translocation of apoptosis-inducing factor in human breast cancer MCF-7 cells. Arch Biochem Biophys. 2020;689: 108458.","journal-title":"Arch Biochem Biophys"},{"key":"1124_CR912","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2022.105388","volume":"82","author":"XY Song","year":"2022","unstructured":"Song XY, Liu PC, Liu WW, et al. Silibinin inhibits ethanol- or acetaldehyde-induced ferroptosis in liver cell lines. Toxicol In Vitro. 2022;82: 105388.","journal-title":"Toxicol In Vitro"},{"key":"1124_CR913","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108284","volume":"685","author":"LL Si","year":"2020","unstructured":"Si LL, Fu JN, Liu WW, et al. Silibinin-induced mitochondria fission leads to mitophagy, which attenuates silibinin-induced apoptosis in MCF-7 and MDA-MB-231 cells. Arch Biochem Biophys. 2020;685: 108284.","journal-title":"Arch Biochem Biophys"},{"key":"1124_CR914","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2023.109644","volume":"743","author":"Q Du","year":"2023","unstructured":"Du Q, Wu X, Ma K, et al. Silibinin alleviates ferroptosis of rat islet beta cell INS-1 induced by the treatment with palmitic acid and high glucose through enhancing PINK1\/parkin-mediated mitophagy. Arch Biochem Biophys. 2023;743: 109644.","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"1124_CR915","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.3390\/antiox12122119","volume":"12","author":"W Duan","year":"2023","unstructured":"Duan W, Ou Z, Huang Y, et al. Silibinin Inhibits Cell Ferroptosis and Ferroptosis-Related Tissue Injuries. Antioxidants (Basel). 2023;12(12):2119.","journal-title":"Antioxidants (Basel)"},{"issue":"7","key":"1124_CR916","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.2174\/1871520621666210608101649","volume":"22","author":"L Zhou","year":"2022","unstructured":"Zhou L, Liu J, Meng W, et al. Evaluation of silibinin-loaded microbubbles combined with ultrasound in ovarian cancer cells: cytotoxicity and mechanisms. Anticancer Agents Med Chem. 2022;22(7):1320\u20137.","journal-title":"Anticancer Agents Med Chem"},{"issue":"4","key":"1124_CR917","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/ptr.8150","volume":"38","author":"S Lotia","year":"2024","unstructured":"Lotia S, Patel S, Patel A, et al. Unravelling the role of Silibinin in targeting CD44+cancer stem cells: therapeutic implications, effective strategies and approaches. Phytother Res. 2024;38(4):1830\u20137.","journal-title":"Phytother Res"},{"issue":"2","key":"1124_CR918","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/life13020492","volume":"13","author":"D Faixov\u00e1","year":"2023","unstructured":"Faixov\u00e1 D, Ratvaj M, Marusc\u00e1kov\u00e1 IC, et al. Silybin showed higher cytotoxic, antiproliferative, and anti-inflammatory activities in the CaCo cancer cell line while retaining viability and proliferation in normal intestinal IPEC-1 cells. Life. 2023;13(2):492.","journal-title":"Life"},{"key":"1124_CR919","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.847905","volume":"13","author":"Y Bai","year":"2022","unstructured":"Bai Y, Chen J, Hu W, et al. Silibinin therapy improves cholangiocarcinoma outcomes by regulating ERK\/mitochondrial pathway. Front Pharmacol. 2022;13: 847905.","journal-title":"Front Pharmacol"},{"key":"1124_CR920","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.lfs.2018.11.037","volume":"217","author":"Z Shi","year":"2019","unstructured":"Shi Z, Zhou Q, Gao S, et al. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation. Life Sci. 2019;217:70\u201380.","journal-title":"Life Sci"},{"issue":"8","key":"1124_CR921","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1080\/01635581.2020.1800764","volume":"73","author":"S Sameri","year":"2021","unstructured":"Sameri S, Saidijam M, Bahreini F, et al. Cancer chemopreventive activities of silibinin on colorectal cancer through regulation of E-cadherin\/\u03b2-catenin pathway. Nutr Cancer. 2021;73(8):1389\u201399.","journal-title":"Nutr Cancer"},{"issue":"10","key":"1124_CR922","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.7150\/jca.84734","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang H, Kim H, Kim SY, et al. Silibinin induces oral cancer cell apoptosis and reactive oxygen species generation by activating the JNK\/c-Jun pathway. J Cancer. 2023;14(10):1875\u201387.","journal-title":"J Cancer"},{"issue":"9","key":"1124_CR923","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152530","volume":"215","author":"X Zhang","year":"2019","unstructured":"Zhang X, Jiang J, Chen Z, et al. Silibinin inhibited autophagy and mitochondrial apoptosis in pancreatic carcinoma by activating JNK\/SAPK signaling. Pathol Res Pract. 2019;215(9): 152530.","journal-title":"Pathol Res Pract"},{"issue":"7","key":"1124_CR924","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.31557\/APJCP.2020.21.7.1877","volume":"21","author":"R Murali Iyangar","year":"2020","unstructured":"Murali Iyangar R, Devaraj E. Silibinin triggers the mitochondrial pathway of apoptosis in human oral squamous carcinoma cells. Asian Pac J Cancer Prev. 2020;21(7):1877\u201382.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1124_CR925","doi-asserted-by":"publisher","first-page":"7665169","DOI":"10.1155\/2021\/7665169","volume":"2021","author":"NYS Yassin","year":"2021","unstructured":"Yassin NYS, AbouZid SF, El-Kalaawy AM, et al. Tackling of renal carcinogenesis in wistar rats by silybum marianum total extract, silymarin, and silibinin via modulation of oxidative stress, apoptosis, Nrf2, PPARgamma, NF-kappaB, and PI3K\/Akt signaling pathways. Oxid Med Cell Longev. 2021;2021:7665169.","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"1124_CR926","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1080\/10715762.2019.1603376","volume":"53","author":"Y Yu","year":"2019","unstructured":"Yu Y, Li LF, Tao J, et al. Silibinin induced apoptosis of human epidermal cancer A431 cells by promoting mitochondrial NOS. Free Radic Res. 2019;53(7):714\u201326.","journal-title":"Free Radic Res"},{"issue":"1\u20132","key":"1124_CR927","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11010-019-03640-6","volume":"463","author":"L Si","year":"2020","unstructured":"Si L, Fu J, Liu W, et al. Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion. Mol Cell Biochem. 2020;463(1\u20132):189\u2013201.","journal-title":"Mol Cell Biochem"},{"key":"1124_CR928","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.phymed.2022.154524","volume":"108","author":"W Liao","year":"2023","unstructured":"Liao W, Zhang L, Chen X, et al. Targeting cancer stem cells and signalling pathways through phytochemicals: A promising approach against colorectal cancer. Phytomedicine. 2023;108:2.","journal-title":"Phytomedicine."},{"issue":"10","key":"1124_CR929","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1055\/a-1223-1734","volume":"70","author":"HE Lashgarian","year":"2020","unstructured":"Lashgarian HE, Adamii V, Ghorbanzadeh V, et al. Silibinin inhibit cell migration through downregulation of RAC1 gene expression in highly metastatic breast cancer cell line. Drug Res. 2020;70(10):478\u201383.","journal-title":"Drug Res"},{"key":"1124_CR930","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s11658-020-00229-6","volume":"25","author":"S Xu","year":"2020","unstructured":"Xu S, Zhang H, Wang A, et al. Silibinin suppresses epithelial-mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1. Cell Mol Biol Lett. 2020;25:36.","journal-title":"Cell Mol Biol Lett"},{"key":"1124_CR931","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jconrel.2020.02.017","volume":"321","author":"MR Huo","year":"2020","unstructured":"Huo MR, Wang HL, Zhang Y, et al. Co-delivery of silybin and paclitaxel by dextran-based nanoparticles for effective anti-tumor treatment through chemotherapy sensitization and microenvironment modulation. J Control Release. 2020;321:198\u2013210.","journal-title":"J Control Release"},{"issue":"9","key":"1124_CR932","first-page":"1211","volume":"24","author":"M Koushki","year":"2021","unstructured":"Koushki M, Khedri A, Aberomand M, et al. Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carcinoma MCF-7 and MDA-MB-231 cell lines. Iran J Basic Med Sci. 2021;24(9):1211\u20139.","journal-title":"Iran J Basic Med Sci"},{"key":"1124_CR933","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123570","volume":"648","author":"R Ghadi","year":"2023","unstructured":"Ghadi R, Pandey PK, Gabhale A, et al. Genipin-crosslinked albumin nanoparticles containing neratinib and silibinin: a dual-death therapy for triple negative breast cancer. Int J Pharm. 2023;648: 123570.","journal-title":"Int J Pharm"},{"key":"1124_CR934","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1016\/j.annonc.2022.02.220","volume":"33","author":"D Jafari-Gharabaghlou","year":"2022","unstructured":"Jafari-Gharabaghlou D, Jabbari A, Soltani A. Development of a magnetic nanostructure for co-delivery of metformin and silibinin on growth of lung cancer cells: Possible action through leptin gene and its receptor regulation. ANN ONCOL. 2022;33:S116\u2013S116.","journal-title":"ANN ONCOL"},{"key":"1124_CR935","doi-asserted-by":"publisher","first-page":"1193708","DOI":"10.3389\/fonc.2023.1193708","volume":"13","author":"E Salmani-Javan","year":"2023","unstructured":"Salmani-Javan E, Jafari-Gharabaghlou D, Bonabi E, et al. Fabricating niosomal-PEG nanoparticles co-loaded with metformin and silibinin for effective treatment of human lung cancer cells. Front Oncol. 2023;13:1193708.","journal-title":"Front Oncol"},{"key":"1124_CR936","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119239","volume":"581","author":"M Jiang","year":"2020","unstructured":"Jiang M, He K, Qiu T, et al. Tumor-targeted delivery of silibinin and IPI-549 synergistically inhibit breast cancer by remodeling the microenvironment. Int J Pharm. 2020;581: 119239.","journal-title":"Int J Pharm"},{"issue":"6","key":"1124_CR937","first-page":"477","volume":"45","author":"S Dalimi-Asl","year":"2020","unstructured":"Dalimi-Asl S, Babaahmadi-Rezaei H, Mohammadzadeh G. Combination of silibinin and curcumin reduced leptin receptor expression in MCF-7 human breast cancer cell line. Iran J Med Sci. 2020;45(6):477\u201384.","journal-title":"Iran J Med Sci"},{"issue":"5","key":"1124_CR938","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1021\/acsomega.9b00224","volume":"4","author":"S Mirzaaghaei","year":"2019","unstructured":"Mirzaaghaei S, Foroughmand AM, Saki G, et al. Combination of epigallocatechin-3-gallate and silibinin: a novel approach for targeting both tumor and endothelial cells. ACS Omega. 2019;4(5):8421\u201330.","journal-title":"ACS Omega"},{"issue":"1","key":"1124_CR939","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/CAD.0000000000001376","volume":"34","author":"G Cerretti","year":"2023","unstructured":"Cerretti G, Cecchin D, Denaro L, et al. Impressive response to dabrafenib and trametinib plus silybin in a heavily pretreated IDH wild-type glioblastoma patient with BRAFV600E -mutant and SOX2 amplification. Anticancer Drugs. 2023;34(1):190\u20133.","journal-title":"Anticancer Drugs"},{"issue":"2","key":"1124_CR940","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ptr.6231","volume":"33","author":"H Karbasforooshan","year":"2019","unstructured":"Karbasforooshan H, Hosseini S, Elyasi S, et al. Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: a randomized, double-blind, placebo-controlled clinical trial. Phytother Res. 2019;33(2):379\u201386.","journal-title":"Phytother Res"},{"key":"1124_CR941","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2147\/DDDT.S404036","volume":"17","author":"JJ Xi","year":"2023","unstructured":"Xi JJ, Cao Y, He RY, et al. Design, synthesis and biological evaluation of glycosylated derivatives of silibinin as potential anti-tumor agents. Drug Des Devel Ther. 2023;17:2063\u201376.","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"1124_CR942","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00044-022-02854-6","volume":"31","author":"Q Wu","year":"2022","unstructured":"Wu Q, Zeng J, Dong J. Synthesis and antitumor activity of novel silibinin and 2,3-dehydrosilybin derivatives with carbamate groups. Med Chem Res. 2022;31(4):533\u201344.","journal-title":"Med Chem Res"},{"issue":"5","key":"1124_CR943","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/antiox9050455","volume":"9","author":"S Dobiasova","year":"2020","unstructured":"Dobiasova S, Rehorova K, Kucerova D, et al. Multidrug resistance modulation activity of silybin derivatives and their anti-inflammatory potential. Antioxidants. 2020;9(5):455.","journal-title":"Antioxidants"},{"issue":"4","key":"1124_CR944","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/antiox13040418","volume":"13","author":"V Romanucci","year":"2024","unstructured":"Romanucci V, Pagano R, Kandhari K, et al. 7-O-tyrosyl silybin derivatives as a novel set of anti-prostate cancer compounds. Antioxidants. 2024;13(4):418.","journal-title":"Antioxidants"},{"issue":"11","key":"1124_CR945","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.apsb.2020.04.005","volume":"10","author":"R Chen","year":"2020","unstructured":"Chen R, Huang L, Hu K. Natural products remodel cancer-associated fibroblasts in desmoplastic tumors. Acta Pharmaceutica Sinica B. 2020;10(11):2140\u201355.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"1124_CR946","doi-asserted-by":"crossref","unstructured":"Amiri M, Jafari S, Lavasanifar A et al. Nano-delivery of Silibinin Potentiate the Induction of Immunogenic Cell Death (ICD) in Melanoma Cells. Curr Pharm Biotechnol. 2024.","DOI":"10.2174\/0113892010280336240227062954"},{"issue":"12","key":"1124_CR947","doi-asserted-by":"publisher","first-page":"22285","DOI":"10.1002\/jcp.28795","volume":"234","author":"S Hossainzadeh","year":"2019","unstructured":"Hossainzadeh S, Ranji N, Naderi Sohi A, et al. Silibinin encapsulation in polymersome: a promising anticancer nanoparticle for inducing apoptosis and decreasing the expression level of miR-125b\/miR-182 in human breast cancer cells. J Cell Physiol. 2019;234(12):22285\u201398.","journal-title":"J Cell Physiol"},{"key":"1124_CR948","doi-asserted-by":"publisher","first-page":"1018759","DOI":"10.3389\/fchem.2022.1018759","volume":"10","author":"R Ravi","year":"2022","unstructured":"Ravi R, Zeyaullah M, Ghosh S, et al. Use of gold nanoparticle-silibinin conjugates: a novel approach against lung cancer cells. Front Chem. 2022;10:1018759.","journal-title":"Front Chem"},{"issue":"10","key":"1124_CR949","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s12272-022-01407-0","volume":"45","author":"DY Lim","year":"2022","unstructured":"Lim DY, Pang M, Lee J, et al. Enhanced bioavailability and hepatoprotective effect of silymarin by preparing silymarin-loaded solid dispersion formulation using freeze-drying method. Arch Pharm Res. 2022;45(10):743\u201360.","journal-title":"Arch Pharm Res"},{"issue":"3","key":"1124_CR950","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/jbm.a.36827","volume":"108","author":"M Alipour","year":"2020","unstructured":"Alipour M, Reza Bigdeli M, Aligholi H, et al. Sustained release of silibinin-loaded chitosan nanoparticle induced apoptosis in glioma cells. J Biomed Mater Res A. 2020;108(3):458\u201369.","journal-title":"J Biomed Mater Res A"},{"issue":"1","key":"1124_CR951","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02652048.2021.2002448","volume":"39","author":"P Patel","year":"2022","unstructured":"Patel P, Raval M, Airao V, et al. Silibinin loaded inhalable solid lipid nanoparticles for lung targeting. J Microencapsul. 2022;39(1):1\u201324.","journal-title":"J Microencapsul"},{"issue":"4","key":"1124_CR952","first-page":"514","volume":"24","author":"F Khakinezhad Tehrani","year":"2021","unstructured":"Khakinezhad Tehrani F, Ranji N, Kouhkan F, et al. PANC-1 cancer stem-like cell death with silybin encapsulated in polymersomes and deregulation of stemness-related miRNAs and their potential targets. Iran J Basic Med Sci. 2021;24(4):514\u201323.","journal-title":"Iran J Basic Med Sci"},{"issue":"4","key":"1124_CR953","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/em.22363","volume":"61","author":"TMB Barros","year":"2020","unstructured":"Barros TMB, Lima APB, Almeida TC, et al. Inhibition of urinary bladder cancer cell proliferation by silibinin. Environ Mol Mutagen. 2020;61(4):445\u201355.","journal-title":"Environ Mol Mutagen"},{"issue":"12","key":"1124_CR954","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1007\/s12033-023-00702-5","volume":"65","author":"S Ranapour","year":"2023","unstructured":"Ranapour S, Motamed N. Effect of silibinin on the expression of Mir-20b, Bcl2L11, and Erbb2 in breast cancer cell lines. Mol Biotechnol. 2023;65(12):1979\u201390.","journal-title":"Mol Biotechnol"},{"issue":"4","key":"1124_CR955","first-page":"469","volume":"23","author":"FK Tehrani","year":"2020","unstructured":"Tehrani FK, Ranji N, Kouhkan F, et al. Apoptosis induction and proliferation inhibition by silibinin encapsulated in nanoparticles in MIA PaCa-2 cancer cells and deregulation of some miRNAs. Iran J Basic Med Sci. 2020;23(4):469\u201382.","journal-title":"Iran J Basic Med Sci"},{"issue":"9","key":"1124_CR956","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3390\/ijms20092190","volume":"20","author":"S Zappavigna","year":"2019","unstructured":"Zappavigna S, Vanacore D, Lama S, et al. Silybin-induced apoptosis occurs in parallel to the increase of ceramides synthesis and miRNAs secretion in human hepatocarcinoma cells. Int J Mol Sci. 2019;20(9):2190.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1124_CR957","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5887","volume":"38","author":"SN Zhang","year":"2024","unstructured":"Zhang SN, Liu Q, Li XZ. Combination of omics, bioinformatics, molecular docking, and experimental validation to elucidate the hepatoprotective effects, mechanisms, and active compounds of Shandougen. Biomed Chromatogr. 2024;38(7): e5887.","journal-title":"Biomed Chromatogr"},{"key":"1124_CR958","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10373","volume":"8","author":"JM Kaipa","year":"2020","unstructured":"Kaipa JM, Starkuviene V, Erfle H, et al. Transcriptome profiling reveals Silibinin dose-dependent response network in non-small lung cancer cells. PeerJ. 2020;8: e10373.","journal-title":"PeerJ"},{"issue":"7","key":"1124_CR959","first-page":"21","volume":"83","author":"N Mishra","year":"2023","unstructured":"Mishra N, Paudel S, Agarwal C, et al. Silibinin modulates migration and survival pathways in bone marrow mast cells via RAC2: Implications in its anti-cancer activity in basal cell carcinoma growth and progression. Cancer Res. 2023;83(7):21.","journal-title":"Cancer Res"},{"issue":"2","key":"1124_CR960","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/febs.15353","volume":"288","author":"MA Iqbal","year":"2021","unstructured":"Iqbal MA, Chattopadhyay S, Siddiqui FA, et al. Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications. FEBS J. 2021;288(2):471\u201385.","journal-title":"FEBS J"},{"issue":"11\u201312","key":"1124_CR961","first-page":"997","volume":"85","author":"K Gioti","year":"2019","unstructured":"Gioti K, Papachristodoulou A, Benaki D, et al. Silymarin enriched extract (silybum marianum) additive effect on doxorubicin-mediated cytotoxicity in PC-3 prostate cancer cells. Planta Med. 2019;85(11\u201312):997\u20131007.","journal-title":"Planta Med"},{"issue":"15","key":"1124_CR962","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1111\/bph.15472","volume":"178","author":"W-Y Fang","year":"2021","unstructured":"Fang W-Y, Tseng Y-T, Lee T-Y, et al. Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-\u03baB\/TNF-\u03b1 and regulating protein synthesis\/degradation pathway. Br J Pharmacol. 2021;178(15):2998\u20133016.","journal-title":"Br J Pharmacol"},{"key":"1124_CR963","doi-asserted-by":"crossref","unstructured":"Song J, He G-N, Dai L. A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes. Biomedicine & Pharmacotherapy. 2023, 162.","DOI":"10.1016\/j.biopha.2023.114705"},{"key":"1124_CR964","doi-asserted-by":"crossref","unstructured":"Liang X, Xie R, Su J et al. Inhibition of RNA polymerase III transcription by Triptolide attenuates colorectal tumorigenesis. Journal of Experimental & Clinical Cancer Research. 2019, 38.","DOI":"10.1186\/s13046-019-1232-x"},{"issue":"5","key":"1124_CR965","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tips.2019.03.002","volume":"40","author":"P Noel","year":"2019","unstructured":"Noel P, Von Hoff DD, Saluja AK, et al. Triptolide and its derivatives as cancer therapies. Trends Pharmacol Sci. 2019;40(5):327\u201341.","journal-title":"Trends Pharmacol Sci"},{"key":"1124_CR966","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.2147\/DDDT.S322502","volume":"15","author":"F Wang","year":"2021","unstructured":"Wang F, An S-J, Yin Y, et al. Triptolide is a promising therapeutic approach in treating thyroid cancer based on in silico and in vitro experiment. Drug Des Devel Ther. 2021;15:4275\u201387.","journal-title":"Drug Des Devel Ther"},{"key":"1124_CR967","doi-asserted-by":"crossref","unstructured":"Lee B, Park Y, Lee Y et al. Triptolide, a Cancer Cell Proliferation Inhibitor, Causes Zebrafish Muscle Defects by Regulating Notch and STAT3 Signaling Pathways. Int J Mol Sci. 2024, 25(9).","DOI":"10.3390\/ijms25094675"},{"key":"1124_CR968","doi-asserted-by":"crossref","unstructured":"Kuo C-S, Yang C-Y, Lin C-K et al. Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-\u03b3-modulated microenvironment <i>in vitro<\/i>, <i>in vivo<\/i>, and in clinical patients. Biomedicine & Pharmacotherapy. 2021, 133.","DOI":"10.1016\/j.biopha.2020.111057"},{"issue":"2","key":"1124_CR969","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/15384047.2019.1679555","volume":"21","author":"H Li","year":"2020","unstructured":"Li H, Li L, Mei H, et al. Antitumor properties of triptolide: phenotype regulation of macrophage differentiation. Cancer Biol Ther. 2020;21(2):178\u201388.","journal-title":"Cancer Biol Ther"},{"key":"1124_CR970","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jconrel.2020.12.003","volume":"329","author":"K Liaw","year":"2021","unstructured":"Liaw K, Sharma R, Sharma A, et al. Systemic dendrimer delivery of triptolide to tumor-associated macrophages improves anti-tumor efficacy and reduces systemic toxicity in glioblastoma. J Control Release. 2021;329:434\u201344.","journal-title":"J Control Release"},{"issue":"1","key":"1124_CR971","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/jcp.29833","volume":"236","author":"X Jiang","year":"2021","unstructured":"Jiang X, Cao G, Gao G, et al. Triptolide decreases tumor-associated macrophages infiltration and M2 polarization to remodel colon cancer immune microenvironment via inhibiting tumor-derived CXCL12. J Cell Physiol. 2021;236(1):193\u2013204.","journal-title":"J Cell Physiol"},{"issue":"15","key":"1124_CR972","doi-asserted-by":"publisher","first-page":"e00149","DOI":"10.1128\/MCB.00149-17","volume":"37","author":"L Zheng","year":"2017","unstructured":"Zheng L, Jia J, Dai H, et al. Triptolide-assisted phosphorylation of p53 suppresses inflammation-induced NF-\u03baB survival pathways in cancer cells. Mol Cell Biol. 2017;37(15):e00149-e1117.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"1124_CR973","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/imm.13196","volume":"160","author":"Y Shu","year":"2020","unstructured":"Shu Y, Qin M, Song Y, et al. M2 polarization of tumor-associated macrophages is dependent on integrin \u03b23 via peroxisome proliferator-activated receptor-\u03b3 up-regulation in breast cancer. Immunology. 2020;160(4):345\u201356.","journal-title":"Immunology"},{"issue":"3","key":"1124_CR974","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11060-019-03193-0","volume":"143","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yu JS. Triptolide reverses helper T cell inhibition and down-regulates IFN-\u03b3 induced PD-L1 expression in glioma cell lines. J Neurooncol. 2019;143(3):429\u201336.","journal-title":"J Neurooncol"},{"issue":"15","key":"1124_CR975","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1055\/s-0033-1350708","volume":"79","author":"B Liu","year":"2013","unstructured":"Liu B, Zhang HQ, Li J, et al. Triptolide downregulates treg cells and the level of IL-10, TGF-\u03b2, and VEGF in melanoma-bearing mice. Planta Med. 2013;79(15):1401\u20137.","journal-title":"Planta Med"},{"issue":"3","key":"1124_CR976","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.7150\/thno.65299","volume":"12","author":"F Yuan","year":"2022","unstructured":"Yuan F, Sun M, Liu Z, et al. Macropinocytic dextran facilitates KRAS-targeted delivery while reducing drug-induced tumor immunity depletion in pancreatic cancer. Theranostics. 2022;12(3):1061\u201373.","journal-title":"Theranostics"},{"issue":"1","key":"1124_CR977","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12951-023-02146-0","volume":"21","author":"S Wang","year":"2023","unstructured":"Wang S, Guo Q, Xu R, et al. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma. J Nanobiotechnol. 2023;21(1):383.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"1124_CR978","first-page":"291","volume":"44","author":"Y Huang","year":"2019","unstructured":"Huang Y, Chen Z, Wang Y, et al. Triptolide exerts an anti-tumor effect on non-small cell lung cancer cells by inhibiting activation of the IL-6\/STAT3 axis. Int J Mol Med. 2019;44(1):291\u2013300.","journal-title":"Int J Mol Med"},{"issue":"1","key":"1124_CR979","doi-asserted-by":"publisher","first-page":"22487","DOI":"10.1038\/s41598-024-72989-6","volume":"14","author":"F Koksalar Alkan","year":"2024","unstructured":"Koksalar Alkan F, Caglayan AB, Alkan HK, et al. Dual activity of Minnelide chemosensitize basal\/triple negative breast cancer stem cells and reprograms immunosuppressive tumor microenvironment. Sci Rep. 2024;14(1):22487.","journal-title":"Sci Rep"},{"issue":"10","key":"1124_CR980","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3858\/emm.2009.41.10.078","volume":"41","author":"Z Wang","year":"2009","unstructured":"Wang Z, Jin H, Xu R, et al. Triptolide downregulates Rac1 and the JAK\/STAT3 pathway and inhibits colitis-related colon cancer progression. Exp Mol Med. 2009;41(10):717\u201327.","journal-title":"Exp Mol Med"},{"issue":"11","key":"1124_CR981","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1111\/j.1745-7254.2006.00415.x","volume":"27","author":"C Zhang","year":"2006","unstructured":"Zhang C, Cui GH, Liu F, et al. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1\/CXCR4 axis in vitro. Acta Pharmacol Sin. 2006;27(11):1438\u201346.","journal-title":"Acta Pharmacol Sin"},{"key":"1124_CR982","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111057","volume":"133","author":"CS Kuo","year":"2021","unstructured":"Kuo CS, Yang CY, Lin CK, et al. Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-\u03b3-modulated microenvironment in vitro, in vivo, and in clinical patients. Biomed Pharmacother. 2021;133: 111057.","journal-title":"Biomed Pharmacother"},{"key":"1124_CR983","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109993","volume":"118","author":"Y Xie","year":"2023","unstructured":"Xie Y, Ding J, Gao J, et al. Triptolide reduces PD-L1 through the EGFR and IFN-\u03b3\/IRF1 dual signaling pathways. Int Immunopharmacol. 2023;118: 109993.","journal-title":"Int Immunopharmacol"},{"key":"1124_CR984","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110346","volume":"120","author":"J Cai","year":"2023","unstructured":"Cai J, Zhong M, Xu J, et al. Codelivery of triptolide and IFN-\u03b3 to boost antitumor immunity for triple-negative breast cancer. Int Immunopharmacol. 2023;120: 110346.","journal-title":"Int Immunopharmacol"},{"key":"1124_CR985","doi-asserted-by":"publisher","first-page":"5159","DOI":"10.1182\/blood-2019-123567","volume":"134","author":"P Roy","year":"2019","unstructured":"Roy P, Giri B, Garrido VT, et al. Evaluation of minnelide as a potential therapeutic agent for preventing the relapse of AML. Blood. 2019;134:5159.","journal-title":"Blood"},{"key":"1124_CR986","doi-asserted-by":"crossref","unstructured":"Li L-b, Yang L-x, Liu L et al. Targeted inhibition of the HNF1A\/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer. Acta Pharmacol Sin. 2024, 45(5):1060\u20131076.","DOI":"10.1038\/s41401-023-01219-y"},{"key":"1124_CR987","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.omto.2020.07.001","volume":"18","author":"KQ Zhang","year":"2020","unstructured":"Zhang KQ, Ma YL, Guo YM, et al. Cetuximab-triptolide conjugate suppresses the growth of EGFR-overexpressing lung cancers through targeting RNA polymerase II. Mol Ther Oncolytics. 2020;18:304\u201316.","journal-title":"Mol Ther Oncolytics"},{"issue":"8","key":"1124_CR988","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1248\/cpb.c19-00300","volume":"67","author":"XP Tong","year":"2019","unstructured":"Tong XP, Jiang P, Li Y, et al. Combined treatment with triptolide and tyrosine kinase inhibitors synergistically enhances apoptosis in non-small cell lung cancer H1975 cells but Not H1299 cells through EGFR\/Akt pathway. Chem Pharm Bull. 2019;67(8):864\u201371.","journal-title":"Chem Pharm Bull"},{"issue":"5","key":"1124_CR989","doi-asserted-by":"publisher","first-page":"20220141","DOI":"10.1002\/EXP.20220141","volume":"3","author":"GY Li","year":"2023","unstructured":"Li GY, Song ZW, Ru Y, et al. Small-molecule nanoprodrug with high drug loading and EGFR, PI3K\/AKT dual-inhibiting properties for bladder cancer treatment. Exploration. 2023;3(5):20220141.","journal-title":"Exploration"},{"key":"1124_CR990","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.lfs.2017.12.037","volume":"194","author":"JW Wang","year":"2018","unstructured":"Wang JW, Zhang Z, Li R, et al. Triptolide inhibits pituitary adenoma cell viability, migration and invasion via ADAM12\/EGFR signaling pathway. Life Sci. 2018;194:150\u20136.","journal-title":"Life Sci"},{"issue":"5","key":"1124_CR991","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3892\/or.2021.8020","volume":"45","author":"Y Zhong","year":"2021","unstructured":"Zhong Y, Le F, Cheng J, et al. Triptolide inhibits JAK2\/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin-resistant SKOV3\/DDP ovarian cancer cells. Oncol Rep. 2021;45(5):69.","journal-title":"Oncol Rep"},{"issue":"5","key":"1124_CR992","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/CAD.0000000000000894","volume":"31","author":"H Hu","year":"2020","unstructured":"Hu H, Zhu SH, Tong Y, et al. Antitumor activity of triptolide in SKOV3 cells and SKOV3\/DDP in vivo and in vitro. Anticancer Drugs. 2020;31(5):483\u201391.","journal-title":"Anticancer Drugs"},{"issue":"13","key":"1124_CR993","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.2174\/1871520623666230413130417","volume":"23","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Yan G, Xi N, et al. Triptolide induces apoptosis and autophagy in cutaneous squamous cell carcinoma via Akt\/mTOR pathway. Anticancer Agents Med Chem. 2023;23(13):1596\u2013604.","journal-title":"Anticancer Agents Med Chem"},{"issue":"16","key":"1124_CR994","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.21037\/atm-21-2944","volume":"9","author":"M Lai","year":"2021","unstructured":"Lai M, Liu L, Zhu L, et al. Triptolide reverses epithelial-mesenchymal transition in glioma cells via inducing autophagy. Ann Transl Med. 2021;9(16):1304.","journal-title":"Ann Transl Med"},{"key":"1124_CR995","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.152953","volume":"62","author":"H Dai","year":"2019","unstructured":"Dai H, Jiang Y, Luo Y, et al. Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1. Phytomedicine. 2019;62: 152953.","journal-title":"Phytomedicine"},{"issue":"16","key":"1124_CR996","first-page":"20143","volume":"16","author":"YY Wen","year":"2024","unstructured":"Wen YY, Li KM, Ni MN, et al. Dendritic polylysine with paclitaxel and triptolide codelivery for enhanced cancer ferroptosis through the accumulation of ROS. ACS Appl Mater Interfaces. 2024;16(16):20143\u201356.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"50","key":"1124_CR997","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202406036","volume":"20","author":"HS Wu","year":"2024","unstructured":"Wu HS, Cao PP, Wang HY, et al. Postoperative injection of a triptolide-preloaded hydrogel prevents the recurrence of glioblastoma by dual-pathway activation of ferroptosis. Small. 2024;20(50): e2406036.","journal-title":"Small"},{"issue":"1","key":"1124_CR998","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3892\/mmr.2022.12904","volume":"27","author":"X Wu","year":"2023","unstructured":"Wu X, Chen SQ, Huang KC, et al. Triptolide promotes ferroptosis by suppressing Nrf2 to overcome leukemia cell resistance to doxorubicin. Mol Med Rep. 2023;27(1):17.","journal-title":"Mol Med Rep"},{"issue":"28","key":"1124_CR999","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202301328","volume":"12","author":"K Fang","year":"2023","unstructured":"Fang K, Sun YT, Yang JX, et al. A dual stimuli-responsive nanoplatform loaded ptiv -triptolide prodrug for achieving synergistic therapy toward breast cancer. Adv Healthc Mater. 2023;12(28): e2301328.","journal-title":"Adv Healthc Mater"},{"key":"1124_CR1000","doi-asserted-by":"publisher","first-page":"3192607","DOI":"10.1155\/2022\/3192607","volume":"2022","author":"X Liu","year":"2022","unstructured":"Liu X, Chen C, Han D, et al. SLC7A11\/GPX4 inactivation-mediated ferroptosis contributes to the pathogenesis of triptolide-induced cardiotoxicity. Oxid Med Cell Longev. 2022;2022:3192607.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"1124_CR1001","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11670-010-0141-5","volume":"22","author":"YA Liu","year":"2010","unstructured":"Liu YA, Zeng LL, Chen Y, et al. Triptolide inhibits cell growth and induces G0\u2013G1 arrest by regulating P21wap1\/cip1 and P27 kip1 in human multiple myeloma RPMI-8226 cells. CHINESE J CANCER RES. 2010;22(2):141\u20137.","journal-title":"CHINESE J CANCER RES"},{"key":"1124_CR1002","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172811","volume":"867","author":"SY He","year":"2020","unstructured":"He SY, Chen M, Lin XL, et al. Triptolide inhibits PDGF-induced proliferation of ASMCs through G0\/G1 cell cycle arrest and suppression of the AKT\/NF-\u03baB\/cyclinDl signaling pathway. Eur J Pharmacol. 2020;867: 172811.","journal-title":"Eur J Pharmacol"},{"key":"1124_CR1003","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108899","volume":"115","author":"TAN Wang","year":"2019","unstructured":"Wang TAN, Ding Y, Yang YF, et al. Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer. Biomed Pharmacother. 2019;115: 108899.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"1124_CR1004","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.32604\/biocell.2023.029269","volume":"47","author":"N Tang","year":"2023","unstructured":"Tang N, Zhan YJ, Mao JY, et al. Silencing ribosomal protein L4 enhances the inhibitory effects of triptolide on non-small cell lung cancer cells by disrupting the mouse double minute 2 protein-P53 tumor suppressor pathway. Biocell. 2023;47(9):2009\u201326.","journal-title":"Biocell"},{"key":"1124_CR1005","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejphar.2019.01.047","volume":"851","author":"YC Ma","year":"2019","unstructured":"Ma YC, Wang Y, Wang L, et al. Triptolide prevents proliferation and migration of Esophageal Squamous Cell Cancer via MAPK\/ERK signaling pathway. Eur J Pharmacol. 2019;851:43\u201351.","journal-title":"Eur J Pharmacol"},{"key":"1124_CR1006","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.biopha.2018.11.008","volume":"109","author":"ZW Zhang","year":"2019","unstructured":"Zhang ZW, Sun CF, Zhang L, et al. Triptolide interferes with XRCC1\/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin. Biomed Pharmacother. 2019;109:1541\u20136.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1124_CR1007","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.21037\/tlcr-21-145","volume":"10","author":"Y Tian","year":"2021","unstructured":"Tian Y, Li PW, Xiao ZH, et al. Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k\/GSK3\/\u03b2-catenin signaling pathway in taxol-resistant human lung adenocarcinoma. Transl Cancer Res. 2021;10(2):1007\u201319.","journal-title":"Transl Cancer Res"},{"key":"1124_CR1008","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejphar.2019.04.052","volume":"855","author":"CW Wu","year":"2019","unstructured":"Wu CW, Wang SG, Lin ML, et al. Downregulation of miR-144 by triptolide enhanced p85\u03b1 - PTEN complex formation causing S phase arrest of human nasopharyngeal carcinoma cells. Eur J Pharmacol. 2019;855:137\u201348.","journal-title":"Eur J Pharmacol"},{"key":"1124_CR1009","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3389\/fonc.2019.00387","volume":"9","author":"XH Liu","year":"2019","unstructured":"Liu XH, Zhao PY, Wang XJ, et al. Triptolide induces glioma cell autophagy and apoptosis via upregulating the ROS\/JNK and downregulating the Akt\/mTOR signaling pathways. Front Oncol. 2019;9:387.","journal-title":"Front Oncol"},{"key":"1124_CR1010","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216622","volume":"587","author":"P Chen","year":"2024","unstructured":"Chen P, Zhong X, Song Y, et al. Triptolide induces apoptosis and cytoprotective autophagy by ROS accumulation via directly targeting peroxiredoxin 2 in gastric cancer cells. Cancer Lett. 2024;587: 216622.","journal-title":"Cancer Lett"},{"key":"1124_CR1011","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.918588","volume":"13","author":"W Yuan","year":"2022","unstructured":"Yuan W, Huang J, Hou S, et al. The antigastric cancer effect of triptolide is associated with H19\/NF-\u03baB\/FLIP Axis. Front Pharmacol. 2022;13: 918588.","journal-title":"Front Pharmacol"},{"issue":"6","key":"1124_CR1012","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1021\/jacs.9b10510","volume":"142","author":"J He","year":"2020","unstructured":"He J, Peng T, Peng Y, et al. Molecularly engineering triptolide with aptamers for high specificity and cytotoxicity for triple-negative breast cancer. J Am Chem Soc. 2020;142(6):2699\u2013703.","journal-title":"J Am Chem Soc"},{"key":"1124_CR1013","doi-asserted-by":"publisher","first-page":"1077640","DOI":"10.3389\/fonc.2023.1077640","volume":"13","author":"C Yuan","year":"2023","unstructured":"Yuan C, Liao Y, Liao S, et al. Triptolide inhibits the progression of glioblastoma U251 cells via targeting PROX1. Front Oncol. 2023;13:1077640.","journal-title":"Front Oncol"},{"issue":"2","key":"1124_CR1014","doi-asserted-by":"publisher","first-page":"109","DOI":"10.14715\/cmb\/2021.67.2.16","volume":"67","author":"C Liu","year":"2021","unstructured":"Liu C, Yuan XL, Liu XB, et al. Effect of triptolide and chemotherapy on carcinoembryonic and carbohydrate antigens levels and first-line treatment of recurrent nasopharyngeal carcinoma. Cell Mol Biol. 2021;67(2):109\u201313.","journal-title":"Cell Mol Biol"},{"issue":"7","key":"1124_CR1015","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41419-020-02762-w","volume":"11","author":"Y-F Shi","year":"2020","unstructured":"Shi Y-F, Liu L, He L-L, et al. Combining triptolide with ABT-199 is effective against acute myeloid leukemia through reciprocal regulation of Bcl-2 family proteins and activation of the intrinsic apoptotic pathway. Cell Death Dis. 2020;11(7):555.","journal-title":"Cell Death Dis"},{"key":"1124_CR1016","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116466","volume":"50","author":"HN Song","year":"2021","unstructured":"Song HN, Xing WL, Shi XJ, et al. Antitumor and toxicity study of mitochondria-targeted triptolide derivatives using triphenylphosphine (TPP+) as a carrier. Bioorg Med Chem. 2021;50: 116466.","journal-title":"Bioorg Med Chem"},{"key":"1124_CR1017","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.2147\/IJN.S241577","volume":"15","author":"MH Cui","year":"2020","unstructured":"Cui MH, Jin MJ, Han MF, et al. Improved antitumor outcomes for colon cancer using nanomicelles loaded with the novel antitumor agent LA67. Int J Nanomed. 2020;15:3563\u201376.","journal-title":"Int J Nanomed"},{"key":"1124_CR1018","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112079","volume":"190","author":"YD Zang","year":"2020","unstructured":"Zang YD, Lai FF, Fu JM, et al. Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: design, synthesis, biological evaluation, and nitric oxide release studies. Eur J Med Chem. 2020;190: 112079.","journal-title":"Eur J Med Chem"},{"key":"1124_CR1019","doi-asserted-by":"publisher","DOI":"10.1016\/j.matdes.2023.111860","volume":"228","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Gu Y, Qi F, et al. Engineering adipocytes for targeting delivery of triptolide derivative and Ce6 for malignant melanoma cytotoxic-PDT synergistic strategy. Mater Des. 2023;228: 111860.","journal-title":"Mater Des"},{"issue":"11","key":"1124_CR1020","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41389-020-00285-9","volume":"9","author":"P Noel","year":"2020","unstructured":"Noel P, Hussein S, Ng S, et al. Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts. Oncogenesis. 2020;9(11):100.","journal-title":"Oncogenesis"},{"key":"1124_CR1021","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3389\/fphar.2019.01175","volume":"10","author":"C Li","year":"2019","unstructured":"Li C, Li Z, Zhang T, et al. 1H NMR-based metabolomics reveals the antitumor mechanisms of triptolide in BALB\/c mice bearing CT26 tumors. Front Pharmacol. 2019;10:1175.","journal-title":"Front Pharmacol"},{"issue":"6","key":"1124_CR1022","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200050","volume":"10","author":"M Uriostegui-Arcos","year":"2020","unstructured":"Uriostegui-Arcos M, Aguayo-Ortiz R, Valencia-Morales MDP, et al. Disruption of TFIIH activities generates a stress gene expression response and reveals possible new targets against cancer. Open Biol. 2020;10(6): 200050.","journal-title":"Open Biol"},{"key":"1124_CR1023","doi-asserted-by":"crossref","unstructured":"1028.Song F, Li J, Shi Q et al. Quantitative Chemical Proteomics Reveals Triptolide Selectively Inhibi ts HCT116 Human Colon Cancer Cell Viability and Migration Through Bind ing to Peroxiredoxin 1 and Annexin A1. Adv Biol. 8(10):e2300452.","DOI":"10.1002\/adbi.202300452"},{"issue":"1","key":"1124_CR1024","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12951-021-01095-w","volume":"19","author":"Z Li","year":"2021","unstructured":"Li Z, Yang G, Han L, et al. Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma. J Nanobiotechnology. 2021;19(1):360.","journal-title":"J Nanobiotechnology"},{"issue":"3","key":"1124_CR1025","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1021\/acsbiomaterials.8b01534","volume":"5","author":"LY Luo","year":"2019","unstructured":"Luo LY, He HY, Li CH, et al. Near-infrared responsive bimetallic nanovesicles for enhanced synergistic chemophotothermal therapy. ACS Biomater Sci Eng. 2019;5(3):1321\u201331.","journal-title":"ACS Biomater Sci Eng"},{"key":"1124_CR1026","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.2147\/IJN.S453199","volume":"19","author":"Y Huang","year":"2024","unstructured":"Huang Y, Wu SY, Li JJ, et al. Self-amplified pH\/ROS dual-responsive co-delivery nano-system with chemo-photodynamic combination therapy in hepatic carcinoma treatment. Int J Nanomed. 2024;19:3737\u201351.","journal-title":"Int J Nanomed"},{"issue":"8","key":"1124_CR1027","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.3390\/cancers11081138","volume":"11","author":"M Hayashi","year":"2019","unstructured":"Hayashi M, Madokoro H, Yamada K, et al. Novel antibody-drug conjugate with anti-CD26 humanized monoclonal antibody and transcription factor IIH (TFIIH) inhibitor, triptolide, inhibits tumor growth via impairing mRNA synthesis. Cancers. 2019;11(8):1138.","journal-title":"Cancers"},{"key":"1124_CR1028","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119907","volume":"241","author":"JX Feng","year":"2020","unstructured":"Feng JX, Xu MJ, Wang JH, et al. Sequential delivery of nanoformulated \u03b1-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer. Biomaterials. 2020;241: 119907.","journal-title":"Biomaterials"},{"issue":"1","key":"1124_CR1029","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.nano.2018.09.002","volume":"15","author":"YQ Zhang","year":"2019","unstructured":"Zhang YQ, Shen Y, Liao MM, et al. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms. Nanomedicine. 2019;15(1):86\u201397.","journal-title":"Nanomedicine"},{"key":"1124_CR1030","doi-asserted-by":"crossref","unstructured":"1036.Paula Sales P, Das Dores Alves de Oliveira M, Figueiredo Watanabe JM et al. Phytochemical characterization, isolation, antioxidant and cytogenotoxic activity of leaves of Heliotropium elongatum (Lehm) I.M. Johnst. J Toxicol Environ Health A. 2023, 86(23):871\u2013897.","DOI":"10.1080\/15287394.2023.2254815"},{"issue":"2","key":"1124_CR1031","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s10600-023-04006-7","volume":"59","author":"X Bai","year":"2023","unstructured":"Bai X, Zhang Y, Wen X, et al. Structure-based optimization of ursolic acid derivatives as anticancer agents. Chem Nat Compd. 2023;59(2):400\u20132.","journal-title":"Chem Nat Compd"},{"key":"1124_CR1032","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.semcancer.2019.08.014","volume":"69","author":"D Kashyap","year":"2021","unstructured":"Kashyap D, Tuli HS, Yerer MB, et al. Natural product-based nanoformulations for cancer therapy: opportunities and challenges. Semin Cancer Biol. 2021;69:5\u201323.","journal-title":"Semin Cancer Biol"},{"key":"1124_CR1033","doi-asserted-by":"crossref","unstructured":"1039.Li S, Guo X, Liu H et al. Ursolic acid, an inhibitor of TMEM16A, co-loaded with cisplatin in hydrogel drug delivery system for multi-targeted therapy of lung cancer. International Journal of Biological Macromolecules. 2024, 277.","DOI":"10.1016\/j.ijbiomac.2024.134587"},{"issue":"2","key":"1124_CR1034","first-page":"750","volume":"25","author":"W Lin","year":"2020","unstructured":"Lin W, Ye H. Anticancer activity of ursolic acid on human ovarian cancer cells via ROS and MMP mediated apoptosis, cell cycle arrest and downregulation of PI3K\/AKT pathway. J BUON. 2020;25(2):750\u20136.","journal-title":"J BUON"},{"issue":"11","key":"1124_CR1035","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1039\/D1BM00087J","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, Luo Z, Zhou D, et al. Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer. Biomater Sci. 2021;9(11):4110\u20139.","journal-title":"Biomater Sci"},{"issue":"12","key":"1124_CR1036","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/jcb.30496","volume":"124","author":"V Mallepogu","year":"2023","unstructured":"Mallepogu V, Sankaran KR, Pasala C, et al. Ursolic acid regulates key EMT transcription factors, induces cell cycle arrest and apoptosis in MDA-MB-231 and MCF-7 breast cancer cells, an in-vitro and in silico studies. J Cell Biochem. 2023;124(12):1900\u201318.","journal-title":"J Cell Biochem"},{"key":"1124_CR1037","doi-asserted-by":"crossref","unstructured":"1043.Wang S, Chang X, Zhang J et al. Ursolic Acid Inhibits Breast Cancer Metastasis by Suppressing Glycolytic Metabolism via Activating SP1\/Caveolin-1 Signaling. Front Oncol. 2021, 11.","DOI":"10.3389\/fonc.2021.745584"},{"issue":"14","key":"1124_CR1038","doi-asserted-by":"publisher","first-page":"6088","DOI":"10.7150\/thno.72509","volume":"12","author":"Q Mao","year":"2022","unstructured":"Mao Q, Min J, Zeng R, et al. Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy. Theranostics. 2022;12(14):6088\u2013105.","journal-title":"Theranostics"},{"key":"1124_CR1039","doi-asserted-by":"crossref","unstructured":"1045.Kadasah SF, Radwan MO. Overview of Ursolic Acid Potential for the Treatment of Metabolic Disorders, Autoimmune Diseases, and Cancers via Nuclear Receptor Pathways. Biomedicines. 2023, 11(10).","DOI":"10.3390\/biomedicines11102845"},{"issue":"11","key":"1124_CR1040","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.3390\/molecules27113399","volume":"27","author":"Z Wang","year":"2022","unstructured":"Wang Z, Zhang P, Jiang H, et al. Ursolic acid enhances the sensitivity of MCF-7 and MDA-MB-231 cells to epirubicin by modulating the autophagy pathway. Molecules. 2022;27(11):3399.","journal-title":"Molecules"},{"issue":"28","key":"1124_CR1041","doi-asserted-by":"publisher","first-page":"7404","DOI":"10.1021\/acs.jafc.0c03202","volume":"68","author":"X Zhang","year":"2020","unstructured":"Zhang X, Li T, Gong ES, et al. Antiproliferative activity of ursolic acid in MDA-MB-231 human breast cancer cells through Nrf2 pathway regulation. J Agric Food Chem. 2020;68(28):7404\u201315.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"1124_CR1042","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/cancers13010136","volume":"13","author":"C-H Liu","year":"2021","unstructured":"Liu C-H, Wong SH, Tai C-J, et al. Ursolic acid and its nanoparticles are potentiators of oncolytic measles virotherapy against breast cancer cells. Cancers (Basel). 2021;13(1):136.","journal-title":"Cancers (Basel)"},{"key":"1124_CR1043","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jconrel.2020.01.015","volume":"320","author":"N Zhang","year":"2020","unstructured":"Zhang N, Liu S, Shi S, et al. Solubilization and delivery of Ursolic-acid for modulating tumor microenvironment and regulatory T cell activities in cancer immunotherapy. J Control Release. 2020;320:168\u201378.","journal-title":"J Control Release"},{"key":"1124_CR1044","doi-asserted-by":"publisher","first-page":"096032712211113","DOI":"10.1177\/09603271221111333","volume":"41","author":"X Cao","year":"2022","unstructured":"Cao X, He Q. Ursolic acid inhibits proliferation, migration and invasion of human papillary thyroid carcinoma cells via CXCL12\/CXCR4\/CXCR7 axis through cancer-associated fibroblasts. Hum Exp Toxicol. 2022;41:09603271221111333.","journal-title":"Hum Exp Toxicol"},{"issue":"24","key":"1124_CR1045","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1111\/bph.14793","volume":"176","author":"K Yang","year":"2019","unstructured":"Yang K, Chen Y, Zhou J, et al. Ursolic acid promotes apoptosis and mediates transcriptional suppression of CT45A2 gene expression in non-small-cell lung carcinoma harbouring EGFR T790M mutations. Br J Pharmacol. 2019;176(24):4609\u201324.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"1124_CR1046","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3390\/molecules27041282","volume":"27","author":"L Zong","year":"2022","unstructured":"Zong L, Cheng G, Zhao J, et al. Inhibitory effect of ursolic acid on the migration and invasion of doxorubicin-resistant breast cancer. Molecules. 2022;27(4):1282.","journal-title":"Molecules"},{"key":"1124_CR1047","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115278","volume":"205","author":"F Luo","year":"2022","unstructured":"Luo F, Zhao J, Liu S, et al. Ursolic acid augments the chemosensitivity of drug-resistant breast cancer cells to doxorubicin by AMPK-mediated mitochondrial dysfunction. Biochem Pharmacol. 2022;205: 115278.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1124_CR1048","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/tox.23032","volume":"36","author":"W Li","year":"2021","unstructured":"Li W, Luo L, Shi W, et al. Ursolic acid reduces Adriamycin resistance of human ovarian cancer cells through promoting the HuR translocation from cytoplasm to nucleus. Environ Toxicol. 2021;36(2):267\u201375.","journal-title":"Environ Toxicol"},{"issue":"1","key":"1124_CR1049","doi-asserted-by":"publisher","first-page":"5192271","DOI":"10.1155\/2021\/5192271","volume":"2021","author":"Z Tang","year":"2021","unstructured":"Tang Z, Dong H, Li T, et al. The synergistic reducing drug resistance effect of cisplatin and ursolic acid on osteosarcoma through a multistep mechanism involving ferritinophagy. Oxid Med Cell Longev. 2021;2021(1):5192271.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"1124_CR1050","doi-asserted-by":"publisher","first-page":"1307323","DOI":"10.1155\/2023\/1307323","volume":"2023","author":"L Fan","year":"2023","unstructured":"Fan L, Wang X, Cheng C, et al. Inhibitory effect and mechanism of ursolic acid on cisplatin-induced resistance and stemness in human lung cancer A549 cells. Evid Based Complement Alternat Med. 2023;2023(1):1307323.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1124_CR1051","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fonc.2019.00501","volume":"9","author":"F Xiang","year":"2019","unstructured":"Xiang F, Fan Y, Ni Z, et al. Ursolic acid reverses the chemoresistance of breast cancer cells to paclitaxel by targeting MiRNA-149-5p\/MyD88. Front Oncol. 2019;9:501.","journal-title":"Front Oncol"},{"issue":"11","key":"1124_CR1052","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.7150\/ijbs.97720","volume":"20","author":"Y-J Fan","year":"2024","unstructured":"Fan Y-J, Pan F-Z, Cui Z-G, et al. The antitumor and sorafenib-resistant reversal effects of ursolic acid on hepatocellular carcinoma via targeting ING5. Int J Biol Sci. 2024;20(11):4190.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"1124_CR1053","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/ptr.6669","volume":"34","author":"J-H Lin","year":"2020","unstructured":"Lin J-H, Chen S-Y, Lu C-C, et al. Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells. Phytother Res. 2020;34(8):2053\u201366.","journal-title":"Phytother Res"},{"issue":"8","key":"1124_CR1054","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/cncr.31978","volume":"125","author":"S Deng","year":"2019","unstructured":"Deng S, Shanmugam MK, Kumar AP, et al. Targeting autophagy using natural compounds for cancer prevention and therapy. Cancer. 2019;125(8):1228\u201346.","journal-title":"Cancer"},{"key":"1124_CR1055","doi-asserted-by":"crossref","unstructured":"1061.Limami Y, Pinon A, Wahnou H et al. Ursolic acid\u2019s alluring journey: one triterpenoid vs. cancer hallmarks. Molecules. 2023, 28(23):7897.","DOI":"10.3390\/molecules28237897"},{"issue":"24","key":"1124_CR1056","doi-asserted-by":"publisher","first-page":"9409","DOI":"10.3390\/ijms21249409","volume":"21","author":"N-R Lee","year":"2020","unstructured":"Lee N-R, Meng RY, Rah S-Y, et al. Reactive oxygen species-mediated autophagy by ursolic acid inhibits growth and metastasis of esophageal cancer cells. Int J Mol Sci. 2020;21(24):9409.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1124_CR1057","first-page":"315","volume":"3","author":"Z Jinyan","year":"2022","unstructured":"Jinyan Z, Shilan C, Xuejiao W, et al. Ursolic acid induces apoptosis and autophagy of HCT-8\/5-FU cells. JHIP. 2022;3(4):315\u201323.","journal-title":"JHIP"},{"issue":"24","key":"1124_CR1058","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.3390\/cells11244079","volume":"11","author":"DL Fogde","year":"2022","unstructured":"Fogde DL, Xavier CP, Balnyt\u0117 K, et al. Ursolic acid impairs cellular lipid homeostasis and lysosomal membrane integrity in breast carcinoma cells. Cells. 2022;11(24):4079.","journal-title":"Cells"},{"issue":"1","key":"1124_CR1059","doi-asserted-by":"publisher","first-page":"1","DOI":"10.32604\/or.2024.055102","volume":"52","author":"X Yang","year":"2024","unstructured":"Yang X, Liang B, Zhang L, et al. Ursolic acid inhibits the proliferation of triple-negative breast cancer stem-like cells through NRF2-mediated ferroptosis. Oncol Res. 2024;52(1):1\u201313.","journal-title":"Oncol Res"},{"key":"1124_CR1060","doi-asserted-by":"crossref","unstructured":"1066.Zhao H, Tang S, Tao Q et al. Ursolic Acid Suppresses Colorectal Cancer by Down-Regulation of Wnt\/\u03b2-Catenin Signaling Pathway Activity. Journal of Agricultural and Food Chemistry. 2023.","DOI":"10.1021\/acs.jafc.2c06775"},{"key":"1124_CR1061","doi-asserted-by":"crossref","unstructured":"1067.Kim K, Shin EA, Jung JH et al. Ursolic Acid Induces Apoptosis in Colorectal Cancer Cells Partially via Upregulation of MicroRNA-4500 and Inhibition of JAK2\/STAT3 Phosphorylation. International Journal of Molecular Sciences. 2019, 20(1).","DOI":"10.3390\/ijms20010114"},{"issue":"4","key":"1124_CR1062","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3746\/pnf.2021.26.4.434","volume":"26","author":"GD Kim","year":"2021","unstructured":"Kim GD. Ursolic acid decreases the proliferation of MCF-7 cell-derived breast cancer stem-like cells by modulating the ERK and PI3K\/AKT signaling pathways. Prev Nutr Food Sci. 2021;26(4):434.","journal-title":"Prev Nutr Food Sci"},{"issue":"3","key":"1124_CR1063","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/biomedicines9030297","volume":"9","author":"D Kang","year":"2021","unstructured":"Kang D, Sp N, Lee J, et al. Antitumor effects of ursolic acid through mediating the inhibition of STAT3\/PD-L1 signaling in non-small cell lung cancer cells. Biomedicines. 2021;9(3):297.","journal-title":"Biomedicines"},{"key":"1124_CR1064","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.622212","volume":"11","author":"M Yang","year":"2021","unstructured":"Yang M, Hu C, Cao Y, et al. Ursolic acid regulates cell cycle and proliferation in colon adenocarcinoma by suppressing cyclin B1. Front Pharmacol. 2021;11: 622212.","journal-title":"Front Pharmacol"},{"issue":"12","key":"1124_CR1065","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1080\/09168451.2020.1813543","volume":"84","author":"M Cao","year":"2020","unstructured":"Cao M, Xiao D, Ding X. The anti-tumor effect of ursolic acid on papillary thyroid carcinoma via suppressing fibronectin-1. Biosci Biotechnol Biochem. 2020;84(12):2415\u201324.","journal-title":"Biosci Biotechnol Biochem"},{"key":"1124_CR1066","doi-asserted-by":"crossref","unstructured":"1072.Huang L, Zhao S, Fang F et al. Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy. Biomaterials. 2021, 268.","DOI":"10.1016\/j.biomaterials.2020.120557"},{"key":"1124_CR1067","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110202","volume":"368","author":"M Piet","year":"2022","unstructured":"Piet M, Paduch R. Ursolic and oleanolic acids in combination therapy inhibit migration of colon cancer cells through down-regulation of the uPA\/uPAR-dependent MMPs pathway. Chem Biol Interact. 2022;368: 110202.","journal-title":"Chem Biol Interact"},{"issue":"19","key":"1124_CR1068","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.3390\/molecules24193444","volume":"24","author":"NS Castrej\u00f3n-Jim\u00e9nez","year":"2019","unstructured":"Castrej\u00f3n-Jim\u00e9nez NS, Leyva-Paredes K, Baltierra-Uribe SL, et al. Ursolic and oleanolic acids induce mitophagy in A549 human lung cancer cells. Molecules. 2019;24(19):3444.","journal-title":"Molecules"},{"issue":"1","key":"1124_CR1069","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3892\/mmr.2022.12898","volume":"27","author":"D Hu","year":"2022","unstructured":"Hu D, Meng RY, Nguyen TV, et al. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway. Mol Med Rep. 2022;27(1):11.","journal-title":"Mol Med Rep"},{"key":"1124_CR1070","doi-asserted-by":"crossref","unstructured":"1076.Fujita M, Chen M-JM, Siwak DR et al. Inhibition of Colorectal Cancer Tumorigenesis by Ursolic Acid and Doxorubicin Is Mediated by Targeting the Akt Signaling Pathway and Activating the Hippo Signaling Pathway. Mol Med Rep. 2022, 27(1):11.","DOI":"10.3892\/mmr.2022.12898"},{"key":"1124_CR1071","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2023.113724","volume":"234","author":"L-W Tong","year":"2024","unstructured":"Tong L-W, Le J-Q, Song X-H, et al. Synergistic anti-tumor effect of dual drug co-assembled nanoparticles based on ursolic acid and sorafenib. Colloids Surf B Biointerfaces. 2024;234: 113724.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1124_CR1072","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106306","volume":"182","author":"H Li","year":"2022","unstructured":"Li H, Yu Y, Liu Y, et al. Ursolic acid enhances the antitumor effects of sorafenib associated with Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer. Pharmacol Res. 2022;182: 106306.","journal-title":"Pharmacol Res"},{"issue":"Pt 3","key":"1124_CR1073","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117351","volume":"319","author":"W Liu","year":"2024","unstructured":"Liu W, Kang S, Chen H, et al. A composition of ursolic acid derivatives from Ludwigia hyssopifolia induces apoptosis in throat cancer cells via the Akt\/mTOR and mitochondrial signaling pathways and by modulating endoplasmic reticulum stress. J Ethnopharmacol. 2024;319(Pt 3): 117351.","journal-title":"J Ethnopharmacol"},{"issue":"18","key":"1124_CR1074","doi-asserted-by":"publisher","first-page":"9796","DOI":"10.3390\/ijms22189796","volume":"22","author":"E Khusnutdinova","year":"2021","unstructured":"Khusnutdinova E, Petrova A, Zileeva Z, et al. Novel a-ring chalcone derivatives of oleanolic and ursolic amides with anti-proliferative effect mediated through ROS-triggered apoptosis. Int J Mol Sci. 2021;22(18):9796.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1124_CR1075","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.7150\/ijbs.67166","volume":"18","author":"W Gou","year":"2022","unstructured":"Gou W, Luo N, Yu B, et al. Ursolic acid derivative UA232 promotes tumor cell apoptosis by inducing endoplasmic reticulum stress and lysosomal dysfunction. Int J Biol Sci. 2022;18(6):2639\u201351.","journal-title":"Int J Biol Sci"},{"issue":"15","key":"1124_CR1076","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3390\/molecules24152751","volume":"24","author":"S Mlala","year":"2019","unstructured":"Mlala S, Oyedeji AO, Gondwe M, et al. Ursolic acid and its derivatives as bioactive agents. Molecules. 2019;24(15):2751.","journal-title":"Molecules"},{"issue":"24","key":"1124_CR1077","doi-asserted-by":"publisher","first-page":"8981","DOI":"10.3390\/molecules27248981","volume":"27","author":"SS Panda","year":"2022","unstructured":"Panda SS, Thangaraju M, Lokeshwar BL. Ursolic acid analogs as potential therapeutics for cancer. Molecules. 2022;27(24):8981.","journal-title":"Molecules"},{"issue":"1","key":"1124_CR1078","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/13880209.2020.1794013","volume":"58","author":"W Gou","year":"2020","unstructured":"Gou W, Luo N, Wei H, et al. Ursolic acid derivative UA232 evokes apoptosis of lung cancer cells induced by endoplasmic reticulum stress. Pharm Biol. 2020;58(1):707\u201315.","journal-title":"Pharm Biol"},{"issue":"10","key":"1124_CR1079","doi-asserted-by":"publisher","first-page":"8875","DOI":"10.3390\/ijms24108875","volume":"24","author":"O Michalak","year":"2023","unstructured":"Michalak O, Cybulski M, Szymanowski W, et al. Synthesis, biological activity, ADME and molecular docking studies of novel ursolic acid derivatives as potent anticancer agents. Int J Mol Sci. 2023;24(10):8875.","journal-title":"Int J Mol Sci"},{"key":"1124_CR1080","doi-asserted-by":"crossref","unstructured":"1086.Guo W, Xu B, Wang X et al. The analysis of the anti-tumor mechanism of ursolic acid using connectively map approach in breast cancer cells line MCF-7. Cancer Manag Res. 2020:3469\u20133476.","DOI":"10.2147\/CMAR.S241957"},{"issue":"1","key":"1124_CR1081","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/mc.23365","volume":"61","author":"S Li","year":"2022","unstructured":"Li S, Wu R, Wang L, et al. Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment\/prevention of human prostate cancer. Mol Carcinog. 2022;61(1):111\u201321.","journal-title":"Mol Carcinog"},{"issue":"1","key":"1124_CR1082","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.apsb.2021.08.012","volume":"12","author":"S Fu","year":"2022","unstructured":"Fu S, Li G, Zang W, et al. Pure drug nano-assemblies: a facile carrier-free nanoplatform for efficient cancer therapy. Acta Pharm Sin B. 2022;12(1):92\u2013106.","journal-title":"Acta Pharm Sin B"},{"issue":"15","key":"1124_CR1083","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1039\/D2TB02328H","volume":"11","author":"F Xu","year":"2023","unstructured":"Xu F, Li M, Que Z, et al. Combined chemo-immuno-photothermal therapy based on ursolic acid\/astragaloside IV-loaded hyaluronic acid-modified polydopamine nanomedicine inhibiting the growth and metastasis of non-small cell lung cancer. J Mater Chem B. 2023;11(15):3453\u201372.","journal-title":"J Mater Chem B"},{"issue":"9","key":"1124_CR1084","doi-asserted-by":"publisher","first-page":"1907857","DOI":"10.1002\/adfm.201907857","volume":"30","author":"KY Ou","year":"2020","unstructured":"Ou KY, Xu XJ, Guan SY, et al. Nanodrug carrier based on poly(ursolic acid) with self-anticancer activity against colorectal cancer. Adv Funct Mater. 2020;30(9):1907857.","journal-title":"Adv Funct Mater"},{"issue":"2","key":"1124_CR1085","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1021\/acsmaterialslett.2c01097","volume":"5","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Ke Q, Wu M, et al. Pore space partition approach of ZIF-8 for pH responsive codelivery of ursolic acid and 5-fluorouracil. ACS Mater Lett. 2023;5(2):466\u201372.","journal-title":"ACS Mater Lett"},{"key":"1124_CR1086","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.121897","volume":"332","author":"Y Guo","year":"2024","unstructured":"Guo Y, Yang X, Zhang Y, et al. Hyaluronic acid\/dextran-based polymeric micelles co-delivering ursolic acid and doxorubicin to mitochondria for potentiating chemotherapy in MDR cancer. Carbohydr Polym. 2024;332: 121897.","journal-title":"Carbohydr Polym"},{"issue":"Pt 4","key":"1124_CR1087","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134587","volume":"277","author":"S Li","year":"2024","unstructured":"Li S, Guo X, Liu H, et al. Ursolic acid, an inhibitor of TMEM16A, co-loaded with cisplatin in hydrogel drug delivery system for multi-targeted therapy of lung cancer. Int J Biol Macromol. 2024;277(Pt 4): 134587.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"1124_CR1088","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1475-2867-13-54","volume":"13","author":"Y Zhu","year":"2013","unstructured":"Zhu Y, Mao Y, Chen H, et al. Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells. Cancer Cell Int. 2013;13(1):54.","journal-title":"Cancer Cell Int"},{"key":"1124_CR1089","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.archoralbio.2016.11.010","volume":"74","author":"Y Ketkaew","year":"2017","unstructured":"Ketkaew Y, Osathanon T, Pavasant P, et al. Apigenin inhibited hypoxia induced stem cell marker expression in a head and neck squamous cell carcinoma cell line. Arch Oral Biol. 2017;74:69\u201374.","journal-title":"Arch Oral Biol"},{"issue":"5","key":"1124_CR1090","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3892\/ijo.2013.2072","volume":"43","author":"D Maggioni","year":"2013","unstructured":"Maggioni D, Garavello W, Rigolio R, et al. Apigenin impairs oral squamous cell carcinoma growth in vitro inducing cell cycle arrest and apoptosis. Int J Oncol. 2013;43(5):1675\u201382.","journal-title":"Int J Oncol"},{"issue":"5","key":"1124_CR1091","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0026-895X(24)12577-1","volume":"59","author":"EM Leslie","year":"2001","unstructured":"Leslie EM, Mao Q, Oleschuk CJ, et al. Modulation of multidrug resistance protein 1 (MRP1\/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Mol Pharmacol. 2001;59(5):1171\u201380.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"1124_CR1092","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/tpj.2016.74","volume":"18","author":"J Vendelbo","year":"2018","unstructured":"Vendelbo J, Olesen RH, Lauridsen JK, et al. Increasing BMI is associated with reduced expression of P-glycoprotein (ABCB1 gene) in the human brain with a stronger association in African Americans than Caucasians. Pharmacogenomics J. 2018;18(1):121\u20136.","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"1124_CR1093","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.canlet.2005.06.002","volume":"237","author":"L-C Chiang","year":"2006","unstructured":"Chiang L-C, Ng LT, Lin I-C, et al. Anti-proliferative effect of apigenin and its apoptotic induction in human Hep G2 cells. Cancer Lett. 2006;237(2):207\u201314.","journal-title":"Cancer Lett"},{"issue":"4","key":"1124_CR1094","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jnutbio.2008.03.005","volume":"20","author":"EJ Choi","year":"2009","unstructured":"Choi EJ, Kim G-H. Apigenin causes G2\/M arrest associated with the modulation of p21Cip1 and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells. J Nutr Biochem. 2009;20(4):285\u201390.","journal-title":"J Nutr Biochem"},{"issue":"2","key":"1124_CR1095","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.tox.2005.09.019","volume":"217","author":"TH Khan","year":"2006","unstructured":"Khan TH, Sultana S. Apigenin induces apoptosis in Hep G2 cells: possible role of TNF-\u03b1 and IFN-\u03b3. Toxicology. 2006;217(2):206\u201312.","journal-title":"Toxicology"},{"issue":"11","key":"1124_CR1096","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1093\/carcin\/17.11.2367","volume":"17","author":"DM Lepley","year":"1996","unstructured":"Lepley DM, Li B, Birt DF, et al. The chemopreventive flavonoid apigenin induces G2\/M arrest in keratinocytes. Carcinogenesis. 1996;17(11):2367\u201375.","journal-title":"Carcinogenesis"},{"key":"1124_CR1097","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-5-76","volume":"5","author":"MB Ujiki","year":"2006","unstructured":"Ujiki MB, Ding X-Z, Salabat MR, et al. Apigenin inhibits pancreatic cancer cell proliferation through G2\/M cell cycle arrest. Mol Cancer. 2006;5:1\u20138.","journal-title":"Mol Cancer"},{"issue":"2","key":"1124_CR1098","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/1098-2744(200006)28:2<102::AID-MC6>3.0.CO;2-2","volume":"28","author":"W Wang","year":"2000","unstructured":"Wang W, Heideman L, Chung CS, et al. Cell-cycle arrest at G2\/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog. 2000;28(2):102\u201310.","journal-title":"Mol Carcinog"},{"issue":"1","key":"1124_CR1099","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0925-4439(95)00011-R","volume":"1271","author":"SJ Korsmeyer","year":"1995","unstructured":"Korsmeyer SJ, Yin X-M, Oltvai ZN, et al. Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim Biophys Acta. 1995;1271(1):63\u20136.","journal-title":"Biochim Biophys Acta"},{"issue":"7 Suppl","key":"1124_CR1100","first-page":"1693s","volume":"59","author":"SJ Korsmeyer","year":"1999","unstructured":"Korsmeyer SJ. BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 1999;59(7 Suppl):1693s\u2013700s.","journal-title":"Cancer Res"},{"issue":"8","key":"1124_CR1101","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18335","volume":"28","author":"J Ji","year":"2024","unstructured":"Ji J, Cheng Z, Zhang J, et al. Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway. J Cell Mol Med. 2024;28(8): e18335.","journal-title":"J Cell Mol Med"},{"key":"1124_CR1102","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.semcancer.2020.05.016","volume":"68","author":"X Lu","year":"2021","unstructured":"Lu X, Efferth T. Repurposing of artemisinin-type drugs for the treatment of acute leukemia. Semin Cancer Biol. 2021;68:291\u2013312.","journal-title":"Semin Cancer Biol"},{"issue":"13","key":"1124_CR1103","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.7150\/thno.55939","volume":"11","author":"B Bai","year":"2021","unstructured":"Bai B, Wu F, Ying K, et al. Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer. Theranostics. 2021;11(13):6225\u201339.","journal-title":"Theranostics"},{"issue":"6","key":"1124_CR1104","doi-asserted-by":"publisher","first-page":"874","DOI":"10.4014\/jmb.1801.01074","volume":"28","author":"HH Lee","year":"2018","unstructured":"Lee HH, Cho H. Improved anti-cancer effect of curcumin on breast cancer cells by increasing the activity of natural killer cells. J Microbiol Biotechnol. 2018;28(6):874\u201382.","journal-title":"J Microbiol Biotechnol"},{"key":"1124_CR1105","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.intimp.2016.07.035","volume":"39","author":"D Liu","year":"2016","unstructured":"Liu D, You M, Xu Y, et al. Inhibition of curcumin on myeloid-derived suppressor cells is requisite for controlling lung cancer. Int Immunopharmacol. 2016;39:265\u201372.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"1124_CR1106","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1080\/00498254.2023.2260886","volume":"53","author":"C-P Yu","year":"2023","unstructured":"Yu C-P, Wang Y-R, Hou Y-C, et al. Two curcumin analogs inhibited the function and protein expression of breast cancer resistance protein: in vitro and in vivo studies. Xenobiotica. 2023;53(5):454\u201364.","journal-title":"Xenobiotica"},{"key":"1124_CR1107","doi-asserted-by":"crossref","unstructured":"1115.He W-t, Zhu Y-h, Zhang T et al. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8\/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein. Chin J Integr Med. 2019, 25(6):416\u2013424.","DOI":"10.1007\/s11655-018-2997-z"},{"key":"1124_CR1108","doi-asserted-by":"crossref","unstructured":"1116.Han W, Yin H, Ma H et al. Curcumin Regulates ERCC1 Expression and Enhances Oxaliplatin Sensitivity in Resistant Colorectal Cancer Cells through Its Effects on miR-409\u20133p. Evid Based Complement Alternat Med. 2020, 2020.","DOI":"10.1155\/2020\/8394574"},{"issue":"9","key":"1124_CR1109","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.2174\/1570180817666200402124503","volume":"17","author":"S Pajaniradje","year":"2020","unstructured":"Pajaniradje S, Mohankumar K, Radhakrishnan R, et al. Indole curcumin reverses muttidrug resistance by reducing the expression of ABCB1 and COX2 in induced multidrug resistant human lung cancer cells. Lett Drug Des Discov. 2020;17(9):1146\u201354.","journal-title":"Lett Drug Des Discov"},{"issue":"4","key":"1124_CR1110","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1139\/bcb-2019-0377","volume":"98","author":"L Gao","year":"2020","unstructured":"Gao L, Zhao PR, Li Y, et al. Reversal of P-glycoprotein-mediated multidrug resistance by novel curcumin analogues in paclitaxel-resistant human breast cancer cells. Biochem Cell Biol. 2020;98(4):484\u201391.","journal-title":"Biochem Cell Biol"},{"issue":"3","key":"1124_CR1111","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0254-6272(17)30071-7","volume":"37","author":"X Jin","year":"2017","unstructured":"Jin X, Wang J, Shen H, et al. Curcumin co-treatment ameliorates resistance to gefitinib in drug resistant NCI-H1975 lung cancer cells. J Tradit Chin Med. 2017;37(3):355\u201360.","journal-title":"J Tradit Chin Med"},{"issue":"4","key":"1124_CR1112","first-page":"1259","volume":"42","author":"Y Tu","year":"2019","unstructured":"Tu Y, Wu Z, Tan B, et al. Emodin: Its role in prostate cancer-associated inflammation (review). Oncol Res. 2019;42(4):1259\u201371.","journal-title":"Oncol Res"},{"key":"1124_CR1113","doi-asserted-by":"publisher","first-page":"153473542110674","DOI":"10.1177\/15347354211067469","volume":"21","author":"SJ McDonald","year":"2022","unstructured":"McDonald SJ, VanderVeen BN, Velazquez KT, et al. Therapeutic potential of emodin for gastrointestinal cancers. Integr Cancer Ther. 2022;21:15347354211067468.","journal-title":"Integr Cancer Ther"},{"issue":"4","key":"1124_CR1114","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3892\/etm.2021.10509","volume":"22","author":"W Li","year":"2021","unstructured":"Li W, Wang D, Li M, et al. Emodin inhibits the proliferation of papillary thyroid carcinoma by activating AMPK. Exp Ther Med. 2021;22(4):1075.","journal-title":"Exp Ther Med"},{"issue":"3","key":"1124_CR1115","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/biomedicines12030486","volume":"12","author":"C-C Wu","year":"2024","unstructured":"Wu C-C, Chen M-S, Chen J-Y. The application of emodin treatment on nasopharyngeal carcinoma therapy. Biomedicines. 2024;12(3):486.","journal-title":"Biomedicines"},{"issue":"6","key":"1124_CR1116","first-page":"2555","volume":"30","author":"W-T Wei","year":"2013","unstructured":"Wei W-T, Lin S-Z, Liu D-L, et al. The distinct mechanisms of the antitumor activity of emodin in different types of cancer (review). Oncol Res. 2013;30(6):2555\u201362.","journal-title":"Oncol Res"},{"issue":"3","key":"1124_CR1117","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.biomed.2012.03.003","volume":"2","author":"S-C Hsu","year":"2012","unstructured":"Hsu S-C, Chung J-G. Anticancer potential of emodin. Biomedicine-Taiwan. 2012;2(3):108\u201316.","journal-title":"Biomedicine-Taiwan"},{"issue":"11","key":"1124_CR1118","doi-asserted-by":"publisher","first-page":"21126","DOI":"10.1002\/jcp.28715","volume":"234","author":"M Tian","year":"2019","unstructured":"Tian M, Tian D, Qiao X, et al. Modulation of Myb-induced NF-kB-STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors. J Cell Physiol. 2019;234(11):21126\u201334.","journal-title":"J Cell Physiol"},{"issue":"6","key":"1124_CR1119","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3390\/molecules24061185","volume":"24","author":"Z Ai","year":"2019","unstructured":"Ai Z, Liu S, Qu F, et al. Effect of stereochemical configuration on the transport and metabolism of catechins from green tea across Caco-2 monolayers. Molecules. 2019;24(6):1185.","journal-title":"Molecules"},{"issue":"17","key":"1124_CR1120","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.3390\/cancers14174200","volume":"14","author":"C Lyu","year":"2022","unstructured":"Lyu C, Wang L, Stadlbauer B, et al. Identification of EZH2 as cancer stem cell marker in clear cell renal cell carcinoma and the anti-tumor effect of epigallocatechin-3-gallate (EGCG). Cancers (Basel). 2022;14(17):4200.","journal-title":"Cancers (Basel)"},{"key":"1124_CR1121","doi-asserted-by":"crossref","unstructured":"1130.Zhu F, Xu Y, Pan J et al. Epigallocatechin gallate protects against MNNG-induced precancerous lesions of gastric carcinoma in rats via PI3K\/Akt\/mTOR pathway. Evid Based Complement Alternat Med. 2021, 2021.","DOI":"10.1155\/2021\/8846813"},{"issue":"6","key":"1124_CR1122","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/molecules29061373","volume":"29","author":"WH Talib","year":"2024","unstructured":"Talib WH, Awajan D, Alqudah A, et al. Targeting cancer hallmarks with epigallocatechin gallate (EGCG): mechanistic basis and therapeutic targets. Molecules. 2024;29(6):1373.","journal-title":"Molecules"},{"issue":"5","key":"1124_CR1123","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/cac2.12417","volume":"43","author":"Y Guo","year":"2023","unstructured":"Guo Y, Cui Y, Li Y, et al. Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L in breast cancer. Cancer Commun. 2023;43(5):582\u2013612.","journal-title":"Cancer Commun"},{"issue":"11","key":"1124_CR1124","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3390\/biom10111481","volume":"10","author":"Y-J Huang","year":"2020","unstructured":"Huang Y-J, Wang K-L, Chen H-Y, et al. Protective effects of epigallocatechin gallate (EGCG) on endometrial, breast, and ovarian cancers. Biomolecules. 2020;10(11):1481.","journal-title":"Biomolecules"},{"issue":"46","key":"1124_CR1125","doi-asserted-by":"publisher","first-page":"14744","DOI":"10.1021\/acs.jafc.2c06645","volume":"70","author":"Y-C Koh","year":"2022","unstructured":"Koh Y-C, Tsai Y-W, Lee P-S, et al. Amination potentially augments the ameliorative effect of curcumin on inhibition of the IL-6\/Stat3\/c-Myc pathway and gut microbial modulation in colitis-associated tumorigenesis. J Agric Food Chem. 2022;70(46):14744\u201354.","journal-title":"J Agric Food Chem"},{"issue":"3","key":"1124_CR1126","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1142\/S0192415X2150035X","volume":"49","author":"Y Liang","year":"2021","unstructured":"Liang Y, Zhang T, Jing S, et al. 20(S)-ginsenoside Rg3 inhibits lung cancer cell proliferation by targeting EGFR-mediated Ras\/Raf\/MEK\/ERK pathway. Am J Chin Med. 2021;49(3):753\u201365.","journal-title":"Am J Chin Med"},{"issue":"2","key":"1124_CR1127","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1142\/S0192415X22500239","volume":"50","author":"J Gao","year":"2022","unstructured":"Gao J, Fu Y, Song L, et al. Proapoptotic effect of icariin on human ovarian cancer cells via the nf-[formula: see text]B\/PI3K-AKT signaling pathway: a network pharmacology-directed experimental investigation. Am J Chin Med. 2022;50(2):589\u2013619.","journal-title":"Am J Chin Med"},{"issue":"4","key":"1124_CR1128","first-page":"925","volume":"57","author":"YM Fan","year":"2020","unstructured":"Fan YM, Li JQ, Yang YX, et al. Resveratrol modulates the apoptosis and autophagic death of human lung adenocarcinoma A549 cells via a p53-dependent pathway: Integrated bioinformatics analysis and experimental validation. Int J Oncol. 2020;57(4):925\u201338.","journal-title":"Int J Oncol"},{"issue":"5","key":"1124_CR1129","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s12282-024-01590-6","volume":"31","author":"BT Franceschi","year":"2024","unstructured":"Franceschi BT, Bezerra PHA, Torqueti MR. Antitumor effects of co-treatment of resveratrol with antitumor drugs in ER- and HER2-positive breast cancer cells are due to induction of apoptosis and modulation of estrogen receptor expression. Breast Cancer. 2024;31(5):754\u201368.","journal-title":"Breast Cancer"},{"issue":"04","key":"1124_CR1130","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1055\/a-1923-4399","volume":"89","author":"WH Huang","year":"2023","unstructured":"Huang WH, Yu LD, Cai WR, et al. Resveratrol protects BEAS-2B cells against erastin-induced ferroptosis through the Nrf2\/Keap1 pathway. Planta Med. 2023;89(04):408\u201315.","journal-title":"Planta Med"},{"key":"1124_CR1131","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.101836","volume":"50","author":"XY Zhu","year":"2023","unstructured":"Zhu XY, Zhang WQ, Xiang HD, et al. Radiation-enhanced self-cascade catalytic Ti3C2Tx-based platform enables controlled release of trans-resveratrol for synergistic radiosensitization against metastasis of orthotopic breast cancer. Nano Today. 2023;50: 101836.","journal-title":"Nano Today"},{"key":"1124_CR1132","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.153048","volume":"465","author":"XH Zhang","year":"2022","unstructured":"Zhang XH, Jiang LP, Chen HB, et al. Resveratrol protected acrolein-induced ferroptosis and insulin secretion dysfunction via ER-stress- related PERK pathway in MIN6 cells. Toxicology. 2022;465: 153048.","journal-title":"Toxicology"},{"key":"1124_CR1133","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3389\/fonc.2020.01038","volume":"10","author":"T Qin","year":"2020","unstructured":"Qin T, Cheng L, Xiao Y, et al. NAF-1 inhibition by resveratrol suppresses cancer stem cell-like properties and the invasion of pancreatic cancer. Front Oncol. 2020;10:1038.","journal-title":"Front Oncol"},{"issue":"8","key":"1124_CR1134","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1111\/jcmm.17242","volume":"26","author":"TY Li","year":"2022","unstructured":"Li TY, Zhang XY, Cheng LL, et al. Modulation of lncRNA H19 enhances resveratrol-inhibited cancer cell proliferation and migration by regulating endoplasmic reticulum stress. J Cell Mol Med. 2022;26(8):2205\u201317.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"1124_CR1135","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3390\/biomedicines10081784","volume":"10","author":"M Savio","year":"2022","unstructured":"Savio M, Ferraresi A, Corpina C, et al. Resveratrol and its analogue 4,4\u2032-dihydroxy-trans-stilbene inhibit lewis lung carcinoma growth in vivo through apoptosis, autophagy and modulation of the tumour microenvironment in a murine model. Biomedicines. 2022;10(8):1784.","journal-title":"Biomedicines"},{"key":"1124_CR1136","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.643489","volume":"12","author":"S Guo","year":"2021","unstructured":"Guo S, Bai X, Liu Y, et al. Inhibition of TMEM16A by natural product silibinin: potential lead compounds for treatment of lung adenocarcinoma. Front Pharmacol. 2021;12: 643489.","journal-title":"Front Pharmacol"},{"issue":"18","key":"1124_CR1137","doi-asserted-by":"publisher","first-page":"9964","DOI":"10.1073\/pnas.1913633117","volume":"117","author":"D Yu","year":"2020","unstructured":"Yu D, Liu Y, Zhou Y, et al. Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism. Proc Natl Acad Sci USA. 2020;117(18):9964\u201372.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1124_CR1138","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/hed.25554","volume":"41","author":"C-Y Yang","year":"2019","unstructured":"Yang C-Y, Lin C-K, Hsieh C-C, et al. Anti-oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient-derived tumor xenograft model. Head Neck. 2019;41(5):1260\u20139.","journal-title":"Head Neck"},{"issue":"6","key":"1124_CR1139","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4149\/neo_2013_077","volume":"60","author":"Q Guo","year":"2013","unstructured":"Guo Q, Nan XX, Yang JR, et al. Triptolide inhibits the multidrug resistance in prostate cancer cells via the downregulation of MDR1 expression. Neoplasma. 2013;60(6):598\u2013604.","journal-title":"Neoplasma"},{"issue":"5","key":"1124_CR1140","first-page":"1569","volume":"43","author":"F Li","year":"2020","unstructured":"Li F, Cui H, Jin X, et al. Triptolide inhibits epithelial-mesenchymal transition and induces apoptosis in gefitinib-resistant lung cancer cells. Oncol Rep. 2020;43(5):1569\u201379.","journal-title":"Oncol Rep"},{"key":"1124_CR1141","doi-asserted-by":"crossref","unstructured":"1150.Aarthy M, Panwar U, Singh SKJSr. Structural dynamic studies on identification of EGCG analogues for the inhibition of Human Papillomavirus E7. Sci Rep. 2020, 10(1):8661.","DOI":"10.1038\/s41598-020-65446-7"},{"key":"1124_CR1142","doi-asserted-by":"crossref","unstructured":"1151.Hu D, Meng RY, Nguyen TV et al. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway. Mol Med Rep. 2023, 27(1).","DOI":"10.3892\/mmr.2022.12898"},{"key":"1124_CR1143","doi-asserted-by":"crossref","unstructured":"Gupta KB, Gao J, Li X et al. Cytotoxic Autophagy: A Novel Treatment Paradigm against Breast Cancer Using Oleanolic Acid and Ursolic Acid. Cancers. 2024, 16(19).","DOI":"10.3390\/cancers16193367"},{"issue":"5","key":"1124_CR1144","first-page":"1816","volume":"46","author":"M Wang","year":"2020","unstructured":"Wang M, Yu H, Wu R, et al. Autophagy inhibition enhances the inhibitory effects of ursolic acid on lung cancer cells. Int J Mol Med. 2020;46(5):1816\u201326.","journal-title":"Int J Mol Med"},{"key":"1124_CR1145","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106259","volume":"130","author":"L Tian","year":"2023","unstructured":"Tian L, Ji H, Wang W, et al. Mitochondria-targeted pentacyclic triterpenoid carbon dots for selective cancer cell destruction via inducing autophagy, apoptosis, as well as ferroptosis. Bioorg Chem. 2023;130: 106259.","journal-title":"Bioorg Chem"},{"issue":"40","key":"1124_CR1146","doi-asserted-by":"publisher","first-page":"41532","DOI":"10.1021\/acsomega.4c05209","volume":"9","author":"W Hou","year":"2024","unstructured":"Hou W, Zou Y, Li J, et al. Synergistic therapy of melanoma by co-delivery of dacarbazine and ferroptosis-inducing ursolic acid using biomimetic nanoparticles. ACS Omega. 2024;9(40):41532\u201343.","journal-title":"ACS Omega"},{"issue":"8","key":"1124_CR1147","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12032-022-01707-x","volume":"39","author":"M Shen","year":"2022","unstructured":"Shen M, Wang D, Sennari Y, et al. Pentacyclic triterpenoid ursolic acid induces apoptosis with mitochondrial dysfunction in adult T-cell leukemia MT-4 cells to promote surrounding cell growth. Med Oncol. 2022;39(8):118.","journal-title":"Med Oncol"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01124-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01124-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01124-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T18:05:04Z","timestamp":1749492304000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-025-01124-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":1147,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1124"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01124-y","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript is approved by all authors for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}